Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3000067	fp-pth	ng/l (ng/l)	28338	117965	0.00%
3000067	fp-pth	— (—)	7446	14987	100.00%	Distribution not available
3000067	fp-pth	ng/l______ (ng/l)	836	4030	0.00%
3000067	fp-pth	NG/L (ng/l)	6	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Obesity

4153

20975

1.97

323.31

4.6

4.0

102.30

85.06

ng/l

19.42

3645

18453

Heart failure and bmi 25plus

2697

8086

2.45

323.31

5.7

3.8

129.89

86.77

ng/l

61.24

2322

6780

Heart failure and coronary heart disease

3285

11246

2.23

322.61

5.9

3.6

141.59

86.12

ng/l

99.39

2868

9421

Osteoporosis with pathological fracture (FG)

964

2700

4.70

320.22

3.2

3.0

73.50

86.78

ng/l

5.74

793

2223

Finngen Rheumatological endpoints

5599

18210

1.82

314.27

4.6

3.9

93.39

86.83

ng/l

4.06

4952

15928

Sub-endpoint used in defining T1D endpoints

2133

8890

2.57

314.00

8.6

4.0

144.47

87.76

ng/l

52.95

1900

7727

Type 2 diabetes, strict (exclude DM1)

5748

19462

1.79

309.10

4.3

3.4

95.74

81.31

ng/l

21.17

4976

16910

Symptoms and signs involving cognition, perception, emotional state and behaviour

6110

24374

1.75

309.03

3.9

4.1

87.75

90.18

ng/l

1.18

5299

21303

Headache

4012

16443

1.98

308.72

3.9

3.5

81.39

83.12

ng/l

0.61

3533

14356

Other diseases of urinary system

6075

20136

1.77

307.69

4.7

3.9

95.53

87.56

ng/l

6.70

5354

17501

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3617

11718

3.63

307.65

3.8

3.9

63.23

89.44

ng/l

55.18

3236

10143

Nephrotic syndrome

642

748

17.01

307.65

14.3

4.2

136.27

76.17

ng/l

21.33

613

670

Renal failure

9450

11975

10.02

307.65

8.8

2.1

145.22

70.25

ng/l

307.65

8531

9905

Continuous positive airway pressure

1425

3557

3.72

307.65

6.0

3.5

108.19

73.59

ng/l

27.08

1271

3118

Other anaemias

3942

15423

2.67

307.65

5.9

3.5

119.26

88.90

ng/l

39.63

3425

13047

Other metabolic disorders

1639

3690

5.60

307.65

4.5

3.2

57.33

78.83

ng/l

22.78

1438

3182

Hypoparathyroidism

630

1060

9.86

307.65

5.3

2.9

55.95

76.85

ng/l

6.97

510

905

Genitourinary diseases

3334

5539

3.21

307.65

6.4

2.3

105.78

62.89

ng/l

74.40

3016

4792

Other septicaemia

3514

12663

2.94

307.65

8.2

3.3

140.91

84.10

ng/l

80.75

3101

10733

Type 1 diabetes, wide definition

1681

5718

3.26

307.65

8.6

4.0

145.13

80.12

ng/l

51.55

1497

5036

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1576

3422

5.89

307.65

4.5

3.1

56.57

78.16

ng/l

21.96

1380

2948

Hypothyroidism and >3 levothyroxin purchases

1748

1504

7.16

307.65

4.1

2.5

69.25

66.19

ng/l

0.46

1568

1376

General symptoms and signs

6760

17544

2.02

307.65

4.8

3.6

95.68

84.46

ng/l

11.88

5944

15309

Diabetes, insulin treatment (Kela reimbursement)

6747

22414

1.88

307.65

5.4

3.6

107.54

83.05

ng/l

51.41

5856

19511

Hypertensive diseases

5718

11693

2.99

307.65

6.6

2.4

110.22

66.00

ng/l

126.74

5121

10200

Type 2 diabetes, wide definition

5982

17512

2.32

307.65

5.6

3.4

114.02

82.84

ng/l

64.70

5201

15138

Acute tubulo-interstitial nephritis

4983

16198

2.84

307.65

6.1

2.3

112.71

67.31

ng/l

120.34

4352

13793

Type 2 diabetes

6502

19736

2.01

307.65

5.1

3.4

105.36

80.78

ng/l

52.21

5662

17168

Abnormalities of breathing

5723

16839

2.04

307.65

4.5

3.9

96.44

84.50

ng/l

13.25

4994

14747

Benign thyroid growths and nodules

2890

11187

2.69

307.65

3.4

3.5

69.45

89.59

ng/l

28.57

2506

9558

Kidney transplant status

1887

1200

138.67

307.65

18.5

3.2

197.68

70.39

ng/l

154.70

1808

1083

Malignant neoplasm of thyroid gland, including Hilmo

984

2210

5.98

307.65

3.4

3.6

50.56

86.30

ng/l

48.59

889

1896

Cerebrovascular diseases (FINNGEN)

1844

4732

2.93

307.65

5.6

2.3

106.56

64.81

ng/l

41.29

1640

4152

Other nutritional deficiencies

4563

21632

2.05

307.65

4.6

4.0

100.45

84.95

ng/l

17.62

3986

19029

Anaemia in chronic diseases classified elsewhere

509

648

15.70

307.65

14.4

4.0

196.93

88.09

ng/l

36.22

473

580

Condition for Implicit Sepsis (Organ dysfunction codes)

7051

20363

2.61

307.65

5.7

3.3

109.61

79.12

ng/l

77.63

6196

17629

Bacterial Sepsis

4688

13751

3.20

307.65

6.9

3.3

128.70

83.01

ng/l

90.18

4148

11679

Disorders resulting from impaired renal tubular function

1115

986

48.03

307.65

17.5

4.0

218.04

85.44

ng/l

79.94

1050

876

Hypothyroidism, other/unspecified

6319

20524

2.16

307.65

3.8

4.0

76.25

93.26

ng/l

39.71

5474

17883

Certain infectious and parasitic diseases

5860

16279

1.88

307.65

5.1

3.0

98.59

77.62

ng/l

38.53

5164

14092

Diabetes, varying definitions

6745

20560

2.00

307.65

5.3

3.5

105.16

79.89

ng/l

56.92

5889

17960

Diabetic nephropathy

2420

5764

5.92

307.65

10.7

3.8

172.36

93.21

ng/l

103.96

2201

4926

Anaemias

2013

1535

9.65

307.65

8.3

2.8

118.04

64.84

ng/l

37.31

1844

1409

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4526

16428

2.37

307.65

5.3

3.7

114.35

89.47

ng/l

37.17

3901

14067

Depression medications

1213

1571

4.07

307.65

3.8

2.6

76.07

65.69

ng/l

2.58

1095

1441

Endocrine, nutritional and metabolic diseases

5144

7989

3.48

307.65

5.0

2.7

92.88

71.65

ng/l

33.15

4579

7037

Pain in throat and chest

5210

16584

1.95

307.65

4.2

3.9

90.86

85.06

ng/l

3.66

4548

14505

Disorders of lipoprotein metabolism and other lipidaemias

5884

16563

2.31

307.65

5.3

3.3

107.40

84.56

ng/l

42.72

5205

14252

All chronic kidney diseases

10117

11825

9.54

307.65

8.5

2.1

136.85

67.35

ng/l

307.65

9190

9912

Disorders of mineral metabolism

1868

2298

14.82

307.65

6.4

3.5

87.18

85.43

ng/l

0.21

1592

1954

ILD medications

8227

20781

2.27

307.65

6.3

3.1

104.38

80.95

ng/l

54.70

7388

17895

Diabetes medication

6677

22250

1.83

307.65

5.2

3.6

104.44

82.13

ng/l

44.52

5814

19419

Aplastic and other anaemias

4415

16195

2.81

307.65

6.7

3.5

125.25

88.50

ng/l

59.97

3859

13734

Erysipelas

4005

16975

2.18

307.65

5.5

3.3

118.00

83.16

ng/l

56.04

3493

14481

Hyperkalaemia

766

1579

6.43

307.65

9.1

3.4

172.00

93.90

ng/l

23.72

679

1316

Dialysis, with operation codes

3439

2730

31.43

307.65

16.5

2.2

206.07

66.45

ng/l

307.65

3269

2329

Caries of dentine

2171

6054

3.99

307.65

10.4

3.5

142.92

86.15

ng/l

51.90

1981

5324

Diabetes mellitus

6786

20530

2.01

307.65

5.3

3.5

105.42

79.65

ng/l

59.39

5925

17937

Hyperparathyroidism

4526

6238

13.84

307.65

8.1

2.8

133.79

82.58

ng/l

93.11

3963

5217

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

635

683

19.09

307.65

12.6

5.3

146.08

87.11

ng/l

16.78

600

612

Septicaemia

3841

13750

2.84

307.65

8.0

3.4

138.19

83.53

ng/l

85.39

3389

11692

Primary hyperparathyroidism

3248

3752

26.04

307.65

5.8

3.2

101.30

85.44

ng/l

12.36

2839

3162

Heart failure, not strict

7497

15836

3.66

307.65

7.8

2.7

133.50

69.49

ng/l

279.38

6660

13574

Type 1 diabetes

2021

6644

3.40

307.65

8.9

3.9

146.18

80.13

ng/l

65.43

1819

5845

Any gastric operation

4709

10707

2.32

307.65

5.0

2.7

92.14

75.84

ng/l

20.46

4159

9257

Insulin medication

4796

17254

2.51

307.65

6.7

3.7

127.23

85.20

ng/l

82.59

4203

14915

Insulin, fast-acting

2999

11625

2.87

307.65

7.7

3.9

138.17

86.11

ng/l

67.28

2635

10091

Dental caries

2431

6804

3.87

307.65

10.6

3.5

141.49

85.69

ng/l

58.60

2224

5972

Disorders of parathyroid gland

5049

7092

13.26

307.65

7.7

2.8

125.90

82.20

ng/l

80.17

4386

5954

Hypothyroidism, drug reimbursement

1562

1092

12.09

307.65

3.9

2.4

59.20

69.16

ng/l

2.06

1412

983

Chronic nephritic syndrome

732

926

14.24

307.65

12.5

3.2

170.98

81.56

ng/l

25.18

679

817

Gout, idiopatic and unspecified

2417

8226

3.43

307.65

7.6

3.8

142.45

95.16

ng/l

50.57

2143

6987

Complications of surgical and medical care, not elsewhere classified

7051

24981

1.99

307.65

5.5

3.6

105.04

85.75

ng/l

30.88

6218

21625

Disorders of calcium metabolism

1674

1723

22.39

307.65

6.3

3.4

86.08

85.56

ng/l

0.05

1420

1458

Gout

2850

7410

3.85

307.65

7.8

3.8

141.85

96.12

ng/l

55.04

2535

6270

Cystic kidney disease, including avohilmo

796

912

19.37

307.65

14.0

4.1

158.88

82.34

ng/l

35.06

758

809

Other disorders of skin and subcutaneous tissue

5321

24042

1.99

307.65

5.8

3.6

111.66

86.55

ng/l

40.57

4704

20678

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1480

4920

3.34

307.65

10.7

4.4

126.47

83.59

ng/l

29.93

1378

4346

Diseases of arteries, arterioles and capillaries (FINNGEN)

1866

3443

4.20

307.65

7.9

2.2

141.14

64.66

ng/l

77.99

1679

2983

Cystic kidney disease

778

839

22.63

307.65

14.2

4.2

159.04

82.76

ng/l

33.30

741

751

Congenital malformations of the urinary system

983

1553

9.95

307.65

13.3

4.3

147.46

79.78

ng/l

36.53

932

1385

Unspecified kidney failure

1866

2603

11.02

307.65

9.0

2.1

155.39

71.36

ng/l

90.03

1711

2147

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1418

4523

3.50

307.65

11.0

4.4

127.44

82.85

ng/l

30.26

1325

4006

Transplanted organ and tissue status

2313

2441

19.47

307.65

16.3

3.2

180.29

77.51

ng/l

135.70

2207

2151

Thyrotoxicosis, other and/or unspecified

1685

6199

3.06

307.65

3.4

3.7

67.24

88.86

ng/l

20.15

1491

5350

Implicit viral Sepsis

2106

6718

3.65

307.65

7.7

3.2

122.54

83.12

ng/l

37.91

1886

5705

Other soft tissue disorders, not elsewhere classified

6141

18555

1.98

307.65

4.4

4.1

91.60

88.61

ng/l

1.35

5411

16122

Renal tubulo-interstitial diseases

10668

19079

4.86

307.65

7.5

2.3

127.38

66.60

ng/l

307.65

9557

16370

Pneumonias (Asthma/COPD co-morbidities)

6862

24021

1.97

307.65

5.7

3.6

107.69

81.18

ng/l

55.13

6071

20940

Explicit Sepsis

3917

13871

2.86

307.65

7.9

3.3

136.83

81.98

ng/l

88.71

3454

11839

Nutritional anaemias

3868

18573

2.14

307.65

5.0

3.7

108.02

88.97

ng/l

18.39

3284

15924

Pneumonia, organism unspecified

6257

22792

1.99

307.65

5.7

3.6

108.16

81.84

ng/l

53.75

5488

19841

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7172

21599

2.24

307.65

7.3

3.0

117.95

77.12

ng/l

120.93

6314

18955

Glomerular disorders in diseases classified elsewhere

2736

3123

17.69

307.65

12.3

3.3

170.46

87.31

ng/l

104.82

2539

2689

L04AD Calcineurin inhibitors

2335

2781

15.65

307.65

15.8

3.4

171.53

79.57

ng/l

114.85

2227

2466

Metabolic disorders

8133

18214

2.94

307.65

5.5

3.4

99.49

82.93

ng/l

27.00

7174

15794

Non-invasive ventilation

2123

4830

4.28

307.65

5.2

3.2

98.97

72.33

ng/l

18.93

1975

4254

Other disorders of urethra and urinary system

4905

17848

2.03

307.65

4.7

3.7

96.59

86.24

ng/l

7.75

4292

15399

Acute renal failure

3206

5926

7.24

307.65

7.6

2.1

137.23

71.00

ng/l

116.43

2885

4901

Low back pain

4972

18265

1.93

307.65

3.7

4.2

86.44

92.27

ng/l

3.58

4294

15892

Obesity and other hyperalimentation

4177

21074

1.97

307.65

4.6

4.0

102.14

84.99

ng/l

19.40

3662

18538

Dyspnoea

6240

24733

1.92

307.65

4.6

3.9

101.22

87.03

ng/l

20.39

5408

21511

L04AA Selective immunosuppressants

2814

6881

5.18

307.65

12.8

3.3

153.17

81.71

ng/l

102.99

2642

5988

ILD medications: prednisolone, methylprednisolone, prednisone

8170

20576

2.36

307.65

6.5

3.1

107.24

81.22

ng/l

62.33

7320

17706

Heart failure and antihypertensive medication

2105

3058

5.13

307.65

7.0

2.2

139.71

63.47

ng/l

105.69

1856

2610

Inflammatory bowel disease treatment related agents

7599

23125

1.91

307.65

4.9

3.8

92.41

88.31

ng/l

2.50

6742

20047

Heart failure,strict

4404

11346

3.03

307.65

5.9

2.6

131.23

70.62

ng/l

181.96

3842

9554

Explicit Sepsis, including avohilmo

3978

14106

2.84

307.65

7.9

3.3

136.54

81.89

ng/l

90.19

3510

12042

Pain in limb

5740

18294

2.11

307.65

4.5

4.0

92.86

88.76

ng/l

2.07

5056

15892

Malignant neoplasm of endocrine gland, including Hilmo

1047

2499

5.49

307.65

3.6

3.8

53.79

87.15

ng/l

39.72

944

2156

Malaise and fatigue

4324

13823

2.69

307.65

4.4

3.5

97.90

86.06

ng/l

8.65

3715

11922

All kidney diseases

11353

18403

4.82

307.65

7.0

2.2

117.57

65.43

ng/l

307.65

10215

15769

Other septicaemia, including avohilmo

3566

12876

2.92

307.65

8.2

3.3

140.56

83.94

ng/l

82.24

3151

10917

First line medication for Crohn's disease

7728

20236

2.18

307.65

6.2

3.1

103.11

81.42

ng/l

44.19

6919

17443

Complications of medical and surgical care

5175

25343

1.95

307.65

5.6

3.7

104.83

87.07

ng/l

19.78

4571

21875

Complications of procedures, not elsewhere classified

5478

24414

1.91

307.65

5.3

3.6

103.79

85.87

ng/l

21.35

4838

21109

Codeine or tramadol medication

6991

22741

1.74

307.65

4.0

90.96

89.81

ng/l

0.38

6141

19734

Other disorders of fluid, electrolyte and acid-base balance

2943

9749

3.23

307.65

5.9

3.2

118.84

86.44

ng/l

28.86

2503

8239

Viral Sepsis

2108

6722

3.65

307.65

7.7

3.2

122.54

83.14

ng/l

37.92

1887

5709

Implicit viral Sepsis, including avohilmo

2854

10294

3.14

307.65

6.7

3.3

115.65

82.82

ng/l

39.60

2549

8736

Pain in joint

3649

11121

2.12

307.65

3.9

4.0

82.19

90.82

ng/l

6.58

3250

9693

Azathioprine

1263

3997

3.61

307.65

10.5

3.9

108.03

86.96

ng/l

5.84

1177

3500

Parasetamol

3940

9733

2.13

307.65

4.5

4.0

93.85

84.24

ng/l

5.87

3445

8647

Nephropathy related operations

3263

3260

24.85

307.65

16.9

2.8

206.50

79.08

ng/l

255.07

3089

2840

Insulin, combination of fast acting with intermediate-acting or long-acting

4804

19981

2.36

307.65

6.7

3.7

127.16

87.02

ng/l

76.63

4208

17235

All-cause Heart Failure

4715

14993

2.40

307.65

5.7

3.7

131.85

84.01

ng/l

118.61

4089

12717

Hypertension, essential

5451

11374

2.93

307.65

5.6

2.3

107.92

66.50

ng/l

111.02

4849

9898

Cardiovascular diseases

3235

6699

2.70

307.65

6.1

2.6

92.02

60.31

ng/l

48.19

2953

6008

Osteoporosis

3314

9882

3.78

307.65

4.0

3.4

82.89

88.80

ng/l

3.12

2813

8285

Secondary hypertension

1772

1405

22.48

307.65

13.4

2.3

169.71

63.46

ng/l

113.38

1632

1222

Disorders of the thyroid gland

6707

21634

2.14

307.65

3.8

4.0

78.55

93.70

ng/l

30.84

5823

18872

ILD medications: azathioprine

1263

3701

3.92

307.65

10.5

3.1

108.03

80.23

ng/l

9.78

1177

3205

Gout, FINNGEN

2850

9519

3.45

307.65

7.8

3.6

141.85

93.70

ng/l

63.21

2535

8051

Infections, IBD-co-morbidities

1366

1650

6.66

307.65

8.4

3.3

126.52

78.03

ng/l

29.76

1238

1451

Intestinal infectious diseases

6181

26638

1.81

307.65

6.0

3.7

104.97

85.50

ng/l

30.87

5458

23130

Heart failure, strict

4821

15189

2.42

307.65

5.8

3.7

131.70

84.21

ng/l

120.24

4189

12891

Used for control exclusion in common control thyroid runs

7097

16535

2.29

307.65

5.0

3.7

93.18

88.18

ng/l

3.14

6279

14400

Examination and observation for other reasons

4023

9137

2.65

307.65

5.0

3.5

94.03

87.00

ng/l

3.64

3683

7860

ILD medications: immunosuppressive drugs

5585

18815

2.97

307.65

8.6

3.1

117.20

79.79

ng/l

76.63

5125

16270

Other dialysis

986

764

81.16

307.65

18.7

4.2

219.30

84.83

ng/l

84.18

949

685

Preparatory care for dialysis

1477

1160

96.86

307.65

20.2

3.4

219.09

89.02

ng/l

127.58

1462

1013

Hypercalcemia

1029

1432

16.24

307.65

5.7

3.7

80.28

89.38

ng/l

1.49

854

1229

Opioids

5854

16239

1.94

307.65

4.4

3.7

92.59

86.38

ng/l

4.26

5166

14110

Hypocalcemia

573

664

21.76

307.65

7.9

3.8

96.82

83.57

ng/l

1.08

490

584

Care involving use of rehabilitation procedures

4433

19831

2.14

307.65

5.5

2.8

97.09

75.47

ng/l

31.02

4000

17062

Iron deficiency anaemia

3360

16300

2.19

307.65

5.1

3.7

108.97

88.66

ng/l

17.85

2858

13975

Other and unspecified anaemias

3922

15330

2.68

307.65

5.9

3.5

119.42

88.97

ng/l

39.57

3407

12969

Pure hypercholesterolaemia

5310

15882

2.27

307.65

5.0

3.3

103.64

85.12

ng/l

29.17

4744

13626

Hypertensive Heart Disease

1840

4576

3.40

307.65

6.2

2.3

134.13

69.91

ng/l

85.14

1593

3793

Persons encountering health services for specific procedures and health care

8073

21568

2.36

307.65

7.1

2.8

116.61

74.26

ng/l

142.92

7260

18648

Bleeding

5612

22489

1.84

307.65

5.7

3.8

112.01

86.03

ng/l

44.57

4865

19449

Chronic kidney disease

7919

8599

16.02

307.65

10.0

2.1

155.54

71.03

ng/l

307.65

7192

7075

Dialysis

1278

756

83.77

307.65

18.5

2.5

211.93

62.25

ng/l

141.77

1216

683

Tramadol

5821

15338

2.45

307.65

4.8

3.8

97.83

87.94

ng/l

8.86

5124

13282

All pneumoniae

6884

24101

1.96

307.65

5.7

3.7

107.50

81.84

ng/l

51.99

6090

21029

Glomerular diseases

3662

5083

12.07

307.65

11.9

3.3

159.80

84.50

ng/l

124.95

3395

4366

Care involving dialysis

2661

2027

56.45

307.65

18.6

3.0

223.32

78.94

ng/l

255.90

2537

1753

Other special examinations and investigations of persons without complaint or reported diagnosis

3722

9221

2.14

307.65

4.8

3.4

95.33

87.27

ng/l

4.09

3283

7923

Codeine

5702

16068

2.01

307.65

4.0

3.7

90.90

86.68

ng/l

2.06

5033

13957

Malignant neoplasm of endocrine gland

947

2136

5.93

307.65

3.6

3.8

52.88

85.66

ng/l

34.90

852

1841

Hypothyroidism, levothyroxine purchases

1748

1504

7.16

307.65

4.1

2.5

69.25

66.19

ng/l

0.46

1568

1376

Glomerulonephritis

1564

2716

8.54

307.65

12.0

4.0

147.89

88.60

ng/l

32.68

1466

2372

IgA nephropathy (IgA glomerulonephritis)

581

520

28.51

307.65

13.4

4.4

150.73

90.18

ng/l

14.81

554

464

Autoimmune diseases excluding thyroid diseases, strict definition

6369

17613

2.06

307.65

5.8

3.7

107.70

88.05

ng/l

27.98

5686

15325

Extracorporeal dialysis

1808

1609

41.04

307.65

19.6

3.6

242.19

85.19

ng/l

178.66

1705

1431

Osteopathies and chondropathies

5379

19211

2.87

307.65

4.6

3.8

93.45

88.06

ng/l

2.70

4648

16580

Implicit bacterial Sepsis

4323

12569

3.39

307.65

6.9

3.3

130.41

83.90

ng/l

84.56

3824

10621

Erysipelas, including avohilmo

5122

19281

2.09

307.65

5.3

3.2

113.42

81.09

ng/l

67.98

4491

16539

Hypothyreosis and Thyroxine purchase for inclusion criteria

6561

21951

2.08

307.65

3.8

4.0

76.34

92.55

ng/l

37.42

5673

19106

Other disorders of kidney and ureter

1815

4136

5.95

307.65

13.3

3.6

180.93

87.66

ng/l

82.55

1662

3551

Hypertensive heart and/or renal disease

2517

4832

4.42

307.65

7.5

2.3

144.41

69.57

ng/l

121.55

2226

4005

Any reimbursement code in KELA

3042

5908

2.71

307.65

4.9

2.2

86.42

64.42

ng/l

27.60

2738

5244

Certain disorders involving the immune mechanism

1663

5953

3.21

307.65

7.7

4.0

107.89

88.41

ng/l

8.42

1510

5166

Diseases of arteries, arterioles and capillaries

4809

18781

2.01

307.65

6.7

3.5

127.65

87.12

ng/l

79.15

4245

15975

Diabetic nephropathy, excluding more controls

2405

4098

6.94

307.65

10.7

3.5

172.64

87.22

ng/l

115.32

2188

3498

Congenital malformations of the urinary system, including avohilmo

1011

1652

9.37

307.65

13.1

4.2

146.96

79.87

ng/l

37.61

957

1469

Cardiovascular diseases (excluding rheumatic etc)

3735

7932

2.86

307.65

6.4

2.5

96.92

60.81

ng/l

68.27

3403

7112

Antihypertensive medication - note that there are other indications

3364

6312

2.94

307.65

6.0

2.3

90.53

60.17

ng/l

48.34

3053

5608

Diarrhoea and gastroenteritis of presumed infectious origin

4662

22785

1.92

307.65

6.2

3.7

106.87

85.85

ng/l

24.96

4107

19789

Oral corticosteroids

7117

22700

1.93

307.65

4.1

3.8

91.40

88.74

ng/l

1.20

6265

19651

Gout, strict definition

1916

5732

4.04

307.65

7.9

3.9

147.74

96.18

ng/l

44.52

1705

4870

Gout, unspecified

2012

6539

3.63

307.65

7.7

3.8

144.21

94.03

ng/l

44.76

1781

5544

Other heart diseases, wide

5762

18185

2.02

307.65

5.4

3.7

104.14

76.99

ng/l

55.70

5097

16035

Asthma, unspecified (mode), excluding more controls

3281

11120

2.23

307.65

4.0

3.3

91.28

77.73

ng/l

11.72

2905

9663

Diseases of oesophagus, stomach and duodenum

7070

23090

1.90

307.65

4.5

3.9

94.99

87.86

ng/l

6.01

6137

20153

Bacterial infection, other or unspecified, including avohilmo

5113

17252

2.68

307.65

6.9

3.3

122.36

81.81

ng/l

86.69

4517

14715

Oedema, not elsewhere classified

2609

10661

2.62

307.65

5.3

3.5

106.50

87.42

ng/l

15.22

2285

9147

Bacterial infection, other or unspecified

4740

16383

2.70

307.65

7.2

3.3

125.43

82.53

ng/l

86.25

4187

13930

Fever of other and unknown origin

4166

15640

2.48

307.65

6.5

3.6

107.71

85.21

ng/l

23.36

3694

13587

6097

18680

2.01

307.65

5.5

3.4

106.16

81.53

ng/l

43.66

5383

16245

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6744

24260

1.95

307.65

5.7

3.7

107.18

82.31

ng/l

48.25

5952

21153

Autoimmune diseases excluding thyroid diseases

6820

19275

2.02

307.65

5.7

3.6

104.60

85.38

ng/l

29.30

6078

16823

Ulcer of lower limb, not elsewhere classified

1493

4907

3.62

307.65

8.5

3.7

148.33

94.07

ng/l

34.22

1336

4108

Polycystic kidney disease

701

668

31.89

307.65

14.2

4.4

166.19

82.99

ng/l

33.18

667

607

Autoimmune diseases

6970

19579

1.89

307.65

5.3

3.6

99.03

84.73

ng/l

20.40

6129

17100

Influenza and pneumonia

7096

23574

1.96

307.65

5.6

3.6

105.82

81.30

ng/l

50.90

6283

20559

Type 1 diabetes, wide definition, subgroup 1

1649

5237

3.53

307.65

8.5

4.0

144.38

79.47

ng/l

50.22

1465

4637

Other diseases of intestines

6456

20660

1.81

307.65

4.7

3.9

93.66

85.91

ng/l

6.46

5725

18049

Other bacterial diseases

7525

22294

2.41

307.65

6.5

3.3

116.57

79.65

ng/l

106.11

6665

19280

Malignant neoplasm of thyroid gland

905

1960

6.26

307.65

3.4

3.6

49.90

85.82

ng/l

45.20

816

1685

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6317

19732

2.00

307.65

5.4

3.5

107.79

80.67

ng/l

57.58

5491

17190

Polyarthropathies

5116

14013

2.53

307.65

6.1

3.9

113.81

87.59

ng/l

37.39

4555

12206

Disorders of other endocrine glands

6445

14098

5.73

307.65

7.0

3.3

116.26

80.36

ng/l

74.74

5615

12251

GASTRO-related operations

4709

10707

2.32

307.65

5.0

2.7

92.14

75.84

ng/l

20.46

4159

9257

Medical observation and evaluation for suspected diseases and conditions

4197

9219

2.46

307.65

4.9

3.4

92.01

87.27

ng/l

2.01

3665

7921

Symptoms and signs involving the urinary system

5243

22190

1.88

307.65

5.0

3.8

100.54

88.87

ng/l

10.32

4533

19181

Implicit Sepsis

6800

19536

2.83

307.65

6.0

3.3

113.57

80.13

ng/l

86.05

5968

16831

Hypertensive Renal Disease

797

755

19.52

307.65

11.5

2.3

176.77

67.98

ng/l

53.62

739

632

Hypertensive diseases (excluding secondary)

3865

6565

3.76

307.65

7.3

2.3

109.83

62.74

ng/l

95.17

3515

5840

Disorders of thyroid, IBD co-morbidities

1626

1803

7.06

307.65

3.4

3.0

65.58

76.94

ng/l

5.21

1453

1592

Hypertension

5715

11689

2.99

307.65

6.6

2.4

110.26

66.00

ng/l

126.78

5118

10196

Implicit Sepsis, including avohilmo

7101

20335

2.73

307.65

5.8

3.3

110.78

79.56

ng/l

81.87

6242

17577

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8569

23032

2.75

307.65

6.0

3.4

109.31

81.47

ng/l

77.96

7544

20002

Cardiac arrhythmias

3440

10501

2.21

307.65

4.5

3.2

96.13

71.27

ng/l

33.69

3034

9310

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6097

18680

2.01

307.65

5.5

3.4

106.16

81.53

ng/l

43.66

5383

16245

Other disorders involving the immune mechanism, not elsewhere classified

651

740

17.12

307.65

12.4

5.0

145.46

85.13

ng/l

18.48

614

659

Hypothyroidism (congenital or acquired)

1773

1510

7.23

307.65

4.2

2.5

71.28

66.09

ng/l

0.93

1590

1382

Implicit bacterial Sepsis, including avohilmo

4691

13447

3.32

307.65

6.7

3.3

127.63

83.22

ng/l

87.46

4141

11400

Insulin, intermediate and long-acting

4418

18728

2.49

307.65

6.6

3.8

126.30

87.32

ng/l

69.00

3861

16165

Other heart diseases

2983

6698

3.11

307.65

6.3

2.5

109.92

62.37

ng/l

76.57

2685

5972

Insulin, fast-acting or short human

3010

12273

2.71

307.65

7.7

3.9

138.04

87.42

ng/l

64.25

2644

10641

Carbimazole or st.post thyroidectomy, condition for graves disease

2479

6809

4.50

307.65

3.3

3.7

53.04

87.66

ng/l

89.70

2244

5861

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

7120

20353

2.55

307.65

5.6

3.3

107.03

78.14

ng/l

71.70

6279

17691

Other bacterial diseases, including avohilmo

7658

22170

2.31

307.65

6.3

3.3

112.54

78.26

ng/l

97.67

6811

19231

Type 2 diabetes, definitions combined

5714

19344

1.79

307.34

4.3

3.3

95.73

81.05

ng/l

21.91

4944

16810

Diverticular disease of intestine

4770

16524

1.89

305.90

4.7

3.7

97.92

89.45

ng/l

5.71

4152

14209

Papillary adenocarcinoma of thyroid gland

669

1469

6.16

305.39

3.7

49.97

85.55

ng/l

32.52

605

1270

Atrial fibrillation and flutter

1793

4314

2.87

305.31

5.4

2.2

112.61

64.40

ng/l

52.73

1571

3765

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2313

6141

2.50

304.15

5.2

2.2

98.42

63.43

ng/l

37.82

2063

5443

Isolated proteinuria

445

681

10.22

302.48

9.4

4.2

119.08

88.78

ng/l

4.58

419

610

Asthma, unspecified (mode)

3407

12401

2.09

300.46

4.0

3.4

91.80

82.22

ng/l

6.39

3002

10739

Other CVD (FINNGEN)

916

1799

4.43

299.49

5.6

2.1

107.85

65.81

ng/l

22.63

792

1515

Statin medication

3725

10688

2.05

298.86

5.6

2.8

102.51

72.55

ng/l

46.45

3326

9273

Diabetic maculopathy, excluding more controls

950

2682

4.13

298.55

9.6

3.5

168.86

85.42

ng/l

37.62

843

2299

Vocal cord dysfunction

942

2243

4.07

296.76

4.1

2.9

75.13

68.95

ng/l

1.55

821

1998

Obesity due to excess calories

3121

15806

2.10

292.38

4.7

4.0

103.66

84.63

ng/l

16.57

2706

13948

Other retinal disorders

4527

19400

1.88

291.23

6.0

3.7

119.91

89.09

ng/l

43.13

3852

16663

Intestinal infectious diseases, including avohilmo, including avohilmo

7158

24921

1.66

290.69

5.1

3.7

99.78

86.03

ng/l

19.84

6333

21577

Hyperlipidaemia, other/unspecified

2671

11450

2.26

290.59

5.9

3.3

119.48

87.65

ng/l

31.34

2259

9689

Covid-19 confirmed case

2801

13745

2.21

289.17

6.5

3.8

116.86

90.80

ng/l

23.42

2448

11784

Disorders of choroid and retina

5398

22334

1.78

288.61

5.8

3.7

114.73

87.94

ng/l

42.23

4611

19297

Codes for special purposes

3645

19373

1.98

288.33

6.0

3.8

110.11

88.34

ng/l

23.30

3175

16804

Provisional assignment of new diseases of uncertain etiology

3640

19349

1.98

287.91

6.0

3.8

109.89

88.39

ng/l

22.92

3170

16784

Thyrotoxicosis

2066

9047

2.54

287.86

3.5

3.6

69.00

86.02

ng/l

15.07

1817

7747

Other and unspecified iron deficiency

2661

12839

2.25

287.47

4.9

3.7

107.75

87.98

ng/l

14.05

2276

11007

Gastro-oesophageal reflux disease

4461

21314

1.86

285.68

4.2

3.9

91.11

88.60

ng/l

0.86

3761

18537

Hernia of abdominal wall, postoperative

1321

4593

3.14

285.17

6.1

2.8

116.96

80.88

ng/l

16.72

1169

3926

Nontoxic multinodular goitre

1706

6924

2.80

284.32

3.4

66.95

90.11

ng/l

24.05

1473

5878

Peripheral artery disease

3221

13044

2.11

283.43

6.9

3.5

137.10

90.46

ng/l

66.05

2822

10960

Type 2 diabetes, definitions combined, including avohilmo

5621

19245

1.76

283.23

4.3

3.4

95.73

81.24

ng/l

20.94

4875

16741

Disorders of lens

4293

14722

1.91

281.04

6.3

3.7

116.47

85.87

ng/l

37.62

3691

12969

Other specific joint derangements/joint disorders

4280

14738

1.89

277.12

3.9

82.62

85.55

ng/l

1.23

3823

12930

Oxycodone

2745

11480

2.19

275.98

4.4

3.7

103.28

91.08

ng/l

5.30

2348

9784

Calculus of kidney and ureter

2153

9736

2.42

275.32

4.1

4.3

86.17

96.95

ng/l

5.31

1933

8430

Nausea and vomiting

2122

9276

2.43

274.64

6.7

3.7

108.97

86.49

ng/l

14.18

1858

7968

Lower back pain or/and sciatica

6628

25812

1.66

273.15

3.7

4.1

85.04

91.06

ng/l

5.42

5758

22458

Unspecified haematuria

2948

12089

2.13

272.10

5.6

4.0

108.25

93.79

ng/l

9.11

2570

10395

General examination and investigation of persons without complaint and reported diagnosis

3473

9197

2.04

271.70

4.7

3.5

95.59

87.18

ng/l

3.46

3031

7907

Atrial fibrillation and flutter with reimbursement

1526

3505

2.96

270.30

4.5

2.2

102.60

65.26

ng/l

41.39

1326

3027

Follow-up examination after treatment for conditions other than malignant neoplasms

2619

8226

2.24

270.12

4.0

3.4

85.15

86.27

ng/l

0.24

2344

7069

Non-ischemic cardiomyopathy

2380

8829

2.34

268.90

5.2

3.5

116.30

81.09

ng/l

43.39

2021

7433

Constipation

5770

23908

1.71

268.20

4.0

4.1

91.23

89.45

ng/l

0.59

4910

20879

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4116

22994

1.86

266.38

5.8

3.7

107.40

87.71

ng/l

17.90

3644

19805

Symptoms and signs involving the circulatory and respiratory systems

5632

16860

1.73

264.11

4.4

3.9

92.14

84.54

ng/l

5.89

4977

14768

Nontoxic goitre/thyroid nodule

2391

11534

2.29

263.89

3.4

3.5

68.01

88.01

ng/l

28.68

2070

9808

Urolithiasis

2265

10632

2.31

263.50

4.2

4.3

86.99

97.72

ng/l

5.44

2026

9214

Asthma (only as main-diagnosis), excluding more controls

3855

11472

1.94

262.68

3.9

3.3

88.48

77.68

ng/l

9.49

3420

9987

Other functional intestinal disorders

3184

15226

2.02

262.08

4.3

3.8

91.36

85.96

ng/l

2.10

2735

13111

Other (not insulin) diabetes medications

5873

21172

1.69

259.04

4.4

3.5

98.47

83.55

ng/l

20.78

5078

18393

Valvular heart disease excluding rheumatic fever

3032

11131

2.07

255.61

5.5

3.6

114.15

79.18

ng/l

45.60

2619

9580

Autoimmune diseases related-to ILD

5264

26810

1.71

255.53

4.5

4.0

89.83

89.28

ng/l

0.14

4639

23279

Acute peritonitis

703

1827

4.85

255.12

14.7

4.0

195.00

91.56

ng/l

32.28

656

1581

Non-rheumatic valve diseases

3014

11041

2.07

255.08

5.4

3.5

114.23

79.40

ng/l

44.83

2601

9493

Asthma, excluding more controls

4064

11472

1.89

254.24

3.9

3.3

88.84

77.68

ng/l

9.99

3632

9987

Benign neoplasm of colon, rectum, anus and anal canal

4378

21634

1.81

254.20

4.8

3.8

101.07

90.90

ng/l

8.95

3854

18456

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6712

22653

1.63

252.43

5.2

3.7

101.90

86.04

ng/l

23.11

5873

19773

Insulin, fast-acting (human)

1044

3447

3.38

252.31

9.3

3.6

146.03

83.73

ng/l

28.13

950

3028

Gout due to impairment of renal function

264

284

24.61

251.09

13.7

3.7

193.84

86.47

ng/l

16.09

242

248

Fall on same level

6627

22416

1.63

249.54

4.4

4.1

92.02

87.05

ng/l

3.07

5759

19786

Hypothyroidism, strict autoimmune

4121

15330

1.84

248.00

3.9

3.4

88.41

88.19

ng/l

0.05

3486

13249

Renal tubulo-interstitial disorders in diseases classified elsewhere

222

183

29.66

247.88

10.7

1.9

128.83

65.29

ng/l

10.07

200

162

Mood disorders, excluding more controls

5594

20178

1.69

247.28

4.0

4.1

88.33

90.33

ng/l

0.69

4845

17684

Abnormal findings on examination of urine, without diagnosis

541

1198

6.03

243.93

8.5

4.2

115.68

92.87

ng/l

3.39

503

1051

Obesity, other/unspecified

2221

10620

2.24

243.87

4.4

3.9

98.02

83.94

ng/l

8.73

2010

9395

Dorsalgia

5714

18623

1.68

243.72

3.8

4.2

84.91

92.05

ng/l

6.27

4996

16209

Neurological diseases, wide definition

1358

2351

3.03

241.09

4.5

3.6

81.35

72.47

ng/l

2.78

1225

2108

Atherosclerosis, excluding cerebral and coronary sclerosis

2964

12273

2.04

240.18

6.7

3.4

138.37

91.29

ng/l

60.19

2594

10279

Persons encountering health services in other circumstances, wide

6864

22763

1.60

239.37

4.9

3.7

99.08

86.17

ng/l

16.96

5961

19847

Nerve, nerve root and plexus disorders

6445

24869

1.61

237.34

4.3

3.9

91.30

90.49

ng/l

0.25

5664

21527

Disorders of gallbladder, biliary tract and pancreas

6063

23972

1.64

236.55

4.5

3.9

96.88

88.83

ng/l

6.87

5276

20803

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1788

3654

2.56

233.86

4.5

3.2

84.06

78.42

ng/l

1.70

1601

3180

Other arrhythmias

3752

15861

1.85

233.77

3.9

3.5

90.50

78.14

ng/l

12.05

3239

13864

Amputation

946

3136

3.54

232.53

10.0

3.7

165.35

96.01

ng/l

31.54

834

2657

Persons encountering health services for examination and investigation

3438

9221

1.94

232.02

4.3

3.4

91.51

87.27

ng/l

1.56

2998

7923

Thyrotoxicosis with diffuse goitre

1110

3999

3.12

231.40

3.2

3.6

61.17

87.47

ng/l

21.22

988

3468

Spondylopathies

4762

16883

1.74

231.27

3.7

4.1

88.34

94.27

ng/l

3.57

4112

14588

Asthma (only as main-diagnosis)

4018

12782

1.83

230.01

3.9

3.5

88.75

82.21

ng/l

3.97

3554

11090

Diabetic retinopathy, excluding more controls

2061

5280

2.43

228.65

8.0

3.5

139.43

84.82

ng/l

47.12

1815

4521

Asthma

4279

12782

1.79

226.07

3.9

3.5

89.66

82.21

ng/l

4.84

3815

11090

Congenital malformations, deformations and chromosomal abnormalities

3406

18204

1.86

224.47

6.9

3.8

103.97

83.85

ng/l

19.52

3097

16038

Excluding asthma or asthma-COPD overlap

4388

12894

1.77

220.27

4.4

3.5

92.02

82.23

ng/l

7.94

3850

11190

Benign neoplasm: Colon

3723

20440

1.81

219.90

4.9

3.8

102.08

91.49

ng/l

8.20

3297

17408

Asthma (mode)

4216

12892

1.78

219.83

3.8

3.5

88.42

82.24

ng/l

3.58

3771

11190

Other cataract

2927

11682

1.98

219.37

6.1

3.7

115.01

86.58

ng/l

24.26

2517

10242

Gastrointestinal diseases

3037

7961

1.98

218.33

4.7

2.8

87.55

75.23

ng/l

8.85

2690

6954

Infections of the skin and subcutaneous tissue

3560

20226

1.81

218.02

6.1

4.1

110.55

87.10

ng/l

23.14

3167

17762

Presence of cardiac and vascular implants and grafts

2916

11526

1.98

218.02

4.9

3.2

122.51

86.55

ng/l

45.95

2524

9878

Diseases of the skin and subcutaneous tissue

5618

17698

1.65

217.73

4.8

3.6

97.67

83.51

ng/l

17.41

4934

15335

Other pulmonary diagnosis

4376

12894

1.76

217.52

4.4

3.5

92.75

82.23

ng/l

8.93

3833

11190

COPD/asthma/ILD related infections

5865

18680

1.63

216.21

4.6

3.4

96.81

81.53

ng/l

19.36

5127

16245

COPD/asthma related infections

5865

18680

1.63

216.21

4.6

3.4

96.81

81.53

ng/l

19.36

5127

16245

Peripheral artery operations in Hilmo

1058

3868

3.10

215.33

8.9

3.5

157.65

93.40

ng/l

32.65

924

3249

Symptoms and signs involving the digestive system and abdomen

5673

17950

1.64

214.80

4.8

3.9

95.29

87.97

ng/l

4.99

4957

15642

Syncope and collapse

2803

12538

1.96

213.88

4.2

3.6

100.00

87.57

ng/l

7.26

2356

10772

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4358

23174

1.72

213.86

4.5

3.9

93.51

91.30

ng/l

0.69

3831

19905

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

6039

25166

1.59

213.83

5.3

3.7

99.51

85.89

ng/l

16.44

5343

21796

Dizziness and giddiness

4662

22391

1.69

213.57

3.9

4.0

88.18

90.68

ng/l

1.04

3979

19465

Chronic tubulo-interstitial nephritis

444

927

6.27

213.06

10.6

2.2

142.47

68.38

ng/l

21.34

409

790

All influenza

1806

8425

2.31

212.23

6.6

3.8

114.38

84.78

ng/l

19.74

1598

7284

COPD differential diagnosis

4337

12895

1.75

208.75

4.4

3.5

92.11

82.24

ng/l

7.96

3806

11193

Other dorsopathies, not elsewhere classified

5644

18655

1.62

208.50

3.7

4.2

83.86

91.97

ng/l

8.02

4968

16239

Senile cataract

3814

13514

1.80

208.49

5.8

3.6

113.49

86.50

ng/l

27.38

3233

11859

ILD differential diagnosis

4334

12892

1.74

208.20

4.4

3.5

91.99

82.24

ng/l

7.79

3803

11190

Sleep apnoea

5665

23052

1.61

207.07

4.2

4.0

94.65

89.27

ng/l

3.51

4841

20201

Benign neoplasms

5324

18254

1.64

206.78

4.9

3.9

95.77

87.94

ng/l

5.65

4703

15972

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3705

19933

1.77

205.87

6.6

3.8

102.35

84.05

ng/l

18.42

3355

17515

Disorders of eyelid, lacrimal system and orbit

5372

25303

1.62

205.83

4.0

87.23

90.06

ng/l

1.31

4651

21966

Hypokalaemia

1001

3655

3.10

204.41

5.0

3.2

98.01

85.17

ng/l

2.77

860

3068

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3730

22237

1.76

204.02

5.6

3.7

106.83

88.49

ng/l

14.31

3288

19192

Certain infectious and parasitic diseases, including avohilmo

3996

11686

1.77

203.73

4.6

3.1

94.78

78.42

ng/l

19.09

3494

10064

Exposure to unspecified factor

6055

27139

1.57

203.57

4.5

4.0

94.79

87.80

ng/l

4.79

5187

23750

STROKE

3238

12262

1.86

202.97

4.8

3.2

102.12

76.14

ng/l

30.10

2843

10565

Hard cardiovascular diseases

4963

18410

1.66

202.10

5.5

3.7

111.03

80.51

ng/l

56.58

4380

15974

Percutaneous Coronary Intervention

4812

18277

1.67

202.01

5.5

3.7

115.25

81.24

ng/l

63.22

4234

15787

Spinal stenosis

3319

13996

1.84

201.85

3.7

4.1

91.91

95.91

ng/l

1.49

2871

11953

Neoplasms

3780

11447

1.79

201.46

4.9

4.0

88.39

85.74

ng/l

0.76

3382

10079

Diseases of the digestive system

3065

17318

1.86

200.00

5.4

3.9

107.38

91.46

ng/l

11.23

2634

14854

Diabetic retinopathy, strict definition

1443

5629

2.61

199.97

9.5

4.4

160.69

98.59

ng/l

35.86

1268

4870

Postmenopausal osteoporosis with pathological fracture

797

2680

3.83

199.70

3.1

3.0

72.75

87.38

ng/l

6.58

648

2182

Other/unspecified cytomegaloviral diseases

298

469

9.88

197.52

15.5

4.1

190.02

78.16

ng/l

21.69

286

426

Haemorrhage from respiratory passages

2291

10512

2.05

196.72

5.0

3.9

110.51

88.69

ng/l

14.94

1974

8954

Cystitis

4944

18542

1.64

196.70

4.2

3.8

89.75

86.49

ng/l

1.56

4355

16048

Hydronephrosis

828

2770

3.35

196.27

7.1

2.2

130.92

68.11

ng/l

24.63

727

2313

Emergency coronary revascularization (for ACS)

5241

20295

1.62

196.26

5.4

3.8

114.87

83.56

ng/l

59.22

4601

17465

Other intervertebral disc disorders

4722

17576

1.66

195.49

3.5

4.1

84.28

93.72

ng/l

9.35

4195

15240

Other and unspecified polyneuropathies, also in other diseases

1456

6490

2.49

195.09

6.3

4.0

114.03

96.60

ng/l

5.87

1297

5529

Systemic connective tissue disorders

2494

13489

1.98

195.08

4.6

3.6

87.29

88.58

ng/l

0.27

2215

11485

Other antidepressants

5835

19399

1.58

194.64

3.5

4.3

86.93

93.70

ng/l

5.11

5026

16980

Coronary revascularization (ANGIO or CABG)

4782

18281

1.66

194.41

5.5

3.7

115.17

81.24

ng/l

62.84

4205

15791

Benzodiazepine use

5920

26457

1.56

194.28

3.5

4.1

85.89

90.74

ng/l

3.18

5001

23167

Pain, not elsewhere classified

1800

8654

2.22

194.22

4.2

3.5

90.44

84.12

ng/l

1.94

1570

7524

Diseases of peritoneum

886

3136

3.28

193.89

12.5

3.7

173.21

89.22

ng/l

31.51

815

2667

Charcot foot

263

365

10.92

193.73

11.0

3.2

162.74

77.64

ng/l

14.68

245

317

Pain (limb, back, neck, head abdominally)

3925

11584

1.76

193.61

4.4

4.0

91.30

90.61

ng/l

0.15

3443

10061

Amputation of toe

695

2150

3.91

193.57

9.9

3.9

164.64

99.12

ng/l

20.75

616

1836

Cytomegalovirus infection, IBD co-morbidity

322

557

8.52

193.35

15.3

4.2

184.98

83.17

ng/l

20.69

310

503

Any mental disorder

6223

20622

1.56

192.42

4.0

4.1

88.11

90.53

ng/l

1.00

5374

18063

Soft tissue disorders

5633

18683

1.59

192.13

4.3

4.1

90.34

88.57

ng/l

0.59

4934

16231

Graves disease, strict definition

858

2992

3.29

191.77

2.8

3.6

52.73

81.20

ng/l

22.80

767

2593

Other bacterial intestinal infections

1387

6090

2.51

191.30

6.5

3.5

119.42

88.27

ng/l

15.27

1225

5158

Mood disorders

5938

25189

1.56

191.13

4.0

4.1

87.24

89.10

ng/l

0.68

5149

22005

Mood [affective] disorders

5924

25170

1.56

190.87

4.0

4.1

87.30

89.07

ng/l

0.63

5139

21993

L04AX Other immunosuppressants

3471

20719

1.76

189.76

5.5

3.9

83.52

88.12

ng/l

1.84

3118

18068

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

619

1134

4.17

189.49

4.7

3.0

99.60

81.67

ng/l

3.10

545

971

Abdominal and pelvic pain

5529

17946

1.59

189.41

4.6

3.9

93.44

87.99

ng/l

3.23

4830

15638

6679

22834

1.53

189.32

4.5

3.7

95.10

86.29

ng/l

8.90

5777

19793

Second line medication for Crohn's disease

3535

21220

1.74

188.58

5.4

3.9

83.44

87.80

ng/l

1.73

3175

18530

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

382

775

6.19

187.42

11.7

3.7

155.95

78.74

ng/l

14.25

352

717

Failure and rejection of transplanted organs and tissues

231

291

13.39

186.97

18.6

4.4

201.94

73.20

ng/l

18.55

222

265

Cytomegaloviral disease, including avohilmo

326

588

7.96

186.89

15.2

4.4

183.78

82.11

ng/l

21.23

314

530

Use of hypnotics and sedatives

6120

23363

1.55

186.72

4.3

4.1

93.20

89.96

ng/l

1.53

5361

20370

Cytomegaloviral disease

325

586

8.01

186.61

15.1

4.4

183.72

82.21

ng/l

21.06

313

528

Sleep apnoea, including avohilmo

5829

23392

1.56

185.93

4.1

92.82

89.13

ng/l

1.97

4976

20538

Polyneuropathies and other disorders of the peripheral nervous system

1584

7462

2.33

184.48

6.1

4.0

112.30

95.12

ng/l

6.37

1407

6370

Episodal and paroxysmal disorders

6134

20724

1.55

184.01

4.0

4.2

88.37

88.05

ng/l

0.08

5335

18111

Ischemic heart diseases

4916

18768

1.62

183.52

5.5

3.7

113.89

80.81

ng/l

62.23

4310

16236

Sleep disorders (combined)

6380

22459

1.53

182.79

3.9

4.1

89.77

89.30

ng/l

0.14

5494

19603

Idiopathic gout

782

2679

3.38

181.11

7.7

3.8

148.75

96.54

ng/l

18.68

697

2284

Neurological diseases

4523

14152

1.65

180.25

4.0

4.3

85.82

87.62

ng/l

0.54

3938

12462

Symptoms and signs involving the skin and subcutaneous tissue

4388

26471

1.63

180.10

4.6

3.9

89.82

88.80

ng/l

0.29

3926

22929

Other bacterial intestinal infections, including avohilmo

1653

7964

2.24

179.71

6.0

3.5

112.73

87.24

ng/l

13.32

1466

6791

Diseases of liver

2263

12184

1.98

178.39

4.7

4.1

92.72

91.48

ng/l

0.24

2002

10565

Major coronary heart disease event

5029

19554

1.60

177.29

5.5

3.8

114.48

82.00

ng/l

61.62

4415

16867

Diseases of the eye and adnexa

3921

11847

1.71

176.76

5.0

3.7

94.06

81.21

ng/l

10.05

3504

10593

Volume depletion

790

2746

3.26

176.36

5.6

3.4

120.27

89.44

ng/l

8.04

660

2295

Bacterial pneumoniae

2601

12763

1.89

176.30

5.5

3.6

113.84

86.67

ng/l

20.26

2361

10938

Anxiety disorders, excluding more controls

4622

18863

1.62

176.24

4.0

4.1

84.30

88.61

ng/l

2.22

4016

16555

Biguanides

5495

22020

1.56

174.82

3.8

94.08

86.98

ng/l

5.45

4721

19159

Malignant neoplasm, wide definition

4874

18354

1.60

172.94

4.2

4.1

86.73

89.39

ng/l

1.02

4316

16006

Abnormalities of heart beat

2237

11684

1.96

172.91

3.8

3.6

92.48

85.67

ng/l

2.29

1912

10058

Malignant neoplasm, including Hilmo

4859

18299

1.60

172.77

4.2

4.1

86.65

89.40

ng/l

1.07

4304

15958

Enterocolitis due to Clostridium difficile

932

3593

2.96

172.72

7.2

3.6

133.31

91.27

ng/l

15.01

825

3020

Diseases of the musculoskeletal system and connective tissue

2629

7114

1.91

172.09

4.6

4.1

86.53

83.92

ng/l

0.60

2354

6264

Depression

5405

24101

1.55

171.05

4.0

4.1

87.01

88.38

ng/l

0.42

4717

21104

Bacterial pneumonia, not elsewhere classified

2477

12124

1.89

169.54

5.5

3.6

114.97

86.56

ng/l

20.80

2264

10374

Implicit fungal Sepsis, including avohilmo

662

2150

3.63

169.04

5.9

3.2

116.88

81.83

ng/l

5.34

582

1826

Chronic periodontitis, including avohilmo

5779

24996

1.52

168.21

5.6

3.7

103.49

87.76

ng/l

18.72

5005

21744

Bacterial intestinal infections, IBD co-morbidities

1381

6395

2.37

167.84

6.5

3.7

120.35

90.52

ng/l

13.89

1222

5423

Periodontitis

5783

25001

1.52

167.74

5.6

3.7

103.30

87.75

ng/l

18.34

5012

21744

Factors influencing health status and contact with health services

1430

3097

2.41

166.13

4.8

2.5

95.51

77.61

ng/l

8.65

1275

2691

Malignant neoplasm

4759

18121

1.59

165.56

4.2

4.1

86.70

89.55

ng/l

1.11

4218

15789

Malignant neoplasm

4753

18095

1.59

165.43

4.2

4.1

86.65

89.60

ng/l

1.17

4213

15766

Sciatica+with lumbago

3034

15966

1.76

164.57

3.7

4.1

81.24

92.55

ng/l

10.49

2706

13864

Psychiatric diseases

5436

18123

1.55

163.45

4.0

4.2

87.78

91.11

ng/l

1.49

4722

15927

Peripheral arterial reconstruction

1279

5835

2.42

162.16

6.9

3.8

145.94

98.35

ng/l

23.49

1114

4910

Abnormal findings on examination of blood, without diagnosis

2869

15318

1.78

162.14

5.0

4.2

98.93

95.66

ng/l

0.91

2567

13192

Other symptoms and signs involving cognitive functions and awareness

3061

16298

1.75

161.57

3.5

4.0

89.27

93.88

ng/l

2.03

2630

13955

Other arthrosis

3056

12093

1.77

161.51

4.0

3.7

86.61

89.51

ng/l

0.72

2686

10464

Hypo-osmolality and hyponatraemia

1273

5737

2.41

161.30

5.1

3.1

103.47

86.64

ng/l

5.27

1053

4779

Osteomyelitis

569

1737

3.87

160.39

9.2

4.3

151.27

93.80

ng/l

13.98

512

1527

Depression or dysthymia

3698

12425

1.68

159.24

3.9

4.4

89.51

94.10

ng/l

1.73

3176

10972

Falls/tendency to fall

5701

19287

1.52

159.23

4.4

4.1

92.00

86.32

ng/l

3.32

4993

17034

Asthma (diagnoses ohter than nonallergic)

5076

27601

1.53

158.81

3.9

4.1

89.61

88.41

ng/l

0.38

4492

23954

Other arthritis (FG)

1876

9844

2.02

158.57

5.1

3.8

97.30

87.55

ng/l

3.57

1657

8552

Asthma-related infections

3605

22143

1.65

157.77

4.2

4.1

94.36

88.53

ng/l

2.78

3180

19138

Asthma, hospital admission 2, infections

3605

22143

1.65

157.77

4.2

4.1

94.36

88.53

ng/l

2.78

3180

19138

Cough

2469

13159

1.84

156.24

4.6

3.8

88.84

84.24

ng/l

1.40

2151

11416

Arthropathies in other diseases classified elsewhere

383

911

5.31

156.17

9.5

3.7

151.12

88.91

ng/l

11.75

351

799

Other systemic involvement of connective tissue (FG)

1698

8525

2.09

155.40

3.3

3.5

78.28

87.27

ng/l

4.25

1484

7260

Paroxysmal tachycardia

1128

3996

2.48

155.30

4.6

2.4

96.37

63.17

ng/l

25.23

994

3499

Benign neoplasm: Parathyroid gland

215

320

13.12

154.97

6.9

3.4

118.59

82.15

ng/l

2.92

194

280

Vitreous haemorrhage

825

3160

2.98

154.84

9.1

4.0

154.17

94.33

ng/l

18.61

740

2711

Hypothyroidism, strict autoimmune, 3 medication purchases required

4653

20650

1.56

154.58

3.8

3.9

86.88

91.62

ng/l

3.01

3919

17951

Ischaemic heart disease, wide definition

4506

18263

1.58

151.05

5.3

3.7

113.94

84.03

ng/l

49.45

3906

15694

Intracranial trauma

2974

11957

1.74

150.90

3.8

4.2

87.53

85.40

ng/l

0.52

2519

10583

Bronchitis

6210

26116

1.47

149.11

4.9

3.7

98.49

86.80

ng/l

13.45

5407

22704

Dorsopathies

5461

18789

1.51

148.44

3.9

4.3

85.74

91.63

ng/l

4.27

4788

16372

Conduction disorders

1837

7749

2.01

148.13

4.6

3.5

107.03

80.48

ng/l

22.53

1549

6622

Injuries to the abdomen, lower back, lumbar spine and pelvis

2595

15108

1.78

148.03

4.2

3.9

89.67

91.80

ng/l

0.49

2218

12984

Other necrotizing vasculopathies (FG)

554

1756

3.76

147.84

7.5

3.6

107.83

90.53

ng/l

2.58

518

1469

Presence of other functional implants

3592

15531

1.65

147.66

4.7

3.1

107.59

82.17

ng/l

29.87

2856

13389

Shoulder lesions

4231

16531

1.59

146.03

3.8

3.9

86.03

91.65

ng/l

3.42

3727

14259

Solid cancers, including Hilmo

4672

18112

1.55

145.89

4.2

4.1

87.55

89.68

ng/l

0.71

4135

15774

Cutaneous abscess, furuncle and carbuncle

1577

8057

2.08

144.47

6.6

4.1

118.68

87.67

ng/l

14.43

1424

7065

Diabetic retinopathy

2537

9191

1.85

144.40

7.5

4.3

137.77

98.18

ng/l

33.33

2209

7915

Coronary atherosclerosis

3803

15393

1.62

144.01

5.5

3.6

120.24

82.32

ng/l

59.00

3316

13150

Symptoms and signs concerning food and fluid intake

804

3126

2.85

143.65

4.6

3.7

79.92

86.67

ng/l

1.34

710

2680

Cholelithiasis, broad definition with cholecystitis

5033

22846

1.51

143.38

4.2

3.8

94.08

88.42

ng/l

3.56

4361

19757

Any event in cancer register

4897

19302

1.53

142.42

4.1

86.75

89.25

ng/l

0.94

4328

16854

Isolated proteinuria with specified morphological lesion

194

277

11.96

142.21

9.9

3.1

149.82

75.93

ng/l

7.52

182

243

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1057

4704

2.48

141.85

6.3

3.6

121.07

88.11

ng/l

11.32

923

3991

Other specified/unspecified arthritis

1628

8460

2.04

141.76

5.2

3.8

98.73

86.90

ng/l

4.34

1444

7340

Urinary track infection

3363

10405

1.68

140.49

4.2

3.0

85.16

73.36

ng/l

11.02

2960

9006

Missing teeth due to accident, extraction or parodontitis

3820

22354

1.59

140.37

4.4

3.9

91.69

91.43

ng/l

0.05

3165

19397

Other necrotizing vasculopathies

652

2346

3.28

140.09

8.1

3.8

111.79

92.44

ng/l

3.49

609

1977

Solid cancers

4561

17862

1.54

140.01

4.2

4.1

87.41

89.77

ng/l

0.81

4037

15543

Glucagon-like peptide-1 (GLP-1) analogues

1805

9754

1.96

139.87

4.7

4.1

96.45

87.13

ng/l

3.49

1559

8623

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1805

9754

1.96

139.87

4.7

4.1

96.45

87.13

ng/l

3.49

1559

8623

Bacterial pneumonia (organism specified)

2768

15227

1.72

139.87

5.6

3.9

113.56

91.07

ng/l

15.46

2504

12968

Arthropathies

4550

15238

1.55

138.93

4.5

4.0

91.36

85.72

ng/l

2.91

4027

13350

Bipolar affective disorders

1050

4655

2.41

138.59

3.4

4.0

79.31

85.81

ng/l

1.52

919

4160

Obesity related asthma

2143

12243

1.85

138.55

4.1

95.15

88.60

ng/l

2.10

1875

10662

Chronic gastritis

1828

9994

1.96

138.16

4.3

3.6

98.20

90.75

ng/l

2.27

1583

8495

Cerebrovascular diseases

4408

20531

1.55

137.75

4.9

3.8

104.14

90.36

ng/l

13.64

3784

17636

Other/unspecified dorsalgia

2229

12698

1.82

137.65

3.9

4.0

85.91

92.15

ng/l

2.44

1945

10952

Unspecified nephritic syndrome

270

540

6.84

137.65

12.1

3.1

155.16

78.39

ng/l

9.89

250

476

Cholelithiasis

4852

22629

1.51

137.60

4.1

3.8

93.20

88.27

ng/l

2.77

4193

19560

Spondylosis

3165

15537

1.66

135.75

3.4

4.1

81.47

94.57

ng/l

15.04

2685

13378

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

479

1475

3.97

135.34

5.7

3.7

104.79

93.86

ng/l

1.53

414

1245

Dermatitis

3691

23760

1.58

133.28

4.9

3.9

98.53

87.91

ng/l

6.73

3233

20644

Dermatitis and eczema

6258

26551

1.43

132.59

4.6

4.0

93.98

88.32

ng/l

3.81

5478

23097

Malignant neoplasm of urinary organs, including Hilmo

849

3556

2.66

131.25

6.2

4.1

133.43

99.33

ng/l

10.08

751

3003

Other disorders of glucose regulation and pancreatic internal secretion

651

2400

3.07

130.79

7.2

4.3

117.57

88.37

ng/l

8.46

584

2095

AV-block

1180

4762

2.27

130.54

4.7

3.5

115.50

83.55

ng/l

17.85

991

4010

Concussion

2555

11858

1.73

130.36

3.5

4.2

83.80

85.56

ng/l

0.39

2153

10490

Diaphragmatic hernia

2351

14076

1.77

129.40

4.1

3.7

90.32

90.29

ng/l

0.01

2055

12006

Asthma-related pneumonia

2361

14083

1.76

128.97

4.6

4.0

102.65

91.04

ng/l

5.55

2106

11979

Gingival hyperplasia

382

1048

4.57

128.96

15.0

4.2

115.41

81.10

ng/l

6.78

354

943

Hernia

5262

24539

1.47

128.57

4.6

3.9

94.57

88.79

ng/l

3.58

4597

21259

Asthma-related pneumonia or sepsis

2361

14122

1.75

127.60

4.6

4.0

102.65

91.05

ng/l

5.54

2106

12010

Asthma, hospital admissions 3, pneumonia

2361

14122

1.75

127.60

4.6

4.0

102.65

91.05

ng/l

5.54

2106

12010

Disorder of lipoprotein metabolism, unspecified

877

3763

2.56

127.29

6.4

3.3

125.98

89.46

ng/l

13.13

758

3156

Other external causes of accidental injury

4213

14026

1.55

127.23

4.1

4.0

89.11

85.90

ng/l

1.28

3642

12352

Dysphagia

1628

8797

1.97

126.85

3.8

3.7

83.89

90.33

ng/l

1.94

1393

7556

Autoimmune hyperthyroidism

498

1611

3.54

126.50

3.2

62.62

80.95

ng/l

4.40

457

1396

Other diseases of the digestive system

2046

11858

1.82

126.14

5.7

3.9

115.06

93.54

ng/l

12.52

1748

10093

Anxiety disorders

4884

23293

1.48

125.96

4.0

4.1

83.79

87.41

ng/l

1.77

4258

20430

Neurotic, stress-related and somatoform disorders

4829

23082

1.48

125.89

4.0

4.1

83.86

87.38

ng/l

1.67

4210

20264

Myalgia

1428

7398

2.04

125.43

3.7

3.8

75.34

86.98

ng/l

7.12

1247

6450

Fracture of femur

1936

9944

1.87

125.38

4.2

3.7

99.31

95.27

ng/l

0.90

1640

8299

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5353

23888

1.46

125.33

4.5

3.9

96.84

89.79

ng/l

5.07

4654

20762

GI-bleeding

2037

11822

1.82

124.82

5.7

3.9

114.77

93.96

ng/l

12.05

1744

10046

Retention of urine

2023

9368

1.84

124.66

4.7

4.0

113.34

96.41

ng/l

6.69

1741

8011

Injuries to the hip and thigh

3050

17495

1.63

124.54

4.2

3.9

98.46

92.68

ng/l

1.76

2613

14961

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

751

3058

2.75

123.69

6.3

4.1

132.51

98.82

ng/l

9.03

667

2581

Adjustment and management of implanted device

1211

5993

2.18

123.05

4.8

2.8

118.58

84.35

ng/l

25.76

1020

4994

Fungal Sepsis

404

1186

4.12

122.11

6.9

3.5

129.44

84.48

ng/l

3.91

363

1018

Fracture of lumbar spine and pelvis

1589

8661

1.97

120.87

4.0

3.7

86.65

94.03

ng/l

2.56

1342

7319

Accidents

4175

14026

1.53

120.78

4.1

4.0

89.09

85.90

ng/l

1.25

3610

12352

Other gastritis (incl. Duodenitis)

1429

7534

2.03

120.57

5.2

3.7

102.43

90.67

ng/l

3.74

1258

6439

Diseases of the respiratory system

3407

10988

1.60

119.17

4.2

3.4

90.46

81.71

ng/l

5.64

2966

9536

2579

15927

1.67

119.17

4.4

4.1

90.61

86.90

ng/l

1.06

2271

13871

Pacemaker

2349

13316

1.73

119.03

4.3

3.9

117.24

94.97

ng/l

18.42

1962

11214

Other reaction to severe stress, and adjustment disorders

1885

10783

1.82

118.95

5.0

4.0

91.90

84.44

ng/l

2.10

1658

9612

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5023

27730

1.45

118.71

4.8

4.0

88.91

88.68

ng/l

0.06

4373

24209

Other joint disorders

4292

15178

1.51

118.18

3.9

83.97

85.86

ng/l

0.59

3773

13291

Coxarthrosis [arthrosis of hip](FG)

3053

13451

1.62

117.78

3.8

3.7

89.27

91.11

ng/l

0.48

2596

11539

Injuries to the head

6113

26411

1.41

117.58

4.0

4.1

91.25

88.29

ng/l

1.36

5203

23187

Explicit bacterial Sepsis, including avohilmo

739

3041

2.66

117.40

7.5

3.3

127.98

84.89

ng/l

14.61

659

2593

Other viral diseases

1560

8456

1.93

117.31

8.3

4.2

109.36

84.42

ng/l

13.22

1420

7513

Cellulitis

1369

7176

2.03

117.03

6.4

4.1

117.88

88.77

ng/l

13.68

1210

6256

Implicit fungal Sepsis

379

1106

4.16

115.87

6.9

3.3

133.16

84.03

ng/l

4.13

341

949

Other acute lower respiratory infections

3068

19043

1.59

115.29

5.5

4.0

103.14

89.94

ng/l

7.96

2650

16474

Viral pneumonia

853

3771

2.46

115.08

6.8

3.7

116.38

84.41

ng/l

10.93

752

3231

Cardiomyopathy

1015

4799

2.27

115.06

5.6

3.7

124.36

82.47

ng/l

23.52

920

4121

Vitamin D deficiency

227

456

6.60

114.40

5.0

4.1

89.98

80.05

ng/l

0.77

194

408

Personality disorders, excluding more controls

1210

6067

2.08

114.33

3.7

4.1

85.47

85.29

ng/l

0.02

1058

5448

Explicit bacterial Sepsis

721

2973

2.66

114.06

7.5

3.3

127.97

84.86

ng/l

14.23

643

2536

Malignant neoplasm of urinary organs

721

2998

2.68

113.44

6.3

4.0

135.67

99.29

ng/l

9.80

640

2524

Arthrosis

3643

13247

1.55

113.31

3.7

3.8

87.83

89.33

ng/l

0.33

3174

11490

Liquid cancers, including Hilmo

2158

11451

1.75

113.15

3.9

4.0

86.81

93.25

ng/l

2.45

1873

9742

Unspecified fall

3049

19604

1.59

113.08

4.3

4.1

92.68

90.58

ng/l

0.53

2602

16977

Viral infections characterized by skin and mucous membrane lesions

2436

15166

1.68

112.83

6.3

4.0

99.06

88.59

ng/l

4.87

2123

13233

Major coronary heart disease event excluding revascularizations

3460

15179

1.56

112.72

5.3

3.6

120.53

83.98

ng/l

54.40

3009

12893

Abnormal findings on diagnostic imaging of lung

2933

18073

1.60

112.60

4.4

3.9

94.71

93.54

ng/l

0.23

2563

15434

External causes of morbidity and mortality

3327

10807

1.59

112.46

4.2

3.8

88.58

83.17

ng/l

2.37

2897

9492

Anxiety (asthma-related co-morbidities)

3065

15115

1.59

112.46

3.8

4.2

78.65

85.63

ng/l

4.41

2688

13420

Other medical care

2774

14888

1.63

111.76

4.1

2.8

102.62

78.32

ng/l

22.07

2376

12625

Visual disturbances and blindness

3125

20646

1.57

111.56

4.3

3.9

88.93

89.29

ng/l

0.07

2753

17806

Exclusions for E4_PCOS_BROAD

1077

5290

2.19

110.97

4.8

4.5

84.89

85.67

ng/l

0.08

926

4664

Other diseases of arteries and capillaries

675

2754

2.74

110.66

11.8

3.5

154.85

86.76

ng/l

24.95

615

2344

Gonarthrosis [arthrosis of knee](FG)

3918

15334

1.51

109.60

3.5

3.7

85.09

89.71

ng/l

2.61

3412

13251

Coagulation defects, purpura and other haemorrhagic conditions

1229

6366

2.07

109.44

5.8

4.0

106.15

89.16

ng/l

5.37

1099

5492

Liquid cancers

1806

9954

1.81

108.52

4.0

4.1

86.69

94.17

ng/l

2.83

1561

8445

Other and unspecified dermatitis

3054

20217

1.57

108.10

4.9

3.8

98.73

87.25

ng/l

6.36

2679

17603

Coxarthrosis

2758

11321

1.63

108.09

3.8

3.7

89.09

90.91

ng/l

0.44

2346

9714

Other CVD

1405

7660

1.97

107.91

4.9

3.8

108.47

96.65

ng/l

3.23

1190

6449

Chronic lower respiratory diseases

6420

25069

1.38

107.67

4.1

92.16

87.92

ng/l

2.43

5651

21858

853

3870

2.37

107.40

6.3

3.6

102.69

82.15

ng/l

6.12

763

3403

Lumbar disc prolapse

3373

16713

1.54

107.33

3.5

4.2

83.07

93.35

ng/l

8.41

2995

14539

Malignant neoplasm of kidney, except renal pelvis

662

2726

2.72

106.57

6.5

4.0

135.59

98.97

ng/l

9.45

590

2301

Idiopathic hypercalciuria

120

139

18.48

106.45

3.9

60.70

76.23

ng/l

1.60

108

126

Myocardial infarction

2780

12505

1.62

106.24

5.8

3.6

126.83

84.00

ng/l

56.44

2435

10599

Diseases of oral cavity, salivary glands and jaws

3183

10696

1.58

106.21

4.2

3.4

92.67

89.58

ng/l

0.92

2698

9205

Venous thromboembolism

3202

20704

1.55

105.79

4.9

3.8

104.22

91.25

ng/l

9.60

2794

17659

Chronic periodontitis, complicated

3221

21118

1.54

105.47

6.1

3.8

109.68

89.56

ng/l

17.61

2811

18347

Recurrent or chronic depression

2000

8205

1.75

105.11

3.5

4.4

79.59

90.16

ng/l

5.83

1739

7328

Chronic ulcer of skin, not elsewhere classified

557

2136

2.98

104.67

7.5

3.5

141.47

90.78

ng/l

10.28

504

1809

Other diseases of anus and rectum

1812

10643

1.78

104.31

4.4

3.7

99.72

90.03

ng/l

3.30

1543

9084

Gastroduodenal ulcer

1584

8986

1.86

103.91

5.5

3.7

113.67

94.99

ng/l

7.16

1374

7610

Iron deficiency anaemia secondary to blood loss (chronic)

1111

5675

2.12

103.89

5.8

3.7

119.57

89.45

ng/l

11.04

934

4827

Sulfonylureas

2051

9871

1.74

103.51

5.7

3.7

127.13

94.27

ng/l

27.04

1724

8278

Chronic apical periodontitis

5976

24781

1.38

103.47

4.5

3.9

96.70

87.53

ng/l

8.09

5127

21683

Disorders of synovium and tendon

2839

15728

1.58

103.41

4.1

3.9

86.46

88.90

ng/l

0.70

2480

13662

Hypotension

1243

6648

2.02

101.67

5.0

3.7

107.95

97.64

ng/l

2.37

1045

5570

Streptococcal septicaemia, including avohilmo

640

2646

2.67

101.37

7.5

3.4

130.06

84.33

ng/l

13.59

569

2253

Diabetic maculopathy

931

4276

2.30

101.19

9.6

4.4

168.84

98.67

ng/l

27.46

826

3682

Amputation of foot

272

699

4.96

100.99

11.8

3.9

181.00

101.25

ng/l

10.89

247

603

Other disorders of lacrimal gland

2245

14128

1.67

100.75

4.0

3.7

86.06

86.78

ng/l

0.12

1918

12168

All anxiety disorders

3119

16156

1.54

100.70

3.8

4.1

78.52

86.32

ng/l

5.44

2736

14321

Selective serotonin reuptake inhibitors

5193

19558

1.41

100.34

3.6

4.4

85.61

93.31

ng/l

6.52

4466

17137

Reimbursement for rheumatic diseases

3237

21909

1.52

99.74

4.3

3.9

80.57

88.63

ng/l

4.89

2875

18927

Viral and other specified intestinal infections, including avohilmo

1393

7374

1.89

99.66

6.9

3.6

97.17

80.75

ng/l

5.79

1271

6470

Multiple myeloma, including Hilmo

405

1356

3.55

99.09

4.4

3.8

91.12

95.75

ng/l

0.40

357

1138

Chronic pancreatitis

787

3591

2.39

99.01

5.9

4.3

113.23

96.17

ng/l

3.01

678

3097

Exclusions for E4_PCOS_CONSORTIUM

3920

17046

1.48

98.93

3.8

3.7

83.42

81.55

ng/l

0.52

3371

14963

Streptococcal septicaemia

623

2573

2.68

98.91

7.5

3.4

130.52

84.42

ng/l

13.33

554

2196

Irritable bowel syndrome

1545

8838

1.83

98.80

3.3

3.5

77.76

84.38

ng/l

2.95

1330

7669

All influenza (not pneumonia)

849

3973

2.28

98.77

6.9

3.9

114.46

83.62

ng/l

9.64

744

3459

Other viral diseases, including avohilmo

1902

11382

1.72

98.33

7.4

4.1

102.20

84.35

ng/l

9.65

1730

10152

Asthma/COPD (KELA code 203)

5125

25046

1.40

98.17

3.7

4.1

87.58

87.95

ng/l

0.10

4485

21836

Myocardial infarction, without ST-elevation

2423

14053

1.63

97.83

5.6

3.8

129.51

95.25

ng/l

30.22

2099

11847

Rotator cuff syndrome

3340

15623

1.52

97.83

3.7

3.9

84.98

92.22

ng/l

4.74

2946

13476

Other headache syndromes

2276

14371

1.64

97.67

3.3

3.8

78.28

85.17

ng/l

3.71

2007

12583

Other diseases of hard tissues of teeth

3093

10586

1.56

97.64

4.4

3.4

93.09

89.31

ng/l

1.32

2628

9130

Hypoglycaemia, other or unspecified

501

1881

3.00

97.25

7.0

4.4

119.85

90.18

ng/l

6.42

452

1640

Gonarthrosis

3291

12511

1.53

96.80

3.5

3.7

84.08

89.82

ng/l

3.27

2867

10804

Vitamin deficiency, wide

400

1340

3.45

96.54

4.8

4.1

91.30

89.64

ng/l

0.12

332

1178

Vitamin deficiency

400

1340

3.45

96.54

4.8

4.1

91.30

89.64

ng/l

0.12

332

1178

Gingivitis and periodontal diseases

5366

20327

1.40

96.46

4.8

3.6

95.19

86.85

ng/l

7.13

4648

17624

Disorders of phosphorus metabolism and phosphatases

19.79

96.41

10.1

4.3

115.91

73.69

ng/l

2.31

Asthma, hospital admissions , main diagnosis only

4419

27720

1.42

96.31

3.9

4.1

88.78

88.44

ng/l

0.08

3897

24090

Injuries to the thorax

2617

17183

1.58

96.10

4.3

4.1

94.84

94.46

ng/l

0.06

2235

14860

Injuries to the elbow and forearm

3974

24141

1.45

96.04

4.1

4.0

90.93

86.70

ng/l

1.74

3385

21044

Rheumatoid arthritis

1784

9431

1.75

95.85

3.5

83.52

87.62

ng/l

0.83

1552

8091

Other diseases of liver

1122

5903

2.03

95.50

4.6

4.0

89.85

89.61

ng/l

0.03

996

5118

Other neurological diseases

4120

22792

1.44

95.10

4.1

3.9

94.52

91.19

ng/l

1.29

3583

19576

Disorders of lacrimal system

2651

17264

1.57

94.33

3.9

3.7

86.22

86.80

ng/l

0.11

2271

14839

Noninfective enteritis and colitis

2528

16524

1.58

94.17

4.7

4.1

91.04

88.30

ng/l

0.68

2235

14431

Thyrotoxicosis with toxic multinodular goitre

535

2138

2.92

94.08

3.4

3.5

72.02

86.85

ng/l

2.65

473

1787

Other anxiety disorders

2275

12284

1.62

93.76

3.7

4.1

78.18

85.31

ng/l

3.57

1996

10935

Convulsions, not elsewhere classified

1174

6177

1.96

93.63

4.8

3.8

88.33

86.09

ng/l

0.32

1036

5397

Visual disturbances

2807

18849

1.55

93.26

4.1

3.9

86.35

88.76

ng/l

0.63

2482

16315

Acute upper respiratory infections

5689

25502

1.37

92.65

4.5

3.8

90.76

88.67

ng/l

0.79

4956

22111

Other diseases of pleura

2646

15250

1.57

91.80

5.3

3.9

114.35

93.99

ng/l

12.36

2252

13021

Dental operations

3324

11628

1.51

91.10

4.1

3.6

93.06

89.99

ng/l

0.99

2811

10072

Other systemic involvement of connective tissue

1728

10470

1.74

91.01

3.4

3.5

78.29

88.13

ng/l

5.24

1511

8916

Angina pectoris

3130

14155

1.52

90.44

4.7

3.5

110.27

82.74

ng/l

32.71

2695

12028

Disorders of continuity of bone

643

2800

2.50

90.23

4.5

3.8

86.63

84.38

ng/l

0.14

572

2453

Benign neoplasm of other and unspecified endocrine glands

875

4326

2.20

90.03

4.8

3.9

95.55

90.60

ng/l

0.71

779

3724

Fracture of rib(s), sternum and thoracic spine

1814

11138

1.71

89.98

4.2

4.1

94.14

95.45

ng/l

0.20

1525

9574

Other diseases of intestine

970

4958

2.10

89.87

6.3

3.7

111.97

90.91

ng/l

3.99

865

4222

Other and/or unspecified nontoxic goitre

605

2591

2.61

89.78

3.2

3.6

64.18

89.61

ng/l

19.90

554

2209

Deforming dorsopathies

1585

9386

1.77

89.65

4.0

4.1

80.18

89.47

ng/l

4.00

1398

8139

Substance abuse, excluding more controls

2668

14823

1.55

88.83

3.9

4.4

93.05

94.33

ng/l

0.23

2310

13107

Acute bronchitis

2352

15054

1.59

88.80

5.3

3.9

102.98

89.24

ng/l

7.09

2008

12969

Viral and other specified intestinal infections

1040

5292

2.00

88.29

8.0

3.7

102.37

80.52

ng/l

6.43

945

4658

Asthma, including avohilmo

6241

26166

1.34

88.27

3.8

4.2

88.32

89.55

ng/l

0.44

5491

22752

Persons encountering health services in other circumstances

2183

13871

1.61

88.14

4.4

3.7

91.70

84.88

ng/l

2.09

1808

12155

Mycoses

1612

9659

1.75

87.87

5.4

4.0

103.65

89.50

ng/l

3.54

1426

8361

Sequelae of external causes of morbidity and mortality

1552

9227

1.78

87.63

5.9

3.8

114.15

90.29

ng/l

9.68

1397

7915

Benign neoplasm: Colon, unspecified

1560

9312

1.78

87.34

5.3

3.8

108.22

92.92

ng/l

6.53

1365

7928

Other disorders of ear

4989

23929

1.38

86.97

4.0

4.1

90.49

89.98

ng/l

0.12

4249

20941

Acute nephritic syndrome

209

492

5.38

86.68

13.2

3.9

128.81

81.20

ng/l

6.48

198

432

Injuries to the knee and lower leg

6312

26106

1.33

86.02

4.2

4.0

90.63

88.54

ng/l

0.80

5549

22703

Carpal tunnel syndrome

3388

20669

1.46

85.60

4.0

3.8

87.30

88.71

ng/l

0.39

2985

17834

Soft tissue disorders related to use, overuse and pressure

1580

9503

1.74

84.65

4.1

3.8

95.05

90.51

ng/l

0.68

1396

8182

Disorders of skin appendages

2569

17150

1.54

84.58

5.2

4.0

97.98

85.30

ng/l

6.91

2275

15104

COPD (mode)

1673

7877

1.73

84.47

4.5

3.4

109.15

87.00

ng/l

11.12

1416

6695

Candidiasis, including avohilmo

1731

10670

1.70

84.29

4.2

3.7

89.31

85.73

ng/l

0.55

1496

9255

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

596

2618

2.55

83.71

4.7

3.7

96.71

92.28

ng/l

0.48

512

2199

Tubulo-interstitial nephritis, not specified as acute or chronic

436

1637

2.93

83.67

7.5

2.1

126.15

68.59

ng/l

12.95

382

1370

Drug-induced cataract

241

651

4.69

83.63

11.7

3.9

145.48

82.11

ng/l

3.62

217

578

Calcific aortic valvular stenosis, operated

1852

11229

1.67

83.04

5.4

3.8

124.11

96.96

ng/l

15.90

1587

9356

Calcific aortic valvular stenosis

1852

11229

1.67

83.04

5.4

3.8

124.11

96.96

ng/l

15.90

1587

9356

Calcific aortic valvular stenosis, including rheumatic fever

1853

11236

1.67

82.62

5.4

3.7

124.25

96.97

ng/l

16.05

1587

9362

Non-selective monoamine reuptake inhibitors

2106

13080

1.61

82.61

3.4

4.0

86.00

91.43

ng/l

1.81

1775

11287

Acute upper respiratory infections of multiple and unspecified sites

4015

21233

1.41

82.49

5.0

3.8

94.89

87.32

ng/l

4.23

3526

18558

Operations 2 for CAVS

1846

11209

1.67

82.24

5.4

3.7

124.42

97.03

ng/l

16.07

1581

9338

Calcific aortic valvular stenosis, diagnosis (helper)

1846

11209

1.67

82.24

5.4

3.7

124.42

97.03

ng/l

16.07

1581

9338

Amputation of ankle bones

217

548

4.94

81.98

13.3

4.0

205.99

97.82

ng/l

13.28

191

472

Polyuria

1287

7396

1.84

81.95

4.2

3.9

91.27

93.82

ng/l

0.45

1103

6346

Any operation in hilmo

139

9.85

81.76

4.0

1.6

84.32

60.16

ng/l

2.01

126

Nonorganic sleeping disorders, excluding more controls

1016

5413

1.96

81.47

4.0

82.63

86.01

ng/l

0.59

903

4820

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1222

6787

1.84

81.44

3.3

4.0

82.57

85.62

ng/l

0.45

1055

6097

Primary_lymphoid and hematopoietic malignant neoplasms

1443

8611

1.77

80.69

4.2

4.1

87.83

94.98

ng/l

2.05

1244

7332

Viral hepatitis, IBD co-morbidity

232

599

4.13

80.42

5.0

2.9

97.96

76.09

ng/l

2.88

214

544

Injury, poisoning and certain other consequences of external causes

2637

8771

1.54

80.30

4.2

3.7

86.27

82.11

ng/l

1.35

2305

7650

Multiple myeloma and malignant plasma cell neoplasms

408

1549

3.08

79.48

4.5

3.8

94.13

96.05

ng/l

0.13

360

1325

Cardiomyopathies, Primary/intrinsic

659

3046

2.32

79.43

6.0

3.9

131.91

83.14

ng/l

18.36

599

2635

Hernia of abdominal wall

2448

16545

1.53

78.75

5.4

4.1

107.34

92.34

ng/l

7.46

2131

14384

Undetermined asthma, excluding more controls

739

3574

2.20

78.73

4.0

3.2

86.42

78.36

ng/l

1.45

649

3077

Symptoms and signs involving the nervous and musculoskeletal systems

3205

22769

1.45

78.62

3.8

4.1

87.35

90.12

ng/l

0.89

2770

19757

Wegener granulomatosis

179

409

5.90

78.39

10.1

3.8

115.48

88.85

ng/l

2.29

170

361

Cardiomyopathy (excluding other)

681

3209

2.27

78.19

6.0

3.9

130.60

82.94

ng/l

18.62

619

2776

Stroke, excluding SAH

3386

17428

1.45

78.00

4.7

3.9

107.16

92.15

ng/l

11.84

2884

14871

Adrenocortical insufficiency

286

893

3.73

77.78

4.4

3.5

75.06

79.52

ng/l

0.38

236

784

Fracture of lower leg, including ankle

3014

20817

1.46

77.76

4.5

4.0

92.90

88.49

ng/l

1.61

2630

18015

KRA_PSY_EATING, excluding more controls

365

1269

3.02

77.52

4.1

3.5

74.95

65.42

ng/l

1.11

325

1187

Other disorders of adrenal gland

331

1126

3.35

77.42

4.3

3.7

78.24

78.79

ng/l

0.04

274

997

Malignant neoplasm of skin, including Hilmo

2934

13638

1.49

77.29

4.7

3.9

100.07

91.88

ng/l

3.48

2516

11667

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2659

17625

1.50

77.16

4.1

4.3

83.24

93.30

ng/l

6.70

2332

15435

Stroke, including SAH

3529

18216

1.43

77.15

4.8

3.9

106.94

91.39

ng/l

13.30

3012

15576

Dental caries, including avohilmo

3953

14653

1.42

77.10

4.2

3.7

92.42

89.31

ng/l

1.18

3372

12677

Caries of dentine, including avohilmo

4232

15838

1.40

77.06

4.2

3.8

91.64

88.73

ng/l

1.14

3621

13756

Myocardial infarction, strict

2473

11786

1.54

76.97

5.7

3.6

126.51

84.62

ng/l

48.66

2160

9978

Diseases of pulp and periapical tissues and dental caries

3588

13109

1.44

76.93

4.2

3.6

92.55

88.76

ng/l

1.41

3041

11338

Acute sinusitis

2633

16402

1.50

76.76

4.8

3.8

90.14

85.61

ng/l

1.33

2311

14453

Paralytic ileus and intestinal obstruction

1472

8910

1.73

76.72

5.0

3.6

104.14

91.68

ng/l

2.79

1260

7572

Functional dyspepsia

1513

9240

1.71

76.46

3.7

3.6

83.24

86.73

ng/l

0.90

1308

8005

Polyarthrosis

1274

6703

1.81

75.48

3.3

3.4

78.37

87.87

ng/l

4.84

1056

5679

DVT of lower extremities and pulmonary embolism

2415

16369

1.53

75.32

4.5

3.8

101.60

92.31

ng/l

4.34

2088

13950

Gastric ulcer

1062

5931

1.90

74.75

5.3

3.8

108.30

94.74

ng/l

3.47

928

5008

Mycoses, including avohilmo

4810

27743

1.35

74.71

4.0

4.1

87.86

89.39

ng/l

0.45

4207

24202

Viral warts

609

2807

2.35

74.60

9.3

4.0

112.94

83.99

ng/l

5.85

543

2474

Acute pancreatitis

1098

6191

1.87

74.57

5.2

4.1

108.98

93.80

ng/l

3.63

952

5342

Cardiac arrest

334

953

3.20

74.39

6.8

2.3

137.87

64.94

ng/l

17.78

294

809

Hyperkinetic disorders, excluding more controls

486

1859

2.54

74.34

4.9

4.6

66.40

71.79

ng/l

0.78

435

1758

Disturbances of skin sensation

1432

8676

1.72

74.25

3.9

3.8

80.16

86.64

ng/l

2.19

1278

7555

Other obstructive and reflux uropathy

272

839

3.62

73.99

8.4

2.3

133.34

64.34

ng/l

8.23

242

730

Disorders of parathyroid gland, other and/or unspecified

121

213

9.85

73.84

6.4

2.8

116.72

77.58

ng/l

2.61

103

179

Diabetic neuropathy

843

4427

2.10

73.81

8.3

5.0

144.55

108.45

ng/l

9.43

749

3816

Other diseases of upper respiratory tract

5783

23244

1.32

73.72

4.0

4.1

86.31

91.96

ng/l

4.44

5051

20125

Purpura and other haemorrhagic conditions

828

4303

2.07

73.49

5.7

4.2

106.66

90.50

ng/l

3.39

740

3711

Benign neoplasm of other and ill-defined parts of digestive system

1125

6468

1.86

72.69

4.6

3.8

97.41

91.51

ng/l

1.14

968

5501

Diseases of the ear and mastoid process

5748

22220

1.32

72.52

4.3

4.1

89.33

89.25

ng/l

0.02

4993

19572

Molar incisor enamel hypoplasia

281

856

3.58

72.44

16.4

5.4

68.60

57.13

ng/l

1.77

272

824

Other viral diseases, not elsewhere classified

979

5354

1.92

72.32

7.6

4.3

98.17

84.17

ng/l

3.41

883

4737

Fibrosis and cirrhosis of liver

546

2458

2.47

72.19

5.4

4.0

96.02

92.69

ng/l

0.31

488

2116

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2693

12589

1.49

71.96

4.7

3.9

98.43

91.96

ng/l

2.37

2313

10717

Disorders of magnesium metabolism

108

168

9.51

71.95

5.1

3.6

105.26

91.03

ng/l

0.49

143

2541

15849

1.50

71.72

4.5

3.7

102.47

94.17

ng/l

3.18

2152

13331

Malignant neoplasm of skin

2789

13170

1.48

71.67

4.6

3.9

98.81

91.76

ng/l

2.68

2402

11244

Drug-induced osteoporosis with pathological fracture

198

529

5.05

71.28

3.9

3.7

79.41

83.92

ng/l

0.28

175

456

Hypoplasia of dental enamel , including avohilmo

269

813

3.64

71.12

16.2

5.5

68.81

57.06

ng/l

1.73

260

784

Symptoms and signs involving speech and voice

1913

12583

1.59

70.81

3.8

82.03

89.71

ng/l

3.18

1670

10831

Intestinal malabsorption

352

1306

3.07

70.56

6.9

3.9

107.02

85.28

ng/l

2.73

310

1139

Sequelae with surgical and medical care as external cause

1226

7267

1.79

70.49

6.1

3.8

115.01

91.05

ng/l

7.50

1100

6195

Persons encountering health services for specific procedures, not carried out

498

2162

2.48

69.93

6.0

2.8

102.74

74.70

ng/l

7.05

452

1886

Skin changes due to chronic exposure to nonionizing radiation

2426

15179

1.51

69.89

4.6

3.7

103.07

94.54

ng/l

3.16

2057

12741

Ischaemic Stroke, excluding all haemorrhages

3162

16740

1.43

69.63

4.7

3.9

107.67

92.80

ng/l

10.93

2691

14245

Thyroiditis, ILD-related definition

700

3495

2.15

69.57

3.9

3.6

81.76

80.50

ng/l

0.15

607

3029

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

853

4563

2.00

69.36

5.1

4.4

97.59

98.02

ng/l

0.04

755

3951

Open wound of head

2902

19417

1.44

69.18

4.2

4.3

94.61

92.94

ng/l

0.36

2416

16934

Disorders of vitreous body and globe

2977

20207

1.44

69.13

5.0

3.8

103.16

89.42

ng/l

8.30

2576

17421

Undetermined asthma

739

3752

2.09

69.02

4.0

3.3

86.42

82.97

ng/l

0.43

649

3223

Benign neoplasm: Transverse colon

714

3623

2.15

68.90

5.0

4.0

97.97

95.53

ng/l

0.27

653

3093

Fracture of forearm

3105

20128

1.43

68.61

4.0

3.8

90.16

85.68

ng/l

1.74

2629

17460

Exposure to other specified factors

4113

26548

1.36

68.59

4.4

4.1

91.31

87.91

ng/l

1.08

3648

23265

Neuromuscular dysfunction of bladder

558

2574

2.35

68.45

4.7

3.9

94.66

91.59

ng/l

0.24

485

2206

Disorders of adult personality and behaviour

1278

7662

1.73

68.42

3.6

4.1

83.21

85.40

ng/l

0.36

1119

6872

Other noninfective gastroenteritis and colitis

1394

8585

1.70

68.11

5.3

4.0

94.83

87.33

ng/l

1.84

1225

7414

Fibromyalgia

555

2553

2.34

68.10

2.8

3.5

69.99

80.72

ng/l

2.34

490

2214

Polycystic ovarian syndrome, consortium definition

3848

16316

1.39

67.99

3.5

3.3

79.78

78.59

ng/l

0.30

3284

14151

Actinic keratosis

2363

14871

1.51

67.83

4.6

3.7

103.47

94.81

ng/l

3.15

2005

12467

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2589

12226

1.49

67.79

4.5

3.9

97.93

92.21

ng/l

1.90

2213

10394

Disorders of sclera, cornea, iris and ciliary body

2867

20528

1.44

67.25

4.7

3.9

96.80

88.90

ng/l

3.64

2531

17861

Any death

3498

17989

1.40

67.03

5.0

3.8

124.06

85.06

ng/l

44.86

3075

15454

Somatoform disorder

900

4937

1.93

66.91

3.3

3.8

76.35

84.93

ng/l

2.29

779

4318

Diseases of pulp and periapical tissues, including avohilmo

5407

21665

1.31

66.72

4.1

4.0

92.19

87.09

ng/l

2.94

4667

18928

Other blood glucose lowering drugs, excl. Insulins

947

5307

1.90

66.47

4.6

3.8

106.00

91.78

ng/l

3.67

796

4477

Disorders of vitreous body

2892

19787

1.44

66.46

4.9

3.8

102.83

89.27

ng/l

7.86

2509

17062

Need for other prophylactic measures

405

1657

2.74

66.43

8.0

4.3

93.59

85.98

ng/l

0.93

388

1460

Schizophrenia or delusion, excluding more controls

1372

8356

1.68

65.50

3.5

4.2

83.96

90.44

ng/l

1.61

1161

7375

Other skin changes

1194

7170

1.76

65.30

6.3

3.7

107.73

91.42

ng/l

4.87

1070

6078

Cholecystectomy

3850

24560

1.36

65.21

4.1

3.8

92.45

89.24

ng/l

1.23

3341

21169

Early onset COPD, excluding more controls

969

5458

1.85

65.06

4.7

3.8

103.69

87.20

ng/l

4.45

837

4751

Degeneration of macula and posterior pole

2839

15691

1.44

65.01

4.1

3.6

100.78

91.58

ng/l

4.29

2331

13307

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

566

2684

2.29

64.87

4.9

3.8

98.63

84.53

ng/l

2.25

498

2311

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

257

849

3.63

64.79

3.8

3.7

93.06

93.58

ng/l

0.03

225

718

Multiple myeloma

257

849

3.63

64.79

3.8

3.7

93.06

93.58

ng/l

0.03

225

718

Acute pancreatitis (for exclusion)

1098

6449

1.79

64.78

5.2

4.1

108.98

93.62

ng/l

3.72

952

5559

Intracranial injury

3054

20697

1.41

64.20

3.7

4.2

90.30

90.36

ng/l

0.01

2533

18056

Basal cell carcinoma, including Hilmo

2588

12318

1.47

64.10

4.6

3.9

99.58

92.11

ng/l

2.82

2213

10474

Enlarged lymph nodes

816

4391

1.95

64.01

4.0

3.7

77.95

87.25

ng/l

2.69

714

3802

SLE (Finngen)

265

889

3.43

63.87

5.8

3.3

91.71

77.00

ng/l

2.06

243

783

Personality disorders

1210

7287

1.72

63.79

3.7

4.1

85.47

85.09

ng/l

0.05

1058

6528

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

833

3889

1.93

63.56

5.7

4.8

71.71

73.92

ng/l

0.31

758

3608

Unspecified privation

641

3213

2.15

63.19

6.2

4.0

109.46

89.97

ng/l

4.23

591

2789

Late syphilis

146

336

5.67

62.94

9.7

4.0

152.42

86.62

ng/l

6.39

132

299

Melanocytic naevi

1602

10400

1.60

62.43

6.0

3.9

102.03

87.22

ng/l

5.87

1449

9086

Misadventures to patients during surgical and medical care

847

4675

1.93

62.32

6.0

3.6

110.73

88.21

ng/l

5.86

742

3990

Pain in thoracic spine

828

4521

1.93

62.28

3.4

4.0

74.64

92.12

ng/l

9.06

738

3899

Late syphilis, including avohilmo

163

410

5.00

62.21

9.4

3.8

149.49

83.06

ng/l

7.41

144

366

Sarcoidosis

757

4043

2.00

61.95

4.6

3.8

85.24

90.19

ng/l

0.58

665

3492

Unspecified contracted kidney

141

10.36

61.73

9.4

3.4

163.56

76.26

ng/l

4.43

122

Candidiasis

842

4653

1.92

61.68

5.1

3.8

100.81

85.66

ng/l

1.83

727

4008

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

619

3099

2.17

61.67

7.0

4.0

122.45

90.66

ng/l

4.26

570

2682

Special screening examination for infectious and parasitic diseases

871

3441

1.89

61.57

3.4

3.5

74.17

81.62

ng/l

1.77

774

3084

Weight loss

668

3444

2.10

61.40

3.8

4.2

80.16

90.27

ng/l

1.97

583

2946

Diagnoses used for exclusion with ILD

1395

8824

1.65

61.39

4.4

4.0

88.45

94.76

ng/l

1.45

1195

7562

Amyloidosis

204

605

4.06

61.01

6.1

3.3

124.56

88.76

ng/l

1.27

178

514

Organic, including symptomatic, mental disorders

2977

15243

1.42

60.98

3.3

4.0

88.86

96.50

ng/l

5.08

2447

12964

Ventral hernia

1354

8525

1.66

60.96

5.2

3.8

102.66

91.39

ng/l

2.79

1173

7295

Chronic rhinitis, nasopharyngitis and pharyngitis

1674

11023

1.57

60.91

3.9

4.1

82.77

89.16

ng/l

2.36

1487

9645

Other renal tubulo-interstitial diseases

188

524

4.20

60.84

10.8

2.3

130.79

64.73

ng/l

8.65

170

464

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1233

7460

1.69

60.77

5.9

3.9

77.12

79.37

ng/l

0.35

1104

6718

Unspecified mental disorder

1893

12795

1.52

60.32

3.5

4.2

82.44

90.15

ng/l

2.93

1619

11246

Elevated blood glucose level

528

2510

2.28

60.28

6.2

4.2

109.37

89.99

ng/l

3.24

468

2177

Trochanteric bursitis

903

5143

1.86

59.93

3.6

3.5

86.40

87.09

ng/l

0.07

799

4374

Complications of internal orthopaedic prosthetic devices, implants and grafts

1352

8565

1.66

59.77

4.2

3.4

97.83

89.57

ng/l

1.30

1156

7214

Basal cell carcinoma

2486

11993

1.46

59.52

4.5

3.9

97.84

92.30

ng/l

1.81

2117

10186

Renal agenesis and other reduction defects of kidney, including avohilmo

131

10.59

59.27

10.8

4.3

130.09

69.69

ng/l

4.34

117

Haemorrhoids and perianal venous thrombosis

1800

12021

1.54

59.14

3.8

3.6

85.56

89.10

ng/l

1.01

1553

10265

In situ neoplasms

2264

15949

1.47

59.13

4.5

3.6

100.82

89.40

ng/l

5.78

1933

13608

Open wound of lower leg

889

5056

1.86

58.98

5.8

4.0

108.10

91.80

ng/l

2.50

785

4323

Conductive and sensorineural hearing loss

4216

21486

1.33

58.91

3.8

4.1

90.52

91.55

ng/l

0.26

3518

18665

Cervicalgia

1123

6801

1.73

58.74

3.5

4.0

79.36

92.12

ng/l

5.82

1009

5836

Decubitus ulcer and pressure area

440

1972

2.47

58.72

8.2

3.5

143.61

94.10

ng/l

8.88

384

1648

Disorders of conjunctiva

4287

25623

1.32

58.70

4.2

4.0

82.93

87.37

ng/l

2.63

3759

22369

Renal agenesis and other reduction defects of kidney

115

11.77

58.38

11.3

4.2

134.61

67.28

ng/l

4.73

104

Acidosis

172

466

4.38

58.30

6.7

3.6

125.50

84.72

ng/l

3.18

147

407

Other viral diseases, not elsewhere classified, including avohilmo

1277

7928

1.66

58.28

6.5

4.2

91.22

83.51

ng/l

1.85

1156

7045

Haemolytic anaemias

274

991

3.20

58.17

9.1

4.2

120.20

87.52

ng/l

4.11

240

871

Cardiomyopathy, other and unspecified

443

1992

2.41

57.75

5.0

3.6

125.22

81.36

ng/l

12.86

400

1730

Artrosis, including avohilmo

3982

16547

1.34

57.74

3.6

4.4

85.57

95.53

ng/l

8.53

3439

14524

Amyloidosis, other/unspecified

177

498

4.38

57.67

6.0

3.2

123.33

88.24

ng/l

1.05

156

422

Abnormal findings on diagnostic imaging of other body structures

880

5040

1.86

57.53

4.5

3.7

90.09

88.45

ng/l

0.21

772

4318

Generalized anxiety disorder

721

3842

1.95

57.45

3.1

3.9

71.60

78.98

ng/l

2.18

644

3460

Fracture of foot, except ankle

1250

7811

1.66

57.40

5.1

4.0

90.76

86.89

ng/l

0.66

1095

6854

Specific personality disorders

1040

6192

1.74

57.35

3.6

4.0

81.70

84.47

ng/l

0.49

911

5547

Use of pramipexole

1292

8182

1.66

57.33

5.4

3.7

107.20

90.40

ng/l

5.36

1091

6965

Noninfectious colitis NAS

787

4363

1.91

56.95

5.3

4.0

97.82

87.51

ng/l

1.74

696

3758

Abnormal weight loss

617

3182

2.11

56.83

3.7

4.2

78.07

90.99

ng/l

3.20

536

2721

Pulmonary heart disease, diseases of pulmonary circulation

1803

12263

1.53

56.82

4.3

3.8

104.08

91.91

ng/l

5.37

1548

10426

Alcohol use disorder, Swedish definition

2535

16571

1.42

56.75

4.1

4.5

96.66

96.71

ng/l

0.01

2200

14567

Delirium, not induced by alcohol and other psychoactive substances

793

4413

1.92

56.73

3.9

100.34

100.94

ng/l

0.05

641

3727

Vascular disorders of the intestines

464

2152

2.36

56.64

6.6

3.6

126.02

95.80

ng/l

5.46

411

1792

Voice disturbances

1495

9795

1.59

56.61

3.7

3.8

79.02

89.07

ng/l

4.49

1318

8463

Injuries to the ankle and foot

3492

22524

1.35

56.42

4.9

4.1

93.06

86.13

ng/l

3.45

3079

19864

Diseases of the myoneural junction and muscle

737

4038

1.95

55.90

4.2

4.1

94.27

93.42

ng/l

0.08

622

3458

Sensorineural hearing loss

4038

20706

1.33

55.74

3.8

4.0

91.13

92.07

ng/l

0.23

3348

17946

Zoster [herpes zoster], including avohilmo

2878

20527

1.39

55.74

4.3

3.7

90.14

89.70

ng/l

0.09

2464

17647

Nonalcoholic fatty liver disease

577

2924

2.12

55.14

3.7

4.1

79.85

85.79

ng/l

1.01

520

2568

Poisoning by drugs, medicaments and biological substances

1095

6684

1.70

55.05

3.6

4.2

88.55

86.12

ng/l

0.28

948

5949

Other disorders of eyelid

2542

17442

1.42

54.67

3.9

3.7

91.91

91.11

ng/l

0.16

2193

14862

Other degenerative diseases of the nervous system

1458

6882

1.60

54.57

3.0

3.9

84.34

91.12

ng/l

2.39

1210

5910

Transient ischemic attack

2880

16950

1.39

54.55

4.0

3.8

99.36

91.93

ng/l

3.36

2491

14420

Abnormal involuntary movements

786

4420

1.89

54.50

3.9

4.1

87.06

90.98

ng/l

0.57

677

3807

Benign neoplasm: Ascending colon

866

5026

1.84

54.46

4.9

3.9

106.19

94.62

ng/l

2.68

774

4270

Zoster [herpes zoster]

1110

6868

1.70

54.19

5.2

3.6

99.11

91.41

ng/l

1.71

945

5816

Hallux valgus (acquired)

1744

8413

1.53

53.91

3.1

3.4

78.48

85.77

ng/l

3.11

1495

7218

Endocarditis

237

819

3.25

53.74

9.0

3.6

164.33

84.01

ng/l

10.62

213

713

Other specified disorders of kidney and ureter

247

882

3.23

53.64

10.1

3.5

152.10

82.77

ng/l

5.91

224

766

Kela-code for severe mental illness

1690

11448

1.52

53.51

3.4

4.2

82.97

90.93

ng/l

2.68

1433

10040

Other diseases of pericardium

289

1112

2.88

53.45

7.9

3.6

143.78

80.10

ng/l

8.21

255

965

Thiazolidinediones

642

3416

2.01

53.39

5.0

4.0

114.25

93.64

ng/l

4.52

550

2912

Other and unspecified local infections of skin and subcutaneous tissue

573

2931

2.09

53.35

7.5

4.1

115.71

87.72

ng/l

5.65

523

2554

Other or unspecified ileus, impaction or obstruction

1003

6051

1.73

53.32

4.9

3.7

104.66

92.16

ng/l

2.81

846

5116

Seropositive rheumatoid arthritis

1301

8317

1.62

53.22

3.4

83.80

88.02

ng/l

0.63

1142

7064

Mental and behavioural disorders due to psychoactive substance use

2756

18596

1.39

53.20

4.0

4.5

94.05

94.66

ng/l

0.10

2378

16380

Migraine

2348

13059

1.43

53.15

3.3

3.9

72.04

82.08

ng/l

9.28

2121

11577

Other local infections of skin and subcutaneous tissue

596

3093

2.06

53.12

7.4

4.1

114.71

88.42

ng/l

5.25

542

2694

2663

17422

1.40

53.10

4.1

4.5

97.18

95.77

ng/l

0.26

2301

15319

Diseases of male genital organs

2020

6964

1.49

53.06

5.9

5.4

108.73

102.68

ng/l

1.25

1797

6223

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

779

4363

1.88

52.90

5.2

3.8

114.69

100.64

ng/l

2.16

670

3587

Allergic asthma (mode), excluding more controls

972

5648

1.73

52.88

3.6

3.3

78.78

74.87

ng/l

0.83

882

4986

Cervical disc disorders

1781

12229

1.50

52.85

3.6

4.2

82.85

94.12

ng/l

6.17

1580

10605

Cyst of kidney

466

2234

2.29

52.69

7.4

3.6

125.93

91.33

ng/l

7.97

404

1923

Substance abuse

2668

18229

1.39

52.18

3.9

4.5

93.05

95.13

ng/l

0.43

2310

16058

Other infectious diseases, including avohilmo

550

2800

2.12

52.17

7.5

4.0

135.64

92.33

ng/l

5.91

478

2405

Speech therapy

1437

9522

1.57

51.75

4.6

3.9

92.15

90.85

ng/l

0.18

1261

8175

Sequelae of cerebrovascular disease

2030

12237

1.47

51.41

4.8

3.8

106.61

94.74

ng/l

4.88

1714

10324

Osteonecrosis

406

1863

2.40

51.19

5.2

3.8

109.86

90.39

ng/l

2.15

350

1609

Other and unspecified drugs and medicaments

526

2659

2.14

51.07

5.0

4.0

100.46

87.08

ng/l

1.85

461

2297

Chronic sinusitis

2083

14784

1.45

51.01

3.7

4.0

81.73

90.30

ng/l

4.41

1827

12888

Familial hypercholesterolemia

785

4490

1.84

50.99

5.6

3.3

113.24

89.10

ng/l

6.44

683

3769

Benign neoplasm: Sigmoid colon

1088

6805

1.69

50.96

5.0

3.9

97.79

94.60

ng/l

0.49

968

5799

Other problems related to primary support group, including family circumstances

554

2752

2.07

50.80

8.3

4.0

70.09

72.01

ng/l

0.27

510

2505

Hypopituitarism

374

1650

2.43

50.69

5.0

4.7

82.99

78.75

ng/l

0.27

329

1508

Non-allergic asthma (mode), excluding more controls

897

5265

1.75

50.47

3.9

3.2

90.03

77.15

ng/l

3.56

803

4554

Acquired haemolytic anaemia

209

709

3.50

50.38

9.0

4.1

124.23

89.53

ng/l

3.33

184

622

Spondylolisthesis/Spondylolysis

974

5928

1.72

50.28

3.7

4.1

81.42

92.86

ng/l

3.61

859

5113

Rheumatism, unspecified

782

4501

1.84

50.15

3.1

3.4

75.80

84.88

ng/l

3.71

672

3828

Other infectious diseases

472

2310

2.22

50.13

7.9

3.9

139.81

92.64

ng/l

5.57

410

1986

Other disorders of veins

2234

15891

1.43

50.01

3.7

3.6

89.88

86.61

ng/l

1.04

1891

13698

Other symptoms and signs involving the digestive system and abdomen

963

5854

1.72

50.00

4.1

3.4

84.55

83.49

ng/l

0.11

801

5050

Ovarian cyst

1730

6708

1.52

49.93

3.5

3.3

82.31

79.61

ng/l

0.54

1505

5818

Persistent mood disorders

979

5970

1.71

49.88

3.7

3.8

88.27

87.21

ng/l

0.12

839

5163

2769

17922

1.37

49.75

4.1

4.5

97.31

95.26

ng/l

0.41

2391

15761

Other complications of surgical and medical care, not elsewhere classified

558

2896

2.06

49.75

4.6

3.5

97.12

84.14

ng/l

2.17

496

2492

Systemic lupus erythematosus

265

1022

2.95

49.61

5.8

3.5

91.71

80.24

ng/l

1.39

243

894

Localized swelling, mass and lump of skin and subcutaneous tissue

1659

11393

1.51

49.50

4.2

3.9

85.36

88.70

ng/l

0.93

1488

9839

Other diseases of blood and blood-forming organs, wide

1190

7644

1.63

49.37

5.3

4.0

97.51

90.88

ng/l

1.39

1051

6579

Intestinal stricture

1700

11757

1.50

49.25

5.2

3.9

105.87

92.45

ng/l

3.64

1465

10031

Abnormal results of function studies

517

2626

2.11

49.19

5.3

4.2

101.17

87.29

ng/l

2.13

457

2294

Urticaria and erythema

1806

12602

1.48

49.19

4.3

4.0

84.35

84.56

ng/l

0.03

1592

11055

Poisoning by medicine

976

5960

1.70

49.07

3.6

4.1

90.28

85.64

ng/l

0.58

849

5307

Immunodeficiencies

318

1344

2.64

48.77

5.7

4.2

85.40

82.05

ng/l

0.29

291

1198

Excessive, frequent and irregular menstruation

1880

6927

1.49

48.75

3.8

3.3

79.82

78.88

ng/l

0.18

1617

6018

Donors of organs and tissues

121

288

4.99

48.74

2.9

2.8

60.27

71.28

ng/l

1.73

114

259

Extrapyramidal and movement disorders

2129

15355

1.43

48.67

3.2

3.9

83.94

92.27

ng/l

3.70

1821

13161

Unstable angina pectoris

1931

10688

1.47

48.62

4.6

3.6

113.72

86.37

ng/l

21.44

1672

8962

Budesonide

715

4028

1.86

48.61

4.0

3.6

85.01

87.01

ng/l

0.25

629

3490

Other pleural conditions

620

3366

1.97

48.57

6.0

3.9

127.22

97.66

ng/l

6.62

539

2877

Subjective visual disturbances

1369

9091

1.57

48.55

3.7

3.8

84.29

88.49

ng/l

0.97

1219

7829

Pulmonary embolism

1624

11172

1.51

48.38

4.3

3.8

101.79

92.05

ng/l

3.38

1394

9506

Hyperplasia of prostate

1492

5547

1.56

48.32

5.2

4.9

111.08

107.17

ng/l

0.51

1306

4884

Later onset COPD, excluding more controls

1160

5621

1.64

48.22

4.0

3.4

110.24

90.42

ng/l

6.20

981

4696

Abnormalities of gait and mobility

737

4229

1.86

48.19

4.4

4.2

94.83

94.38

ng/l

0.04

644

3604

Squamous cell neoplasms and carcinomas of the skin

638

3504

1.95

48.08

5.1

3.7

115.91

100.68

ng/l

2.00

553

2868

Pulmonary heart disease

1624

11197

1.51

47.83

4.3

3.8

101.79

92.43

ng/l

3.15

1394

9535

Nontoxic single thyroid nodule

432

2081

2.25

47.81

3.0

3.7

66.91

88.84

ng/l

7.61

355

1785

Other diseases of pancreas

511

2619

2.11

47.80

5.9

4.1

109.99

94.17

ng/l

2.22

444

2240

Fall on same level involving ice and snow

3009

22884

1.34

47.76

4.1

4.0

91.37

88.77

ng/l

0.73

2638

19864

Other extrapyramidal and movement disorders in other diseases

1369

9135

1.56

47.72

3.5

3.9

86.05

91.14

ng/l

1.26

1188

7841

Artificial opening status

345

1523

2.49

47.65

6.5

3.3

112.21

83.62

ng/l

2.70

314

1324

Disorders of ocular muscles, binocular movement, accommodation and refraction

2312

16766

1.40

47.47

4.5

4.1

82.60

85.89

ng/l

0.83

2019

14791

Injuries to the shoulder and upper arm

4387

26901

1.28

47.42

4.1

89.50

90.82

ng/l

0.37

3815

23349

Other enthesopathies

1456

9818

1.53

47.28

3.4

3.9

82.43

87.92

ng/l

1.38

1276

8553

Other disorders of bone

915

5562

1.71

47.05

4.3

3.9

88.63

85.43

ng/l

0.40

812

4889

Phobic anxiety disorders

549

2856

1.99

46.96

4.5

4.1

80.11

77.58

ng/l

0.25

495

2602

Inflammatory bowel disease

1485

10071

1.52

46.94

4.2

4.3

87.63

89.47

ng/l

0.29

1318

8867

Adenocarcinoma and Papillary adenocarcinoma of kidney

116

281

5.29

46.84

10.2

4.6

165.46

103.75

ng/l

3.93

106

241

Follicular adenocarcinoma of thyroid gland, including Hilmo

113

269

5.46

46.82

2.1

3.8

45.49

81.67

ng/l

12.60

237

Gonarthrosis,primary

4669

22497

1.28

46.73

3.5

4.1

85.77

93.43

ng/l

7.51

4035

19398

Allergic asthma (mode)

972

5837

1.67

46.67

3.6

3.4

78.78

78.71

ng/l

0.01

882

5140

Other crystal arthropathies

175

560

3.75

46.65

5.0

3.7

91.24

97.84

ng/l

0.39

145

471

Complications of cardiac and vascular prosthetic devices, implants and grafts

173

548

3.73

46.57

15.7

3.7

203.99

90.65

ng/l

12.96

152

473

Crystal arthropathies, rheuma endpoint

175

562

3.74

46.38

5.0

3.6

91.24

96.15

ng/l

0.27

145

468

Enthesopathies of lower limb, excluding foot

1115

7137

1.62

46.30

3.8

4.1

83.01

91.13

ng/l

2.53

981

6225

Haemorrhage, not elsewhere classified

267

1064

2.79

46.26

9.3

3.7

149.15

91.89

ng/l

7.90

232

895

Umbilical hernia

1280

8452

1.57

46.22

5.8

4.3

111.91

94.13

ng/l

5.40

1122

7387

Other and unspecified myopathies

535

2819

2.04

46.10

4.0

98.00

95.62

ng/l

0.19

442

2421

Other and unspecified disorders of skin and subcutaneous tissue

400

1905

2.29

45.89

5.2

3.6

100.61

85.91

ng/l

1.94

332

1638

Hyperaldosteronism

202

704

3.30

45.79

5.9

3.2

109.29

83.17

ng/l

3.03

183

619

Menorrhagia

1706

6548

1.50

45.57

3.3

76.10

80.43

ng/l

1.53

1432

5665

Mixed hyperlipidaemia

242

924

2.89

45.43

5.1

3.5

127.79

89.89

ng/l

3.85

208

792

Background retinopathy and retinal vascular changes

175

567

3.63

45.35

9.3

3.9

148.00

90.64

ng/l

6.15

164

493

Nonorganic sleeping disorders

1016

6401

1.65

45.13

4.0

4.1

82.63

86.14

ng/l

0.62

903

5644

Other diseases of stomach and duodenum

401

1923

2.26

45.01

5.5

3.8

104.50

93.00

ng/l

1.52

367

1636

Personal history of other diseases and conditions

518

2686

2.01

44.86

5.3

2.9

83.99

64.82

ng/l

4.51

475

2400

Emotionally unstable personality disorder

520

2715

2.00

44.62

3.3

3.8

76.40

76.98

ng/l

0.06

461

2454

Lung transplant status

183

6.66

44.34

8.4

5.3

112.26

83.96

ng/l

2.01

167

Lung transplantation

183

6.64

44.31

8.4

5.3

112.26

83.96

ng/l

2.01

167

Pleural effusion

861

5259

1.72

44.27

5.8

3.9

122.88

97.18

ng/l

7.90

734

4474

Nontoxic diffuse goitre

235

908

2.95

43.99

3.2

3.5

63.63

85.51

ng/l

5.93

201

775

DVT of lower extremities

1026

6543

1.64

43.97

5.1

3.7

105.39

92.55

ng/l

3.23

904

5584

Benign neoplasm: Stomach

602

3354

1.93

43.88

4.0

3.8

94.44

91.05

ng/l

0.36

524

2843

Procreative management

1528

8642

1.50

43.87

5.3

4.5

79.30

85.62

ng/l

1.76

1394

7707

Substance use, excluding alcohol

883

5414

1.69

43.76

4.1

4.4

90.16

90.08

ng/l

0.01

760

4804

Other endocrine disorders

304

1255

2.53

43.70

8.0

5.3

74.79

66.26

ng/l

0.74

255

1160

Panic disorder

621

3453

1.87

43.60

3.6

3.9

81.38

78.65

ng/l

0.37

545

3097

Speech and linguistic disorders, excluding more controls

358

1533

2.30

43.60

8.0

4.8

73.23

75.84

ng/l

0.25

333

1407

SLE, strict definition

247

983

2.86

43.53

5.9

3.5

90.05

78.71

ng/l

1.32

228

867

SLE, ICD10

247

983

2.86

43.53

5.9

3.5

90.05

78.71

ng/l

1.32

228

867

Superficial injury of head

1291

8649

1.54

43.48

3.5

4.0

91.28

89.38

ng/l

0.31

1102

7506

Persons with potential health hazards related to communicable diseases

1552

10659

1.48

43.33

7.2

4.2

105.01

81.84

ng/l

11.83

1388

9570

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

558

3004

1.95

43.29

5.2

4.8

67.94

74.50

ng/l

1.45

518

2707

Pruritus

665

3812

1.85

43.23

6.2

3.5

112.50

84.61

ng/l

7.03

595

3257

Disorders of psychological development

523

2554

1.98

43.15

7.1

5.1

69.29

75.20

ng/l

1.05

479

2332

Primary biliary cholangitis, wide definition

184

632

3.39

43.11

5.1

3.3

81.76

80.41

ng/l

0.07

169

548

Migraine without aura

855

5209

1.69

43.10

3.8

4.1

74.56

77.82

ng/l

0.57

781

4707

Phlebitis and thrombophlebitis (not including DVT)

1189

7870

1.57

42.94

5.6

3.8

109.97

89.94

ng/l

6.59

1038

6777

COPD-related respiratory insufficiency

673

3889

1.84

42.78

6.0

4.0

129.05

98.22

ng/l

8.34

563

3324

Pyogenic arthritis

365

1714

2.28

42.75

7.0

3.8

111.54

91.92

ng/l

2.44

318

1464

Unspecified acute lower respiratory infection

769

4596

1.75

42.48

6.0

4.1

105.68

90.39

ng/l

3.00

683

4011

Disease of hard tissues of teeth, NOS

2610

10203

1.37

42.37

3.8

3.4

85.78

88.84

ng/l

0.99

2204

8832

Meniscus derangement

2492

12343

1.37

42.26

3.7

3.8

87.38

89.88

ng/l

0.63

2160

10685

Corns and callosities

405

2002

2.19

42.00

7.5

3.6

135.22

86.26

ng/l

8.22

363

1716

COPD

2338

14165

1.38

41.81

4.4

4.1

106.20

94.41

ng/l

5.12

1990

12118

Eating disorder

366

1720

2.23

41.76

4.1

3.8

74.86

68.24

ng/l

0.66

326

1583

Congenital malformations and deformations of the musculoskeletal system

450

2286

2.08

41.75

5.6

5.1

65.83

71.93

ng/l

1.08

422

2075

Trigger finger

755

4517

1.75

41.68

4.9

3.8

92.71

88.59

ng/l

0.52

658

3919

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1222

8159

1.54

41.49

3.3

4.1

82.57

84.81

ng/l

0.31

1055

7280

Amiodarone users

575

3211

1.92

41.40

4.3

4.2

120.48

98.78

ng/l

6.16

524

2752

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

147

450

3.78

41.39

11.2

4.5

100.61

70.37

ng/l

3.19

138

415

Seborrhoeic keratosis

1385

9537

1.51

41.35

5.7

3.4

105.62

88.00

ng/l

7.00

1233

8097

Clear cell adenocarcinoma of kidney

308

1383

2.47

41.27

5.7

4.0

127.57

95.54

ng/l

4.31

273

1186

Type 1 diabetes, definitions combined

410

2020

2.12

41.24

8.5

4.8

106.33

68.38

ng/l

8.47

376

1863

Other congenital malformations of the digestive system

284

1220

2.55

41.13

10.5

5.7

88.34

76.23

ng/l

1.26

269

1112

Abnormal serum enzyme levels

1419

9452

1.50

41.05

4.8

4.7

94.87

101.99

ng/l

1.95

1300

8178

Melanocytic naevi of trunk

630

3605

1.84

41.02

7.1

4.0

107.64

88.71

ng/l

3.80

574

3156

Non-allergic asthma (mode)

897

5560

1.66

40.94

3.9

3.4

90.03

82.02

ng/l

1.62

803

4797

Syphilis

179

620

3.28

40.88

8.9

4.3

144.46

87.15

ng/l

6.44

162

553

Syphilis, including avohilmo

179

620

3.28

40.88

8.9

4.3

144.46

87.15

ng/l

6.44

162

553

5-aminosalicylic acid

920

5798

1.64

40.66

3.9

84.32

86.78

ng/l

0.32

816

5072

ILD, hospital admission 2, with pulmonary infections

546

3008

1.93

40.63

4.8

3.5

108.09

89.94

ng/l

2.80

480

2563

Fracture of shoulder and upper arm

1929

14078

1.41

40.54

4.3

4.0

92.42

90.55

ng/l

0.35

1664

12078

Cirrhosis of liver, NAS

345

1633

2.32

40.47

6.0

4.2

107.25

94.99

ng/l

1.15

305

1415

Myocarditis

202

737

2.91

40.43

4.4

2.1

93.05

62.05

ng/l

4.75

183

642

Visual impairment including blindness (binocular or monocular)

441

2282

2.09

40.24

6.5

3.9

117.94

91.57

ng/l

3.60

381

1925

Type 1 diabetes, strict (exclude DM2)

406

2014

2.11

40.11

8.5

4.8

106.49

68.19

ng/l

8.49

372

1861

Nail disorders

471

2488

2.02

40.02

6.2

4.1

115.00

85.69

ng/l

4.73

413

2177

Covid-19 suspected case

968

6204

1.61

39.95

5.2

3.8

91.54

84.24

ng/l

1.49

828

5490

Post-traumatic stress disorder

348

1634

2.23

39.92

3.3

3.8

72.48

71.26

ng/l

0.10

307

1501

Vitamin B12 deficiency anaemia

600

3423

1.86

39.83

4.4

3.6

105.00

90.84

ng/l

2.39

502

2877

Drug-induced hypoglycaemia without coma

130

379

4.04

39.73

8.3

3.9

124.18

85.69

ng/l

3.56

118

336

Other abnormal uterine and vaginal bleeding

1229

5918

1.55

39.71

3.3

80.35

81.53

ng/l

0.19

988

5080

Viral warts, including avohilmo

1025

6672

1.59

39.59

7.0

4.0

96.93

85.01

ng/l

2.68

914

5873

Valvular operations

661

3871

1.78

39.32

4.8

3.9

121.11

83.19

ng/l

11.64

572

3313

Urticaria

1423

9912

1.48

39.27

4.2

4.0

84.47

83.64

ng/l

0.10

1257

8697

Keratitis

1739

12552

1.42

39.25

4.7

4.0

97.48

89.60

ng/l

2.46

1529

10915

Fissure and fistula of anal and rectal regions

1110

7363

1.56

39.20

3.7

3.8

89.16

88.11

ng/l

0.13

957

6374

Other embolism and thrombosis

698

4168

1.76

39.19

5.8

3.7

108.31

92.00

ng/l

2.75

612

3552

Eating disorders

442

2280

2.02

39.19

4.4

3.9

87.39

72.71

ng/l

1.78

392

2074

Disturbance of activity and attention

487

2531

1.94

38.90

5.0

65.15

71.72

ng/l

1.11

439

2360

Suicide or other Intentional self-harm

1062

6995

1.57

38.72

3.5

4.1

86.30

87.13

ng/l

0.09

911

6213

Primary gonarthrosis, bilateral

2801

18158

1.32

38.70

3.3

4.0

85.27

93.51

ng/l

5.78

2393

15528

Polymyalgia rheumatica

816

5105

1.69

38.67

3.3

3.5

80.65

93.82

ng/l

4.95

701

4225

Other respiratory diseases principally affecting the interstitium

990

6459

1.60

38.64

5.4

3.9

114.17

97.14

ng/l

2.83

876

5474

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1925

14013

1.39

38.62

3.8

4.6

94.26

97.03

ng/l

0.52

1665

12343

Conjunctivitis

3703

23818

1.27

38.55

4.1

4.0

80.17

85.86

ng/l

3.94

3270

20814

Scoliosis

450

2367

2.01

38.44

4.1

72.67

82.19

ng/l

1.76

396

2033

Other chronic obstructive pulmonary disease

2227

13679

1.37

38.34

4.3

4.1

106.98

94.74

ng/l

5.13

1892

11689

Diseases of external ear

1788

13028

1.41

38.29

4.7

4.1

94.61

89.92

ng/l

1.06

1486

11337

Other general symptoms and signs

283

1239

2.42

38.29

3.6

3.8

69.59

78.60

ng/l

1.54

239

1103

Migraine with aura

1072

7080

1.56

38.27

2.9

3.9

68.96

80.97

ng/l

9.15

988

6298

Retinal detachments and breaks

1823

13341

1.41

38.17

5.3

3.7

107.82

90.25

ng/l

8.71

1584

11486

Acquired absence of organs, not elsewhere classified

107

282

4.60

38.11

10.9

3.5

175.06

80.45

ng/l

3.86

246

Superficial injury of lower leg

1304

8993

1.50

38.08

4.5

3.9

96.39

87.49

ng/l

2.14

1132

7798

Status post-ami

1284

6652

1.51

38.06

5.5

3.7

130.11

88.25

ng/l

27.29

1129

5551

Infection of intervertebral disc (pyogenic)

120

344

4.22

38.01

5.8

4.1

137.75

98.62

ng/l

1.52

110

292

Diseases of salivary glands

1635

11759

1.43

37.93

4.0

3.9

84.13

87.41

ng/l

0.76

1428

10211

Malignant neoplasm of breast, including Hilmo

2237

10729

1.37

37.77

2.7

3.3

75.58

81.10

ng/l

2.78

1930

9186

Other hammer toe(s) (acquired)

951

5603

1.61

37.70

3.3

3.4

84.42

88.20

ng/l

0.63

812

4711

Malignant neoplasm of breast, HER2-negative, including Hilmo

2236

10730

1.37

37.65

2.7

3.3

75.60

81.10

ng/l

2.77

1929

9186

Ulcerative colitis

1120

7516

1.54

37.48

4.3

4.2

87.13

89.46

ng/l

0.34

992

6580

Chronic laryngitis and laryngotracheitis

739

4530

1.71

37.40

3.7

3.8

75.13

91.74

ng/l

6.39

630

3899

Other disorders starting during childhood or adolecense, excluding more controls

199

712

2.82

37.37

10.8

5.5

68.87

59.14

ng/l

1.23

194

679

Nonischemic cardiomyopathy

524

2921

1.90

37.36

5.6

3.8

115.91

85.37

ng/l

8.80

468

2475

Acquired absence of limb

212

5.22

37.25

12.5

3.8

202.14

85.40

ng/l

5.60

188

COPD related to multimorbidity

2046

12905

1.38

36.92

4.4

4.0

109.34

96.61

ng/l

5.60

1734

10991

Other eating disorders

231

945

2.60

36.87

4.4

4.1

74.62

63.92

ng/l

0.74

199

873

Other chronic obstructive pulmonary disease, including avohilmo

2755

17577

1.32

36.86

4.1

4.0

101.77

94.16

ng/l

3.01

2340

15101

Neovascular glaucoma

267

1184

2.49

36.74

7.4

3.8

136.56

92.07

ng/l

4.61

232

1014

Pain associated with micturition

653

3900

1.76

36.65

4.4

3.7

83.46

86.27

ng/l

0.37

564

3347

Personal history of malignant neoplasm

505

2812

1.92

36.63

3.0

72.81

75.08

ng/l

0.38

474

2428

1756

11033

1.41

36.58

3.7

3.6

101.70

94.39

ng/l

1.82

1400

9241

Duodenal ulcer

570

3280

1.83

36.48

5.6

4.0

124.28

98.78

ng/l

3.97

487

2784

Mouth breathing

1801

13215

1.40

36.42

4.3

4.6

92.98

91.32

ng/l

0.27

1583

11705

Other sleep disorders

548

3116

1.84

36.30

4.2

4.3

92.87

90.86

ng/l

0.21

484

2733

Coronary artery bypass grafting

1239

6286

1.51

36.24

5.7

3.7

134.33

88.53

ng/l

28.51

1089

5255

Malignant neoplasm of breast

2195

10640

1.37

36.17

2.6

3.3

75.06

81.04

ng/l

3.23

1890

9103

Glaucoma

3048

20433

1.30

36.17

4.2

3.8

97.97

91.90

ng/l

2.47

2546

17452

Open wound of ankle and foot

509

2838

1.89

36.12

7.6

4.3

130.23

90.66

ng/l

7.31

448

2502

Diseases of inner ear

2845

21352

1.30

35.98

3.5

3.9

84.19

90.87

ng/l

4.11

2405

18391

Malignant neoplasm of breast, HER2-negative

2192

10636

1.36

35.94

2.6

3.3

75.08

81.06

ng/l

3.22

1887

9100

Spondyloarthritis

826

5235

1.63

35.92

4.4

3.8

99.41

91.58

ng/l

0.97

737

4504

Transport accidents

2020

12519

1.37

35.92

4.3

4.0

90.08

86.04

ng/l

0.94

1796

11083

Idiopathic hypoparathyroidism

11.25

35.88

4.9

4.3

56.67

78.84

ng/l

0.84

Glaucoma secondary to other eye disorders

267

1196

2.46

35.88

7.4

4.0

136.56

94.50

ng/l

4.18

232

1028

Epilepsy

1427

10084

1.45

35.64

4.2

4.4

87.58

89.77

ng/l

0.35

1224

8810

Hyperkinetic disorders

511

2771

1.86

35.61

5.0

5.3

65.26

71.56

ng/l

1.11

460

2588

Other disorders of bladder

585

3413

1.80

35.61

4.4

4.1

102.30

97.54

ng/l

0.41

463

2917

Mental and behavioural disorders due to alcohol

2210

15956

1.34

35.60

3.9

4.6

95.19

96.44

ng/l

0.20

1903

14079

Benign neoplasm: Rectum, anus and anal canal

1072

7242

1.54

35.48

4.6

3.9

98.47

94.61

ng/l

0.68

934

6173

Carcinoma in situ of skin of upper limb, including shoulder

215

894

2.81

35.39

6.9

3.8

121.02

98.36

ng/l

1.43

183

759

Other shoulder lesions

474

2603

1.92

35.34

3.8

4.0

80.26

88.26

ng/l

1.22

414

2252

Lichen simplex chronicus and prurigo

373

1907

2.11

35.25

5.6

3.8

115.46

87.90

ng/l

4.12

329

1649

Other respiratory disorders and diseases

1074

7261

1.54

35.20

5.2

4.0

115.26

96.08

ng/l

3.79

908

6167

Other diseases of the respiratory system

1074

7261

1.54

35.20

5.2

4.0

115.26

96.08

ng/l

3.79

908

6167

Alcohol use disorder, ICD-based

1770

13030

1.39

35.16

3.7

4.6

93.68

96.82

ng/l

0.58

1534

11488

Exclusion endpoint for clefts

145

486

3.41

35.13

8.2

7.0

99.96

68.80

ng/l

1.83

140

457

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

12.90

35.11

9.0

1.5

146.75

61.10

ng/l

3.09

Leiomyoma of uterus

3254

14465

1.29

35.04

3.4

3.3

81.78

79.95

ng/l

0.64

2758

12517

Schizophrenia or delusion

1372

9690

1.45

35.02

3.5

4.2

83.96

90.18

ng/l

1.53

1161

8519

Disorders of vestibular function (Vertigo)

2500

18876

1.32

34.98

3.5

3.8

82.57

89.95

ng/l

4.85

2107

16206

Fitting and adjustment of other devices

1830

11922

1.39

34.92

3.9

2.7

93.80

81.24

ng/l

6.27

1514

10025

Benign neoplasm: Rectum

965

6405

1.58

34.91

4.7

3.9

98.55

94.94

ng/l

0.58

847

5478

Anosmia

108

281

3.98

34.89

3.2

2.1

73.77

76.29

ng/l

0.15

242

Conjunctivitis (acute, non atopic), including avohilmo

4928

24649

1.22

34.81

4.1

86.70

90.43

ng/l

1.91

4340

21465

Erosion of teeth , including avohilmo

1175

8078

1.50

34.72

6.4

4.1

93.73

85.39

ng/l

1.77

1036

7168

Other and unspecified coagulation defects

287

1337

2.32

34.70

5.6

3.9

101.01

81.81

ng/l

2.05

262

1189

Benign neoplasm: Descending colon

424

2282

2.01

34.65

5.0

4.0

104.55

94.25

ng/l

1.29

393

1978

Carcinoma in situ of skin of other and unspecified parts of face

570

3359

1.83

34.59

5.4

3.5

117.61

96.19

ng/l

3.43

485

2778

Ascites

423

2267

1.99

34.57

6.4

3.7

118.83

91.72

ng/l

4.77

387

1939

ILD, hospital admissions 3, with pneumonia sepsis

480

2678

1.91

34.51

4.8

3.6

107.34

90.62

ng/l

2.16

420

2271

Magnesium deficiency

9.86

34.50

4.1

3.9

90.33

88.60

ng/l

0.04

Other disorders of eye and adnexa

728

4537

1.68

34.43

4.6

4.0

86.07

85.43

ng/l

0.06

665

3932

Pain and other conditions associated with female genital organs and menstrual cycle

895

4839

1.59

34.40

3.2

3.4

68.82

76.08

ng/l

2.17

778

4296

Immunodeficiency with predominantly antibody defects

178

676

2.97

34.38

6.4

4.2

85.25

81.12

ng/l

0.27

166

607

Schizophrenia, schizotypal and delusional disorders

1374

9745

1.45

34.26

3.5

4.2

83.81

90.25

ng/l

1.61

1159

8567

Other enthesopathy of foot (+metatarsalgia)

540

3119

1.82

34.09

3.8

84.39

85.31

ng/l

0.08

479

2697

Sequelae of other external causes

332

1647

2.17

34.07

6.2

3.8

122.74

87.23

ng/l

4.14

308

1436

Graves ophthalmopathy, strict

168

626

3.09

34.02

3.0

3.6

53.37

81.23

ng/l

9.19

153

552

Disorders of muscles

499

2816

1.86

33.98

4.2

4.0

84.65

91.88

ng/l

0.92

436

2428

Adhesive capsulitis of shoulder

819

5260

1.62

33.97

4.6

3.9

90.86

91.53

ng/l

0.07

728

4528

Varicose veins

3158

19006

1.28

33.86

3.7

90.49

89.70

ng/l

0.19

2687

16296

Malignant neoplasm of breast, ER-positive, including Hilmo

1776

9760

1.39

33.81

2.5

3.3

72.21

81.86

ng/l

7.11

1528

8311

Impingement syndrome of shoulder

1102

7537

1.51

33.77

3.6

4.1

80.87

92.18

ng/l

4.40

981

6540

Asthma and allergy, excluding more controls

503

2796

1.83

33.75

3.4

3.2

75.67

70.82

ng/l

0.77

450

2496

Disorders of lacrimal system and orbit in diseases classified elsewhere

180

696

2.94

33.75

2.9

3.5

53.36

80.03

ng/l

9.69

162

622

Mental retardation, excluding more controls

203

790

2.69

33.71

6.5

5.6

68.05

68.62

ng/l

0.03

185

741

Crohn disease

595

3535

1.76

33.68

4.4

4.2

91.27

87.26

ng/l

0.37

531

3127

Metatarsalgia

507

2888

1.85

33.66

3.7

3.8

84.89

85.57

ng/l

0.06

447

2489

Other congenital malformations of the digestive system, including avohilmo

313

1517

2.22

33.66

9.9

5.4

89.09

77.02

ng/l

1.38

294

1372

Problems related to lifestyle

451

2469

1.90

33.65

4.3

3.8

96.58

86.04

ng/l

1.02

400

2203

Other and unspecified nonorganic psychotic disorders

795

5067

1.62

33.60

3.2

4.2

81.14

86.93

ng/l

0.85

685

4512

Caries of enamel

4558

24634

1.23

33.58

5.0

3.9

87.50

88.09

ng/l

0.16

4084

21561

Alcoholic liver disease

488

2753

1.87

33.53

4.0

4.4

93.81

100.44

ng/l

0.76

424

2399

Malignant neoplasm of breast, HER-positive

1770

9753

1.39

33.40

2.5

3.3

72.24

81.83

ng/l

7.00

1523

8304

Iridocyclitis

1095

7501

1.51

33.39

5.1

3.9

96.24

89.90

ng/l

1.12

972

6471

Postprocedural disorders of digestive system, not elsewhere classified

225

970

2.59

33.30

5.8

3.8

90.74

87.21

ng/l

0.15

201

843

Viral pneumonia (known virus, not influenza)

198

806

2.76

33.29

8.1

4.5

111.95

90.27

ng/l

1.98

180

706

Coxarthrosis, primary

3184

21174

1.27

33.29

3.6

3.9

88.50

93.14

ng/l

2.07

2686

18099

Other specified congenital malformation syndromes affecting multiple systems

128

414

3.60

33.23

8.3

7.4

100.76

68.23

ng/l

1.68

123

393

Faecal incontinence

570

3384

1.79

33.22

3.5

3.1

88.87

84.01

ng/l

0.46

461

2863

Cervicobrachial syndrome

1020

6891

1.53

33.11

3.3

4.0

77.38

89.43

ng/l

5.17

928

5981

Recurrent and persistent haematuria

189

5.24

33.10

8.3

3.2

145.43

77.14

ng/l

2.38

164

Conjunctivitis (acute, non atopic)

1321

9327

1.45

33.10

5.0

4.2

87.21

85.74

ng/l

0.22

1179

8198

Other congenital malformations

424

2298

1.95

33.06

5.4

4.9

89.11

74.53

ng/l

1.74

391

2073

Other symptoms and signs involving the circulatory and respiratory systems

348

1769

2.09

32.95

5.0

3.9

89.89

85.17

ng/l

0.41

299

1521

Internal derangement of knee

1583

11447

1.40

32.86

3.8

3.9

86.16

88.26

ng/l

0.40

1347

9996

Other coagulation defects

401

2147

1.99

32.80

5.3

3.9

102.13

87.11

ng/l

1.81

360

1872

Other postsurgical states

354

1819

2.08

32.77

5.3

3.1

92.00

78.29

ng/l

1.35

325

1590

Inflammatory diseases of female pelvic organs

3124

17047

1.28

32.75

3.4

3.3

76.16

79.10

ng/l

1.21

2682

14774

Traumatic subdural haemorrhage

666

3836

1.69

32.52

4.6

4.0

112.03

97.96

ng/l

2.21

555

3253

Rheumatoid arthritis, including avohilmo

1950

14780

1.35

32.47

3.4

3.7

82.17

89.03

ng/l

2.09

1696

12665

Cystic fibrosis

13.47

32.13

5.9

2.9

79.97

65.33

ng/l

0.63

Hepatic failure, not elsewhere classified

236

1053

2.47

32.13

5.4

4.0

97.31

92.14

ng/l

0.33

211

924

Primary biliary cholangitis (PBC)

162

610

3.04

32.07

4.1

3.0

83.89

79.67

ng/l

0.25

147

526

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

683

4250

1.66

32.07

3.5

4.1

86.54

82.83

ng/l

0.35

592

3812

Acute posthaemorrhagic anaemia

225

984

2.52

31.99

7.7

3.4

149.53

88.05

ng/l

7.04

195

851

Diplopia

675

4213

1.68

31.91

3.8

3.9

87.41

91.85

ng/l

0.49

597

3606

Left ventricular outflow tract obstruction (LVOTO), broad definition

467

2639

1.86

31.85

6.9

4.8

129.31

87.43

ng/l

7.26

427

2379

Pericarditis

198

816

2.64

31.77

8.1

3.6

123.47

81.78

ng/l

4.12

183

713

Alzheimer disease, excluding more controls

936

4008

1.57

31.57

2.8

3.9

86.13

95.16

ng/l

2.65

766

3398

Systemic lupus erythematosus, unspecified

201

846

2.67

31.51

5.2

3.6

85.67

79.86

ng/l

0.51

184

750

Heartburn

560

3338

1.75

31.45

3.9

3.7

89.92

88.53

ng/l

0.11

474

2883

Dilated cardiomyopathy

581

3508

1.74

31.44

5.6

4.4

132.17

99.19

ng/l

7.83

527

3034

Asthma and allergy

503

2855

1.79

31.43

3.4

75.67

73.40

ng/l

0.28

450

2542

Alcohol-induced chronic pancreatitis

305

1511

2.15

31.21

5.6

4.7

116.59

99.06

ng/l

1.31

257

1353

Injuries to unspecified part of trunk, limb or body region

543

3228

1.77

31.13

5.4

4.2

101.43

89.18

ng/l

1.80

476

2807

Cholangitis (primary sclerosing, PSC)

357

1878

2.04

31.01

6.2

4.1

96.09

91.63

ng/l

0.40

320

1624

Aortic aneurysm

1049

7086

1.50

30.84

5.2

3.8

112.56

94.49

ng/l

5.36

901

6026

Behavioural syndromes associated with physiological disturbances and physical factors

4538

25586

1.22

30.73

3.7

4.1

82.99

89.28

ng/l

4.66

3979

22329

Combinations of oral blood glucose lowering drugs

1273

9100

1.44

30.72

3.9

4.1

89.72

91.99

ng/l

0.39

1106

7872

Disorders of orbit

263

1248

2.30

30.63

3.7

3.8

67.10

83.31

ng/l

3.04

234

1094

Emotional disorders starting during childhood or adolecense, excluding more controls

165

604

2.78

30.62

6.0

5.2

66.16

56.95

ng/l

0.72

148

577

Graves ophthalmopathy

178

720

2.81

30.55

2.9

3.6

53.52

80.16

ng/l

9.53

161

638

Mixed and other personality disorders

348

1816

2.02

30.37

3.6

4.0

91.69

81.26

ng/l

0.91

301

1637

Vascular diseases of the intestine

253

1189

2.33

30.32

6.7

3.3

130.07

91.98

ng/l

4.16

225

994

Fibroblastic disorders

1091

7603

1.48

30.29

4.1

4.0

95.55

95.08

ng/l

0.05

958

6524

Crohn's disease NAS

319

1623

2.09

30.24

4.4

4.5

95.10

83.30

ng/l

0.92

288

1453

Renal cell carcinoma of kidney

207

897

2.55

30.14

5.9

3.6

140.10

93.20

ng/l

4.71

184

753

Other diseases of lip and oral mucosa

2079

16074

1.32

29.80

3.9

83.99

87.26

ng/l

0.87

1770

13989

Other inflammation of eyelid

752

4894

1.60

29.73

4.1

3.9

84.98

89.57

ng/l

0.66

653

4211

Benign neoplasm: Caecum

608

3783

1.70

29.64

4.6

3.9

98.37

94.76

ng/l

0.41

529

3205

Gonarthrosis, primary, with knee surgery

3038

19074

1.26

29.64

3.3

4.0

83.12

93.77

ng/l

10.42

2570

16294

Viral pneumonia (unknown virus, not influenza)

347

1836

2.01

29.40

7.2

4.2

124.17

89.30

ng/l

4.39

302

1615

Infections with a predominantly sexual mode of transmission

1187

8404

1.44

29.39

5.0

3.8

90.47

82.15

ng/l

2.16

1054

7514

Paracetamol or NSAID medication

675

2084

1.67

29.28

4.4

6.0

88.18

93.11

ng/l

0.65

613

1875

Arterial embolism and thrombosis

325

1691

2.05

29.10

7.1

3.4

147.10

91.54

ng/l

6.55

288

1423

Other/unspecified enthesopathies of lower limb, excluding foot

359

1927

1.97

28.95

3.3

4.2

74.08

88.40

ng/l

4.02

321

1671

Other and unspecified effects of external causes

1196

8538

1.44

28.86

4.7

4.1

89.75

86.08

ng/l

0.63

1043

7539

Other and unspecified mood [affective] disorders

301

1518

2.08

28.84

3.4

3.9

81.10

75.55

ng/l

0.65

264

1375

Ulcerative colitis, NAS

626

3927

1.66

28.70

4.4

4.2

89.31

88.02

ng/l

0.11

553

3460

Non-Hodgkin lymphoma, all, including Hilmo

657

4183

1.64

28.64

3.7

4.0

84.43

96.63

ng/l

2.62

552

3533

Other benign neoplasms of skin

1885

14482

1.33

28.49

4.7

3.8

97.83

89.92

ng/l

2.32

1601

12477

Respiratory insufficiency

409

2291

1.87

28.46

4.1

3.5

106.70

92.27

ng/l

1.98

332

1943

COPD, hospital admission 2, with asthma infections

1604

10343

1.37

28.43

4.4

4.1

111.56

97.58

ng/l

4.35

1354

8793

Aortic valve malfunction, age under 60 years

425

2419

1.85

28.36

7.1

4.7

133.67

88.95

ng/l

7.20

390

2170

Intestinal adhesions without obstruction

457

2662

1.81

28.33

5.1

3.7

102.30

91.56

ng/l

1.00

382

2250

Hydrocele

490

2894

1.76

28.30

7.2

4.9

131.09

106.26

ng/l

3.71

444

2534

Hyperfunction of pituitary gland

227

1041

2.32

28.26

5.0

3.3

85.95

72.53

ng/l

0.80

198

940

Small fibre neuropathy

194

844

2.56

28.24

6.4

4.0

106.15

91.17

ng/l

0.98

174

734

Disorders of refraction and accommodation

1252

9010

1.42

28.15

4.8

4.2

79.78

83.26

ng/l

0.58

1090

7992

Stomatitis and related lesions

959

6623

1.50

28.15

3.9

4.0

82.20

87.31

ng/l

1.05

828

5758

Spondylopathies (FG)

557

3406

1.69

28.12

3.9

3.8

85.24

87.33

ng/l

0.18

498

2979

Autoimmune hepatitis, wide definition

245

1165

2.26

28.10

4.2

3.4

88.28

82.13

ng/l

0.59

216

1002

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

180

753

2.60

27.94

7.6

6.6

95.15

70.66

ng/l

1.64

170

712

Dermatophytosis

678

4372

1.62

27.90

5.6

4.1

107.39

94.53

ng/l

2.17

611

3778

Speech and linguistic disorders

390

2075

1.88

27.81

8.2

5.4

70.77

73.49

ng/l

0.30

365

1898

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1467

10902

1.38

27.79

4.7

4.1

92.99

89.83

ng/l

0.54

1233

9504

Coeliac disease

597

3743

1.67

27.71

4.3

4.1

90.06

84.02

ng/l

0.72

504

3248

Pneumocystosis, including avohilmo

143

548

3.02

27.66

6.8

4.2

110.85

85.83

ng/l

2.10

130

489

Pneumocystosis

143

548

3.02

27.66

6.8

4.2

110.85

85.83

ng/l

2.10

130

489

Cerebral palsy and other paralytic syndromes

548

3365

1.70

27.66

4.0

4.3

82.81

88.66

ng/l

0.83

483

2920

Seronegative rheumatoid arthritis

577

3591

1.68

27.62

3.1

3.5

76.66

88.49

ng/l

3.41

498

3043

Excessive attrition of teeth

2726

21710

1.26

27.58

5.1

4.0

86.32

86.56

ng/l

0.05

2385

19181

Irregular menses

2129

12448

1.31

27.51

3.8

3.4

77.62

76.25

ng/l

0.30

1899

10964

Other osteochondrodysplasias, including avohilmo

101

320

3.76

27.49

5.5

4.5

60.85

74.17

ng/l

1.51

291

Primary adrenocortical insufficiency

275

4.00

27.41

3.5

3.7

59.02

80.31

ng/l

2.65

240

Follicular adenocarcinoma of thyroid gland

166

5.27

27.40

2.3

4.1

46.42

82.53

ng/l

6.61

145

Extreme obesity with alveolar hypoventilation

243

1170

2.26

27.39

4.4

3.7

117.26

87.61

ng/l

3.65

200

1025

COPD, hospital admissions

2229

14775

1.30

27.29

4.3

4.0

106.78

95.82

ng/l

4.26

1889

12638

Allergic purpura

177

748

2.60

27.17

6.6

4.3

119.21

84.69

ng/l

2.67

164

665

Other epidermal thickening

266

1329

2.16

27.02

5.5

3.7

110.17

85.47

ng/l

2.92

242

1158

Other mental disorders due to brain damage and dysfunction and to physical disease

657

4250

1.62

26.99

3.6

3.9

87.23

97.90

ng/l

2.79

556

3601

Acute suppurative otitis media

953

6136

1.48

26.98

6.9

4.2

90.19

81.22

ng/l

1.59

859

5529

Dermatophytosis, including avohilmo

3033

24245

1.24

26.97

3.7

4.2

86.54

90.43

ng/l

1.71

2665

21217

Congenital malformation of biliary tract

8.94

26.89

18.3

7.9

53.42

53.50

ng/l

0.00

1272

8693

1.41

26.88

3.5

3.4

96.47

94.35

ng/l

0.31

1003

7236

Migraine without aura and triptan purchases

661

4254

1.60

26.87

3.6

4.0

71.53

77.20

ng/l

1.44

609

3849

Otitis externa

1065

7558

1.45

26.87

5.0

4.1

94.25

88.42

ng/l

1.00

920

6605

Redundant prepuce, phimosis and paraphimosis

734

4749

1.56

26.84

5.6

5.4

112.65

104.07

ng/l

0.92

654

4255

Other and unspecified urticaria

905

6237

1.50

26.81

4.5

4.0

82.59

83.63

ng/l

0.12

795

5458

Ingrowing nail

283

1445

2.09

26.79

6.8

4.1

118.66

83.75

ng/l

4.24

249

1284

Benign neoplasm: Adrenal gland

428

2497

1.82

26.72

4.2

4.0

95.45

90.49

ng/l

0.51

383

2149

COPD, early/later onset

2247

14896

1.29

26.66

4.3

4.0

106.97

95.81

ng/l

4.43

1907

12742

Schizoaffective disorder

343

1865

1.93

26.58

3.4

4.0

84.08

81.72

ng/l

0.13

293

1665

Other and unspecified nerve root and plexus disorders, also in other diseases

953

6646

1.48

26.49

3.3

4.0

77.70

90.92

ng/l

4.73

833

5783

Fall on and from stairs and steps

1280

9398

1.40

26.42

4.0

3.9

89.62

89.45

ng/l

0.02

1090

8096

Carcinoma in situ of skin of trunk

231

1115

2.31

26.38

6.4

3.8

125.17

100.87

ng/l

1.81

203

940

Invasive ventilation

382

2164

1.87

26.23

6.3

4.4

119.83

91.19

ng/l

4.02

329

1892

Other disorders of nervous system

359

1998

1.91

26.23

5.4

4.1

94.76

90.74

ng/l

0.34

312

1736

Carcinoma in situ of skin of scalp and neck

197

896

2.47

26.17

6.6

4.0

129.30

104.53

ng/l

1.30

168

762

Nonsuppurative otitis media

909

5429

1.49

26.08

5.9

4.1

84.85

81.55

ng/l

0.45

818

4811

Collagenous colitis

497

3032

1.73

26.08

4.8

3.7

88.29

87.70

ng/l

0.05

434

2595

Overexertion and strenuous or repetitive movements

463

2764

1.75

26.08

4.2

4.1

83.02

88.40

ng/l

0.57

429

2435

Other congenital malformations, including avohilmo

578

3641

1.65

26.07

4.9

4.6

85.63

78.16

ng/l

0.93

530

3232

Sulfasalazine

1247

9123

1.40

26.05

3.4

3.7

80.02

86.86

ng/l

1.27

1110

7916

Benign neoplasm of urinary organs

285

1484

2.08

25.91

5.5

3.7

100.88

90.59

ng/l

0.97

255

1277

Manic episode

165

688

2.60

25.90

3.5

4.0

82.08

80.94

ng/l

0.04

149

615

Uterine polyps

1414

6105

1.39

25.86

3.5

3.3

80.06

81.82

ng/l

0.32

1219

5263

Juvenile arthritis (FINNGEN)

211

974

2.30

25.84

6.0

4.9

99.05

70.12

ng/l

1.13

200

880

Pulmonary oedema

132

500

2.99

25.81

9.6

3.7

192.09

96.45

ng/l

3.05

121

425

Amputation of thigh

194

875

2.44

25.81

10.4

3.7

176.15

101.67

ng/l

7.05

164

731

Secondary parkinsonism, excluding more controls

148

590

2.75

25.66

2.7

3.3

80.98

94.11

ng/l

0.96

121

516

Primary Sclerosing Cholangitis, IBD and UDCA required

133

505

2.92

25.58

8.4

4.9

95.00

87.60

ng/l

0.36

127

457

Other symptoms and signs involving the urinary system

491

2997

1.71

25.40

5.3

4.0

101.79

92.75

ng/l

0.89

438

2595

Fentanyl

509

3126

1.69

25.38

4.9

3.6

117.63

95.90

ng/l

2.42

430

2616

Malnutrition

158

662

2.70

25.28

5.6

5.1

84.87

81.05

ng/l

0.18

132

587

Other bursopathies

625

4045

1.61

25.25

4.1

3.9

91.52

93.58

ng/l

0.21

541

3447

Childhood asthma (age<16), excluding more controls

368

1586

1.85

25.23

5.3

3.5

71.74

68.59

ng/l

0.26

336

1467

Sequelae of injuries, of poisoning and of other consequences of external causes

1038

7413

1.44

25.22

3.9

4.2

86.17

90.98

ng/l

0.94

911

6518

IBD patients in KELA-register

935

6549

1.46

25.18

4.3

86.38

89.40

ng/l

0.41

838

5796

Glucosamine medication

2525

16254

1.27

25.17

3.1

3.7

82.91

92.10

ng/l

6.47

2106

13745

Cramp and spasm

253

1273

2.13

25.09

3.9

4.3

86.68

87.31

ng/l

0.03

217

1140

Pneumonia due to other infectious organisms, not elsewhere classified

191

865

2.40

25.01

6.3

3.6

105.87

83.05

ng/l

2.49

166

752

Anterior Iridocyclitis

936

6583

1.47

24.99

5.2

3.9

96.94

90.43

ng/l

1.00

825

5687

Flat foot [pes planus] (acquired)

487

2982

1.71

24.97

3.3

3.6

80.74

86.00

ng/l

0.52

419

2577

Other specified and unspecified personality disorders

378

2159

1.83

24.80

4.0

81.86

81.27

ng/l

0.05

335

1933

Temporomandibular joint disorders, including avohilmo

1936

14680

1.30

24.78

3.5

3.8

72.99

82.53

ng/l

6.40

1689

13000

COPD, hospital admissions 3, with asthma pneumonia sepsis

1350

8628

1.38

24.74

4.4

4.1

114.26

99.14

ng/l

4.09

1136

7316

conjunctival haemorrhage

425

2529

1.78

24.71

5.1

4.1

100.26

92.16

ng/l

0.95

365

2156

Other inflammatory liver diseases

346

1940

1.90

24.67

4.4

3.9

92.99

90.35

ng/l

0.23

303

1690

Strabismus

1184

8652

1.40

24.63

4.5

4.2

85.06

85.50

ng/l

0.05

1044

7574

Cardiodefibrillation

1725

13330

1.32

24.61

4.4

4.1

113.00

96.61

ng/l

8.76

1472

11379

Superficial injury of abdomen, lower back and pelvis

719

4818

1.54

24.56

4.4

4.1

91.79

88.93

ng/l

0.31

617

4189

Calculus of lower urinary tract

271

1408

2.06

24.50

4.7

4.5

97.84

104.85

ng/l

0.40

238

1226

Childhood asthma (age<16)

369

1607

1.83

24.48

5.4

3.7

71.73

70.72

ng/l

0.07

337

1487

Other specified/unspecified necrotizing vasculopathies

105

364

3.36

24.47

9.4

3.9

147.60

86.25

ng/l

2.56

321

Amenorrhoea

270

1389

2.03

24.47

4.1

3.6

76.64

73.65

ng/l

0.24

246

1253

Acute and subacute iridocyclitis

876

6111

1.48

24.45

5.3

3.9

97.96

90.04

ng/l

1.25

773

5281

Osteonecrosis due to drugs

120

451

3.13

24.34

4.2

3.8

73.42

82.81

ng/l

0.57

105

397

Other arterial embolism and thrombosis

167

724

2.53

24.29

9.2

3.7

165.54

92.95

ng/l

4.56

152

617

Other inflammation of eyelid, including avohilmo

1980

15596

1.29

24.28

3.7

4.0

81.20

85.52

ng/l

1.30

1747

13752

Melanocytic naevi, other sites/unspecified

403

2366

1.79

24.25

7.4

3.9

121.14

85.30

ng/l

5.14

357

2089

Suppurative and unspecified otitis media

1381

9153

1.36

24.20

5.7

4.1

89.10

83.97

ng/l

0.88

1227

8135

Other diseases of oesophagus

471

2883

1.71

24.20

4.5

3.8

98.86

94.15

ng/l

0.36

391

2434

Other follicular disorders

335

1862

1.89

24.18

5.8

4.1

117.10

83.42

ng/l

3.73

304

1671

Striking against or struck by other objects

1388

10417

1.36

24.18

4.4

4.7

89.18

90.80

ng/l

0.17

1210

9242

Sicca syndrome [Sjögren]

470

2889

1.72

24.16

3.2

3.4

76.49

83.23

ng/l

0.96

403

2432

Paget disease

122

5.86

24.12

2.8

4.1

72.21

88.11

ng/l

0.89

105

Oter anti-inflammatory and antirheumatic agents, non-steroids

1105

4346

1.43

24.05

3.7

6.0

94.14

119.24

ng/l

9.60

932

3754

Blepharochalasis

1539

11800

1.34

23.99

3.7

88.62

89.91

ng/l

0.23

1312

10058

Follow-up examination after treatment for malignant neoplasms

478

2938

1.69

23.99

3.8

3.3

94.39

93.64

ng/l

0.06

419

2472

Unspecified misadventure during surgical and medical care

314

1728

1.94

23.95

5.6

3.9

108.99

92.17

ng/l

1.61

287

1508

Adverse effects, not elsewhere classified

874

6114

1.47

23.92

5.0

4.0

90.91

83.16

ng/l

1.56

765

5374

Polyp of the female genital tract

1464

6228

1.36

23.84

3.4

3.3

79.52

81.58

ng/l

0.41

1261

5368

Endometriosis

1510

6621

1.35

23.83

3.3

76.81

79.98

ng/l

0.93

1305

5740

Acute pharyngitis

561

3538

1.61

23.76

5.8

4.3

78.46

82.81

ng/l

0.58

520

3206

Special screening examination for neoplasms

281

1483

1.98

23.76

6.1

3.6

106.53

91.01

ng/l

1.28

250

1279

Other disorders of conjunctiva

724

4913

1.53

23.66

4.7

3.9

97.91

92.65

ng/l

0.65

612

4193

Benign neoplasm: Kidney

225

1118

2.21

23.60

5.5

3.7

101.52

88.04

ng/l

1.19

200

964

Superficial injury of hip and thigh

776

5332

1.51

23.55

4.1

3.7

100.55

92.57

ng/l

1.07

645

4506

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

111

403

3.12

23.52

9.3

5.8

109.07

71.20

ng/l

1.59

101

371

Papulosquamous disorders

1857

14597

1.30

23.50

3.9

4.0

88.05

89.72

ng/l

0.32

1591

12696

Type 1 diabetes, strict definition, subgroup 1

267

1384

2.00

23.45

8.1

5.3

104.38

63.66

ng/l

6.64

246

1306

Carcinoma in situ of skin

495

3111

1.69

23.41

5.2

3.7

109.05

94.06

ng/l

2.56

417

2622

Oesophageal varices

231

1160

2.15

23.26

5.8

4.2

93.98

93.17

ng/l

0.04

209

1016

Thoracic aortic aneurysm

633

4188

1.57

23.19

5.3

3.9

110.20

92.86

ng/l

3.04

544

3603

Smoking dependency

410

2449

1.76

23.17

5.4

4.1

99.86

90.03

ng/l

0.92

363

2164

Discitis, unspecified

117

441

3.00

23.14

5.8

4.0

127.61

92.85

ng/l

2.00

107

378

Mental and behavioural disorders due to tobacco

410

2452

1.75

23.07

5.4

4.1

99.86

89.90

ng/l

0.93

363

2173

Disorders of breast

2418

17242

1.26

23.06

3.2

3.3

74.66

79.93

ng/l

3.33

2109

14876

Type of accident

1351

10205

1.35

23.05

4.6

4.0

91.30

89.78

ng/l

0.21

1134

8891

Heart failure and hypertrophic cardiomyopathy

131

526

2.84

23.05

6.4

4.0

123.32

91.82

ng/l

2.89

124

459

Type 1 diabetes, strict definition

280

1483

1.95

23.04

8.2

5.2

103.33

63.80

ng/l

6.74

258

1400

Other hearing loss

1483

11004

1.34

22.96

4.0

3.8

103.70

95.83

ng/l

1.50

1200

9326

Familial hypercholesterolemia, with ischemic heart disease

473

2945

1.69

22.95

5.8

3.6

120.71

89.15

ng/l

5.84

411

2451

Lesion of ulnar nerve

615

4051

1.57

22.90

4.1

93.58

92.85

ng/l

0.06

541

3527

Unspecified urinary incontinence

505

3204

1.66

22.80

3.5

3.4

85.41

84.59

ng/l

0.06

381

2694

Psychotic depression

266

1400

1.99

22.74

3.6

4.3

89.39

88.29

ng/l

0.05

221

1237

Drug-induced osteoporosis

108

400

3.17

22.54

4.4

3.5

77.63

81.81

ng/l

0.26

103

351

Thyrotoxicosis with toxic single thyroid nodule

219

4.06

22.52

4.2

3.2

63.51

78.01

ng/l

0.78

192

Artificial joint operation, meniscal resection

4442

24287

1.18

22.51

3.4

4.1

83.90

93.70

ng/l

8.95

3844

20975

Agoraphobia

135

544

2.63

22.49

2.9

4.2

67.54

75.29

ng/l

0.72

124

501

Drug-induced adrenocortical insufficiency

133

544

2.78

22.49

5.5

4.0

81.70

79.96

ng/l

0.07

111

485

Prurigo nodularis

165

743

2.47

22.35

6.3

3.5

118.74

83.71

ng/l

2.98

146

648

Other juvenile arthritis

181

835

2.30

22.28

6.1

5.0

102.59

68.01

ng/l

1.18

171

764

Fall involving bed

226

1151

2.15

22.23

4.2

4.0

109.55

95.65

ng/l

0.91

188

964

Other/unspecified synovitis and tenosynovitis

522

3339

1.62

22.21

4.6

3.8

89.81

89.13

ng/l

0.05

450

2878

Thrombocytopenia, unspecified

371

2188

1.79

22.20

5.7

4.3

99.43

92.56

ng/l

0.65

322

1907

Special screening examination for other diseases and disorders

470

2922

1.66

22.14

5.9

3.6

130.32

89.60

ng/l

6.27

415

2514

Moderate visual impairment, binocular

198

960

2.26

22.11

6.8

3.6

132.12

91.07

ng/l

2.91

164

796

Oesophagitis

278

1508

1.96

22.06

5.5

4.1

99.89

93.60

ng/l

0.41

249

1300

Rash and other nonspecific skin eruption

487

3081

1.65

22.03

4.7

4.0

93.97

88.61

ng/l

0.57

439

2640

Superficial injury of thorax

701

4785

1.51

21.99

4.2

4.1

96.50

93.30

ng/l

0.32

607

4145

Inflammatory bowel disease, strict (require KELA)

935

6720

1.42

21.85

4.3

86.38

88.95

ng/l

0.34

838

5948

Herpesviral [herpes simplex] infections, including avohilmo

1112

8225

1.38

21.80

4.1

3.6

80.51

84.26

ng/l

0.86

970

7197

Acute and transient psychotic disorders

493

3128

1.63

21.71

3.6

4.0

87.50

86.54

ng/l

0.06

413

2756

Nonhereditary hypogammaglobulinemia

264

3.63

21.68

6.0

3.5

73.87

74.64

ng/l

0.04

235

Seborrhoeic dermatitis

467

2932

1.66

21.66

5.1

4.0

101.64

90.94

ng/l

1.03

400

2544

Other disorders of the musculoskeletal system and connective tissue

733

5074

1.50

21.64

3.6

3.9

90.77

91.67

ng/l

0.06

652

4352

Atopic dermatitis, strict definition with reimbursement

1163

8308

1.37

21.63

4.4

4.1

76.68

79.46

ng/l

0.58

1030

7468

Ovarian dysfunction

260

1376

1.96

21.63

3.2

2.7

85.50

65.04

ng/l

0.87

231

1242

Acute gastritis

368

2178

1.78

21.62

4.5

3.8

99.14

91.99

ng/l

0.67

313

1846

Infections with a predominantly sexual mode of transmission, including avohilmo

1469

10319

1.32

21.59

4.7

3.9

87.40

81.96

ng/l

1.40

1300

9252

Sleep disorders

4239

24971

1.18

21.44

3.4

4.1

80.87

89.20

ng/l

8.36

3714

21786

Other and unspecified tonsillitis

1127

6912

1.38

21.42

5.4

4.4

82.68

84.89

ng/l

0.31

1023

6254

Colonic or urogenital fistula

1203

9040

1.36

21.38

3.8

4.1

89.42

91.40

ng/l

0.28

1038

7859

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

100

5.81

21.24

8.4

3.3

117.24

80.56

ng/l

1.45

Obsessive-compulsive disorder

243

1266

1.99

21.18

3.9

4.4

77.52

72.98

ng/l

0.35

220

1168

Monoarthritis, not elsewhere classified

212

1064

2.12

21.13

4.2

3.8

92.37

86.56

ng/l

0.35

179

922

Traction detachment of retina

188

4.15

21.12

11.6

3.6

217.89

89.32

ng/l

3.95

162

Carcinoma in situ of skin of lower limb, including hip

165

768

2.44

21.03

6.8

3.4

108.08

91.29

ng/l

1.52

142

640

Benign paroxysmal vertigo

1504

11703

1.32

20.97

3.7

83.47

89.64

ng/l

2.34

1244

10027

ILD, hospital admissions

764

5366

1.48

20.95

4.7

4.0

101.01

97.08

ng/l

0.43

673

4541

Algoneurodystrophy

165

756

2.35

20.92

4.1

3.8

87.19

79.30

ng/l

0.31

155

683

Other Crohn's disease

299

1680

1.86

20.91

5.0

4.3

92.04

82.20

ng/l

0.94

272

1503

Restless leg syndrome

713

4943

1.50

20.90

3.1

3.8

83.37

88.49

ng/l

0.92

625

4254

Progressive vascular leukoencephalopathy

266

1464

1.98

20.78

3.1

3.3

91.54

96.52

ng/l

0.48

237

1201

Protozoal diseases, including avohilmo

185

897

2.26

20.71

6.0

4.0

108.42

85.71

ng/l

2.17

167

792

Other disorders of amino-acid metabolism

5.97

20.67

8.9

3.2

115.33

87.49

ng/l

0.55

Disorders of oesophagus in diseases classified elsewhere

139

602

2.57

20.59

5.6

3.8

118.86

92.86

ng/l

1.40

116

511

Other (seronegative) rheumatoid arthritis, wide

952

6961

1.41

20.57

3.3

3.6

78.53

89.29

ng/l

4.18

818

5912

Protozoal diseases

180

867

2.28

20.54

6.2

4.0

109.39

86.14

ng/l

2.18

163

763

Bronchiectasis

432

2713

1.68

20.45

3.8

87.51

90.97

ng/l

0.39

359

2282

Xerosis cutis

121

495

2.76

20.42

4.4

3.3

100.95

82.74

ng/l

1.38

112

423

Other and unspecified injuries of head

389

2375

1.72

20.40

3.9

4.0

91.76

89.25

ng/l

0.20

339

2068

Methotrexate

644

4394

1.52

20.34

3.4

3.5

74.91

85.71

ng/l

3.44

570

3764

Nonsuppurative otitis media, including avohilmo

1247

8161

1.34

20.32

5.6

4.0

89.31

83.08

ng/l

1.31

1125

7221

Bulimia nervosa (incl. atypical)

135

571

2.50

20.28

3.8

3.6

77.94

64.98

ng/l

1.44

123

521

Disorders of purine and pyrimidine metabolism

125

5.03

20.26

7.8

3.2

113.11

83.57

ng/l

1.21

108

Herpesviral [herpes simplex] infections

546

3607

1.57

20.24

4.9

3.7

89.08

85.20

ng/l

0.43

472

3123

Other or ill-defined heart diseases

238

1257

1.99

20.22

7.3

3.7

118.95

78.72

ng/l

4.03

214

1101

Necrosis of pulp, including avohilmo

2493

20313

1.23

20.11

4.2

88.90

88.25

ng/l

0.11

2154

18004

Early onset COPD

969

7124

1.40

20.01

4.7

4.3

103.69

94.05

ng/l

1.82

837

6191

Cervicocranial syndrome

496

3215

1.60

20.00

3.4

3.9

77.94

91.17

ng/l

3.63

446

2740

Psoriasis

1270

9716

1.34

19.91

4.1

85.69

90.98

ng/l

1.29

1088

8487

Certain conditions originating in the perinatal period

319

1631

1.80

19.88

8.2

5.3

64.04

64.48

ng/l

0.05

305

1519

Migraine with aura and triptan purchases

619

4197

1.51

19.87

2.7

4.0

65.97

77.73

ng/l

7.03

568

3765

Orchitis and epididymitis

359

2151

1.73

19.83

6.0

5.0

109.46

104.61

ng/l

0.33

304

1892

Other interstitial pulmonary diseases

767

5447

1.46

19.78

4.7

3.9

100.81

97.22

ng/l

0.39

676

4608

Osteopathy in diseases classified elsewhere

209

3.98

19.74

9.7

3.8

140.32

79.74

ng/l

1.68

178

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

397

2461

1.70

19.72

6.2

3.7

115.50

88.01

ng/l

3.95

340

2118

Other symptoms and signs involving the nervous and musculoskeletal systems

1907

15348

1.26

19.69

3.6

4.0

83.28

88.30

ng/l

1.53

1642

13372

Other chondrocalcinosis

101

388

3.03

19.67

4.6

3.8

92.43

87.40

ng/l

0.22

341

Left bundle-branch block

353

2119

1.74

19.66

3.4

3.3

94.04

82.08

ng/l

1.82

298

1802

Memory loss

483

3143

1.61

19.61

3.2

3.9

89.16

97.74

ng/l

1.68

416

2669

Fenamates

723

3420

1.48

19.51

2.9

6.0

80.71

113.04

ng/l

20.10

626

2994

Other strabismus

929

6777

1.40

19.50

4.3

4.1

79.35

83.28

ng/l

0.58

814

5991

Other specified/unspecified systemic involvement of connective tissue

297

1711

1.84

19.47

3.6

3.5

76.99

80.32

ng/l

0.38

275

1472

ILD, hospital admissions 1, main diag only

686

4792

1.49

19.47

4.7

4.0

103.52

97.05

ng/l

0.76

605

4062

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1516

11722

1.30

19.44

4.1

84.42

83.65

ng/l

0.13

1350

10432

Necrobiosis lipoidica, not elsewhere classified

120

4.96

19.41

8.5

3.2

113.65

80.89

ng/l

1.04

106

Acne

355

2114

1.72

19.41

6.7

4.4

99.99

69.81

ng/l

4.79

329

1936

Reactive arthropathies

370

2255

1.71

19.28

4.3

3.8

94.79

87.66

ng/l

0.66

333

1952

Interstitial lung disease

767

5474

1.45

19.25

4.7

4.0

100.81

97.18

ng/l

0.39

676

4630

Interstitial lung disease endpoints

767

5474

1.45

19.25

4.7

4.0

100.81

97.18

ng/l

0.39

676

4630

Other disorders of patella

654

4516

1.48

19.15

3.2

3.8

75.63

85.21

ng/l

1.97

579

3985

Parkinson's disease, excluding more controls

605

3785

1.52

19.12

2.9

4.0

86.86

95.21

ng/l

0.91

493

3241

Retinal vascular occlusion

615

4223

1.52

19.11

6.1

3.6

119.20

95.28

ng/l

5.18

533

3561

Impotence

238

1284

1.95

19.08

6.8

5.0

119.14

107.81

ng/l

0.69

214

1124

Vasomotor and allergic rhinitis

1547

11901

1.29

19.07

3.7

4.3

75.18

87.02

ng/l

8.22

1369

10507

Urethral stricture

259

1437

1.90

19.04

4.1

4.4

113.55

105.98

ng/l

0.36

227

1249

Pure hyperglyceridaemia

122

513

2.59

19.01

5.7

3.8

132.76

89.07

ng/l

2.81

105

440

Alcohol abuse, main dg, excluding more controls

538

3579

1.54

18.96

3.5

4.6

90.69

94.34

ng/l

0.35

464

3199

Olecranon bursitis

269

1511

1.87

18.93

5.5

4.6

106.87

100.37

ng/l

0.33

242

1328

Paralytic ileus

197

1005

2.09

18.91

5.7

3.9

122.55

98.37

ng/l

0.71

177

851

Emotional disorders and disorders of social functioning with onset specific to childhood

192

941

2.08

18.86

6.0

67.81

60.34

ng/l

0.62

175

900

Recurrent aphthous stomatitis , including avohilmo

693

4873

1.47

18.78

3.8

4.0

77.90

86.92

ng/l

2.48

589

4214

Specific development disorders of scholastic skills

179

859

2.14

18.78

8.6

6.1

67.00

65.83

ng/l

0.07

167

820

Otitis media, unspecified

446

2623

1.61

18.77

6.2

4.3

68.63

75.16

ng/l

1.45

402

2355

Other/unspecified crystal arthropathies

197

4.08

18.76

5.2

3.4

89.49

86.11

ng/l

0.11

170

Cardiac murmurs and other cardiac sounds

424

2657

1.63

18.75

5.3

4.3

88.15

75.45

ng/l

2.03

382

2322

Ptosis of eyelid

582

3973

1.53

18.71

4.3

3.8

92.79

94.13

ng/l

0.12

526

3361

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2473

19654

1.22

18.71

3.5

3.8

76.63

83.57

ng/l

4.83

2165

17212

Other disorders of optic [2nd] nerve and visual pathways

315

1864

1.78

18.70

5.7

4.3

103.88

87.05

ng/l

1.33

279

1640

Reactive arthropathies, FINNGEN

303

1767

1.79

18.69

4.0

3.9

92.40

87.54

ng/l

0.37

276

1531

Atopic dermatitis

2474

16303

1.22

18.68

3.8

4.0

76.69

83.29

ng/l

4.44

2189

14470

Attention to artificial openings

209

1093

2.04

18.65

6.2

2.9

101.03

82.21

ng/l

1.64

184

939

Presence of other devices

1173

8817

1.34

18.63

4.5

3.1

98.70

86.58

ng/l

3.48

1019

7495

Anorexia (incl.atypical)

231

1240

1.94

18.58

4.4

4.0

91.71

73.03

ng/l

1.52

208

1120

Ocular pain

404

2546

1.65

18.58

4.2

3.9

80.07

82.67

ng/l

0.26

365

2228

Corneal ulcer

788

5670

1.43

18.51

5.1

4.0

103.19

89.11

ng/l

2.82

704

4930

Mental retardation

205

1059

2.05

18.50

6.5

7.3

67.73

72.26

ng/l

0.35

187

993

Diseases of spleen

116

487

2.66

18.46

6.1

4.0

110.14

86.95

ng/l

1.23

108

427

Hyperhidrosis

155

727

2.27

18.46

2.7

3.4

64.38

78.41

ng/l

2.36

127

638

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1270

9841

1.32

18.39

3.3

3.6

82.92

89.16

ng/l

1.10

1116

8397

Neuralgia and neuritis, unspecified

248

1374

1.90

18.38

3.7

3.8

82.55

88.26

ng/l

0.33

219

1190

Alzheimer’s disease (Atypical or mixed), excluding more controls

464

2236

1.61

18.38

2.6

3.6

92.83

99.95

ng/l

0.87

340

1864

Congenital malformations of the circulatory system

614

4108

1.50

18.37

5.9

4.9

81.75

82.79

ng/l

0.11

555

3669

Other and unspecified immunodeficiencies with predominantly antibody defects

313

3.14

18.36

7.1

4.2

84.36

72.82

ng/l

0.64

279

Crohn's disease of large intestine

228

1230

1.95

18.35

4.9

4.4

101.09

84.23

ng/l

1.42

206

1104

Hypoplasia of dental enamel, prenatal , including avohilmo

147

4.74

18.32

27.9

9.0

72.07

47.37

ng/l

1.87

142

Plantar fascial fibromatosis

453

2938

1.60

18.31

3.5

3.8

83.64

87.25

ng/l

0.40

400

2542

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

221

1151

1.96

18.31

10.4

6.1

74.32

63.08

ng/l

1.17

214

1090

Total colectomy operation

201

1044

2.05

18.30

6.2

4.2

113.94

87.75

ng/l

1.51

182

926

Total colectomy

201

1044

2.05

18.30

6.2

4.2

113.94

87.75

ng/l

1.51

182

926

Dementia, including avohilmo

2446

13835

1.23

18.25

3.0

4.0

86.53

97.96

ng/l

9.65

1975

11710

Retinal vascular disorders

618

4287

1.50

18.21

6.1

3.6

118.83

95.56

ng/l

4.97

536

3614

Alcohol-induced acute pancreatitis

166

806

2.20

18.20

5.4

4.5

110.43

96.44

ng/l

0.81

147

720

Fracture at wrist and hand level

1452

11390

1.29

18.14

4.6

4.5

91.73

91.45

ng/l

0.03

1272

10006

Seropositive rheumatoid arthritis, wide

1300

10127

1.32

18.06

3.4

3.6

83.80

89.29

ng/l

0.92

1142

8640

Other/unspecified seropositive rheumatoid arthritis

1289

10031

1.32

18.06

3.3

3.6

83.43

89.28

ng/l

1.01

1133

8554

Otitis externa, unspecified

500

3323

1.56

18.02

5.5

4.2

89.93

85.92

ng/l

0.40

450

2924

Other and unspecified visual disturbances

514

3443

1.55

18.01

3.9

3.8

91.25

88.11

ng/l

0.28

459

2947

Suppurative and necrotic conditions of lower respiratory tract

267

1524

1.85

18.01

5.6

4.3

115.37

97.66

ng/l

1.43

241

1334

Carcinoma in situ of skin of ear and external auricular canal

104

421

2.78

17.97

6.5

4.6

125.54

112.45

ng/l

0.48

361

Allergic conjunctivitis

2581

20781

1.21

17.85

3.6

3.9

76.66

83.73

ng/l

5.26

2263

18216

Assault

466

3047

1.57

17.83

3.9

4.6

89.87

87.45

ng/l

0.20

418

2776

Cholangitis (primary sclerosing, PSC), with reimbursement 202

108

444

2.68

17.83

9.6

4.9

95.38

80.29

ng/l

0.73

102

401

Alcohol dependence

1050

7944

1.35

17.76

3.6

4.7

95.78

99.03

ng/l

0.41

904

7030

Postprocedural musculoskeletal disorders, not elsewhere classified

387

2455

1.66

17.69

3.4

3.8

95.85

92.16

ng/l

0.15

348

2102

Superficial injury of ankle and foot

500

3330

1.54

17.68

5.2

4.3

92.98

82.67

ng/l

1.27

457

2975

Fracture of skull and facial bones

898

6646

1.38

17.66

4.3

4.5

90.55

93.24

ng/l

0.32

786

5848

Abscess of anal and rectal regions

339

2067

1.70

17.61

5.7

4.2

111.33

89.91

ng/l

2.27

301

1826

Ulcer of oesophagus

325

1971

1.73

17.57

4.8

3.9

116.35

100.28

ng/l

1.35

279

1679

Leisure time condition

822

6016

1.40

17.54

4.2

4.0

90.41

90.49

ng/l

0.01

673

5212

Thyroiditis

340

2087

1.71

17.53

3.2

3.7

75.28

83.49

ng/l

1.11

294

1796

Mental disorders, not otherwise specified

325

1964

1.72

17.51

4.2

4.0

78.24

78.80

ng/l

0.05

292

1762

Hyperprolactinaemia

143

663

2.28

17.49

4.7

3.2

91.97

70.92

ng/l

0.85

125

603

Radiculopathy

718

5141

1.44

17.47

3.8

4.0

91.49

96.10

ng/l

0.54

620

4353

Monoamine oxidase A inhibitors

520

3510

1.53

17.45

3.5

4.1

84.29

93.40

ng/l

1.73

440

3034

Atopic dermatitis, strict definition

1103

8231

1.33

17.33

4.5

4.3

75.95

79.15

ng/l

0.70

992

7404

Polyarteritis nodosa and related conditions

363

2.89

17.30

6.7

4.1

103.33

79.83

ng/l

1.42

322

Impacted cerumen

583

4044

1.50

17.24

4.4

4.1

90.43

92.70

ng/l

0.20

434

3461

Chronic hepatitis, not elsewhere classified

184

951

2.08

17.18

4.1

3.6

86.64

81.32

ng/l

0.36

170

836

Cerebral cysts

255

1453

1.84

17.17

5.1

4.3

89.63

87.89

ng/l

0.10

227

1294

Cardiomyopathy in other diseases

137

4.44

17.13

4.1

2.7

111.33

80.07

ng/l

1.59

120

Disorder of pancreatic internal secretion, other and/or unspecified

191

3.82

17.11

7.2

4.0

92.35

82.67

ng/l

0.39

171

Other diseases of biliary tract

443

2913

1.59

17.07

4.9

3.8

99.34

91.30

ng/l

0.94

386

2457

Social phobias

282

1645

1.76

17.06

4.1

4.3

81.24

75.03

ng/l

0.59

256

1513

Hepatomegaly and splenomegaly, not elsewhere classified

216

3.49

16.92

7.1

4.2

118.49

84.11

ng/l

0.55

195

Anankastic personality disorder

172

868

2.09

16.89

3.0

3.8

74.40

76.80

ng/l

0.17

151

784

Postmenopausal bleeding

1379

5646

1.31

16.88

3.0

3.3

81.62

82.85

ng/l

0.21

1176

4827

Injury of unspecified body region

376

2391

1.64

16.79

5.6

4.1

103.03

88.93

ng/l

1.59

331

2075

Other disorders of white blood cells

271

1592

1.80

16.65

5.8

4.1

97.60

91.57

ng/l

0.47

239

1390

Parkinson's disease, strict definition, excluding more controls

555

3562

1.50

16.64

2.9

4.0

83.11

95.73

ng/l

2.66

454

3044

Psoriatic and enteropathic arthropathies

463

3080

1.55

16.55

3.6

3.8

80.23

88.19

ng/l

1.23

401

2677

Mental retardation, wide definition

209

1129

1.95

16.51

6.4

7.0

67.66

72.49

ng/l

0.38

191

1057

Hypermobility syndrome

217

1192

1.90

16.45

3.0

3.6

63.73

74.11

ng/l

2.35

192

1075

Cholecystitis

658

4697

1.44

16.41

4.4

3.8

102.23

94.75

ng/l

1.04

570

3957

Vasculitis limited to skin, not elsewhere classified

159

797

2.17

16.40

5.6

3.4

104.58

84.51

ng/l

1.80

140

691

Crohn's disease of small intestine

290

1734

1.74

16.40

4.5

4.2

97.79

83.26

ng/l

1.16

256

1546

Other specified/unspecified bacterial intestinal infections

323

1995

1.70

16.34

4.9

3.8

91.32

88.35

ng/l

0.25

281

1725

Insomnia

4088

24785

1.16

16.28

3.3

4.1

79.90

89.04

ng/l

10.13

3585

21626

Chronic diseases of tonsils and adenoids

3360

18181

1.18

16.28

4.1

4.3

79.94

88.59

ng/l

6.42

3045

15974

Polyarteritis nodosa

161

3.97

16.26

8.1

3.4

117.04

86.97

ng/l

0.99

140

Dermatitis due to substances taken internally

265

1555

1.79

16.24

5.2

3.8

98.54

82.59

ng/l

1.59

228

1357

Hyperosmolality and hypernatraemia

345

2.84

16.15

3.5

3.3

85.30

86.83

ng/l

0.06

294

Ankylosing spondylitis

338

2107

1.66

16.12

4.2

4.4

85.62

96.09

ng/l

0.99

302

1854

Inflammatory disease of uterus

571

3983

1.47

16.08

3.1

3.4

73.10

77.58

ng/l

0.86

505

3488

Right bundle-branch block

180

941

2.03

16.08

4.5

3.2

91.62

81.00

ng/l

0.76

144

812

Myositis

141

679

2.25

16.04

4.3

3.9

82.24

87.66

ng/l

0.30

122

591

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

767

5629

1.39

16.00

3.5

3.3

70.67

76.70

ng/l

1.73

676

4944

Injuries to the neck

928

7007

1.35

15.99

3.9

4.1

84.31

89.37

ng/l

0.77

814

6140

Malignant neoplasm of bladder, including Hilmo

510

3442

1.51

15.99

4.4

4.3

112.04

105.09

ng/l

0.63

431

2889

Kyphosis

379

2.77

15.93

5.0

4.0

75.90

86.12

ng/l

0.76

328

Superficial injury of wrist and hand

850

6340

1.37

15.92

4.1

4.4

87.35

85.55

ng/l

0.21

749

5597

Abdominal aortic aneurysm (AAA)

415

2698

1.57

15.91

5.4

3.8

120.66

101.40

ng/l

2.61

356

2254

Giant cell arteritis

250

1464

1.83

15.89

3.5

3.6

88.26

92.64

ng/l

0.29

222

1232

Acne vulgaris

270

1589

1.74

15.78

6.6

4.4

98.65

69.06

ng/l

3.92

252

1462

Unknown and unspecified causes of morbidity

284

1709

1.72

15.61

4.6

3.5

103.83

85.98

ng/l

1.58

252

1471

Benign neoplasm: Small intestine

226

1292

1.88

15.59

5.4

3.8

121.07

91.47

ng/l

3.09

193

1109

Disorders of tooth development and eruption

619

3559

1.44

15.57

5.5

3.3

88.67

79.95

ng/l

1.61

550

3154

Follicular cysts of skin and subcutaneous tissue

782

5789

1.38

15.55

5.0

4.0

102.98

90.81

ng/l

2.30

702

5034

Female genital prolapse

1378

6058

1.29

15.51

2.9

3.3

76.75

82.02

ng/l

1.96

1163

5205

Retinal detachment with retinal break

584

4128

1.46

15.51

5.3

3.9

109.92

93.74

ng/l

2.55

510

3544

Barrett oesophagus

241

1398

1.82

15.49

4.4

4.2

101.71

96.48

ng/l

0.27

213

1212

Astigmatism

289

1754

1.72

15.47

5.6

4.7

74.72

79.66

ng/l

0.51

253

1568

Degenerative macular diseases

610

4355

1.45

15.47

4.3

3.4

102.93

91.96

ng/l

1.63

498

3671

Cushing syndrome

255

3.13

15.45

3.6

3.0

101.73

69.18

ng/l

1.79

225

Speech disturbances, not elsewhere classified

447

3010

1.55

15.43

4.2

4.0

88.85

96.01

ng/l

0.80

373

2558

Deviated nasal septum

1304

10330

1.28

15.40

3.7

4.6

87.09

98.54

ng/l

4.85

1162

9049

Other/unspecified rheumatoid arthritis

619

4441

1.44

15.27

3.8

3.5

89.46

90.31

ng/l

0.05

527

3735

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

286

1736

1.71

15.22

5.4

3.2

93.88

72.71

ng/l

3.67

263

1576

therapeutic use

182

981

2.01

15.22

5.3

3.4

89.01

87.36

ng/l

0.07

155

837

Other disorders starting during childhood or adolescence

206

1128

1.88

15.21

10.8

6.3

67.71

59.63

ng/l

1.01

201

1067

Pneumonia derived septicemia

176

934

2.01

15.19

7.4

4.5

108.04

89.70

ng/l

1.29

155

818

Diseases of middle ear and mastoid

2339

16051

1.20

15.16

5.1

4.1

91.76

87.17

ng/l

1.12

2078

14127

Hypertrophic cardiomyopathy

216

1226

1.88

15.12

6.5

4.4

116.25

94.12

ng/l

2.52

201

1067

Noninflammatory disorders of female genital tract

1711

6955

1.25

15.08

3.5

3.4

76.21

78.72

ng/l

0.67

1459

6045

Other noninfective disorders of lymphatic vessels and lymph nodes

194

1067

1.94

15.03

6.0

3.4

110.99

85.36

ng/l

2.22

168

928

Hypothyroidism due to medicaments and other exogenous substances

318

2.88

14.99

4.3

3.6

79.34

82.47

ng/l

0.15

281

Dementia

2266

13005

1.21

14.97

2.9

3.9

85.47

98.14

ng/l

11.13

1821

10986

Ulcerative enterocolitis

144

715

2.14

14.95

5.0

4.1

108.32

84.36

ng/l

1.33

131

641

Periapical abscess

1996

16617

1.22

14.93

4.4

4.2

95.13

89.69

ng/l

1.24

1702

14638

Other localized connective tissue disorders

126

603

2.30

14.85

9.3

3.3

131.68

76.33

ng/l

4.67

115

532

Dissociative [conversion] disorders

159

817

2.04

14.83

3.1

3.6

71.57

73.08

ng/l

0.12

130

739

Anuria and oliguria

171

3.70

14.81

7.7

3.8

128.66

82.64

ng/l

1.90

145

Colectomy operation

792

5938

1.37

14.71

4.9

3.9

106.46

94.24

ng/l

2.19

704

5051

Psoriasis vulgaris

782

5841

1.37

14.70

4.5

4.3

89.55

93.05

ng/l

0.44

673

5111

Somnolence, stupor and coma

201

1122

1.89

14.66

5.2

4.1

101.54

95.98

ng/l

0.30

179

976

Malignant neoplasm of renal pelvis, including Hilmo

293

2.91

14.53

5.5

3.9

122.52

99.33

ng/l

0.98

249

Neuroendocrine tumor and carcinoma of pancreas

158

3.81

14.52

6.0

4.2

62.47

86.41

ng/l

1.71

133

!Aliquae complicationes praecoces traumatis

212

1208

1.85

14.49

5.1

4.2

110.44

90.15

ng/l

1.16

177

1065

Early complications of trauma

212

1208

1.85

14.49

5.1

4.2

110.44

90.15

ng/l

1.16

177

1065

Benign neoplasm: Skin of other and unspecified parts of face

505

3526

1.48

14.47

4.7

3.8

103.50

90.66

ng/l

1.33

407

2995

Abnormal findings in nipple discharge synovial fluid wound secretions

396

2.61

14.44

7.2

4.0

105.88

80.86

ng/l

1.16

352

Papilloedema, unspecified

119

559

2.29

14.42

5.2

4.3

104.89

82.19

ng/l

0.79

100

503

Ganglion

838

6332

1.35

14.41

3.6

3.8

80.66

86.02

ng/l

1.14

737

5527

Inflammatory diseases of the central nervous system

360

2346

1.59

14.41

4.4

4.2

84.54

87.06

ng/l

0.22

316

2055

Malignant melanoma, including Hilmo

782

5865

1.37

14.40

4.4

3.9

103.28

96.04

ng/l

0.99

662

4976

Achilles tendinitis

430

2906

1.53

14.38

4.3

4.4

90.15

95.70

ng/l

0.56

384

2525

Other noninflammatory disorders of vulva and perineum

430

2909

1.53

14.34

4.0

3.4

82.45

80.26

ng/l

0.21

376

2544

Alzheimer’s disease (Late onset), excluding more controls

721

3437

1.40

14.32

2.8

3.8

86.17

96.06

ng/l

2.70

603

2880

Other disorders of electrolyte and fluid balance, not elsewhere classified

217

3.24

14.23

3.4

2.6

94.00

82.61

ng/l

0.38

177

Temporal arteritis

219

1277

1.85

14.22

3.4

3.5

85.87

90.99

ng/l

0.33

195

1068

Other symptoms and signs involving general sensations and perceptions

216

1248

1.83

14.16

3.2

3.9

78.95

90.97

ng/l

1.47

175

1063

Deficiency of other B group vitamins

121

578

2.27

14.16

3.8

3.6

84.80

88.78

ng/l

0.22

507

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

279

1718

1.69

14.15

4.1

98.45

82.16

ng/l

1.27

249

1519

Acute bronchiolitis

241

1283

1.76

14.10

9.1

5.9

77.07

64.82

ng/l

1.10

225

1190

Pneumonia due to Streptococcus pneumoniae

181

992

1.92

13.97

4.9

3.9

97.84

86.43

ng/l

0.82

156

864

Tinnitus

1052

8245

1.30

13.97

3.6

4.0

82.68

90.02

ng/l

2.24

907

7190

Macular pucker

771

5810

1.37

13.96

4.3

3.7

98.98

92.85

ng/l

0.79

651

4939

Other diseases of blood and blood-forming organs

325

2090

1.63

13.96

4.5

4.0

94.05

92.42

ng/l

0.11

281

1811

Benign neoplasm: Endocrine pancreas

174

3.67

13.92

5.0

3.7

91.93

80.67

ng/l

0.48

149

Symptoms and signs involving emotional state

141

714

2.09

13.86

3.9

4.2

74.58

81.53

ng/l

0.41

118

642

Other and unspecified follicular disorders

185

1025

1.90

13.85

6.4

4.1

125.79

86.95

ng/l

2.59

166

919

Rosacea

570

4094

1.43

13.82

4.8

3.7

87.17

85.26

ng/l

0.21

493

3552

Specific development disorders of speech and language

248

1436

1.73

13.76

8.3

5.6

74.01

75.53

ng/l

0.11

231

1304

Other abnormalities of plasma proteins

431

2.49

13.69

6.3

4.0

133.03

89.57

ng/l

2.15

381

Malignant immunoproliferative diseases

287

2.92

13.66

4.6

4.2

91.60

85.13

ng/l

0.22

253

Nummular dermatitis

380

2539

1.55

13.62

4.8

4.0

98.12

93.20

ng/l

0.44

320

2190

Adrenogenital disorders

106

4.47

13.57

7.6

3.5

159.55

72.37

ng/l

2.04

Other and unspecified disorders of vitreous body

2059

16978

1.21

13.56

3.5

3.8

83.98

87.79

ng/l

1.33

1769

14615

Diseases of tongue

283

1771

1.67

13.54

4.8

3.3

89.24

88.46

ng/l

0.05

246

1532

Vascular dementia

503

3422

1.47

13.54

3.0

3.6

98.54

103.45

ng/l

0.60

399

2840

Wide developmental disorders, excluding more controls

115

527

2.22

13.53

4.8

6.0

53.01

59.83

ng/l

1.03

101

509

Other disorders of cornea

456

3165

1.49

13.51

4.2

3.8

92.84

88.02

ng/l

0.56

394

2703

Pyothorax

203

1168

1.83

13.49

5.4

4.3

109.72

100.01

ng/l

0.54

188

1022

Mucosal proctocolitis

480

3353

1.47

13.47

4.0

4.3

86.04

89.19

ng/l

0.31

438

2994

Sleep disorders, other/unspecified

156

825

1.99

13.45

4.1

4.2

88.69

78.89

ng/l

0.38

135

754

Giant cell arteritis with polymyalgia rheumatica

219

1298

1.81

13.45

3.4

3.5

85.87

90.46

ng/l

0.29

195

1092

Other and unspecified vasculitis limited to skin

136

694

2.12

13.40

5.9

3.5

109.05

84.13

ng/l

2.09

120

604

Inflammatory diseases of prostate (prostatitis)

445

3067

1.49

13.39

4.2

4.8

94.66

103.80

ng/l

1.08

388

2705

Granulomatous disorders of skin and subcutaneous tissue

141

727

2.08

13.37

6.0

3.6

96.39

77.15

ng/l

1.57

125

644

Other female pelvic inflammatory diseases

735

5532

1.37

13.34

3.3

76.76

79.86

ng/l

0.41

601

4755

L02BG Aromatase inhibitors

1561

12712

1.24

13.32

2.5

3.3

71.15

82.26

ng/l

10.04

1348

10793

Exposure to other and unspecified inanimate mechanical forces

316

2035

1.61

13.32

5.8

4.6

90.28

87.02

ng/l

0.23

294

1811

Use of antiglaucoma preparations and miotics

413

2827

1.52

13.31

5.1

3.5

105.23

94.86

ng/l

1.22

346

2344

Crohn disease (strict definition, require KELA, min 2 HDR)

249

1514

1.71

13.29

4.5

4.3

87.70

81.20

ng/l

0.50

223

1361

Any dementia, excluding more controls

1835

10492

1.22

13.28

3.0

3.9

89.45

97.85

ng/l

3.98

1489

8832

Abnormal blood-pressure reading, without diagnosis

221

1306

1.77

13.28

4.7

3.8

82.59

80.49

ng/l

0.14

196

1116

Iron deficiency

128

634

2.12

13.27

3.4

4.3

72.05

68.81

ng/l

0.19

111

572

Hallux rigidus

607

4436

1.41

13.27

3.0

3.6

78.05

89.19

ng/l

4.01

521

3787

Type1 diabetes, definitions combined, early onset

235

1400

1.73

13.25

9.2

6.1

109.77

70.16

ng/l

5.14

216

1314

Scleritis and episcleritis

270

1684

1.67

13.14

4.5

3.6

90.47

80.14

ng/l

0.98

245

1498

Disorders of optic nerve and visual pathways

404

2752

1.52

13.12

5.1

4.1

96.66

84.49

ng/l

1.14

356

2425

Other specified/unspecified soft tissue disorders

234

1410

1.74

13.11

3.6

3.4

86.37

87.65

ng/l

0.09

207

1180

Excessive earwax

3011

23728

1.16

13.08

3.9

4.1

88.14

91.65

ng/l

1.23

2507

20593

Benign neoplasm of meninges

521

3734

1.45

13.08

3.8

3.5

86.87

88.75

ng/l

0.21

452

3163

Gangrene, not elsewhere classified

184

3.36

13.06

15.7

3.7

174.18

85.61

ng/l

4.09

156

Viral hepatitis

269

1674

1.66

13.06

4.7

4.4

95.16

85.64

ng/l

0.95

244

1508

Hypertrophy of breast in women and men

833

6391

1.33

13.05

3.4

3.6

77.93

81.53

ng/l

0.65

725

5598

Other specified and unspecified disorders of eye and adnexa

188

1071

1.86

13.00

5.4

3.9

98.68

88.20

ng/l

0.59

181

934

Coxibs

1211

5038

1.28

13.00

2.9

6.2

82.93

115.73

ng/l

29.18

1043

4395

Other and unspecified rosacea

411

2817

1.51

13.00

4.8

3.7

89.94

86.36

ng/l

0.34

354

2441

Benign neoplasm: Liver/bile ducts

133

678

2.10

12.99

4.2

3.7

91.31

81.55

ng/l

0.49

113

615

Sequelae of injuries of upper limb

412

2823

1.51

12.98

3.5

4.1

85.72

89.18

ng/l

0.31

358

2477

ILD-related respiratory insufficiency

181

1025

1.89

12.93

5.2

3.9

108.38

98.94

ng/l

0.58

162

875

Convalescence

241

1468

1.72

12.92

4.5

2.6

80.70

75.56

ng/l

0.49

209

1258

Somnolence

287

2.76

12.79

5.1

4.4

103.75

78.93

ng/l

0.91

256

Oxicams

1041

4624

1.30

12.79

3.3

6.1

83.46

118.99

ng/l

28.01

908

4012

Crohn disease (strict definition, require KELA)

250

1538

1.69

12.76

4.5

4.2

87.50

81.51

ng/l

0.45

224

1383

Wet age-related macular degeneration

938

7084

1.31

12.71

3.7

3.4

107.12

94.82

ng/l

2.33

748

5871

Eosinophilic disease (BM)

317

2.63

12.69

5.5

3.7

112.17

82.83

ng/l

1.79

280

Malignant melanoma

691

5190

1.37

12.69

4.5

4.0

104.17

96.19

ng/l

1.00

588

4387

Testicular dysfunction

138

713

2.02

12.67

5.5

4.6

107.03

93.23

ng/l

0.58

122

652

Erythema intertrigo

138

721

2.06

12.67

4.9

3.8

100.15

85.58

ng/l

1.07

125

624

Varicella [chickenpox]

175

978

1.87

12.66

8.8

4.9

96.40

84.60

ng/l

0.85

165

890

Other bacterial agents as the cause of diseases classified to other chapters

280

2.82

12.56

9.8

3.7

130.49

78.79

ng/l

3.54

248

Benign neoplasm of thyroid gland

176

997

1.89

12.56

2.9

3.5

71.12

81.02

ng/l

1.09

152

866

Open wound of forearm

401

2750

1.50

12.54

4.7

4.1

96.67

90.42

ng/l

0.46

339

2397

Other disorders of pigmentation

231

1408

1.73

12.52

4.0

3.7

95.24

83.86

ng/l

0.93

211

1215

Benign neoplasm: Liver

121

606

2.14

12.46

3.8

3.7

86.78

80.08

ng/l

0.31

103

548

Tobacco use

228

1382

1.72

12.44

4.7

4.2

99.65

88.22

ng/l

0.66

208

1234

Follow-up care involving plastic surgery

187

1078

1.83

12.40

3.8

2.7

68.87

73.18

ng/l

0.38

150

936

Congenital malformations of heart and great arteries

516

3598

1.43

12.40

6.4

5.0

84.38

81.76

ng/l

0.29

467

3224

Other disorders of iris and ciliary body

146

782

1.99

12.39

6.7

3.9

118.11

89.68

ng/l

2.16

128

681

Coxarthrosis, primary, with hip surgery

2318

18438

1.18

12.38

3.5

3.8

87.88

93.73

ng/l

2.31

1948

15689

Benign neoplasm: Cerebral meninges

476

3393

1.46

12.38

3.9

3.5

87.57

86.78

ng/l

0.08

411

2876

Pneumonitis due to solids and liquids

375

2549

1.52

12.37

4.3

4.0

92.17

98.36

ng/l

0.60

307

2168

Secondary and unspecified malignant neoplasm of lymph nodes

372

2526

1.53

12.36

3.6

4.1

79.56

95.92

ng/l

3.31

314

2141

Secondary thrombocytopenia

324

2.65

12.35

5.5

4.0

125.73

82.33

ng/l

2.20

292

Acetic acid derivatives and related substances

1203

4958

1.27

12.34

3.4

6.2

86.71

116.27

ng/l

19.07

1027

4318

Non-follicular lymphoma

442

3108

1.47

12.33

3.9

4.1

87.29

96.32

ng/l

1.17

371

2649

Family history of malignant neoplasm

448

3146

1.46

12.32

3.4

2.8

71.22

72.12

ng/l

0.10

383

2743

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

265

1669

1.64

12.31

4.6

4.3

86.72

81.86

ng/l

0.36

237

1494

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

668

5008

1.36

12.25

4.2

4.3

87.36

89.52

ng/l

0.22

598

4426

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

602

4446

1.38

12.20

4.1

4.3

87.03

89.77

ng/l

0.26

535

3941

Other viral hepatitis

225

1363

1.71

12.18

5.1

4.4

97.52

83.88

ng/l

1.32

207

1234

Other noninflammatory disorders of uterus, except cervix

1056

5591

1.29

12.16

3.2

3.3

85.95

83.04

ng/l

0.57

870

4776

Atypical facial pain

244

1518

1.68

12.13

2.9

3.6

73.26

83.15

ng/l

1.07

207

1319

Medicines for HER+ breast cancer

1842

14477

1.21

12.13

2.6

3.4

72.98

82.73

ng/l

7.91

1591

12312

Delivery

1448

9260

0.81

12.11

3.0

3.6

76.53

83.27

ng/l

3.02

1219

7960

Hyphaema and other vascular disorders of iris and ciliary body

115

573

2.17

12.11

7.3

3.8

129.20

91.82

ng/l

2.35

500

Infective dermatitis

481

3437

1.44

12.08

4.8

3.9

101.60

90.65

ng/l

1.41

400

2959

Bacterial, viral and other infectious agents, including avohilmo

346

2321

1.54

12.08

6.9

4.6

105.85

87.03

ng/l

2.89

303

2085

Diffuse large B-cell lymphoma

238

1476

1.70

12.07

4.5

3.8

85.32

94.29

ng/l

0.67

198

1257

Diffuse large B-cell lymphoma, including Hilmo

238

1476

1.70

12.07

4.5

3.8

85.32

94.29

ng/l

0.67

198

1257

Diffuse large B-cell lymphoma, helper endpoint

238

1476

1.70

12.07

4.5

3.8

85.32

94.29

ng/l

0.67

198

1257

Other aneurysm

245

1527

1.68

12.05

7.6

3.7

113.41

92.04

ng/l

2.57

223

1319

Agranulocytosis

508

3672

1.43

12.04

5.4

4.0

97.34

88.48

ng/l

1.08

455

3162

Testicular hypofunction

123

622

2.07

12.04

5.9

4.5

108.48

93.93

ng/l

0.53

107

567

Complications following infusion, transfusion and therapeutic injection

390

2.45

12.04

7.9

3.5

109.15

78.49

ng/l

1.49

340

Viral hepatitis, including avohilmo

277

1771

1.61

12.04

4.7

4.4

94.75

85.79

ng/l

0.90

251

1598

Other and unspecified mental retardation

464

2.32

12.03

4.9

8.2

54.00

61.48

ng/l

0.58

444

Secondary parkinsonism

148

806

1.97

12.01

2.7

4.0

80.98

97.69

ng/l

1.40

121

702

Other and unspecified epidermal thickening

135

712

2.02

12.00

6.7

4.0

121.51

84.89

ng/l

2.44

122

628

Other and unspecified mononeuropathies, also in other diseases

149

812

1.96

11.99

4.7

3.6

99.17

86.10

ng/l

0.82

126

704

Lung diseases due to external agents

610

4537

1.38

11.96

4.2

4.0

92.68

98.48

ng/l

0.82

508

3863

Spontaneous rupture of synovium and tendon

362

2462

1.52

11.92

4.2

4.0

87.00

93.39

ng/l

0.73

297

2095

Juvenile rheumatoid arthirtis

439

2.30

11.92

4.1

4.2

102.40

73.13

ng/l

0.41

399

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

662

4988

1.36

11.91

3.4

4.1

84.09

95.85

ng/l

2.40

570

4237

Post-traumatic wound infection, not elsewhere classified

134

706

2.02

11.91

5.4

4.3

114.87

88.30

ng/l

1.07

110

629

Single spontaneous delivery

1445

9244

0.81

11.87

2.9

3.6

75.58

83.31

ng/l

3.99

1219

7945

Respiratory disorders in diseases classified elsewhere

394

2.45

11.87

5.4

3.8

74.10

81.94

ng/l

0.56

349

Other abnormal findings in urine

452

2.33

11.83

3.9

97.04

85.03

ng/l

0.48

394

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

384

2.41

11.82

4.9

3.9

61.84

70.74

ng/l

0.73

352

Family history of other conditions

261

2.70

11.73

7.3

2.9

91.57

65.23

ng/l

1.39

237

Pre-eclampsia or eclampsia

840

6544

1.31

11.73

4.8

3.3

92.74

76.89

ng/l

3.99

724

5756

Pneumococcal septicemia

165

934

1.87

11.72

6.6

4.7

104.46

89.10

ng/l

0.96

144

825

Glaucoma suspect

1777

14998

1.20

11.68

4.1

3.8

93.83

90.86

ng/l

0.58

1487

12798

Autism spe, excluding more controls

350

2.41

11.67

4.3

5.3

56.46

61.77

ng/l

0.50

335

Ulcerative colitis (strict definition, require KELA)

617

4607

1.37

11.66

4.2

4.3

87.03

89.99

ng/l

0.30

549

4079

Radial styloid tenosynovitis [de Quervain]

235

1459

1.67

11.63

3.6

3.5

79.20

80.43

ng/l

0.08

203

1276

Bacterial, viral and other infectious agents

321

2138

1.55

11.63

7.2

4.5

108.90

87.91

ng/l

3.12

280

1916

Benign neoplasm: Pituitary gland, craniopharyngeal duct

231

1433

1.69

11.61

4.4

4.0

76.78

87.56

ng/l

1.38

203

1264

Single delivery by forceps and vacuum extractor

258

2401

0.63

11.59

2.6

4.3

63.25

78.24

ng/l

4.66

236

2205

Hidradenitis suppurativa

146

795

1.92

11.54

4.9

4.1

106.79

77.17

ng/l

1.69

135

720

Subacute thyroiditis

161

907

1.87

11.52

3.5

3.7

72.96

84.01

ng/l

1.18

138

788

Other and unspecified disorders of white blood cells

195

1164

1.77

11.50

5.8

4.0

91.86

89.79

ng/l

0.11

170

1023

Secondary parkinsonism+Parkinsonism in other disease

149

825

1.93

11.48

2.7

3.9

80.72

96.78

ng/l

1.34

122

713

Other and unspecified diseases of blood and blood-forming organs

140

761

1.97

11.46

5.3

3.9

105.83

90.05

ng/l

0.94

128

670

Collapsed vertebra, not elsewhere classified

228

2.96

11.45

4.4

3.2

77.77

82.19

ng/l

0.19

190

Other and unspecified vascular occlusions

456

3269

1.44

11.44

6.3

3.6

122.40

94.44

ng/l

4.85

392

2750

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

227

1399

1.67

11.43

3.1

4.6

81.39

84.52

ng/l

0.18

193

1284

Other viral hepatitis, including avohilmo

232

1440

1.66

11.43

5.0

4.4

97.27

84.39

ng/l

1.26

213

1304

Congenital deformities of feet

116

589

2.09

11.42

4.8

4.6

74.36

75.83

ng/l

0.05

106

536

Melanocytic naevi of upper limb, including shoulder

121

626

2.07

11.42

5.8

3.9

101.32

80.67

ng/l

1.45

108

559

Lactose intolerance

133

707

1.98

11.41

3.8

3.4

86.12

79.73

ng/l

0.34

113

619

Myopia

479

3449

1.42

11.38

4.9

4.0

85.27

79.31

ng/l

0.55

407

3075

Complications of other internal prosthetic devices, implants and grafts

212

1297

1.72

11.38

5.6

3.4

102.95

87.43

ng/l

1.60

195

1106

Short Achilles tendon (acquired)

136

732

1.97

11.34

3.3

3.5

77.13

82.62

ng/l

0.34

127

639

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

337

2.52

11.32

9.4

3.7

125.63

77.59

ng/l

3.66

298

Infective bursitis

131

697

1.99

11.29

4.7

4.4

110.63

92.32

ng/l

0.92

114

610

Synovial cyst of popliteal space [Baker]

330

2231

1.53

11.26

3.6

3.8

82.07

91.97

ng/l

1.31

281

1887

Allergic urticaria

344

2343

1.52

11.24

3.8

3.9

86.38

78.48

ng/l

0.62

310

2053

Biological medication for rheuma

662

5025

1.34

11.19

3.5

4.3

75.71

84.42

ng/l

0.92

615

4472

Other keratitis

450

3220

1.43

11.19

5.4

4.0

100.30

87.90

ng/l

1.62

405

2798

Dentofacial anomalies [including malocclusion]

2967

20355

1.15

11.18

4.1

4.0

75.37

85.70

ng/l

10.35

2584

17979

Status epilepticus

167

962

1.82

11.10

4.9

4.4

108.90

91.32

ng/l

0.84

144

844

Encephalitis

142

781

1.93

11.10

4.1

4.4

80.50

85.52

ng/l

0.35

125

697

Palmar fascial fibromatosis [Dupuytren]

608

4573

1.36

11.04

4.3

101.01

100.15

ng/l

0.07

528

3901

Emotional disorders starting during childhood or adolescence

168

957

1.80

10.97

6.0

6.7

66.08

60.06

ng/l

0.43

151

916

Mental and behavioural disorders due to sedatives or hypnotics

257

1653

1.61

10.96

3.0

4.2

82.78

84.49

ng/l

0.12

212

1486

Recurrent dislocation of patella

164

937

1.80

10.94

3.8

4.0

69.72

71.74

ng/l

0.17

152

849

Other/unspecified reactive arthropathies

273

1786

1.59

10.90

4.1

93.30

85.76

ng/l

0.61

249

1563

L04AC Interleukin inhibitors

252

1617

1.61

10.88

3.6

4.2

71.01

80.61

ng/l

1.43

239

1453

Lesion of lateral popliteal nerve

209

1286

1.70

10.85

4.4

4.0

80.87

92.64

ng/l

1.20

190

1121

Acute laryngitis and tracheitis

394

2717

1.45

10.84

5.5

4.1

78.85

78.18

ng/l

0.04

355

2450

Sequelae of injuries of lower limb

373

2599

1.48

10.83

4.1

4.0

89.51

88.39

ng/l

0.08

339

2277

Other factor of the environment

318

2.52

10.82

7.4

4.1

134.08

85.49

ng/l

1.67

285

Malignant neoplasm of digestive organs, including Hilmo

1897

11871

1.19

10.78

3.8

4.0

91.88

93.75

ng/l

0.40

1653

10097

Arterial embolism and thrombosis of lower extremity artery

168

979

1.81

10.77

5.2

3.5

134.42

91.94

ng/l

2.30

145

825

Acne, including avohilmo

650

3979

1.34

10.74

5.1

4.2

90.59

72.72

ng/l

4.05

597

3623

Behavioural disorders, excluding more controls

301

2.46

10.73

4.7

4.8

99.14

68.48

ng/l

1.19

288

Other drug-induced secondary parkinsonism

278

2.67

10.71

3.0

3.8

90.59

81.68

ng/l

0.24

244

Gastrojejunal ulcer

294

2.56

10.69

7.4

4.1

130.63

90.90

ng/l

1.27

253

Otalgia

377

2642

1.47

10.69

3.9

4.4

74.65

82.44

ng/l

1.46

342

2311

Chromosomal abnormalities, not elsewhere classified

101

501

2.15

10.63

5.5

7.8

66.04

63.22

ng/l

0.15

484

Artificial joint re-operation

362

2535

1.49

10.58

3.8

3.7

93.91

91.85

ng/l

0.07

317

2134

Hypotension due to drugs

420

2.30

10.55

4.0

3.9

110.42

89.81

ng/l

1.05

365

Psoriatic arthropathies

385

2710

1.46

10.53

3.6

3.8

78.43

88.53

ng/l

1.74

330

2354

D07AA Corticosteroids, weak (group I)

584

4391

1.35

10.48

4.2

4.5

76.33

80.85

ng/l

0.60

528

3893

Pre-eclampsia

759

5926

1.31

10.47

4.5

3.3

91.79

75.73

ng/l

3.77

652

5215

Retinal haemorrhage

142

799

1.90

10.47

5.2

3.5

114.82

90.93

ng/l

1.29

123

677

Other peripheral vascular diseases

345

2388

1.49

10.45

3.7

3.4

87.55

82.04

ng/l

0.54

308

2037

Complications of genitourinary prosthetic devices, implants and grafts

128

696

1.96

10.43

6.6

3.4

127.18

83.46

ng/l

2.21

112

605

Primary ovarian failure

372

2.31

10.39

3.5

3.0

118.27

65.74

ng/l

0.67

334

Corneal scars and opacities

143

807

1.88

10.36

6.2

3.9

109.00

85.18

ng/l

1.58

129

704

Unspecified/other endometriosis

317

2108

1.51

10.36

3.6

3.5

69.51

76.35

ng/l

1.36

284

1875

Other and unspecified psoriasis

295

1986

1.54

10.35

4.5

4.2

90.47

90.62

ng/l

0.01

249

1747

Other and unspecified nail disorders

119

634

2.00

10.35

5.1

3.6

113.09

80.88

ng/l

1.41

106

565

Chondrocostal junction syndrome [Tietze]

186

1129

1.74

10.34

3.1

3.6

82.43

81.69

ng/l

0.04

174

983

Superficial injury of forearm

400

2845

1.44

10.33

4.3

4.2

90.58

82.75

ng/l

0.69

347

2510

Myocardial infarction, with ST-elevation

735

5732

1.31

10.32

5.4

4.1

128.14

99.57

ng/l

8.42

653

4860

Iridocyclitis in diseases classified elsewhere

100

503

2.14

10.31

4.4

4.2

91.17

82.08

ng/l

0.49

446

Other and unspecified injuries of ankle and foot

172

1018

1.76

10.31

3.6

4.4

80.48

77.87

ng/l

0.18

148

918

Personal history of risk-factors, not elsewhere classified

242

2.65

10.30

3.5

3.3

79.64

66.62

ng/l

0.71

216

Other/unspecified enthesopathies, not elsewhere classified

348

2418

1.48

10.29

4.0

3.8

99.90

91.39

ng/l

0.53

296

2060

Adenomyosis (Endometriosis of uterus)

599

4544

1.35

10.26

3.2

3.4

79.36

82.32

ng/l

0.47

533

3923

Assault by bodily force

260

1701

1.57

10.21

3.8

4.5

88.91

83.19

ng/l

0.39

235

1550

Congenital deformities of feet, including avohilmo

159

924

1.80

10.21

4.5

75.47

75.76

ng/l

0.01

144

843

Other prurigo

302

2.52

10.20

6.0

3.6

143.22

80.17

ng/l

3.18

268

R07AX Other respiratory system products

+∞

10.19

6.8

10.0

55.60

49.24

ng/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

551

4131

1.36

10.19

3.5

4.0

76.09

84.36

ng/l

1.43

489

3664

Disorders of adrenal gland, other and/or unspecified

112

3.70

10.18

4.2

3.0

82.36

74.04

ng/l

0.19

102

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

142

800

1.85

10.12

10.0

5.2

75.34

68.47

ng/l

0.46

132

734

Other orthopaedic follow-up care

245

1592

1.60

10.12

4.5

2.7

91.75

78.68

ng/l

1.16

219

1367

268

1766

1.55

10.11

3.2

3.3

75.63

71.97

ng/l

0.26

238

1621

Crossbite

282

1732

1.55

10.09

10.1

5.4

68.14

69.33

ng/l

0.12

261

1614

Other disorders of penis

339

2347

1.48

10.06

5.9

5.5

115.31

101.45

ng/l

0.95

299

2103

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

202

2.92

10.00

4.5

3.6

92.33

88.13

ng/l

0.10

171

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

114

3.69

9.97

9.4

3.1

112.73

85.05

ng/l

0.55

Entropion and trichiasis of eyelid

411

2968

1.43

9.95

4.2

3.8

96.88

99.05

ng/l

0.20

360

2482

Secondary right heart disease

210

1329

1.66

9.93

4.1

4.0

125.21

93.92

ng/l

3.23

177

1128

Paralytic strabismus

312

2144

1.51

9.93

4.8

4.1

106.13

93.06

ng/l

0.74

279

1853

Varicella [chickenpox], including avohilmo

197

1219

1.67

9.91

8.8

5.0

91.84

79.47

ng/l

1.09

187

1121

Allergic rhinitis

1142

9264

1.23

9.90

3.7

4.3

72.10

82.39

ng/l

5.29

1019

8284

Other specified and unspecified retinal disorders

175

1060

1.74

9.85

6.2

3.8

102.84

88.94

ng/l

0.77

153

914

Lichen simplex chronicus

161

953

1.78

9.84

5.2

3.7

100.91

84.36

ng/l

1.19

142

839

Sacroiliitis, not elsewhere classified

161

946

1.76

9.83

3.6

4.0

68.64

80.56

ng/l

0.93

146

844

Other encephalitis

131

731

1.90

9.82

4.3

81.18

84.77

ng/l

0.21

114

652

Chondropathies

586

4462

1.34

9.82

3.7

4.1

84.06

87.22

ng/l

0.42

519

3915

severe traumatic brain injury, does not include concussion

970

7861

1.26

9.81

4.5

4.1

108.25

98.34

ng/l

1.72

805

6679

Folate deficiency anaemia

276

2.57

9.80

3.5

3.7

98.19

88.20

ng/l

0.33

240

Oesophageal obstruction

168

1008

1.75

9.77

4.0

3.9

91.23

97.42

ng/l

0.34

138

855

Other autoimmune haemolytic anaemias

361

2.36

9.75

5.3

3.8

92.88

84.22

ng/l

0.38

316

Tooth eruption problems

441

3100

1.40

9.72

8.0

4.5

77.33

70.47

ng/l

1.07

417

2852

Injury of intra-abdominal organs

108

567

2.01

9.72

5.4

4.4

98.81

87.32

ng/l

0.59

507

Other ulcerative colitis

224

1440

1.61

9.68

4.8

4.2

92.12

86.60

ng/l

0.28

198

1286

Polycystic ovarian syndrome

156

911

1.76

9.65

3.2

2.8

92.51

61.35

ng/l

0.78

137

827

Paraplegia, diplegia of upper limbs

108

571

2.02

9.65

3.9

4.1

75.75

88.21

ng/l

0.76

504

Congenital malformations of the musculoskeletal system, not elsewhere classified

333

2.36

9.64

5.3

4.2

61.66

71.08

ng/l

0.64

305

Other disorders of bone density and structure

112

599

1.97

9.55

3.8

4.0

81.92

81.04

ng/l

0.03

538

Other infective otitis externa

256

1703

1.56

9.53

5.1

4.1

97.65

89.15

ng/l

0.58

222

1500

Panniculitis affecting regions of neck and back

154

906

1.78

9.53

4.3

4.1

84.30

89.76

ng/l

0.40

138

785

Benign neoplasm: Other and unspecified parts of small intestine

472

2.15

9.52

4.6

3.5

127.07

83.32

ng/l

2.32

408

Mental and behavioural disorders due to opioids

121

660

1.90

9.52

3.3

4.6

80.02

85.44

ng/l

0.26

610

Phakomatoses, not elsewhere classified

260

2.56

9.51

4.9

5.1

105.16

75.02

ng/l

0.60

236

Additional codes for the location of defect, injury or illness

259

1731

1.55

9.49

4.6

4.1

75.94

88.42

ng/l

1.98

230

1516

Alcoholic gastritis

297

2.43

9.47

3.9

4.7

114.44

93.80

ng/l

0.51

260

Mixed connective tissue disease

486

2.11

9.41

3.5

4.0

93.38

84.25

ng/l

0.22

427

Congenital iodine-deficiency syndrome/hypothyroidism

145

846

1.82

9.41

4.6

3.6

113.35

84.80

ng/l

1.52

119

721

Chronic iridocyclitis

215

1382

1.62

9.41

4.2

3.9

76.64

86.19

ng/l

0.95

185

1210

Implicit parasitic Sepsis, including avohilmo

128

3.35

9.41

5.1

3.0

94.54

77.53

ng/l

0.63

111

Other and unspecified acquired haemolytic anaemias

257

2.60

9.38

7.5

4.1

124.33

89.45

ng/l

1.10

223

Other acute viral hepatitis

280

2.48

9.37

3.9

4.3

83.72

86.67

ng/l

0.11

255

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

149

874

1.78

9.34

4.1

4.2

85.11

82.22

ng/l

0.13

140

780

Presbycusis

720

5612

1.30

9.32

3.6

101.96

98.15

ng/l

0.43

540

4676

Lifestyle-related condition

288

2.47

9.32

7.6

3.9

142.01

84.48

ng/l

1.83

255

Other and unspecified glaucoma

352

2508

1.46

9.32

4.5

3.6

99.38

93.64

ng/l

0.49

292

2093

Endometriosis of pelvic peritoneum

599

4181

1.33

9.30

3.3

3.4

70.05

78.90

ng/l

3.56

531

3692

Car occupant injured in other and unspecified transport accidents

689

5396

1.30

9.29

4.4

4.0

87.55

87.15

ng/l

0.03

614

4739

Injuries to the wrist and hand

4578

27554

1.11

9.28

4.1

89.10

88.66

ng/l

0.10

4006

24086

Burns and corrosions

501

3762

1.36

9.26

4.5

4.6

88.81

88.87

ng/l

0.00

436

3361

Other nutritional anaemias

251

2.58

9.25

6.4

3.6

109.34

82.07

ng/l

0.99

221

Disorder of thyroid, unspecified

354

2.31

9.25

2.5

3.0

68.20

81.78

ng/l

1.13

305

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

180

1117

1.70

9.25

5.0

3.5

88.29

87.55

ng/l

0.04

154

971

Generalized skin eruption due to drugs and medicaments

184

1149

1.68

9.18

5.5

4.0

106.72

84.84

ng/l

1.77

160

1017

Corticotropin deficiency

229

2.69

9.17

3.4

3.7

90.25

78.26

ng/l

0.35

205

COPD, hospital admissions 1, only main diagnosis

1529

11172

1.19

9.15

4.4

4.1

108.34

98.24

ng/l

2.92

1281

9497

Other misadventures during surgical and medical care

120

669

1.91

9.12

7.0

3.9

109.87

83.13

ng/l

1.33

104

591

Hypertrophic disorders of skin

226

1477

1.58

9.10

3.8

3.6

87.27

77.64

ng/l

0.55

199

1306

Other and unspecified injuries of lower leg

313

2184

1.47

9.10

4.1

4.0

89.95

83.65

ng/l

0.58

283

1924

Other and unspecified abdominal hernia

200

1278

1.64

9.10

5.1

3.6

107.43

89.19

ng/l

0.99

167

1112

Myelodysplastic syndrome, including Hilmo

147

869

1.79

9.09

3.6

3.7

86.37

96.37

ng/l

0.80

127

724

Mild mental retardation

111

603

1.94

9.06

8.2

6.1

76.29

75.73

ng/l

0.02

101

560

Amblyopia ex anopsia

182

1136

1.67

9.04

6.2

5.2

62.91

77.43

ng/l

3.04

157

1027

Other pulmonary heart/vessel disease

226

1488

1.59

9.01

4.1

4.0

121.85

94.07

ng/l

2.93

192

1256

Ulcerative proctitis

233

1537

1.56

8.98

4.1

83.68

85.67

ng/l

0.12

210

1382

Mitochondrial myopathy

101

3.73

8.96

4.7

4.4

95.52

69.96

ng/l

0.62

Endocrine disorders, other/unspecified

424

2.13

8.93

2.7

3.1

88.91

75.05

ng/l

0.39

377

Lateral epicondylitis

488

3673

1.36

8.89

2.8

4.0

72.89

88.37

ng/l

5.43

429

3224

Primary coxarthrosis, bilateral

1386

11752

1.20

8.89

3.5

3.8

90.56

94.06

ng/l

0.63

1149

9973

Melanocytic naevi of lower limb, including hip

196

1251

1.63

8.88

6.2

3.9

99.82

83.08

ng/l

1.24

180

1104

Episcleritis

217

1416

1.59

8.87

4.6

3.6

94.20

80.06

ng/l

1.18

195

1259

Unspecified protein-energy malnutrition

174

2.98

8.85

5.4

3.8

99.19

71.36

ng/l

0.84

152

Disorders of myoneural junction and muscle in diseases classified elsewhere

228

2.67

8.81

5.9

3.5

102.99

83.16

ng/l

0.73

201

Other abnormal findings of blood chemistry

210

1365

1.60

8.79

4.0

4.1

101.33

91.33

ng/l

0.69

179

1197

Bronchitis, not specified as acute or chronic

339

2415

1.44

8.79

5.0

4.1

109.06

91.56

ng/l

1.80

288

2083

Other superficial mycoses

516

2.00

8.78

6.8

4.3

108.73

83.29

ng/l

0.91

465

Other and unspecified paralytic syndromes

361

2.25

8.78

3.7

3.9

80.38

85.33

ng/l

0.24

321

Sudden idiopathic hearing loss

434

3227

1.38

8.76

4.3

4.0

105.85

93.31

ng/l

0.85

366

2788

Vascular dementia (subcortical)

190

1213

1.65

8.75

3.2

3.8

89.42

105.51

ng/l

2.31

163

1007

Prolonged pregnancy

247

3107

0.67

8.74

2.1

3.7

65.53

76.14

ng/l

2.07

233

2844

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

260

1731

1.51

8.74

7.3

5.0

71.88

68.93

ng/l

0.28

244

1590

Acute generalized exanthematous pustulosis

206

1337

1.61

8.73

5.2

4.0

101.49

85.74

ng/l

1.23

179

1174

Allergic contact dermatitis

537

4112

1.33

8.72

3.7

3.5

83.08

81.06

ng/l

0.16

451

3586

Necrotizing fasciitis

129

3.27

8.71

6.8

3.5

151.29

82.64

ng/l

2.03

114

Perforation of tympanic membrane

414

3058

1.39

8.69

4.4

4.0

86.90

87.55

ng/l

0.05

365

2648

Intermittent heterotropia

227

1498

1.56

8.68

5.5

5.0

74.30

74.24

ng/l

0.00

204

1361

Other specified disorders of muscle

129

744

1.82

8.65

4.1

4.0

90.18

84.91

ng/l

0.22

111

643

Malignant neoplasm of small intestine, including Hilmo

145

867

1.76

8.64

5.5

4.0

106.97

93.59

ng/l

0.78

129

750

Other otitis externa (chronic)

285

1979

1.49

8.62

4.8

4.0

103.89

87.37

ng/l

1.45

232

1742

Hypermetropia

304

2133

1.47

8.61

5.8

4.5

77.96

78.20

ng/l

0.02

273

1894

Carrier of infectious disease

108

592

1.92

8.59

6.0

4.0

90.72

81.64

ng/l

0.58

525

Hypertrophy of breast

713

5674

1.28

8.58

2.8

3.4

71.26

78.16

ng/l

1.90

618

4958

Lactose intolerance, other/unspecified

115

642

1.88

8.58

3.6

3.3

79.01

79.21

ng/l

0.01

563

Polyarthritis, unspecified

157

958

1.71

8.56

4.3

3.7

86.95

87.03

ng/l

0.00

143

831

Heterophoria

315

2227

1.45

8.56

3.7

4.0

80.75

79.37

ng/l

0.06

257

1968

Benign neoplasm: Duodenum

136

805

1.80

8.53

5.8

3.9

117.20

90.65

ng/l

1.97

115

702

Cluster headache, strict

131

759

1.79

8.53

3.5

4.0

80.81

81.71

ng/l

0.04

120

691

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

643

5044

1.29

8.52

4.5

3.7

82.10

79.11

ng/l

0.37

577

4541

Ankylosing spondylitis, ICD10

322

2287

1.45

8.52

4.1

4.3

85.32

90.10

ng/l

0.34

290

2036

Systemic sclerosis (FG)

116

654

1.88

8.52

3.6

3.7

72.92

84.21

ng/l

1.17

101

561

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1094

9098

1.22

8.50

3.7

4.3

81.21

87.59

ng/l

1.49

984

8074

All dysplastic lesions of the vulva

199

1291

1.61

8.49

5.2

3.2

100.72

75.39

ng/l

2.40

177

1124

Lung cancer and mesothelioma

779

5302

1.27

8.48

3.3

3.5

84.92

90.18

ng/l

0.99

677

4495

Malignant neoplasm of head and neck, including Hilmo

391

2871

1.40

8.48

3.4

4.3

82.25

99.48

ng/l

3.42

331

2434

109

602

1.91

8.47

3.6

4.0

97.68

83.49

ng/l

0.38

547

Bruxism

440

2.08

8.46

3.8

3.7

61.38

74.54

ng/l

1.54

396

Unspecified lump in breast

725

5805

1.28

8.39

3.0

3.2

79.49

81.15

ng/l

0.25

648

4943

Brachial plexus disorders

330

2358

1.43

8.39

2.7

3.7

68.11

79.73

ng/l

2.76

300

2096

Oligomenorrhoea

136

801

1.76

8.38

3.3

3.5

77.72

75.80

ng/l

0.10

123

701

Unspecified event, undetermined intent

109

604

1.90

8.38

5.0

4.8

94.83

85.83

ng/l

0.45

544

Volvulus

132

775

1.79

8.38

6.0

3.8

103.91

96.73

ng/l

0.29

115

668

Non-Hodgkin lymphoma, all

201

1310

1.60

8.36

3.2

3.8

88.79

96.63

ng/l

0.40

169

1109

Secondary polycythaemia

106

584

1.92

8.34

4.3

97.05

95.56

ng/l

0.06

509

Autoimmune thyroiditis

421

2.09

8.34

2.6

4.1

55.30

77.23

ng/l

5.37

376

Cytomegaloviral pneumonitis

5.66

8.33

13.9

3.0

133.05

74.21

ng/l

2.02

Congenital malformations of cardiac septa

278

1872

1.48

8.32

6.3

5.7

77.62

74.38

ng/l

0.32

248

1712

Excessive vomiting in pregnancy

291

2038

1.46

8.30

3.4

3.3

73.83

72.82

ng/l

0.10

253

1808

Salpingitis and oophoritis

776

6269

1.26

8.28

3.7

3.4

82.04

79.67

ng/l

0.29

668

5437

Complications of labour and delivery

2125

13458

0.87

8.27

3.1

3.5

75.52

78.70

ng/l

1.21

1851

11723

Benign neoplasm of eye and adnexa

468

3553

1.35

8.25

3.9

89.78

90.62

ng/l

0.07

399

3047

Other peripheral vertigo

417

3115

1.38

8.24

2.7

3.8

76.68

90.22

ng/l

4.15

354

2651

Event of undetermined intent

236

1591

1.53

8.23

4.2

4.6

90.88

85.03

ng/l

0.40

209

1423

Alcohol abuse, main dg

538

4151

1.32

8.23

3.5

4.6

90.69

93.56

ng/l

0.26

464

3693

Pre-eclampsia or poor fetal growth

1055

8734

1.22

8.22

4.7

3.4

88.26

75.11

ng/l

4.03

921

7791

Other injuries of lower limb, level unspecified

240

2.51

8.21

5.3

3.9

91.12

80.19

ng/l

0.55

215

Congenital malformations of the respiratory system, including avohilmo

106

590

1.93

8.21

6.4

5.4

70.84

73.40

ng/l

0.17

536

Organ-limited amyloidosis

101

3.47

8.14

8.7

3.2

161.08

95.03

ng/l

1.68

Bullous disorders

265

1840

1.50

8.13

4.6

3.9

118.98

93.20

ng/l

2.19

231

1580

Adalimumab

356

2593

1.40

8.10

3.4

4.2

80.46

81.24

ng/l

0.03

329

2331

Any dementia

1995

12066

1.16

8.09

3.0

3.8

89.94

98.02

ng/l

4.02

1617

10087

Benign neoplasm of major salivary glands

409

3053

1.38

8.09

3.9

4.0

90.16

92.58

ng/l

0.22

346

2626

Other disorders of the genitourinary system

621

4912

1.30

8.09

4.2

3.4

88.02

86.26

ng/l

0.19

520

4130

Hypogonadotropic hypogonadism

103

565

1.90

8.08

3.7

5.3

92.45

92.52

ng/l

0.00

516

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

144

872

1.72

8.08

4.1

4.3

85.82

83.29

ng/l

0.13

132

788

Use of biperiden

211

1399

1.56

8.07

3.4

4.1

81.53

87.98

ng/l

0.54

181

1243

Idiopathic thrombocytopenic purpura

136

814

1.76

8.06

4.7

4.6

90.92

89.97

ng/l

0.04

121

727

Perineal laceration during delivery

280

3208

0.69

8.04

2.4

3.6

56.36

73.09

ng/l

7.16

260

2920

Malignant melanoma of skin, including Hilmo

602

4736

1.30

8.03

4.5

4.0

103.61

96.07

ng/l

0.85

516

4009

Intracranial and intraspinal abscess and granuloma

281

2.36

8.01

5.5

4.0

98.91

85.29

ng/l

0.39

252

Campylobacter enteritis

119

687

1.82

8.01

6.5

4.1

113.77

82.37

ng/l

1.88

106

613

Encephalopathy

230

2.52

8.01

4.8

4.0

108.29

94.26

ng/l

0.31

198

Bell's palsy

467

3554

1.34

8.00

4.3

3.9

91.93

90.16

ng/l

0.14

393

3046

Open bite

195

1270

1.58

8.00

8.0

5.3

67.00

67.69

ng/l

0.06

189

1174

Examination and encounter for administrative purposes

295

2086

1.45

7.99

4.5

3.6

97.13

96.53

ng/l

0.03

267

1773

Other and unspecified haemorrhagic conditions

416

2.09

7.98

5.8

4.3

88.50

85.74

ng/l

0.11

372

Single delivery by caesarean section

396

3040

0.73

7.96

3.4

4.3

73.91

78.42

ng/l

0.41

354

2786

Mixed conductive and sensorineural hearing loss

543

4227

1.32

7.95

4.1

3.9

96.55

93.64

ng/l

0.25

459

3622

Blindness or visual impairment, binocular

125

3.21

7.95

8.4

4.1

113.38

80.87

ng/l

0.83

108

Dystonia

237

1618

1.52

7.91

2.9

3.8

69.66

83.38

ng/l

3.22

208

1410

Other disorders of breast

598

4714

1.30

7.89

3.5

3.3

72.57

79.71

ng/l

1.83

526

4050

Other specified/unspecified inflammatory spondylopathies

161

1006

1.65

7.88

3.5

4.0

85.05

83.66

ng/l

0.08

141

890

Malignant neoplasm of bladder

273

1910

1.47

7.87

4.3

4.1

106.89

107.27

ng/l

0.02

236

1601

Other other unspecified disorders of the circulatory system

173

1110

1.63

7.81

4.5

4.0

115.85

89.10

ng/l

1.82

153

967

Sacrococcygeal disorders, not elsewhere classified

126

743

1.77

7.81

2.7

3.6

66.41

80.82

ng/l

2.42

110

650

Spinal instabilities

117

677

1.81

7.80

3.7

4.0

71.79

84.89

ng/l

1.27

100

595

Other predominantly sexually transmitted diseases, not elsewhere classified

547

4258

1.30

7.79

4.6

3.7

85.02

79.41

ng/l

0.74

493

3804

Benign neoplasm: Oesophagus

312

2.27

7.76

5.2

3.6

111.14

82.90

ng/l

1.35

272

Visual field defects

360

2654

1.40

7.75

4.9

4.0

104.21

92.00

ng/l

1.18

314

2276

Premature rupture of membranes

420

3961

0.74

7.74

2.7

3.6

59.16

75.44

ng/l

8.81

369

3595

Cerebral aneurysm, nonruptured

372

2758

1.39

7.73

5.7

3.8

95.49

88.93

ng/l

0.62

325

2371

Benign lipomatous neoplasm

1247

10607

1.19

7.69

3.8

3.9

87.19

91.03

ng/l

0.81

1058

9174

Cluster headache, wide

139

844

1.70

7.67

3.4

4.1

79.07

83.20

ng/l

0.20

127

762

Hypersomnia

312

2.23

7.65

2.8

3.8

70.48

78.02

ng/l

0.43

278

Hemiplegia

207

1383

1.55

7.64

3.9

4.1

84.87

90.01

ng/l

0.40

173

1215

Other/unspecified soft tissue disorders related to use, overuse and pressure

125

741

1.76

7.64

2.7

3.7

80.55

81.46

ng/l

0.06

104

661

Orthopaedic devices associated with adverse incidents

106

607

1.89

7.61

3.7

3.6

72.19

88.88

ng/l

1.75

530

Other disorders of binocular movement

522

1.91

7.54

4.3

4.0

82.94

72.68

ng/l

0.51

477

Other disorders of thyroid

398

2.09

7.54

2.5

3.3

68.14

81.21

ng/l

1.09

351

Other specified and unspecified disorders of conjunctiva

243

2.41

7.52

6.0

3.8

100.44

77.38

ng/l

0.60

212

Traumatic subarachnoid haemorrhage

150

935

1.66

7.52

4.8

3.7

114.11

95.17

ng/l

1.13

123

799

Other specified/unspecified dorsopathies

145

898

1.68

7.50

3.6

3.8

98.29

88.60

ng/l

0.37

135

767

Malignant neoplasm of breast, ER-negative, including Hilmo

1014

7951

1.21

7.44

3.1

3.2

82.67

81.91

ng/l

0.10

861

6697

Anxious personality disorder

354

2.10

7.44

3.6

4.0

85.72

77.80

ng/l

0.33

320

Benign neoplasm of mouth and pharynx

448

3432

1.34

7.42

4.1

4.0

87.00

91.57

ng/l

0.48

390

2949

Contusion of other and unspecified parts of foot

191

1260

1.56

7.42

5.1

4.5

87.38

76.96

ng/l

0.73

172

1144

Autism

443

1.96

7.42

4.3

5.6

56.44

70.49

ng/l

2.00

416

Melanoma in situ

219

1498

1.53

7.39

4.2

3.7

92.35

93.10

ng/l

0.04

183

1290

Secondary uncertain malignant neoplasm

545

4282

1.30

7.38

3.4

4.0

83.25

96.78

ng/l

2.43

463

3610

Triptan medication for migraine, single purchase ok

3111

19001

1.12

7.37

3.2

4.2

74.30

86.15

ng/l

13.91

2770

16723

Migraine, single triptan purchase ok & required. ICD-code if available is included

3111

19001

1.12

7.37

3.2

4.2

74.30

86.15

ng/l

13.91

2770

16723

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

701

5668

1.26

7.36

4.3

4.4

94.45

90.76

ng/l

0.42

661

4903

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

189

2.62

7.36

8.5

5.0

137.25

83.89

ng/l

1.62

171

Other specified/unspecified disorders of bone/cartilage

111

644

1.80

7.35

4.8

3.9

81.98

83.78

ng/l

0.09

570

Trigeminal neuralgia

251

1757

1.47

7.35

3.4

77.95

84.62

ng/l

0.79

213

1511

Medical abortion

2862

13898

1.12

7.34

3.3

78.63

79.72

ng/l

0.29

2486

11995

Emphysema

302

2183

1.42

7.33

4.3

4.1

92.79

97.62

ng/l

0.42

257

1875

Myeloproliferative diseases

365

2724

1.38

7.33

3.6

3.9

86.19

92.88

ng/l

0.83

322

2322

Congenital malformations of the respiratory system

546

1.91

7.32

6.9

5.5

71.45

73.02

ng/l

0.09

499

Anomalies of dental arch relationship, including avohilmo

705

5149

1.26

7.31

6.1

4.1

76.38

79.76

ng/l

0.57

623

4585

Focal epilepsy

857

7078

1.23

7.31

4.1

4.4

82.60

90.09

ng/l

1.68

739

6175

Other and unspecified types of non-Hodgkin lymphoma, hilmo

189

1256

1.57

7.30

3.8

3.9

81.22

94.55

ng/l

1.37

156

1083

Tumor necrosis factor alpha inhibitors

564

4450

1.29

7.30

3.4

4.3

76.76

83.08

ng/l

0.48

520

3967

Other erythematous conditions

167

1081

1.62

7.27

4.4

3.8

80.68

85.42

ng/l

0.33

149

944

Pediculosis, acariasis and other infestations, including avohilmo

602

4789

1.28

7.24

4.1

4.4

92.26

83.12

ng/l

1.11

530

4263

Hepatocellular carcinoma, including Hilmo

121

723

1.75

7.22

4.0

4.1

92.55

100.46

ng/l

0.50

108

609

Other/unspecified disorders of vestibular function

199

1341

1.55

7.21

3.7

85.48

91.10

ng/l

0.40

175

1153

Implicit parasitic Sepsis

109

3.20

7.20

5.9

3.1

103.37

80.66

ng/l

0.82

Ulcerative colitis (strict definition, all Crohn cases excluded)

501

3903

1.31

7.20

3.9

4.4

84.17

89.70

ng/l

0.59

444

3466

Pollen allergy

619

4872

1.27

7.18

3.8

4.7

67.37

75.22

ng/l

2.34

555

4426

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

204

1379

1.53

7.17

4.2

4.0

89.45

95.85

ng/l

0.59

181

1175

Other condition

557

4403

1.29

7.16

5.2

4.1

92.92

89.31

ng/l

0.36

491

3840

Acute alcohol intoxication

918

7646

1.22

7.13

3.9

4.7

97.62

97.09

ng/l

0.05

771

6749

Embedded teeth, including avohilmo

273

1942

1.43

7.13

6.8

4.3

87.08

74.22

ng/l

1.58

257

1767

Melanocytic naevi of other and unspecified parts of face

242

1693

1.47

7.12

4.8

3.7

84.96

83.90

ng/l

0.08

222

1480

Superficial injury of shoulder and upper arm

473

3668

1.32

7.10

3.7

4.2

87.38

90.53

ng/l

0.28

417

3174

Postzoster neuralgia

478

1.95

7.09

4.4

3.4

98.07

87.29

ng/l

0.63

408

Enteropathic arthropathies

511

1.89

7.06

3.5

4.3

83.74

83.02

ng/l

0.02

462

Retinal breaks without detachment

664

5370

1.26

7.06

4.1

3.7

83.58

89.84

ng/l

1.29

571

4661

Delivery, wide proxy

1244

7718

0.84

7.05

3.0

3.4

77.32

83.24

ng/l

2.10

1063

6599

Malignant neoplasm of small intestine

112

663

1.79

7.05

5.9

3.9

109.37

90.90

ng/l

1.21

577

Congenital malformations of genital organs

327

2393

1.39

7.00

5.0

4.2

76.53

70.58

ng/l

0.53

293

2169

Hypertension, Pulmonary Arterial

206

2.49

7.00

3.3

2.2

106.26

64.10

ng/l

2.85

177

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.52

6.99

3.3

5.4

47.81

78.87

ng/l

2.51

Embolic stroke with flimmer

118

707

1.75

6.99

4.4

3.4

114.78

90.05

ng/l

2.08

105

588

Injury of eye and orbit

493

3848

1.30

6.97

4.7

4.6

91.99

91.44

ng/l

0.04

440

3431

Pyoderma

479

1.92

6.95

5.0

4.1

96.77

80.06

ng/l

0.75

421

Eosinophilia

416

2.00

6.93

5.9

4.4

111.12

83.91

ng/l

1.61

371

Dronedarone medication

129

795

1.71

6.93

2.9

3.0

94.89

79.94

ng/l

1.36

102

685

Other congenital malformations of limb(s)

157

2.70

6.92

5.6

5.8

82.49

69.41

ng/l

0.23

147

Asthma and opportunity respiratory infection

226

1577

1.49

6.91

3.7

85.60

91.30

ng/l

0.54

198

1341

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

292

2131

1.42

6.91

3.1

3.6

82.00

83.65

ng/l

0.13

229

1815

Melanoma in situ of upper limb, including shoulder

215

2.48

6.90

4.0

3.4

88.02

79.73

ng/l

0.20

186

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

385

2925

1.35

6.85

4.1

3.9

84.43

91.10

ng/l

0.90

328

2513

Toxic effects of substances chiefly nonmedicinal as to source

410

3134

1.33

6.85

4.0

4.3

89.58

88.00

ng/l

0.09

364

2773

Lesion of radial nerve

153

983

1.62

6.83

3.9

3.8

103.18

89.45

ng/l

0.55

128

858

Supervision of normal pregnancy

451

3328

0.76

6.83

2.5

3.7

66.16

76.40

ng/l

3.80

415

3034

Other superficial mycoses, including avohilmo

371

2796

1.35

6.82

4.1

86.25

81.93

ng/l

0.34

323

2495

Childhood allergy (age < 16)

361

2220

1.36

6.79

5.5

5.6

63.55

66.08

ng/l

0.28

338

2082

Cauda equina syndrome

335

2.11

6.78

2.4

3.6

84.97

80.75

ng/l

0.17

299

Crowding of teeth, including avohilmo

290

1735

1.41

6.77

9.1

5.2

69.77

64.43

ng/l

0.59

273

1616

Benign neoplasm: salivary glands, exclude unknown (D119)

362

2732

1.36

6.75

3.7

4.0

88.75

91.76

ng/l

0.27

309

2352

Other complications of labour and delivery, not elsewhere classified

158

2134

0.65

6.75

2.7

3.5

52.69

71.36

ng/l

7.34

144

1952

Other bursitis of hip

106

626

1.79

6.73

3.1

3.3

83.76

82.77

ng/l

0.05

539

Melanocytic naevi of scalp and neck

103

602

1.79

6.71

5.1

4.1

98.18

82.95

ng/l

0.87

538

Biomechanical lesions, not elsewhere classified

224

1566

1.48

6.71

4.1

3.8

85.80

91.64

ng/l

0.57

204

1347

Combined immunodeficiencies

269

2.26

6.71

4.8

3.4

94.00

81.56

ng/l

0.51

238

Hypertrophic scar

199

1356

1.51

6.70

3.9

3.7

87.03

77.72

ng/l

0.47

175

1199

Alcohol withdrawal state with delirium

239

1686

1.46

6.70

3.9

4.8

83.78

104.18

ng/l

3.47

215

1501

Contusion of ankle

150

962

1.61

6.69

5.2

4.3

83.57

78.19

ng/l

0.38

135

865

Ectropion of eyelid

191

1296

1.53

6.69

5.1

3.9

116.84

104.59

ng/l

0.80

170

1079

Drug-induced obesity

204

2.44

6.66

4.0

4.5

89.91

79.72

ng/l

0.29

185

Postmenopausal atrophic vaginitis

1212

5641

1.19

6.65

3.1

3.3

75.97

82.59

ng/l

2.89

1037

4852

Other melanin hyperpigmentation

115

698

1.75

6.64

4.4

3.2

101.38

84.27

ng/l

0.95

103

602

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

622

5027

1.26

6.63

4.3

4.4

94.45

89.93

ng/l

0.49

588

4362

Fracture of neck

253

1810

1.44

6.62

4.7

4.2

107.99

98.14

ng/l

0.51

215

1555

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

298

2186

1.40

6.62

4.4

3.7

104.64

95.45

ng/l

0.83

266

1859

Disorders of speech understanding and production

179

1175

1.55

6.61

7.7

5.6

71.31

72.88

ng/l

0.09

168

1064

Other disorders of carbohydrate metabolism

3.29

6.61

7.6

4.5

93.75

80.82

ng/l

0.32

Urethritis and urethral syndrome

545

1.83

6.61

3.9

3.3

76.07

81.08

ng/l

0.25

475

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

245

2.32

6.59

3.8

80.85

85.79

ng/l

0.18

214

Pregnancy hypertension

1542

12035

1.16

6.58

4.5

3.3

88.64

75.43

ng/l

5.74

1358

10635

Benign neoplasm: Parotid gland

327

2443

1.38

6.56

3.6

4.0

87.27

92.67

ng/l

0.55

278

2101

Acute alcohol intoxication, ICD10

691

5649

1.24

6.55

3.7

4.7

93.02

95.19

ng/l

0.20

577

5033

Medial epicondylitis

148

953

1.61

6.54

3.4

3.9

81.28

82.55

ng/l

0.06

130

844

Anogenital herpesviral [herpes simplex] infection

199

1360

1.50

6.53

4.4

3.7

71.50

74.32

ng/l

0.31

174

1224

Other neurotic disorders

192

1309

1.52

6.52

3.1

3.7

89.72

86.47

ng/l

0.19

158

1137

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

105

3.18

6.50

3.9

82.83

81.22

ng/l

0.04

Chorioretinal inflammation

122

754

1.69

6.47

5.5

3.8

86.38

82.96

ng/l

0.19

104

671

Benign neoplasm: Skin of eyelid, including canthus

689

5656

1.24

6.45

3.9

3.7

88.08

90.91

ng/l

0.34

582

4819

malignant neoplasm of male genital organs, including Hilmo

966

4870

1.20

6.45

4.4

5.1

105.31

109.56

ng/l

0.56

832

4250

Anorexia

376

2.01

6.44

3.8

4.2

92.05

76.10

ng/l

0.43

331

Vertical strabismus

147

953

1.61

6.38

4.2

3.8

76.16

84.81

ng/l

0.74

126

843

Vulvovaginal ulceration/inflammation in other diseases

246

1759

1.43

6.38

4.1

3.3

71.84

72.60

ng/l

0.07

217

1551

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1261

8569

0.85

6.37

2.8

3.6

70.58

77.57

ng/l

2.55

1135

7639

Abnormal findings on diagnostic imaging of central nervous system

198

1364

1.50

6.36

3.7

3.9

78.96

84.51

ng/l

0.37

180

1196

Other and unspecified iridocyclitis

194

1332

1.51

6.36

4.7

3.9

84.76

84.50

ng/l

0.01

180

1177

Vascular dementia (mixed)

106

637

1.76

6.36

2.9

4.0

98.21

108.01

ng/l

0.55

539

Factitial dermatitis

129

2.87

6.36

5.9

3.0

114.34

69.01

ng/l

1.81

117

Dissection of aorta

132

835

1.65

6.35

4.9

3.9

125.88

97.10

ng/l

1.34

115

711

Brain meningioma, including Hilmo

231

1642

1.46

6.35

3.8

3.5

89.77

87.18

ng/l

0.18

194

1391

Postpartum haemorrhage

567

5806

0.80

6.34

2.9

3.6

62.51

76.06

ng/l

7.81

508

5250

Neuroendocrine tumor and carcinoma of small intestine

387

1.99

6.32

4.4

3.6

112.45

90.30

ng/l

1.04

333

Gluteal tendinitis

183

1244

1.52

6.32

3.4

3.8

77.78

87.65

ng/l

1.08

153

1062

Etanercept

250

1799

1.43

6.30

3.5

4.1

85.47

79.34

ng/l

0.18

231

1593

Benign neoplasm: Skin of trunk

180

1222

1.53

6.29

6.2

3.9

97.78

85.85

ng/l

0.88

154

1076

Disorders of eyelid in diseases classified elsewhere

141

909

1.62

6.28

4.8

3.6

86.18

82.94

ng/l

0.17

117

788

Pyoderma gangrenosum

217

2.38

6.28

4.8

3.9

82.32

77.66

ng/l

0.15

192

Malignant melanoma of skin

484

3832

1.29

6.26

4.8

4.0

106.60

96.54

ng/l

1.04

422

3236

Brain meningioma

224

1588

1.46

6.26

3.6

3.5

84.36

86.40

ng/l

0.16

188

1344

Malignant neoplasm of anus and anal canal, including Hilmo

339

2.06

6.24

3.2

3.7

89.66

91.77

ng/l

0.08

294

Central retinal artery occlusion

107

648

1.74

6.23

5.4

4.0

111.11

100.57

ng/l

0.41

561

Adult respiratory distress syndrome

312

2.09

6.16

7.6

4.1

135.49

86.59

ng/l

2.43

277

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

132

2.83

6.12

2.8

4.2

97.26

96.43

ng/l

0.01

111

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1148

9887

1.17

6.10

3.7

4.3

85.43

93.34

ng/l

1.85

1006

8600

Unspecified visual impairment (binocular)

420

1.92

6.09

4.5

4.4

122.95

80.01

ng/l

2.05

366

Congenital malformations of the nervous system

536

1.80

6.09

5.2

5.7

53.65

70.26

ng/l

2.94

497

Malignant neoplasm of other connective and soft tissue, including Hilmo

174

1182

1.53

6.08

3.6

4.1

88.74

91.88

ng/l

0.22

150

1014

Disorders of iron metabolism

326

2.03

6.07

5.8

3.7

85.30

84.65

ng/l

0.02

288

Other and unspecified corneal deformities and disorders

140

909

1.60

6.06

4.2

3.9

88.24

86.21

ng/l

0.10

124

803

Multifocal fibrosclerosis

176

2.54

6.06

4.2

3.3

76.42

88.35

ng/l

0.65

149

Carcinoma in situ of skin, other sites/unspecified

528

1.83

6.03

7.2

3.7

144.62

89.50

ng/l

1.58

452

Pemphigoid

137

890

1.62

6.02

3.9

117.44

97.52

ng/l

1.01

120

763

Abscess of lung

385

1.95

6.02

6.1

4.5

125.36

90.31

ng/l

1.11

337

Schizophrenia

534

4290

1.26

6.01

3.3

4.3

88.46

91.84

ng/l

0.26

448

3804

Benign neoplasm: Choroid

293

2187

1.38

6.01

3.6

3.8

87.97

90.81

ng/l

0.20

247

1881

Crohn disease (strict definition, all UC cases excluded)

181

1239

1.50

6.00

3.9

4.2

80.96

83.52

ng/l

0.15

164

1115

Injury of urinary and pelvic organs

494

1.83

6.00

5.8

4.3

103.09

89.70

ng/l

0.55

444

Scabies, including avohilmo

488

3880

1.28

5.99

4.0

4.4

87.76

80.98

ng/l

0.65

432

3488

Pustular psoriasis

198

1384

1.48

5.98

3.4

3.7

75.48

83.14

ng/l

0.97

166

1207

Other specified/unspecified hearing loss

385

2983

1.32

5.98

4.8

4.0

109.73

93.54

ng/l

1.41

343

2554

Fitting and adjustment of external prosthetic device

3.39

5.97

8.0

2.8

216.56

72.62

ng/l

1.83

Male infertility

118

733

1.65

5.97

7.8

5.7

149.56

102.24

ng/l

1.82

107

683

Benign neoplasm: Rectosigmoid junction

186

1288

1.50

5.97

4.2

3.9

96.76

94.15

ng/l

0.15

161

1109

Other secondary gonarthrosis

229

1644

1.44

5.96

3.8

4.1

83.48

92.37

ng/l

1.05

197

1426

Suggestive for eosinophilic asthma

360

2764

1.33

5.96

3.5

4.1

89.53

92.75

ng/l

0.26

311

2397

Systemic sclerosis

116

726

1.68

5.96

3.6

3.4

72.92

80.75

ng/l

0.74

101

627

Open wound of wrist and hand

1654

14122

1.14

5.96

4.3

4.5

91.00

93.37

ng/l

0.43

1446

12490

Appendectomy

2603

22456

1.11

5.94

4.1

4.0

86.43

87.46

ng/l

0.18

2284

19729

Malignant neoplasm of breast, HER-negative

926

7559

1.20

5.92

3.0

3.2

82.05

82.10

ng/l

0.01

784

6349

Pilonidal cyst

244

1763

1.41

5.91

6.1

4.5

101.86

84.42

ng/l

1.51

219

1615

Chronic viral hepatitis

159

1062

1.53

5.91

5.6

4.5

107.65

84.49

ng/l

1.93

144

966

Carcinoma in situ of other and unspecified digestive organs

193

1348

1.49

5.90

5.5

4.2

112.82

95.09

ng/l

1.58

174

1174

Other benign neoplasms of connective and other soft tissue

390

3032

1.31

5.89

3.9

4.0

90.52

89.34

ng/l

0.07

335

2629

Use of disulfiram, acamprosate or naltrexone

280

2075

1.38

5.86

2.9

4.7

80.82

94.34

ng/l

1.65

239

1874

Aneurysms, operations, SAH

685

5678

1.23

5.82

5.2

3.6

99.79

90.27

ng/l

1.61

597

4836

Other lesions of median nerve

132

857

1.61

5.80

4.5

3.3

99.58

88.25

ng/l

0.62

106

715

Atopic conjunctivitis

173

1184

1.51

5.78

4.5

4.3

77.48

77.18

ng/l

0.02

154

1064

Multiple delivery

185

2628

0.69

5.77

3.3

4.2

77.37

83.43

ng/l

0.52

161

2348

Other retinal artery occlusion

110

685

1.69

5.77

6.1

3.9

127.82

98.81

ng/l

1.47

595

Lagophthalmos

371

1.97

5.76

5.3

3.5

108.59

81.89

ng/l

0.58

318

Corneal degeneration

518

1.81

5.76

4.6

3.5

91.79

82.72

ng/l

0.57

450

Malignant neoplasm of renal pelvis

154

2.58

5.75

3.9

3.7

88.84

91.02

ng/l

0.05

127

Other congenital malformations of intestine, including avohilmo

300

2.08

5.74

6.0

4.5

66.81

73.01

ng/l

0.35

269

Open wound of abdomen, lower back and pelvis

114

713

1.66

5.74

4.4

4.7

100.19

88.53

ng/l

0.33

647

Convergent concomitant strabismus

199

1400

1.46

5.71

4.4

4.2

71.21

77.36

ng/l

0.59

185

1262

Conduct disorder

389

1.89

5.71

4.7

6.1

98.85

72.90

ng/l

0.94

375

Acute appendicitis

2780

23502

1.10

5.70

4.1

88.26

89.46

ng/l

0.22

2467

20679

Chronic conjunctivitis

130

843

1.61

5.70

3.9

4.3

71.51

79.73

ng/l

0.91

121

746

Malignant neoplasm of digestive organs

1663

11269

1.14

5.68

3.7

4.0

91.67

94.66

ng/l

0.70

1444

9557

Caught, crushed, jammed or pinched in or between objects

187

1303

1.47

5.67

4.6

4.7

90.01

85.18

ng/l

0.30

165

1171

Chronic suppurative otitis media

254

1869

1.39

5.63

4.2

97.22

87.42

ng/l

0.46

224

1626

Thyroiditis, unspecified

358

1.95

5.60

3.1

3.5

95.13

79.27

ng/l

0.54

314

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

288

2.07

5.59

4.7

3.5

91.56

79.29

ng/l

0.41

261

Rare circulating lymphoid malignancy, including Hilmo

122

783

1.62

5.59

4.4

5.2

84.72

89.73

ng/l

0.24

103

693

Impetigo

161

1093

1.51

5.58

6.0

5.1

75.45

74.63

ng/l

0.05

141

997

Pulmonary eosinophilia, not elsewhere classified

310

2.04

5.58

4.0

3.5

88.05

81.91

ng/l

0.23

270

Hodgkin lymphoma, hilmo

107

665

1.67

5.58

3.8

4.3

84.24

85.93

ng/l

0.06

589

Congenital malformations of eye, ear, face and neck

220

1583

1.42

5.56

5.7

4.8

86.68

77.45

ng/l

0.82

200

1439

Endometriosis of ovary

653

5088

1.23

5.56

3.6

3.4

78.54

80.36

ng/l

0.26

563

4436

Dislocation, sprain and strain of joint and ligaments of hip

172

1191

1.50

5.53

4.2

3.7

95.39

91.42

ng/l

0.21

157

1009

Other fall from one level to another

825

6976

1.20

5.52

4.3

4.6

82.15

89.57

ng/l

1.67

721

6161

Autism spe

467

1.79

5.50

4.3

6.4

56.46

70.87

ng/l

2.11

442

Postprocedural disorders of nervous system

232

1687

1.40

5.49

2.9

3.8

60.50

76.48

ng/l

5.80

204

1515

Other surgical follow-up care

130

848

1.58

5.49

5.6

2.9

94.56

78.47

ng/l

1.25

120

743

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

245

1796

1.39

5.49

3.7

81.01

83.23

ng/l

0.15

218

1589

Other and unspecified injuries of shoulder and upper arm

132

866

1.58

5.47

4.3

4.2

85.91

89.96

ng/l

0.20

118

761

Malignant neoplasm of head and neck

308

2343

1.34

5.46

3.3

4.2

78.74

99.86

ng/l

4.14

260

1987

Pustulosis palmaris et plantaris

179

1251

1.48

5.46

3.4

3.6

74.98

81.63

ng/l

0.75

152

1094

Bullous pemphigoid

107

673

1.68

5.45

3.9

130.78

94.19

ng/l

1.83

578

Acute nasopharyngitis (common cold)

359

2763

1.31

5.41

5.8

4.7

103.51

91.99

ng/l

1.17

320

2490

Generalized epilepsy

151

1021

1.52

5.38

3.9

5.0

84.60

80.16

ng/l

0.20

127

930

Haemangioma and lymphangioma, any site

363

2833

1.31

5.37

4.1

82.33

85.00

ng/l

0.24

319

2463

Contusion of toe(s) without damage to nail

601

1.69

5.37

5.5

4.4

99.16

76.29

ng/l

0.98

548

Meralgia paraesthetica

140

935

1.55

5.36

2.8

3.9

75.77

88.02

ng/l

1.25

119

815

Long labour

557

5757

0.81

5.36

2.7

3.6

65.13

76.01

ng/l

5.16

492

5180

Other diseases of peritoneum

191

1356

1.46

5.36

4.6

3.5

89.67

85.17

ng/l

0.31

166

1171

Calcific tendinitis of shoulder

213

1537

1.42

5.35

3.2

3.8

75.70

84.95

ng/l

1.06

191

1341

Septal defects

250

1814

1.39

5.35

6.0

5.9

75.91

73.69

ng/l

0.19

219

1662

Vascular syndromes of brain in cerebrovascular disorders

195

1391

1.45

5.34

4.6

3.9

108.37

100.70

ng/l

0.42

178

1188

Focal epilepsy, mode (most common among epilepsy diagnosis)

732

6153

1.21

5.33

3.8

4.3

82.67

90.69

ng/l

1.73

626

5357

Labour and delivery complicated by fetal stress [distress]

454

3690

0.79

5.32

3.1

3.6

63.88

73.78

ng/l

3.88

411

3387

Later onset COPD

1290

9087

1.15

5.31

3.9

109.41

99.43

ng/l

2.20

1078

7602

Other and unspecified mononeuropathies of lower limb

122

794

1.60

5.31

3.2

3.5

71.94

83.85

ng/l

1.58

684

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

999

8353

1.17

5.31

3.2

4.0

97.09

95.05

ng/l

0.22

878

7111

Sequelae of injuries of neck and trunk

113

721

1.63

5.30

3.6

4.0

69.36

87.61

ng/l

1.63

103

643

Behavioural disorders

399

1.84

5.30

4.7

6.2

99.14

72.60

ng/l

0.97

381

Unspecified jaundice

190

1347

1.45

5.30

4.7

3.9

91.85

91.38

ng/l

0.02

167

1153

Protein-energy malnutrition of moderate and mild degree

289

2.07

5.29

3.8

5.5

70.17

76.95

ng/l

0.27

255

Other facial nerve disorders

121

786

1.60

5.29

2.9

3.5

78.46

81.13

ng/l

0.15

100

675

Malignant neoplasm of liver and intrahepatic bile ducts

125

817

1.59

5.28

3.8

4.0

88.35

97.03

ng/l

0.74

112

684

Lymphoid leukaemia

236

1740

1.40

5.28

4.0

4.6

87.69

93.92

ng/l

0.50

205

1511

Acute lymphadenitis

203

1456

1.43

5.27

4.3

90.97

80.00

ng/l

0.75

180

1308

Arthropathic psoriasis

417

3316

1.28

5.27

3.6

4.1

78.02

90.24

ng/l

2.56

359

2900

Other salmonella infections, including avohilmo

163

1125

1.49

5.26

4.0

3.6

89.91

84.15

ng/l

0.23

137

995

Prepatellar bursitis

153

1042

1.51

5.26

5.5

4.8

138.22

98.23

ng/l

0.98

138

928

Portal vein thrombosis

419

1.84

5.21

5.6

4.3

83.78

86.56

ng/l

0.09

371

Separation of retinal layers (serosa)

154

1054

1.51

5.20

7.0

4.0

127.34

86.39

ng/l

2.38

141

935

Drug-induced thyroiditis

3.51

5.19

4.1

96.45

78.34

ng/l

0.37

Diseases of appendix

3006

24677

1.09

5.19

4.2

4.1

88.88

89.57

ng/l

0.12

2670

21663

Other inflammation of vagina/vulva

137

916

1.54

5.18

3.2

3.5

74.60

72.36

ng/l

0.18

118

817

Alopecia areata

109

695

1.63

5.15

3.4

4.2

75.77

75.23

ng/l

0.03

619

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

163

1129

1.48

5.14

2.9

3.7

71.88

83.63

ng/l

1.76

148

998

Hypertrichosis

448

1.78

5.13

4.6

3.7

91.24

69.49

ng/l

1.12

406

Disturbances of smell and taste

171

1200

1.47

5.11

3.0

3.7

75.03

84.17

ng/l

1.22

149

1046

Injury of other and unspecified intrathoracic organs

236

1746

1.38

5.11

4.2

4.4

87.21

97.39

ng/l

1.00

205

1540

Malignant neoplasm of colon, including Hilmo

773

6531

1.20

5.10

3.8

3.9

96.26

96.39

ng/l

0.01

689

5451

Acute epiglottitis

318

1.95

5.10

3.3

4.2

102.16

83.41

ng/l

0.61

287

Acute appendicitis, no complications

2084

18733

1.11

5.09

4.0

4.2

86.53

89.23

ng/l

0.48

1859

16567

Other conjunctival vascular disorders and cysts

107

684

1.64

5.09

4.5

3.6

90.91

83.79

ng/l

0.32

600

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1744

13543

1.13

5.07

4.6

3.3

88.60

75.81

ng/l

6.10

1545

11900

Other lack of coordination

468

1.78

5.07

3.1

4.3

72.75

82.48

ng/l

0.56

416

Inguinal hernia

2274

13695

1.11

5.07

4.9

4.4

97.29

96.70

ng/l

0.09

1994

11868

malignant neoplasm of male genital organs

932

4803

1.18

5.06

4.3

5.1

106.34

109.51

ng/l

0.37

804

4188

Systemic sclerosis, icd10

114

741

1.61

5.06

3.7

3.5

73.33

79.79

ng/l

0.56

647

Other salmonella infections

141

955

1.53

5.05

4.2

3.5

91.17

83.91

ng/l

0.26

115

840

Disorder of carbohydrate metabolism, other/unspecified

3.45

5.05

5.9

4.0

73.54

81.48

ng/l

0.20

Severe visual impairment, binocular

132

2.58

5.03

12.2

3.5

172.50

80.58

ng/l

2.25

115

Asthma mixed form (mode), excluding more controls

166

1157

1.47

5.03

4.0

3.2

87.49

76.46

ng/l

0.83

141

1012

Disorders of globe

114

741

1.61

5.02

6.7

3.5

114.19

86.34

ng/l

2.02

639

Other and unspecified injuries of abdomen, lower back and pelvis

349

1.89

5.01

4.3

3.8

83.38

83.04

ng/l

0.01

310

Viral infections of the central nervous system, including avohilmo

285

2174

1.34

5.01

3.7

3.9

81.42

84.26

ng/l

0.24

244

1900

Unspecific neurodegenerative disorder

2076

12856

1.12

4.99

2.7

3.9

85.14

98.65

ng/l

11.20

1663

10766

Muscle strain

120

787

1.57

4.97

4.6

4.0

88.84

83.87

ng/l

0.20

105

697

Congenital malformations of trachea and bronchus

281

2.04

4.97

6.0

4.5

70.51

72.99

ng/l

0.11

249

Traumatic ischaemia of muscle

300

1.97

4.97

5.1

4.2

111.01

84.11

ng/l

0.70

264

Burns and corrosions of multiple and unspecified body regions

522

1.71

4.96

5.2

5.0

93.99

87.84

ng/l

0.22

476

Appendicitis, broad definition

2968

24492

1.09

4.96

4.2

4.1

89.09

89.47

ng/l

0.06

2638

21513

Other noninflammatory disorders of vagina

319

2476

1.32

4.95

4.1

3.3

86.13

80.57

ng/l

0.49

269

2147

Personal history of allergy to drugs, medicaments and biological substances

251

2.06

4.95

3.1

81.93

71.93

ng/l

0.48

229

Atrophic disorders of skin

675

5681

1.21

4.95

3.6

3.3

81.86

79.99

ng/l

0.25

592

4832

Antenatal screening

501

3441

0.81

4.93

3.0

3.7

67.55

77.06

ng/l

2.59

469

3137

Persons encountering health services in circumstances related to reproduction

2164

13134

1.11

4.93

4.8

4.5

78.64

87.80

ng/l

4.90

1962

11675

Infection due to other mycobacteria

434

1.80

4.93

5.1

2.7

75.62

76.77

ng/l

0.05

378

Injuries involving multiple body regions

142

968

1.51

4.92

4.5

4.0

108.79

85.93

ng/l

1.00

120

856

Optic atrophy

472

1.76

4.91

5.4

4.6

81.07

79.28

ng/l

0.06

430

Infection due to other mycobacteria, including avohilmo

457

1.77

4.90

4.9

2.7

75.81

77.44

ng/l

0.07

398

Other and unspecified erythematous conditions

145

997

1.51

4.90

4.4

3.8

80.65

84.06

ng/l

0.21

128

871

Other and specified injuries of hip and thigh

103

658

1.63

4.89

5.6

3.7

102.80

89.01

ng/l

0.47

563

Sexual dysfunction

366

1.85

4.88

5.1

4.9

111.59

89.40

ng/l

0.68

337

Anogenital herpesviral [herpes simplex] infection, including avohilmo

325

2527

1.30

4.87

3.7

3.5

71.53

75.91

ng/l

0.64

286

2267

Panniculitis, unspecified

282

2.01

4.87

3.0

79.76

78.51

ng/l

0.04

246

Pleural plaque

366

2898

1.29

4.87

3.9

4.2

97.04

106.12

ng/l

1.03

295

2479

Wide developmental disorders

115

747

1.58

4.86

4.8

7.3

53.01

63.84

ng/l

2.17

101

716

Viral infections of the central nervous system

264

2002

1.35

4.86

3.9

83.73

84.52

ng/l

0.05

226

1750

Congenital deformities of hip, including avohilmo

471

1.74

4.85

5.5

5.9

58.17

66.82

ng/l

0.71

441

Pediculosis, acariasis and other infestations

204

1487

1.40

4.84

4.8

4.5

101.83

86.81

ng/l

0.85

181

1335

Ankylosing hyperostosis [Forestier]

325

1.92

4.84

4.0

3.7

95.20

89.03

ng/l

0.21

274

Benign neoplasm: Connective and other soft tissue of head, face and neck

398

1.82

4.84

4.2

3.8

79.73

79.48

ng/l

0.01

353

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

268

2041

1.35

4.83

3.7

3.9

84.99

92.14

ng/l

0.81

238

1729

Third [oculomotor] nerve palsy

529

1.71

4.82

6.0

4.2

139.01

87.55

ng/l

1.18

466

Effects of foreign body entering through natural orifice

844

7245

1.18

4.79

4.1

4.7

83.67

94.45

ng/l

2.97

740

6403

Other maltreatment syndromes

611

1.64

4.79

3.6

4.6

77.75

85.77

ng/l

0.44

558

Human immunodeficiency virus [HIV] disease, including avohilmo

376

1.83

4.78

2.4

4.4

78.26

90.65

ng/l

0.82

343

Disorders of copper metabolism

6.61

4.78

10.8

2.3

66.98

70.04

ng/l

0.08

Focal epilepsy, strict definition

771

6576

1.19

4.78

4.1

4.3

82.57

90.73

ng/l

1.82

667

5723

Ménière disease

396

3175

1.27

4.77

3.0

3.7

76.58

90.77

ng/l

4.02

337

2707

Sequelae of infectious and parasitic diseases

265

2016

1.34

4.76

4.6

3.9

103.83

90.66

ng/l

0.81

215

1753

Malignant neoplasm of prostate, including Hilmo

927

4704

1.17

4.76

4.3

5.1

104.94

109.98

ng/l

0.68

801

4095

Autoimmune hepatitis

221

2.13

4.76

2.3

3.1

74.05

76.66

ng/l

0.08

194

Dislocation, sprain and strain of joints and ligaments of thorax

134

910

1.52

4.75

4.5

4.2

87.36

86.92

ng/l

0.02

124

813

Other and unspecified intracranial injuries

120

797

1.56

4.75

3.1

4.3

72.82

98.18

ng/l

3.58

104

703

Persistent delusional disorders

299

2316

1.32

4.75

3.9

3.8

91.13

88.28

ng/l

0.20

257

1997

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

193

2.19

4.75

2.2

5.5

74.97

97.17

ng/l

1.28

183

Polycythaemia vera

144

995

1.50

4.74

3.4

3.7

84.68

94.20

ng/l

0.77

126

847

Other specified/unspecified spondylopathies

110

719

1.59

4.74

4.4

3.7

108.75

93.55

ng/l

0.76

602

Hirsutism in women

384

1.81

4.74

4.1

3.9

83.74

69.85

ng/l

0.59

350

Car occupant injured in noncollision transport accident

121

804

1.55

4.74

5.4

4.2

110.15

86.97

ng/l

1.15

111

723

Marginal zone B-cell lymphoma, including Hilmo

455

1.77

4.74

4.4

3.9

92.71

93.00

ng/l

0.01

394

Fistulae involving female genital tract

470

1.75

4.73

4.1

3.0

78.20

73.11

ng/l

0.20

412

Human immunodeficiency virus [HIV] disease

370

1.83

4.73

2.2

4.5

74.85

91.32

ng/l

1.39

338

Myeloproliferative diseases (CML excluded)

318

2488

1.31

4.72

3.3

3.8

85.13

93.61

ng/l

1.12

278

2118

Disorders of optic nerve, not elsewhere classified

602

1.66

4.72

6.6

3.8

128.20

86.99

ng/l

1.66

528

Mental and behavioural disorders due to use of other stimulants, including caffeine

451

1.73

4.70

4.0

5.4

86.62

84.24

ng/l

0.09

422

106

656

1.61

4.68

13.8

8.7

52.09

51.76

ng/l

0.04

106

643

Human immunodeficiency virus [HIV] disease resulting in other conditions

320

1.89

4.67

2.2

4.5

78.03

92.12

ng/l

1.00

292

Mature T/NK-cell lymphomas, hilmo

359

1.86

4.67

3.7

4.1

96.32

89.77

ng/l

0.16

320

Chronic thyroiditis

2.91

4.66

1.8

2.3

58.71

71.02

ng/l

0.74

Ulcerative ileocolitis

132

897

1.51

4.64

4.9

4.2

112.82

84.98

ng/l

1.35

120

807

Sequelae of infectious and parasitic diseases, including avohilmo

272

2085

1.33

4.64

4.5

3.9

102.74

90.52

ng/l

0.75

220

1807

Shoulder region

389

1.82

4.64

3.7

3.9

77.45

84.25

ng/l

0.32

346

Alcohol induced polyneuropathy

230

2.09

4.64

4.2

4.3

97.18

88.88

ng/l

0.31

203

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

321

1.88

4.63

2.2

4.5

78.03

92.12

ng/l

1.00

292

Disorder of the sleep-wake schedule

395

1.79

4.63

4.4

4.9

77.97

71.47

ng/l

0.22

363

Disorders of synovium and tendon in diseases classified elsewhere

541

1.68

4.62

6.4

4.1

105.78

86.14

ng/l

1.01

473

Crushed, pushed or stepped on by crowd or human stampede

236

1772

1.36

4.61

4.4

4.8

78.29

80.37

ng/l

0.16

215

1607

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

542

1.68

4.61

4.9

4.2

89.30

83.71

ng/l

0.21

485

Other secondary coxarthrosis

144

1001

1.49

4.60

4.4

3.8

89.83

90.04

ng/l

0.01

127

877

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

182

2.19

4.57

2.7

3.4

71.46

62.04

ng/l

0.44

170

Recurrent dislocation and subluxation of joint

202

1484

1.38

4.54

3.7

3.8

81.90

82.74

ng/l

0.04

181

1327

Erythema nodosum

126

856

1.53

4.54

4.9

3.4

84.45

81.28

ng/l

0.16

113

740

Benign neoplasm of breast

518

4298

1.23

4.53

3.1

3.2

78.30

80.84

ng/l

0.30

453

3629

Benign neoplasm: Long bones of lower limb

116

773

1.55

4.52

3.4

4.2

68.74

84.51

ng/l

1.61

104

698

Exophthalmic conditions

290

1.95

4.51

5.3

3.4

90.75

82.66

ng/l

0.28

253

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

254

1940

1.34

4.50

3.9

4.0

87.44

98.25

ng/l

1.50

226

1627

Dental pulpitis, including avohilmo

3701

22046

1.08

4.50

3.9

4.2

86.49

87.90

ng/l

0.31

3247

19505

Raynaud syndrome

329

2598

1.29

4.49

2.7

3.8

71.48

82.60

ng/l

2.88

297

2264

Nystagmus and other irregular eye movements

363

1.83

4.48

7.2

5.2

100.33

76.96

ng/l

1.10

331

Lethal midline granuloma

10.28

4.47

15.8

2.5

97.78

66.93

ng/l

—

Scar conditions and fibrosis of skin

159

1130

1.45

4.47

4.4

3.6

82.92

78.92

ng/l

0.23

144

996

591

1.63

4.46

14.4

8.9

52.13

51.23

ng/l

0.11

579

Unspecified human immunodeficiency virus [HIV] disease

185

2.17

4.43

2.2

5.4

74.24

96.47

ng/l

1.21

176

Use of cabergoline

290

1.92

4.43

6.1

4.1

96.86

85.60

ng/l

0.23

263

Motor neuron disease (with DMD)

477

1.70

4.42

4.1

3.8

63.62

92.70

ng/l

3.49

429

Macular cyst

147

1037

1.48

4.42

5.9

3.7

108.13

93.75

ng/l

0.83

132

889

Striae atrophicae

255

1.99

4.41

4.2

3.7

84.89

68.83

ng/l

0.90

224

Viral encephalitis, not elsewhere classified/unspecified

525

1.67

4.41

5.0

4.1

91.11

83.57

ng/l

0.29

470

Burns and corrosions of external body surface, specified by site

367

2942

1.27

4.37

4.6

4.7

88.20

88.83

ng/l

0.04

315

2635

Haemangioma, any site

336

2671

1.28

4.37

4.0

79.74

85.20

ng/l

0.62

294

2327

Congenital deformities of hip

409

1.75

4.37

6.1

6.0

59.38

63.53

ng/l

0.24

382

Congenital malformations of great arteries

610

1.62

4.36

8.1

8.0

77.09

61.05

ng/l

0.96

581

Seropositive rheumatoid arthritis, strict definition

617

5217

1.20

4.36

3.0

3.7

76.93

87.76

ng/l

3.24

540

4473

Exposure to other and unspecified animate mechanical forces

113

755

1.54

4.36

5.6

4.9

91.40

79.59

ng/l

0.63

105

688

Ventricular septal defect, a heart condition

604

1.62

4.34

6.2

7.5

73.14

60.97

ng/l

0.84

570

Rheumatic fever incl heart disease

124

848

1.51

4.31

6.0

3.7

135.07

93.45

ng/l

1.85

109

731

Other abnormal immunological findings in serum

536

1.65

4.30

3.4

4.2

88.74

77.43

ng/l

0.48

487

LSIL lesion of the cervix uteri, vagina or vulva

472

3895

1.23

4.28

4.0

3.3

81.10

75.24

ng/l

0.73

429

3448

Conductive hearing loss, unspecified

314

2483

1.29

4.27

4.3

4.2

83.49

87.28

ng/l

0.30

280

2170

Optic atrophy, wide definition

499

1.68

4.26

5.3

4.5

81.07

79.56

ng/l

0.05

455

Abscess of tendon sheath

142

2.35

4.26

7.1

2.9

175.96

74.46

ng/l

2.85

128

Diffuse brain injury

108

717

1.54

4.25

2.8

3.9

68.56

90.66

ng/l

2.66

641

Mixed disorders of conduct and emotions, excluding more controls

299

1.85

4.25

7.5

5.1

92.89

59.79

ng/l

1.09

283

Vertigo of central origin

493

1.69

4.24

2.7

3.6

62.86

84.47

ng/l

2.81

423

389

1.75

4.24

4.5

3.5

104.25

70.77

ng/l

1.09

351

Dislocation, sprain and strain of joints and ligaments of head

142

998

1.46

4.23

4.3

4.6

73.94

79.25

ng/l

0.36

121

904

Poisoning by narcotics and psychodysleptics [hallucinogens]

279

1.90

4.23

3.0

4.3

61.92

83.96

ng/l

2.31

254

Burns and corrosions confined to eye and internal organs

576

1.61

4.23

3.0

4.3

79.85

87.58

ng/l

0.38

517

Hereditary hypogammaglobulinemia

2.83

4.22

5.2

5.5

72.29

81.74

ng/l

0.34

Undescended testicle

266

1.95

4.22

10.3

8.4

66.45

64.48

ng/l

0.09

258

Hepatocellular carcinoma

554

1.63

4.21

3.0

3.8

84.99

100.90

ng/l

1.33

468

Scabies

152

1083

1.44

4.19

4.2

4.6

95.18

81.96

ng/l

0.56

136

975

Hereditary erythropoietic porphyria

9.52

4.17

9.4

2.2

75.13

72.36

ng/l

—

Sequelae of other and unspecified infectious and parasitic diseases

175

1279

1.40

4.16

5.1

4.1

106.20

84.19

ng/l

1.10

145

1143

Sixth [abducent] nerve palsy

140

989

1.46

4.15

4.2

3.9

96.53

92.93

ng/l

0.14

126

851

Senility

274

1.90

4.14

2.1

3.2

87.22

93.27

ng/l

0.22

220

Other acute skin changes due to ultraviolet radiation

135

948

1.47

4.11

3.9

3.6

99.02

88.94

ng/l

0.56

115

822

Benign neoplasm: Skin, unspecified

158

1141

1.43

4.10

5.8

3.9

97.92

88.06

ng/l

0.73

142

997

Vascular dementia (undefined)

180

1313

1.39

4.10

3.0

3.7

106.79

107.76

ng/l

0.04

130

1080

Chronic suppurative otitis media, including avohilmo

294

2320

1.29

4.09

4.5

98.72

86.23

ng/l

0.70

261

2025

Presbyopia

278

2178

1.30

4.08

3.2

3.8

82.48

83.55

ng/l

0.05

245

1938

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

319

2545

1.28

4.08

4.1

3.9

91.54

87.24

ng/l

0.27

267

2198

LSIL lesion of the vulva

118

810

1.51

4.08

5.6

3.2

102.90

74.90

ng/l

1.68

106

719

Other disorders of male genital organs

115

781

1.51

4.08

5.8

5.5

121.60

99.99

ng/l

0.96

102

702

Carcinoma in situ of skin of eyelid, including canthus

3.22

4.08

3.6

4.5

109.00

95.55

ng/l

0.18

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

176

1293

1.39

4.06

5.1

4.1

106.09

84.16

ng/l

1.11

146

1156

Focal brain injury

203

1522

1.36

4.06

4.9

4.2

109.69

98.48

ng/l

0.59

171

1321

Hypothermia

451

1.69

4.03

4.1

4.0

107.46

89.31

ng/l

0.70

399

Other obstetric conditions, not elsewhere classified

845

4616

1.16

4.03

3.1

3.4

72.19

70.58

ng/l

0.13

769

4235

Paranoid personality disorder

389

1.74

4.02

3.3

3.8

83.26

82.77

ng/l

0.02

349

Pedestrian injured in transport accident

261

2034

1.31

4.01

4.2

4.0

87.62

87.41

ng/l

0.01

223

1761

Melanoma in situ of lower limb, including hip

209

2.08

4.00

4.2

3.6

94.24

77.43

ng/l

0.51

182

Psoriasis (vulgaris), strict definition

119

820

1.49

3.98

3.2

4.2

76.48

85.84

ng/l

0.57

736

Spirochaetal infections, other/unspecified

355

2875

1.26

3.98

3.6

4.1

71.41

90.19

ng/l

5.77

320

2477

Enteropathogenic Escherichia coli infection

2.74

3.97

7.2

5.0

103.20

81.62

ng/l

0.30

Adenocarcinoma of pancreas

862

0.56

3.96

2.7

3.7

94.07

93.60

ng/l

0.01

738

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

198

1490

1.36

3.95

3.2

3.9

80.97

97.34

ng/l

3.13

178

1251

Malignant neoplasm of bone and articular cartilage, including Hilmo

502

1.64

3.92

4.6

4.3

104.27

88.32

ng/l

0.49

436

Injury of nerves and spinal cord at thorax level

115

2.45

3.91

2.0

4.6

73.02

88.89

ng/l

0.53

104

Other specified/unspecified nutritional deficiencies

175

2.15

3.90

5.6

4.4

105.63

95.03

ng/l

0.23

155

Malignant neoplasm of other connective and soft tissue

103

695

1.54

3.89

3.8

4.0

86.98

95.56

ng/l

0.53

594

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

3.38

3.89

2.5

4.6

75.53

76.15

ng/l

0.02

Thyrotropin deficiency

267

1.90

3.89

2.9

3.6

109.07

78.56

ng/l

0.40

241

Other injuries of spine and trunk, level unspecified

224

1.99

3.89

6.0

4.0

141.49

90.36

ng/l

1.08

202

Assault by sharp object

302

1.82

3.88

2.8

4.5

108.87

88.93

ng/l

0.41

281

Other diseases of gallbladder

187

1402

1.37

3.87

4.2

3.8

92.60

90.64

ng/l

0.10

168

1206

Allergic colitis

517

1.62

3.87

8.5

7.2

61.20

57.25

ng/l

0.25

497

Obstructed labour due to malposition and malpresentation of fetus

509

5598

0.83

3.85

2.9

3.6

68.80

76.01

ng/l

1.79

467

5096

Autonomic disorders

648

1.55

3.84

4.4

3.9

72.83

88.07

ng/l

0.88

563

Psoriatic arthropathies, ICD10

375

3066

1.24

3.82

3.6

4.0

78.64

88.32

ng/l

1.59

325

2679

Other disorders of Eustachian tube

122

854

1.48

3.82

4.1

3.7

75.52

83.29

ng/l

0.80

106

760

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

121

848

1.48

3.78

3.1

3.9

80.32

94.17

ng/l

1.51

103

727

Chronic lymphocytic leukaemia, helper endpoint

121

848

1.48

3.78

3.1

3.9

80.32

94.17

ng/l

1.51

103

727

Chronic lymphocytic leukaemia

121

848

1.48

3.78

3.1

3.9

80.32

94.17

ng/l

1.51

103

727

Nail dystrophy

150

2.23

3.78

4.3

3.3

83.38

74.29

ng/l

0.26

131

Left ventricular outflow tract obstruction, narrow definition

172

1277

1.38

3.76

5.5

5.6

88.36

81.26

ng/l

0.46

158

1167

Abnormal spermatozoa

277

3478

0.78

3.76

3.7

5.1

107.22

109.99

ng/l

0.12

189

3060

Endometriosis ASRM stages 1,2

617

5285

1.18

3.74

3.3

3.4

70.51

76.44

ng/l

1.94

545

4627

Acute otitis externa, noninfective

469

1.65

3.74

4.9

3.7

119.29

78.22

ng/l

1.33

421

Other nonscarring hair loss

278

1.86

3.73

5.0

3.7

82.85

74.45

ng/l

0.28

247

Malignant neoplasm of prostate

898

4652

1.15

3.73

4.2

5.1

105.64

110.03

ng/l

0.55

777

4049

Osteosarcoma

3.45

3.73

6.7

7.7

68.84

68.37

ng/l

0.01

UC patients in KELA-register (code 208), prior to 1994

160

1179

1.39

3.72

4.7

4.1

91.18

88.55

ng/l

0.14

148

1042

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

813

4452

1.16

3.69

3.1

3.4

72.17

69.68

ng/l

0.21

739

4088

Atrial septal defect

147

1063

1.41

3.68

6.4

5.8

79.07

72.02

ng/l

0.72

131

981

Primary angle-closure glaucoma

195

1487

1.35

3.65

4.8

3.6

91.38

94.44

ng/l

0.20

162

1243

Cutaneous lupus erythematosus

106

731

1.51

3.65

4.9

3.3

80.70

79.21

ng/l

0.07

636

Other and unspecified mononeuropathies of upper limb

108

745

1.49

3.64

3.8

4.1

80.24

86.10

ng/l

0.37

653

Pneumothorax

249

1956

1.30

3.64

4.5

4.1

98.33

97.11

ng/l

0.06

223

1708

Benign neoplasm: Skin of lower limb, including hip

113

789

1.48

3.62

5.2

3.7

108.31

83.02

ng/l

1.71

100

699

HSIL lesion of the vulva

546

1.59

3.62

5.5

3.1

105.96

78.16

ng/l

1.51

482

Viral agents as the cause of diseases classified to other chapters

560

1.57

3.61

7.2

4.6

96.26

80.59

ng/l

0.96

508

Superficial injuries involving multiple body regions

648

1.53

3.61

4.5

4.0

92.77

84.91

ng/l

0.31

581

Other psoriatic arthropathies

364

2987

1.24

3.61

3.6

4.0

78.74

88.19

ng/l

1.47

315

2615

Maltreatment syndromes

147

1070

1.40

3.60

3.2

4.6

85.95

78.79

ng/l

0.32

128

973

Benign neoplasm: Skin of lip

373

1.72

3.60

3.6

103.53

87.30

ng/l

0.44

334

Asthma mixed form (mode)

166

1233

1.37

3.59

4.0

3.4

87.49

82.61

ng/l

0.28

141

1074

6-mercaptopurine

100

679

1.50

3.59

3.2

4.7

70.64

80.91

ng/l

0.78

613

Other specified and unspecified disorders of lens

299

1.83

3.58

2.5

3.2

116.95

85.22

ng/l

0.51

250

Burn and corrosion confined to eye and adnexa

472

1.62

3.58

3.2

4.4

80.45

87.30

ng/l

0.33

428

Nasal polyp

681

5899

1.17

3.58

3.6

4.4

86.68

96.62

ng/l

2.47

596

5134

Abrasion of teeth

1474

13380

1.11

3.58

4.0

3.8

79.52

86.79

ng/l

2.92

1268

11701

Residual foreign body in soft tissue

164

1218

1.37

3.57

4.0

4.4

93.83

87.83

ng/l

0.33

143

1079

Chalazion

414

3443

1.22

3.57

3.6

4.1

80.70

89.21

ng/l

1.09

362

2972

Malignant neoplasm of thymus, including Hilmo

2.59

3.57

6.2

4.1

82.90

88.81

ng/l

0.11

Tongue abnormality

257

2037

1.29

3.56

4.5

3.8

88.44

87.72

ng/l

0.05

223

1739

Viral agents as the cause of diseases classified to other chapters, including avohilmo

651

1.52

3.56

6.8

4.8

92.95

80.79

ng/l

0.77

587

Maternal care for known or suspected abnormality of pelvic organs

601

4730

0.85

3.55

2.9

3.6

68.45

76.85

ng/l

1.67

539

4270

Myotonic disorders

174

2.07

3.55

3.8

4.0

66.97

88.42

ng/l

1.44

157

Problems related to social environment

111

774

1.48

3.54

3.7

3.8

78.82

85.39

ng/l

0.37

681

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

189

2.04

3.54

3.3

3.8

84.13

78.76

ng/l

0.15

169

Lesion of plantar nerve

255

2021

1.29

3.54

2.8

3.5

78.06

86.49

ng/l

1.14

225

1708

Benign neoplasm: Pharynx, unspecified

203

1.99

3.54

4.5

3.3

79.01

79.15

ng/l

0.01

177

Tonsillectomy and adenotomy

1877

11958

1.10

3.52

4.2

4.5

72.79

84.01

ng/l

6.90

1723

10777

Dependent personality disorder

524

1.59

3.52

4.5

3.5

113.78

78.87

ng/l

1.60

464

Drug-induced interstitial lung disorders, unspecified

3.15

3.51

4.3

3.4

116.08

73.65

ng/l

—

HSIL lesion of the vagina

399

1.69

3.50

4.7

3.0

121.12

75.37

ng/l

2.18

357

Contact with sharp glass

117

824

1.45

3.50

3.5

4.6

87.55

80.98

ng/l

0.28

112

749

Severe visual impairment, monocular

277

1.83

3.50

7.8

3.2

106.42

78.57

ng/l

1.14

240

Benign neoplasm: Anus and anal canal

118

837

1.46

3.49

4.4

3.9

93.79

90.16

ng/l

0.15

719

Cysts of oral region, not elsewhere classified

209

1617

1.32

3.47

6.6

4.2

114.65

88.86

ng/l

1.30

186

1431

Malignant neoplasm of ureter, including Hilmo

234

1.92

3.47

6.8

4.1

160.55

103.81

ng/l

1.12

199

Alzheimer disease, including avohilmo

1827

11596

1.10

3.46

2.8

3.7

88.06

98.63

ng/l

6.37

1502

9596

Carcinoid syndrome

234

1.91

3.45

3.1

105.31

77.00

ng/l

1.00

207

Injury of cranial nerves

156

2.13

3.43

3.9

3.4

68.76

75.59

ng/l

0.27

142

Pyogenic granuloma

463

1.62

3.43

5.6

4.0

87.37

80.84

ng/l

0.28

413

All dysplastic lesions of the vagina

110

773

1.47

3.43

4.8

3.2

105.64

75.36

ng/l

1.96

685

Gonococcal infection, including avohilmo

128

922

1.42

3.42

3.3

3.6

84.90

78.69

ng/l

0.37

108

822

Other hyperalimentation

2.70

3.41

3.6

4.1

62.00

81.81

ng/l

0.75

Toxic effect of alcohol

455

1.61

3.40

6.0

4.6

128.61

85.43

ng/l

1.00

403

Toxic effect of other and unspecified substances

248

1.84

3.40

1.7

4.0

79.27

77.47

ng/l

0.04

224

Nutritional and metabolic disorders in diseases classified elsewhere

8.21

3.39

18.8

7.6

56.04

78.83

ng/l

—

Triptan medication for migraine, min. 3 purchases

2073

14281

1.09

3.39

3.1

3.9

71.56

81.64

ng/l

7.84

1880

12694

Dermatographic urticaria

232

1824

1.29

3.38

3.6

87.09

78.73

ng/l

0.36

201

1608

Right hemicolectomy

240

1900

1.29

3.38

5.8

3.8

115.11

96.51

ng/l

1.73

209

1622

Other specified and unspecified disorders of eyelid

403

1.67

3.37

3.5

84.81

82.23

ng/l

0.07

352

Other congenital malformations of circulatory system

102

709

1.49

3.37

3.2

4.1

72.87

83.89

ng/l

0.85

631

Hypertension, portal

2.62

3.36

7.4

4.9

124.56

80.09

ng/l

0.82

Inguinal or femoral hernia, bilateral

368

3046

1.23

3.36

5.2

4.6

91.74

103.43

ng/l

1.49

329

2662

Gonococcal infection

122

876

1.43

3.35

3.1

3.5

83.40

78.95

ng/l

0.25

103

777

Abnormality of white blood cells, not elsewhere classified

229

1.90

3.34

5.6

3.7

98.60

77.44

ng/l

0.87

210

Carcinoma in situ of vagina

158

2.11

3.34

5.7

3.0

118.88

69.73

ng/l

1.91

139

Ulcer of vagina/vulva

115

819

1.45

3.33

2.9

3.6

76.25

77.69

ng/l

0.07

102

713

Benign neoplasm: Other/unspecified site

412

1.65

3.32

3.4

3.7

87.81

84.70

ng/l

0.09

370

Malignant neoplasm of stomach, including Hilmo

221

1732

1.30

3.32

3.6

3.9

91.23

96.67

ng/l

0.45

196

1455

Congenital malformations of ovaries, fallopian tubes and broad ligaments

177

1346

1.34

3.32

3.5

3.3

81.74

72.33

ng/l

0.52

162

1202

All dysplastic lesions of the cervix uteri, vagina or vulva

968

8409

1.13

3.32

3.8

3.4

81.69

75.17

ng/l

1.40

867

7476

Benign neoplasm: Skin of ear and external auricular canal

157

1177

1.37

3.32

4.4

4.0

105.43

95.43

ng/l

0.46

134

1020

101

704

1.49

3.32

3.4

4.1

90.76

97.29

ng/l

0.34

604

Benign neoplasm: Connective and other soft tissue of thorax

111

2.35

3.31

2.5

3.7

71.73

76.57

ng/l

0.17

Other and unspecified acute skin changes due to ultraviolet radiation

687

1.49

3.31

4.5

3.6

110.87

93.06

ng/l

0.87

588

Tuberculosis of other organs

623

1.52

3.29

5.1

3.5

118.84

88.73

ng/l

1.42

529

Benign neoplasm of other and unspecified sites

130

949

1.41

3.27

2.8

3.8

80.50

88.69

ng/l

0.48

112

831

Keratoconus

548

1.54

3.26

5.3

4.4

102.69

85.33

ng/l

0.86

490

Vasomotor rhinitis (mode)

276

2229

1.26

3.25

3.7

3.8

82.87

87.97

ng/l

0.48

238

1944

Other and unspecified injuries of thorax

429

1.62

3.25

3.9

4.3

96.15

86.90

ng/l

0.39

387

Helminthiases

438

1.61

3.24

5.8

4.0

90.49

76.38

ng/l

0.61

394

Cluster headache, strict, including avohilmo

155

1161

1.36

3.24

3.2

3.9

78.44

80.42

ng/l

0.10

141

1045

Dislocation, sprain and strain of joints and ligaments of knee

2269

19033

1.08

3.23

3.6

4.1

78.49

86.51

ng/l

4.93

2026

16832

Benign neoplasm of ovary

758

6682

1.15

3.22

3.7

3.2

88.05

80.93

ng/l

0.69

662

5677

Burns classified according to extent of body surface involved

224

1.88

3.22

6.9

4.5

117.11

82.40

ng/l

0.88

200

Benign neoplasm of middle ear and respiratory system

284

2303

1.25

3.22

4.1

93.30

93.31

ng/l

0.00

250

2012

Other papulosquamous disorders

292

1.76

3.20

4.5

3.7

148.99

75.99

ng/l

1.61

263

Epiphora

101

710

1.48

3.20

3.1

3.6

97.19

84.64

ng/l

0.59

617

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

502

4295

1.18

3.19

3.6

4.0

83.63

90.51

ng/l

1.15

431

3733

Degenerative diseases of the nervous system

1749

11561

1.10

3.19

2.8

3.8

90.00

98.52

ng/l

3.93

1421

9620

Malignant neoplasm of larynx, including Hilmo

431

1.60

3.18

3.1

4.1

68.11

103.82

ng/l

2.73

358

Alzheimer’s disease (Early onset)

103

1445

0.70

3.18

3.1

3.5

88.53

98.40

ng/l

0.47

1192

Dislocation of lens

433

1.61

3.17

5.6

3.6

134.74

97.59

ng/l

1.26

369

Parapsoriasis

456

1.59

3.16

3.4

4.3

81.58

79.88

ng/l

0.07

410

Peroneal tendinitis

393

1.63

3.14

4.5

3.7

86.57

80.43

ng/l

0.20

352

Benign neoplasm of bone and articular cartilage

285

2317

1.25

3.14

3.4

4.0

73.08

84.00

ng/l

1.83

253

2059

Other and unspecified papulosquamous disorders

169

2.03

3.13

2.7

3.4

116.60

72.51

ng/l

1.30

154

Drug-induced acute pancreatitis

4.33

3.13

4.4

4.5

93.41

77.62

ng/l

—

Inguinal hernia, bilateral

357

2971

1.22

3.11

5.2

4.7

90.21

103.53

ng/l

2.08

321

2597

Spondylopathies in diseases classified elsewhere

341

1.69

3.11

3.6

3.9

111.96

94.74

ng/l

0.47

294

Disorder of external ear, unspecified

126

923

1.40

3.10

5.1

4.0

110.16

88.30

ng/l

1.21

115

822

Carcinoma in situ of oral cavity, oesophagus and stomach

163

2.06

3.10

3.6

4.0

118.00

84.39

ng/l

0.53

140

L01XE Protein kinase inhibitors

213

1683

1.30

3.10

3.6

3.9

106.86

91.68

ng/l

1.21

189

1460

Bitten or struck by other mammals

386

3236

1.21

3.10

4.9

4.0

88.96

80.96

ng/l

0.37

339

2860

L02BA Anti-estrogens

712

6269

1.15

3.08

2.6

3.3

77.55

81.76

ng/l

0.86

623

5344

Viral conjunctivitis

499

1.55

3.08

5.9

3.9

95.96

79.87

ng/l

0.84

450

Congenital absence, atresia and stenosis of small intestine

4.08

3.07

18.5

3.5

46.91

48.74

ng/l

0.08

Burn and corrosion of ankle and foot

310

1.71

3.07

6.9

4.3

88.11

83.50

ng/l

0.16

275

Disorders of urea cycle metabolism

6.60

3.06

5.6

1.8

135.29

58.38

ng/l

—

Bicipital tendinitis

161

1226

1.34

3.04

4.4

4.1

82.04

89.97

ng/l

0.71

155

1078

Pleural plaque with presence of asbestos

260

2104

1.26

3.04

3.6

4.6

91.38

109.46

ng/l

2.57

210

1822

Primary open-angle glaucoma

1473

12979

1.10

3.04

3.6

3.7

96.09

94.58

ng/l

0.22

1195

10911

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

2.76

3.03

3.3

4.1

89.56

88.70

ng/l

0.01

Open wound of hip and thigh

107

765

1.43

3.02

5.1

4.5

143.86

84.64

ng/l

0.95

688

Ethmoidectomy

439

3734

1.19

3.00

3.0

4.1

73.41

89.66

ng/l

3.78

372

3287

Embedded and impacted teeth

723

5158

1.14

3.00

6.9

4.3

83.16

77.79

ng/l

0.85

664

4699

Localized skin eruption due to drugs and medicaments

298

1.72

2.99

3.5

4.0

81.19

77.94

ng/l

0.09

265

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

115

1564

0.72

2.99

2.9

3.5

77.83

78.03

ng/l

0.01

1358

Other abortion

200

1.89

2.99

2.8

3.6

73.41

67.87

ng/l

0.25

173

Other specified/unspecified deforming dorsopathies

415

1.59

2.97

3.2

3.5

77.97

76.39

ng/l

0.08

356

Impacted maxillary molar

146

1097

1.35

2.97

6.6

4.1

81.25

69.19

ng/l

0.96

131

998

Varus deformity, not elsewhere classified

299

1.72

2.96

3.4

4.4

62.96

81.63

ng/l

1.40

262

Intentional self-harm by sharp object

462

1.55

2.95

3.5

4.7

84.61

78.24

ng/l

0.11

428

Monoplegia

409

1.60

2.95

3.5

3.6

76.46

78.12

ng/l

0.05

356

Adenocarcinoma and ductal carcinoma of pancreas

1071

0.67

2.94

2.7

3.7

100.92

92.38

ng/l

0.32

922

Stenosis and insufficiency of lacrimal passages

386

3259

1.20

2.94

3.7

86.80

89.71

ng/l

0.25

332

2758

Neurofibromatosis, type 1

144

2.06

2.94

3.8

4.3

108.70

74.54

ng/l

0.33

131

Unspecified threat to breathing

216

1.84

2.93

5.1

4.4

104.97

76.93

ng/l

0.60

199

FESS (DNB20)

422

3587

1.19

2.92

3.0

4.1

70.29

89.74

ng/l

7.85

355

3158

Viral conjunctivitis, including avohilmo

134

1001

1.37

2.91

5.9

4.0

84.19

77.51

ng/l

0.47

120

899

Malignant neoplasm of larynx

338

1.65

2.91

3.3

4.2

69.05

105.93

ng/l

2.15

290

Nontraumatic intracranial haemmorrhage

818

7287

1.13

2.91

4.9

3.7

106.87

94.31

ng/l

2.65

690

6142

Other intracranial haemorrhages

128

952

1.38

2.90

3.7

3.8

107.79

101.06

ng/l

0.28

106

815

Benign neoplasm: Skin of scalp and neck

100

715

1.44

2.88

5.0

4.2

100.39

85.69

ng/l

0.55

634

Hereditary corneal dystrophies

152

1163

1.35

2.88

3.4

3.5

88.86

85.73

ng/l

0.17

128

1001

Abscess of external ear

285

1.71

2.87

6.8

4.0

114.39

80.71

ng/l

1.34

257

Rheumatic valve diseases

607

1.48

2.86

6.1

3.7

140.08

94.87

ng/l

1.40

520

LSIL lesion of the cervix uteri

343

2867

1.21

2.86

3.6

3.2

75.42

73.61

ng/l

0.17

315

2556

Hordeolum and other deep inflammation of eyelid

216

1724

1.28

2.86

4.7

4.2

88.77

83.58

ng/l

0.35

192

1521

Haemorrhagic disorder due to circulating anticoagulants

413

1.60

2.86

5.1

4.2

119.31

97.64

ng/l

1.06

357

Cervical polyps

381

3223

1.20

2.84

3.6

3.4

85.85

81.08

ng/l

0.50

335

2813

CR(E)ST syndrome

479

1.55

2.83

3.8

3.3

70.85

76.88

ng/l

0.36

420

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

561

1.50

2.82

4.3

3.7

117.52

87.20

ng/l

1.50

481

Hypertensive encephalopathy

2.32

2.82

11.4

3.0

114.50

79.32

ng/l

1.10

Acute appendicitis, with complications

696

6153

1.14

2.81

4.5

4.2

93.55

92.84

ng/l

0.07

608

5369

Cluster headache, wide,, including avohilmo

163

1258

1.32

2.81

3.1

3.9

77.05

81.11

ng/l

0.23

148

1127

Aortic arch syndrome [Takayasu]

3.02

2.80

4.8

4.3

83.12

67.75

ng/l

0.31

Deep bite

383

2842

1.20

2.80

7.1

4.8

68.39

73.89

ng/l

1.16

345

2577

Ulcerative rectosigmoiditis

259

2114

1.24

2.78

4.1

4.2

92.90

89.28

ng/l

0.19

228

1878

Contracture of joint

288

1.70

2.78

4.9

3.8

104.04

80.88

ng/l

0.47

260

Contact with other hot metals

359

1.62

2.76

4.7

4.8

78.70

84.92

ng/l

0.22

322

Syndrome of inappropriate secretion of antidiuretic hormone

134

2.08

2.75

3.3

3.1

82.98

79.15

ng/l

0.07

115

Contact with heat and hot substances

177

1386

1.30

2.75

5.4

4.8

99.52

84.49

ng/l

1.16

155

1243

Postpartum hemorraghe, all women as controls

567

6324

0.87

2.75

2.9

3.5

62.51

74.41

ng/l

6.39

508

5744

Essential (haemorrhagic) thrombocythaemia

147

1126

1.34

2.75

3.3

3.6

89.67

90.12

ng/l

0.02

132

965

Drug-induced polyneuropathy

268

1.74

2.74

4.1

5.2

98.58

73.77

ng/l

0.66

233

Carcinoma in situ of colon

117

868

1.39

2.74

5.6

3.7

114.06

90.57

ng/l

1.56

104

751

Toxic effect of ethanol

111

813

1.39

2.73

5.0

4.5

99.08

85.70

ng/l

0.36

101

726

Other articular cartilage disorders

588

1.47

2.73

3.8

3.7

114.12

92.77

ng/l

0.46

510

Toxic effect of carbon monoxide

441

1.55

2.72

3.6

4.0

73.46

89.65

ng/l

1.34

389

Pathological resorption of teeth

134

1014

1.35

2.71

5.6

4.3

95.92

86.87

ng/l

0.53

118

902

Injury of muscle and tendon at lower leg level

499

4325

1.17

2.71

5.0

4.4

102.45

96.57

ng/l

0.55

448

3801

Spasmodic torticollis

123

921

1.37

2.70

2.9

3.7

66.04

80.71

ng/l

2.41

108

809

Pneumonia due to Haemophilus influenzae

2.30

2.69

6.9

2.6

67.50

72.23

ng/l

0.09

Eustachian salpingitis and obstruction

227

1835

1.25

2.67

5.3

4.2

101.80

83.36

ng/l

1.08

205

1667

Erectile dysfunction

258

2118

1.24

2.67

5.6

4.9

118.85

109.94

ng/l

0.59

220

1848

Other disorders affecting eyelid function

254

1.74

2.67

3.5

3.7

73.60

78.75

ng/l

0.13

221

Malignant neoplasm of colon

612

5391

1.15

2.66

3.8

99.40

97.06

ng/l

0.24

541

4514

Benign lipomatous neoplasm of other sites/unspecified

339

2859

1.20

2.66

3.8

3.9

90.34

92.00

ng/l

0.13

286

2438

Benign mammary dysplasia

616

5436

1.15

2.66

3.4

3.2

73.74

81.75

ng/l

2.91

532

4563

Pedestrian injured in collision with pedal cycle

110

811

1.39

2.65

2.6

4.2

73.37

87.97

ng/l

1.87

719

Dysplasia of cervi uteri

786

4927

1.13

2.64

3.7

3.4

77.44

78.59

ng/l

0.14

700

4325

Use of levodopa decarboxylase inhibitor

579

5089

1.15

2.64

2.8

3.9

81.51

98.56

ng/l

4.90

472

4280

Other and unspecified trigeminal disorders

412

1.56

2.64

3.1

3.2

68.31

75.86

ng/l

0.48

364

Oral lichen planus and hypothyroidism or thyroxine medication

638

1.45

2.62

3.2

79.34

77.17

ng/l

0.07

561

Nonpyogenic thrombosis of intracranial venous system

232

1.76

2.61

4.9

4.2

75.62

72.94

ng/l

0.07

209

Malignant neoplasm of bone and articular cartilage of limbs

102

2.21

2.61

4.6

5.7

78.32

77.95

ng/l

0.01

Postpartum hemorraghe, parous women as controls

567

5405

0.87

2.61

2.9

3.3

62.51

72.85

ng/l

4.90

508

4890

Open wound of shoulder and upper arm

461

1.52

2.60

4.9

4.2

100.51

87.98

ng/l

0.39

409

Impacted teeth

499

3713

1.16

2.60

6.8

4.4

82.15

75.08

ng/l

0.86

449

3404

Mental and behavioural disorders of puerperium, not classified elsewhere

224

1.76

2.60

2.7

3.9

71.46

72.19

ng/l

0.02

206

Maternal care for other conditions predominantly related to pregnancy

596

5109

1.14

2.59

3.5

75.16

73.47

ng/l

0.21

546

4632

263

1.70

2.58

4.9

4.2

123.39

89.66

ng/l

0.46

235

Tuberculosis, IBD comorbidity

265

2191

1.23

2.57

4.4

3.5

99.92

94.78

ng/l

0.34

230

1844

Injury of muscle and tendon at hip and thigh level

346

2929

1.20

2.57

4.8

4.2

93.96

90.90

ng/l

0.19

323

2580

Other and unspecified injuries of forearm

173

1.88

2.57

4.3

4.2

73.43

76.04

ng/l

0.05

157

Lichen planus

538

4719

1.15

2.55

3.4

3.7

92.22

89.49

ng/l

0.27

458

4023

Pregnancy with abortive outcome

2861

14046

1.07

2.53

3.3

77.70

79.77

ng/l

0.74

2477

12102

Female infertility, associated with anovulation

171

1345

1.28

2.53

2.5

3.5

82.83

72.00

ng/l

0.22

148

1241

Malignant neoplasm of eye and adnexa, including Hilmo

433

1.53

2.52

4.9

4.0

135.58

94.40

ng/l

1.33

370

Chronic Coagulation defects

623

1.44

2.52

4.3

83.95

76.06

ng/l

0.29

560

Perioral dermatitis

589

1.45

2.52

5.6

3.4

85.93

72.54

ng/l

0.71

526

Degenerative myopia

190

1.84

2.52

4.5

3.5

78.04

82.91

ng/l

0.23

164

Tuberculosis of other organs, strict

718

1.41

2.51

5.4

3.5

120.06

91.80

ng/l

1.37

609

Other, unspecified and serous retinal detachments

120

906

1.36

2.51

6.9

4.0

111.02

93.23

ng/l

1.07

101

782

Other degenerative diseases of the basal ganglia

576

1.46

2.50

2.4

4.2

84.43

95.20

ng/l

0.38

502

Lower leg

183

1.85

2.50

4.1

4.0

72.15

74.24

ng/l

0.08

158

Vitamin A deficiency

104

2.16

2.49

1.9

3.4

66.15

77.44

ng/l

0.45

Glaucoma-related operations

251

2077

1.23

2.49

3.3

3.6

91.81

93.38

ng/l

0.10

215

1739

Herpesviral keratitis and keratoconjunctivitis

161

1267

1.30

2.47

5.0

3.8

98.57

88.88

ng/l

0.68

144

1102

Fourth [trochlear] nerve palsy

618

1.44

2.47

4.9

3.9

88.07

88.68

ng/l

0.02

549

Hypertrophy of tongue papillae

362

1.58

2.47

6.0

3.4

91.60

75.59

ng/l

0.55

319

Unspecified abortion

170

1346

1.29

2.47

3.6

3.5

79.63

75.16

ng/l

0.39

144

1196

Primary open-angle glaucoma, strict

1195

10940

1.10

2.46

3.6

3.7

95.74

94.45

ng/l

0.17

969

9191

Panhypopituitarism

435

1.52

2.46

3.8

4.5

77.97

86.82

ng/l

0.41

392

Peptic ulcer

252

1.70

2.45

5.7

3.8

88.77

88.02

ng/l

0.02

214

Malignant neoplasm of vulva, including Hilmo

471

1.51

2.45

3.7

2.9

99.65

79.56

ng/l

0.73

407

Colorectal cancer, including Hilmo

1078

9172

1.10

2.45

3.7

3.9

95.95

95.80

ng/l

0.02

940

7721

Foreign body in respiratory tract

180

1437

1.28

2.44

3.8

4.4

73.29

85.30

ng/l

1.26

151

1275

Other benign neoplasms of uterus

250

2075

1.23

2.44

2.9

3.0

84.29

84.76

ng/l

0.03

190

1709

Parkinson's disease, including avohilmo

642

5712

1.14

2.44

2.9

3.9

86.40

98.66

ng/l

1.78

525

4818

Other deformities of toe(s)

136

1050

1.32

2.43

3.6

94.93

88.82

ng/l

0.34

107

897

Female infertility

931

5042

1.11

2.42

2.9

3.4

72.09

77.18

ng/l

0.64

829

4452

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

704

1.39

2.41

4.9

3.4

88.39

76.68

ng/l

0.49

622

Tuberculosis of other organs, strict, including avohilmo

732

1.39

2.41

5.6

3.5

122.16

91.21

ng/l

1.57

621

Achalasia of cardia

462

1.50

2.41

2.9

4.1

67.11

92.20

ng/l

3.36

392

201

2471

0.80

2.40

3.4

4.4

97.38

103.86

ng/l

0.37

171

2154

Malignant neoplasm of thymus

2.39

6.9

4.4

93.75

94.15

ng/l

0.01

Dementia in Alzheimer disease

671

6279

0.89

2.39

2.7

3.7

89.70

102.33

ng/l

3.08

472

5203

Female infertility, cervical, vaginal, other or unspecified origin

858

4945

1.12

2.38

2.8

3.4

72.10

77.42

ng/l

0.62

771

4375

Granuloma annulare

406

1.53

2.38

4.3

3.6

84.54

77.21

ng/l

0.28

359

Respiratory conditions due to other external agents

632

1.42

2.38

3.6

3.5

91.55

83.97

ng/l

0.35

542

Intracerebral haemorrhage

508

4460

1.15

2.37

4.8

3.8

110.45

96.34

ng/l

1.98

417

3740

Congenital malformations of spine and bony thorax, including avohilmo

156

1.89

2.37

6.3

6.1

49.12

66.65

ng/l

1.30

146

Inflammatory disorders of breast

207

1684

1.25

2.36

3.8

3.2

75.58

72.27

ng/l

0.34

186

1484

Fasciculation

270

1.65

2.36

3.2

4.3

73.57

87.58

ng/l

0.80

245

Meningitis

169

1346

1.28

2.35

4.3

4.1

77.33

84.86

ng/l

0.80

149

1188

Superficial injury of ankle and foot, unspecified

2.13

2.35

2.6

4.4

81.60

74.67

ng/l

0.09

Other and unspecified injuries of wrist and hand

132

1019

1.32

2.35

4.7

4.6

88.48

81.89

ng/l

0.37

111

911

Adult-onset Still disease

2.29

2.34

3.3

3.5

59.92

82.77

ng/l

0.76

Burn and corrosion of trunk

101

751

1.38

2.34

3.7

4.7

77.14

87.43

ng/l

0.55

674

Androgenic alopecia

248

1.69

2.34

2.8

3.4

78.83

74.67

ng/l

0.08

221

Other and unspecified parapsoriasis

114

2.07

2.34

4.1

94.95

89.36

ng/l

0.14

Patellar tendinitis

301

1.60

2.34

3.9

4.7

79.46

91.19

ng/l

0.56

272

Sequelae of injuries of head

167

1329

1.28

2.33

4.1

4.5

94.02

92.07

ng/l

0.09

135

1189

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

401

1.53

2.33

6.3

3.6

115.28

90.37

ng/l

1.26

343

Von Willebrand disease

311

1.60

2.32

3.6

72.54

69.51

ng/l

0.11

280

Mental and behavioural disorders associated with the puerperium

232

1.70

2.32

2.7

3.9

71.46

69.48

ng/l

0.07

215

Other conditions related to polyarteritis nodosa

2.64

2.32

3.8

3.0

73.92

68.15

ng/l

0.10

Other contact dermatitis

271

2271

1.21

2.30

4.6

3.6

92.72

85.47

ng/l

0.55

233

1980

Alzheimer’s disease (Atypical or mixed)

506

4399

1.15

2.29

2.6

3.5

92.40

100.71

ng/l

1.28

373

3626

Pedal cyclist injured in other and unspecified transport accidents

387

3342

1.17

2.29

4.2

4.3

85.56

88.18

ng/l

0.20

333

2940

Aphakia

335

1.56

2.29

6.6

3.9

120.98

93.75

ng/l

0.61

288

Foreign body entering into or through eye or natural orifice

251

2090

1.22

2.28

4.3

4.7

84.54

91.83

ng/l

0.68

221

1866

Disorders of brain, other and unspecified

234

1.69

2.28

8.7

4.0

94.98

90.18

ng/l

0.11

204

Malignant neoplasm of oral cavity, including Hilmo

156

1238

1.28

2.26

3.0

3.8

70.19

94.04

ng/l

5.28

136

1071

Filariasis, including avohilmo

3.21

2.25

2.9

3.4

69.60

75.05

ng/l

—

Filariasis

3.21

2.25

2.9

3.4

69.60

75.05

ng/l

—

Respiratory distress of newborn

444

1.48

2.24

11.1

10.2

44.65

49.59

ng/l

0.96

439

Drug-induced neutropenia

268

2254

1.21

2.24

4.1

4.0

101.87

88.55

ng/l

0.99

239

1946

Melanoma of uvea

259

1.65

2.24

4.9

3.8

153.53

85.70

ng/l

1.76

226

Benign neoplasm: Connective and other soft tissue of pelvis

2.58

2.23

4.0

6.1

71.61

72.26

ng/l

0.02

Congenital malformations of spine and bony thorax

145

1.90

2.22

6.7

6.4

49.67

62.71

ng/l

1.02

135

Benign leiomyoma with endometriosis

675

6066

1.13

2.21

3.3

3.1

81.81

81.21

ng/l

0.08

562

5137

Erythema multiforme

623

1.40

2.20

5.2

4.2

87.43

85.38

ng/l

0.08

555

Assault by unspecified means

379

1.51

2.19

4.1

4.6

112.84

84.17

ng/l

1.01

352

Disorders of glycine metabolism

6.03

2.19

12.6

1.7

99.28

83.50

ng/l

—

Assault by other specified means

182

1.76

2.18

5.2

4.1

92.20

82.71

ng/l

0.21

168

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.23

2.18

7.2

4.9

66.68

90.22

ng/l

0.99

N06DA Anticholinesterases

1668

12012

1.08

2.18

2.7

3.7

83.17

98.89

ng/l

14.80

1339

9982

Use of anticholinesterases

1668

12012

1.08

2.18

2.7

3.7

83.17

98.89

ng/l

14.80

1339

9982

Benign neoplasm: Skin of upper limb, including shoulder

548

1.43

2.18

5.6

3.6

136.87

82.49

ng/l

1.45

487

Cytomegaloviral hepatitis

2.39

2.18

16.0

3.1

109.07

69.57

ng/l

0.75

Malignant neoplasm of parotid gland, including Hilmo

261

1.64

2.17

3.6

4.4

75.11

88.80

ng/l

0.69

223

Other congenital malformations of skin, including avohilmo

268

2258

1.20

2.17

3.2

4.3

77.14

80.89

ng/l

0.40

240

2005

Helminthiases, including avohilmo

134

1049

1.30

2.17

4.8

4.7

80.50

76.72

ng/l

0.23

118

955

Galactorrhea

214

1.70

2.15

3.1

4.1

63.86

75.99

ng/l

0.76

193

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

2.24

2.15

4.9

4.2

74.12

77.52

ng/l

0.10

Dyshidrosis [pompholyx]

374

1.51

2.14

3.5

3.8

69.58

75.18

ng/l

0.27

329

Chondromalacia

712

1.37

2.13

3.0

4.2

67.51

85.66

ng/l

2.09

645

Malignant neoplasm of oropharynx, including Hilmo

491

1.44

2.12

3.9

4.2

103.83

98.86

ng/l

0.11

433

Normotensive glaucoma

381

3316

1.17

2.12

4.0

3.6

99.51

92.90

ng/l

0.59

318

2759

Nosocomial condition (hospital)

155

1.84

2.12

3.0

3.8

74.10

86.94

ng/l

0.69

136

Myocardial infarction, unclassifiable

889

7244

1.10

2.10

5.6

3.8

131.14

100.47

ng/l

10.23

753

6024

Endovascular or surgical operations to intracerebral aneurysms

221

1838

1.22

2.10

5.7

3.7

97.79

89.92

ng/l

0.54

205

1592

Malignant neoplasm of stomach

181

1474

1.25

2.10

3.8

88.57

97.16

ng/l

0.74

161

1242

Enterohaemorrhagic Escherichia coli infection

2.88

2.10

3.9

2.6

78.80

60.88

ng/l

—

Other vitreous opacities

155

1243

1.27

2.10

3.8

90.38

90.17

ng/l

0.01

124

1075

Malignant neoplasm of testis

270

1.59

2.09

7.0

4.6

121.15

101.04

ng/l

0.63

240

L01XX Other antineoplastic agents

229

1914

1.22

2.09

3.2

3.8

86.09

93.38

ng/l

0.74

206

1632

Other mycoses, not elsewhere classified/unspecified

105

2.05

2.08

12.6

4.2

154.10

78.71

ng/l

1.28

Circumscribed brain atrophy

639

1.38

2.08

3.2

3.9

77.85

94.29

ng/l

1.45

554

Malignant neoplasm of brain

826

0.69

2.07

2.4

4.4

82.68

91.66

ng/l

0.26

730

Other sexually transmitted chlamydial diseases, including avohilmo

209

1725

1.22

2.07

4.2

4.1

70.55

71.95

ng/l

0.10

182

1593

Other noninflammatory disorders of cervix uteri

199

1643

1.23

2.07

2.9

3.2

78.60

81.94

ng/l

0.27

163

1406

Malignant neoplasm of testis, including Hilmo

311

1.55

2.06

7.0

4.8

117.32

104.71

ng/l

0.38

277

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

5.42

2.05

1.4

10.7

56.00

95.55

ng/l

—

Pleural plaque without asbestos

141

1123

1.28

2.05

5.2

4.0

115.52

103.04

ng/l

0.63

114

951

Foreign body in alimentary tract

185

1516

1.24

2.04

3.3

4.5

78.75

91.68

ng/l

1.38

159

1332

Schizotypal disorder

469

1.44

2.04

2.8

4.2

68.95

84.12

ng/l

0.92

419

Ophthalmic devices associated with adverse incidents

2.88

2.02

5.6

3.8

88.80

79.85

ng/l

—

Apocrine sweat disorders, other sweat gland disorders

106

2.02

2.9

3.1

89.00

72.24

ng/l

0.34

False labour

726

4982

0.90

2.02

2.6

3.7

62.69

76.21

ng/l

10.23

656

4556

Pseudomembranous colitis

203

1.70

2.02

7.4

3.6

108.52

86.50

ng/l

0.59

177

Palindromic rheumatism

250

1.62

2.01

2.7

3.9

79.19

84.46

ng/l

0.17

223

Tibial collateral bursitis [Pellegrini-Stieda]

282

1.58

2.01

3.2

3.1

95.06

77.28

ng/l

0.80

253

Pregnancy, childbirth and the puerperium

1189

6710

0.92

2.00

3.0

3.4

80.93

83.90

ng/l

0.60

1001

5667

Pedal cyclist injured in transport accident

775

7047

1.11

2.00

4.0

4.2

84.32

88.70

ng/l

0.66

691

6169

Congenital malformations of aortic and mitral valves

135

1071

1.28

2.00

5.7

5.4

85.88

82.29

ng/l

0.18

127

984

Hand

143

1.85

2.00

6.4

3.3

73.01

79.80

ng/l

0.16

130

malignant neoplasm of female genital organs, including Hilmo

763

6612

1.11

1.99

3.4

3.2

87.11

83.19

ng/l

0.62

642

5506

Other congenital malformations of skin

134

1063

1.28

1.99

3.6

4.5

82.28

79.40

ng/l

0.16

120

950

Procedures for purposes other than remedying health state

669

1.36

1.99

3.8

2.6

77.21

70.96

ng/l

0.36

585

Poisoning by medicine, drug-induced

291

1.56

1.98

3.4

4.2

79.41

81.91

ng/l

0.05

267

Classical phenylketonuria

4.33

1.98

5.7

3.4

71.92

67.94

ng/l

—

Malignant neoplasm of tonsil, including Hilmo

398

1.47

1.97

3.1

4.3

100.09

98.50

ng/l

0.03

352

Trichomoniasis, including avohilmo

269

1.60

1.96

3.0

2.9

70.71

73.30

ng/l

0.09

236

Lichen planus, including avohilmo

772

7034

1.11

1.95

3.2

3.8

87.18

89.19

ng/l

0.27

653

6026

Propionic acid derivatives

1153

5351

1.09

1.95

3.5

6.4

85.79

111.47

ng/l

12.47

1014

4705

Other specified disorders of external ear

128

1014

1.29

1.94

3.9

4.6

89.51

101.48

ng/l

1.02

112

902

Atrial septal defect, secundum type

105

809

1.32

1.94

6.6

6.3

79.99

67.65

ng/l

1.13

755

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.15

1.94

2.1

3.9

155.35

67.38

ng/l

0.94

Other menopausal disorders

1079

5543

1.09

1.93

2.8

3.4

75.82

80.93

ng/l

1.57

951

4829

Postinfectious hypothyroidism

122

1.90

1.93

8.8

2.6

141.92

76.86

ng/l

0.81

108

Other sexually transmitted chlamydial diseases

135

1073

1.27

1.92

4.2

4.1

69.31

73.98

ng/l

0.31

120

984

Vitiligo

277

1.57

1.92

6.2

3.4

105.46

72.80

ng/l

1.13

250

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms, including avohilmo

4.91

1.92

1.4

10.3

56.00

107.58

ng/l

—

Malignant neoplasm of mesothelium and soft tissue

145

1168

1.26

1.91

3.9

86.48

93.18

ng/l

0.46

123

1003

Hereditary retinal dystrophy

351

1.50

1.91

6.5

3.8

86.70

81.60

ng/l

0.18

315

Isolated patent ductus arteriosus

299

1.55

1.91

9.5

8.7

70.15

56.63

ng/l

0.44

286

Benign neoplasm of brain and other parts of central nervous system

229

1931

1.20

1.90

4.4

4.0

84.32

89.27

ng/l

0.32

202

1679

Unspecified parasitic disease

191

1.70

1.90

7.5

4.2

145.81

82.42

ng/l

1.58

168

Carcinoma in situ of breast, intraductal

360

3149

1.16

1.90

3.0

3.3

76.64

80.92

ng/l

0.50

304

2669

Impaction of intestines

168

1.74

1.89

5.4

4.0

120.25

93.47

ng/l

0.50

145

Family history of certain disabilities and chronic diseases leading to disablement

126

997

1.28

1.89

5.1

2.7

86.70

66.19

ng/l

2.05

113

886

Injury of muscle and tendon at shoulder and upper arm level

1360

12697

1.08

1.89

3.9

4.4

87.83

96.41

ng/l

2.70

1199

11044

Carcinoma in situ of other and unspecified sites

146

1180

1.26

1.89

3.9

4.3

102.74

102.39

ng/l

0.01

118

1027

Small cell lung cancer, helper endpoint

702

0.68

1.85

3.1

3.9

98.44

98.68

ng/l

0.00

600

Benign neoplasm: other/unspecified salivary gland

101

783

1.32

1.85

4.5

3.7

96.20

91.34

ng/l

0.21

685

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

141

1138

1.26

1.84

4.4

4.0

92.55

93.53

ng/l

0.04

124

1000

Motor neuron disease ALS

454

1.42

1.84

2.4

3.6

72.10

95.02

ng/l

1.83

406

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

371

1.47

1.84

4.1

3.6

87.03

82.24

ng/l

0.18

329

Embolic stroke

170

1398

1.23

1.84

5.2

3.7

118.49

98.67

ng/l

1.52

152

1171

Tuberculosis, wide

270

2317

1.18

1.83

4.6

3.6

101.24

95.95

ng/l

0.36

235

1954

Myeloid leukaemia

758

1.32

1.82

4.6

4.2

84.87

93.94

ng/l

0.51

668

Non-small cell lung cancer, squamous, helper endpoint

116

1461

0.78

1.82

2.6

4.0

66.13

101.60

ng/l

7.04

1237

Bus occupant injured in other and unspecified transport accidents

186

1.69

1.82

5.9

3.2

131.00

79.36

ng/l

0.93

161

Malignant neoplasm of oral cavity

116

916

1.29

1.82

3.1

3.7

66.90

94.44

ng/l

5.13

789

Injury of muscle and tendon at ankle and foot level

575

1.37

1.81

3.1

4.2

72.37

83.21

ng/l

0.88

519

Malignant neoplasm of vulva

358

1.49

1.80

4.0

2.9

104.64

79.21

ng/l

0.70

310

Testicular dysfunction, other/unspecified

2.06

1.80

1.9

5.1

94.96

95.08

ng/l

0.00

Trichomoniasis

243

1.60

1.79

3.1

2.9

68.30

74.44

ng/l

0.23

211

Congenital malformations of breast

322

1.49

1.79

2.2

3.8

77.60

69.10

ng/l

0.36

294

HSIL lesion of the cervix uteri, vagina or vulva

601

5431

1.11

1.79

3.8

3.4

82.18

75.33

ng/l

1.06

540

4841

Malignant neoplasm of tonsil and base of tongue, including Hilmo

568

1.37

1.79

2.7

4.2

94.03

97.74

ng/l

0.10

505

Foreign body in ear

491

1.40

1.79

5.2

4.8

86.97

74.82

ng/l

0.56

445

Diabetes mellitus in pregnancy

887

5171

1.09

1.78

4.4

3.5

81.81

72.11

ng/l

2.37

801

4744

Foreign body or object entering through skin

186

1548

1.22

1.78

3.8

4.5

85.65

87.11

ng/l

0.07

161

1383

Burn and corrosion of shoulder and upper limb, except wrist and hand

508

1.39

1.78

5.2

4.8

104.40

85.15

ng/l

0.70

456

Dermatitis herpetiformis

475

1.41

1.78

4.0

115.19

84.69

ng/l

0.76

421

Other operation for atrial fibrillation

126

1.85

1.78

4.6

185.84

96.48

ng/l

1.18

106

Tuberculosis, wide, including avohilmo

273

2352

1.18

1.77

4.6

3.6

101.99

95.91

ng/l

0.43

237

1982

Anti-inflammatory and antirheumatic products, non-steroids

1148

5352

1.08

1.77

4.0

6.4

88.87

111.45

ng/l

9.30

1009

4706

Localized scleroderma [morphea]

434

1.43

1.76

5.3

2.9

93.00

73.83

ng/l

0.98

385

Mental and behavioural disorders due to cannabinoids

448

1.40

1.75

2.1

5.2

64.97

86.76

ng/l

1.65

419

Other benign neoplasm of uterus: Other parts/unspecified

195

1643

1.22

1.74

2.4

2.9

83.48

84.89

ng/l

0.10

142

1330

Calcaneal spur

359

1.47

1.74

2.7

3.4

72.21

81.38

ng/l

0.75

321

Lichen ruber planus, wide definition including periferal and oral lichen planus

916

8462

1.09

1.74

3.2

3.8

85.47

88.40

ng/l

0.49

775

7290

Melanoma in situ of other and unspecified parts of face

411

1.44

1.74

5.1

3.7

92.78

86.82

ng/l

0.25

352

Polycystic ovarian syndrome, broad definition

255

2184

1.18

1.73

3.0

3.3

82.24

71.05

ng/l

0.37

223

1998

All dysplastic lesions of the cervix uteri

771

6951

1.10

1.73

3.6

3.4

76.88

74.88

ng/l

0.26

698

6211

Idiopathic pulmonary fibrosis

300

2610

1.16

1.73

4.0

3.8

91.26

99.25

ng/l

0.98

266

2205

Kaposi sarcoma, including Hilmo

2.81

1.73

2.9

4.8

62.37

90.87

ng/l

—

Other bullous disorders

103

810

1.30

1.71

5.4

4.0

125.34

84.78

ng/l

1.56

718

Atypical virus infections of central nervous system

245

1.57

1.71

3.6

3.5

91.84

79.76

ng/l

0.27

214

Unspecified parasitic disease, including avohilmo

197

1.64

1.71

7.5

4.2

145.81

81.60

ng/l

1.61

173

Vestibular neuronitis

320

2799

1.16

1.70

3.9

4.0

92.68

91.71

ng/l

0.06

266

2416

Struck by thrown, projected or falling objec

154

1265

1.23

1.70

4.7

4.8

81.60

86.89

ng/l

0.37

141

1129

Use of other anti-dementia drugs

1321

9955

1.07

1.70

2.3

3.7

81.64

100.61

ng/l

17.76

1027

8246

Use of memantine

1321

9955

1.07

1.70

2.3

3.7

81.64

100.61

ng/l

17.76

1027

8246

ILD medications: pirfenidone

270

1.54

1.70

2.3

3.7

72.46

101.56

ng/l

1.81

234

Other disorders of choroid

404

1.43

1.67

3.7

3.6

109.40

81.18

ng/l

0.80

352

Injury of nerves at forearm level

278

1.52

1.67

4.5

4.1

91.57

75.42

ng/l

0.66

251

Nonspecific lymphadenitis

188

1578

1.21

1.67

3.8

3.7

81.17

81.24

ng/l

0.00

158

1389

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

270

1.52

1.67

2.6

4.4

79.38

80.77

ng/l

0.04

246

Generalized epilepsy, mode (most common among epilepsy diagnosis)

732

1.31

1.66

3.2

4.7

93.67

79.08

ng/l

0.55

667

Parkinson's disease

605

5501

1.11

1.66

2.9

4.0

86.86

98.73

ng/l

1.57

493

4643

Pedal cyclist injured in noncollision transport accidents

370

3271

1.14

1.66

4.1

4.3

81.49

88.10

ng/l

0.81

346

2900

Peritonsillar abscess

614

5583

1.11

1.64

4.1

4.4

82.56

93.28

ng/l

2.38

533

4969

Vascular dementia (other)

224

1.59

1.64

2.7

3.8

85.19

98.90

ng/l

0.66

191

Selective deficiency of immunoglobulin M [IgM]

4.12

1.63

6.0

9.0

124.60

64.05

ng/l

—

Secondary malignant neoplasm of respiratory and digestive organs

518

0.66

1.63

1.7

3.6

97.36

94.99

ng/l

0.03

444

Malignant neoplasm of palate

2.12

1.63

4.7

4.2

61.76

86.90

ng/l

1.55

Other congenital malformations of face and neck

647

1.32

1.62

3.7

4.5

82.72

79.74

ng/l

0.11

584

Oral leukoplakia, including avohilmo

100

790

1.29

1.62

4.3

4.0

76.73

87.25

ng/l

0.97

700

Allergic contact dermatitis due to drugs in contact with skin

623

1.33

1.61

4.4

3.6

126.31

78.57

ng/l

1.16

555

Malignant neoplasm, without specification of site, including Hilmo

167

1392

1.22

1.61

3.5

78.50

92.36

ng/l

1.67

145

1159

Multiple gestation

186

2204

0.84

1.61

3.1

3.8

64.76

78.43

ng/l

3.13

172

1999

Sleepwalking [somnambulism]

2.15

1.61

3.9

2.9

52.54

73.39

ng/l

0.81

Benign neoplasm: Pancreas

112

899

1.28

1.60

6.7

3.8

81.16

90.62

ng/l

0.67

772

Atypical virus infections of central nervous system, including avohilmo

249

1.54

1.60

3.6

3.5

91.84

80.20

ng/l

0.26

218

Blood alcohol or alcohol intoxication level

483

1.37

1.60

4.9

4.7

83.60

88.23

ng/l

0.18

432

Mantle cell lymphoma, including Hilmo

357

1.44

1.59

4.3

4.0

92.83

98.46

ng/l

0.13

308

Whooping cough, including avohilmo

356

1.43

1.59

6.8

3.8

145.94

69.34

ng/l

1.37

326

Mixed disorders of conduct and emotions

389

1.41

1.59

7.5

6.5

92.89

65.24

ng/l

0.85

364

Contraceptive management

1349

8844

1.07

1.58

4.1

4.3

77.29

86.68

ng/l

3.91

1211

7915

Non-small cell lung cancer, including Hilmo

553

4705

1.11

1.58

3.0

4.0

81.56

99.09

ng/l

6.07

488

3954

Histrionic personality disorder

131

1.77

1.58

2.1

3.3

59.31

69.31

ng/l

0.50

114

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

307

2696

1.15

1.57

5.8

3.1

102.15

75.31

ng/l

4.52

282

2317

Macular hole

237

2046

1.18

1.57

4.3

3.7

87.73

90.80

ng/l

0.25

199

1734

Other meningitis

400

1.41

1.57

5.3

4.0

82.19

80.58

ng/l

0.06

354

Colorectal cancer

937

8347

1.08

1.56

3.6

3.9

97.37

96.30

ng/l

0.13

809

7007

Reduction defects of lower limb, including avohilmo

2.05

1.55

6.3

4.3

79.14

64.87

ng/l

0.34

Early lumbar disc prolapse, operated

218

1864

1.18

1.55

3.9

4.6

81.25

88.59

ng/l

0.49

202

1718

Benign neoplasm: Vulva

681

1.31

1.55

3.1

3.3

100.91

77.18

ng/l

1.08

592

Postpartum haemorrhage due to retained placenta

236

2735

0.86

1.55

2.3

3.1

57.95

72.34

ng/l

6.39

213

2488

Operations for atrial fibrillation

385

1.42

1.55

4.1

4.3

131.34

94.04

ng/l

1.25

336

Patent foramen ovale

592

1.33

1.54

6.6

6.1

67.03

74.57

ng/l

0.59

542

Demyelinating diseases of the central nervous system

249

2156

1.17

1.54

3.6

3.7

74.54

79.90

ng/l

0.49

219

1917

Femoral hernia, unilateral

104

832

1.28

1.53

4.4

3.8

94.62

89.56

ng/l

0.17

729

Inguinal hernia, unilateral

104

832

1.28

1.53

4.4

3.8

94.62

89.56

ng/l

0.17

729

Inguinal of femoral hernia, unilateral

104

832

1.28

1.53

4.4

3.8

94.62

89.56

ng/l

0.17

729

Heberden's nodes [with arthropathy]

269

1.51

1.53

3.6

3.3

75.01

79.71

ng/l

0.17

230

Cerebral amyloid angiopathy

164

1.68

1.53

4.1

4.0

86.05

85.49

ng/l

0.01

144

Injury of nerves at wrist and hand level

108

866

1.27

1.53

4.0

4.3

102.44

90.05

ng/l

0.49

773

Tracheo-bronchomalasia

2.07

1.52

2.2

3.9

32.72

64.29

ng/l

—

Malignant neoplasm of gum, including Hilmo

269

1.50

1.52

1.7

3.7

56.12

87.37

ng/l

3.83

237

Personality and behavioural disorders due to brain disease, damage and dysfunction

360

1.42

1.52

2.6

4.5

71.69

91.84

ng/l

2.08

327

Degeneration of the brain due to alcohol

541

1.34

1.52

2.9

4.6

108.60

101.56

ng/l

0.15

481

Other hereditary haemolytic anaemias

164

1.66

1.51

4.1

4.5

74.17

75.56

ng/l

0.04

146

Placenta praevia

1004

0.77

1.51

3.2

3.8

66.12

75.99

ng/l

0.74

917

Frostbite

244

1.52

1.50

4.6

4.1

127.72

82.94

ng/l

1.65

220

Knuckle pads

2.52

1.50

9.2

3.2

108.56

76.35

ng/l

—

Viral meningitis, including avohilmo

109

878

1.26

1.49

3.3

4.1

73.73

81.30

ng/l

0.48

797

Frontotemporal dementia

157

1.67

1.49

3.2

3.6

83.18

87.00

ng/l

0.12

137

Transient synovitis

172

1.62

1.48

5.9

4.8

61.19

66.02

ng/l

0.22

161

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

2.47

1.48

9.4

1.8

109.36

76.31

ng/l

—

Abnormal findings on diagnostic imaging of breast

484

1.36

1.48

3.9

2.9

80.65

74.97

ng/l

0.27

421

Assault by blunt object

286

1.47

3.8

4.9

85.23

90.56

ng/l

0.15

261

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

221

1906

1.17

1.47

4.3

4.1

85.88

93.00

ng/l

0.72

190

1680

Rickettsioses

2.44

1.47

7.7

4.3

144.73

84.74

ng/l

—

Divergent concomitant strabismus

237

2055

1.17

1.46

3.7

3.9

83.86

82.35

ng/l

0.09

212

1811

Alzheimer’s disease (undefined)

239

0.53

1.46

1.2

3.0

104.60

102.33

ng/l

—

199

Gastrointestinal stromal tumor and sarcoma

348

1.42

1.44

4.1

99.84

96.01

ng/l

0.08

301

Dislocation, sprain and strain of joints and ligaments of elbow

201

1723

1.18

1.44

4.1

4.3

81.86

77.23

ng/l

0.43

177

1539

Other disorders following mastoidectomy

120

1.78

1.43

3.0

3.8

81.35

92.16

ng/l

0.33

106

Endometriosis of fallopian tube

182

1.59

1.43

4.0

3.4

70.61

73.97

ng/l

0.07

159

Occlusion and stenosis of arteries, not leading to stroke

356

1.41

1.43

4.9

3.5

114.90

97.44

ng/l

0.41

312

Congenital ovarian cysts

120

982

1.24

1.43

3.8

3.3

88.61

70.82

ng/l

0.86

109

882

conjunctival degenerations and deposits

618

1.31

1.42

4.3

3.7

107.41

84.98

ng/l

0.56

543

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

680

1.29

1.42

4.0

3.8

109.11

84.52

ng/l

0.56

601

Viral meningitis

104

839

1.26

1.42

3.3

3.9

74.51

81.48

ng/l

0.42

760

Other specific arthropathies, wide

547

1.32

1.42

2.4

3.7

78.88

86.07

ng/l

0.38

475

Other bursal cyst

426

1.37

1.41

4.5

3.8

88.66

86.48

ng/l

0.08

385

Other diseases of spinal cord

797

1.26

1.40

3.8

3.9

77.15

87.68

ng/l

0.67

701

Other puerperal infections

181

1542

1.18

1.39

2.6

3.4

62.41

70.57

ng/l

1.48

168

1395

Diffuse (eosinophilic) fasciitis

2.31

1.38

2.1

4.0

67.56

73.67

ng/l

—

Maternal care for known or suspected malpresentation of fetus

399

3166

0.89

1.38

3.0

3.7

67.62

75.70

ng/l

1.11

367

2904

Labyrinthitis

1.91

1.38

5.4

3.3

84.57

77.14

ng/l

0.13

Personal history of certain other diseases

315

1.42

1.38

3.7

2.7

93.67

62.76

ng/l

1.80

284

Flatback syndrome

2.66

1.38

2.3

3.0

60.25

77.30

ng/l

—

Benign neoplasm: Conjunctiva

115

944

1.24

1.37

4.3

3.9

85.00

85.93

ng/l

0.05

828

Congenital mitral valve regurgitation

2.20

1.37

6.8

8.5

59.55

62.49

ng/l

0.10

Malignant neoplasm of other and unspecified urinary organs

1.95

1.36

8.3

4.6

193.68

103.40

ng/l

1.29

Degeneration of nervous system due to alcohol

551

1.32

1.36

2.9

4.6

108.60

103.18

ng/l

0.11

487

Exposure to smoke, fire and flames

577

1.31

1.35

3.2

4.4

79.15

89.69

ng/l

0.60

516

Haemophilus septicemia

2.17

1.35

20.6

3.9

154.91

83.06

ng/l

1.04

Golimumab

101

818

1.25

1.34

2.6

4.2

68.02

82.85

ng/l

1.09

744

Benign neoplasm: Tongue

802

1.26

1.34

4.4

3.7

94.21

86.07

ng/l

0.22

708

Other dermatomyositis

122

1.72

1.34

3.0

3.3

52.07

82.18

ng/l

2.45

106

Spermatocele

209

1809

1.17

1.34

5.0

4.8

105.49

107.86

ng/l

0.12

186

1575

Rickettsioses, including avohilmo

2.23

1.34

7.2

4.0

135.06

78.08

ng/l

—

Drug-induced myopathy

2.05

1.34

3.7

3.0

188.42

71.86

ng/l

1.08

Benign neoplasm: Nasopharynx

235

1.50

1.33

2.7

3.7

81.86

84.22

ng/l

0.06

207

Congenital malformations of breast, including avohilmo

343

1.39

1.33

2.2

3.8

77.60

69.45

ng/l

0.34

313

Other diseases of appendix

319

1.42

1.33

5.2

3.7

80.31

82.76

ng/l

0.08

286

LSIL lesion of the vagina

422

1.36

1.33

5.2

3.3

81.67

74.71

ng/l

0.22

379

Female infertility, tubal origin

139

1164

1.21

1.33

3.4

3.6

75.57

75.29

ng/l

0.02

125

1060

Certain zoonotic bacterial diseases, including avohilmo

103

839

1.25

1.32

3.8

4.0

98.02

84.01

ng/l

0.66

743

Non-allergic asthma

295

2616

1.14

1.32

4.3

4.5

93.49

88.45

ng/l

0.43

262

2286

Benign neoplasm: Brain, unspecified

138

1.66

1.32

4.2

3.5

75.16

74.32

ng/l

0.03

123

Postpartum care and examination

282

2004

0.88

1.32

3.6

3.5

70.51

73.00

ng/l

0.19

251

1818

Twin gestation

183

2127

0.85

1.31

3.1

3.8

65.14

77.90

ng/l

2.82

170

1930

Malignant neoplasm of tonsil and base of tongue

475

1.33

1.31

2.5

4.2

94.98

100.44

ng/l

0.13

421

Oral lichen planus

106

869

1.24

1.31

3.7

3.6

97.24

82.62

ng/l

0.51

759

Drowning and submersion while in natural water

117

0.41

1.30

2.2

4.4

45.60

96.02

ng/l

—

106

Myasthenia gravis

485

1.33

1.30

3.8

4.2

92.94

88.43

ng/l

0.12

427

ILD medications: acetylcysteine

178

1.56

1.30

4.1

88.47

95.39

ng/l

0.14

151

Benign neoplasm: Larynx

100

814

1.25

1.30

3.2

4.0

84.29

95.99

ng/l

0.79

713

Femoral hernia

160

1364

1.19

1.28

4.3

3.7

93.33

93.08

ng/l

0.01

139

1173

Benign neoplasm: Brain, supratentorial

381

1.37

1.28

4.7

4.0

87.00

77.63

ng/l

0.28

338

Other demyelinating diseases of the central nervous system

102

832

1.24

1.28

4.6

3.8

87.72

79.11

ng/l

0.38

748

Carcinoma in situ, bladder

130

1090

1.21

1.27

3.9

4.4

107.26

102.74

ng/l

0.19

104

948

Certain zoonotic bacterial diseases

469

1.33

1.27

3.5

3.9

83.79

81.30

ng/l

0.09

415

Colon adenocarcinoma

459

4185

1.11

1.26

3.8

3.9

101.20

98.33

ng/l

0.27

409

3500

Crushing injury of hip and thigh

2.89

1.26

1.0

4.0

81.20

73.26

ng/l

—

Alzheimer disease

1551

10542

1.06

1.25

2.8

3.6

89.72

98.73

ng/l

4.08

1258

8719

Bilateral sagittal split ramus osteotomy operation

719

0.76

1.25

2.2

3.8

73.54

78.11

ng/l

0.27

656

Malignant neoplasm of oropharynx

383

1.36

1.25

2.8

4.4

97.63

100.00

ng/l

0.04

338

Endometriosis ASRM stages 3,4

847

7923

1.07

1.24

3.4

3.2

77.90

79.52

ng/l

0.26

719

6821

Bacterial meningitis

109

901

1.23

3.9

4.1

74.72

86.87

ng/l

1.23

797

LeFortI or BSSO operation

862

0.78

1.22

2.9

3.9

72.27

78.88

ng/l

0.48

784

Ankylosing spondylitis, strict definition

116

965

1.22

3.3

4.3

72.98

83.34

ng/l

0.68

110

866

Symptoms and signs involving appearance and behaviour

165

1.56

1.21

3.8

3.5

95.00

76.00

ng/l

0.48

145

Peripheral retinal degeneration

105

867

1.23

1.21

3.8

3.6

82.74

83.32

ng/l

0.03

762

Parkinson's disease, strict definition

555

5119

1.09

1.20

2.9

3.9

83.11

98.46

ng/l

3.80

454

4319

Malignant neoplasm of lip, including Hilmo

274

1.42

1.20

5.5

4.0

134.06

103.63

ng/l

0.96

237

Congenital malformations of uterus and cervix

411

1.33

1.20

4.1

3.6

67.13

71.20

ng/l

0.25

375

Bursitis of shoulder

678

1.26

1.20

2.8

3.6

72.62

84.77

ng/l

0.97

593

Other and unspecified disease of Bartholin gland

109

906

1.23

1.20

3.1

3.3

88.87

78.59

ng/l

0.78

776

Benign neoplasm: Peripheral nerves and autonomic nervous system

448

1.33

1.19

2.2

3.8

66.97

84.24

ng/l

1.50

392

Diaper [napkin] dermatitis

2.15

1.19

18.0

6.5

132.20

56.54

ng/l

—

Cyst of Bartholin Gland

125

1051

1.21

1.19

3.0

3.3

80.26

74.15

ng/l

0.32

115

924

Arthropathy in Crohn disease

241

1.45

1.18

2.7

3.6

86.47

83.42

ng/l

0.06

218

Suppurative otitis media, unspecified

607

1.27

1.17

5.9

3.9

102.69

80.49

ng/l

0.78

544

Other and unspecified syphilis, including avohilmo

1.92

1.17

9.8

3.9

154.33

86.50

ng/l

0.65

Anomalies of pupillary function

537

1.29

1.17

3.4

3.9

70.42

76.08

ng/l

0.34

483

Burn and corrosion of wrist and hand

108

897

1.22

1.17

4.2

4.8

90.00

83.06

ng/l

0.34

816

Retained placenta and membranes, without haemorrhage

345

3813

0.90

1.16

3.1

3.4

79.07

77.97

ng/l

0.10

294

3322

Alzheimer’s disease (undefined), excluding more controls

214

0.58

1.16

1.2

3.2

104.60

112.59

ng/l

—

168

Mandibular retrognathia AND surgery (BSSO)

563

0.74

1.16

2.2

3.9

72.46

77.76

ng/l

0.27

519

Respiratory tuberculosis, confirmed, including avohilmo

476

1.31

1.16

4.5

4.0

98.13

91.21

ng/l

0.20

416

Narcolepsy and cataplexy

135

1.60

1.15

4.9

3.5

80.93

70.79

ng/l

0.25

121

Other disorders of breast and lactation associated with childbirth

310

1.38

1.15

3.3

3.7

57.70

66.84

ng/l

1.14

281

Sequelae of poliomyelitis

210

1.48

1.14

4.4

3.3

115.78

84.79

ng/l

0.66

179

MS-disease / Multiple Sclerosis

205

1798

1.15

1.14

2.7

3.8

64.74

79.46

ng/l

3.13

178

1613

Use of teriflunomide

193

1.48

1.12

3.1

4.1

81.35

78.73

ng/l

0.06

179

Injury of muscle and tendon at wrist and hand level

423

3870

1.10

1.11

4.5

91.68

95.78

ng/l

0.39

376

3404

Left hemicolectomy

677

1.25

1.11

4.8

3.9

101.12

93.45

ng/l

0.24

595

Cerebral arteritis

1.90

1.10

4.9

2.8

59.92

80.60

ng/l

1.07

Pneumoconiosis due to asbestos and other mineral fibres

533

1.28

1.10

4.1

4.8

96.16

115.78

ng/l

1.01

456

Other disorders of amniotic fluid and membranes

287

3084

0.89

1.10

2.9

3.7

65.11

76.91

ng/l

2.39

245

2816

Habit and impulse disorders

304

1.37

1.10

1.9

5.0

84.90

83.75

ng/l

0.02

283

Contact with sharp object, undetermined intent

497

1.29

1.09

3.0

5.0

96.60

88.44

ng/l

0.21

447

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

411

1.32

1.09

8.2

10.7

52.47

49.94

ng/l

0.21

405

Generalized epilepsy, strict definition

516

1.28

1.08

3.4

5.1

86.87

76.29

ng/l

0.33

472

Dementia in other diseases classified elsewhere

169

1471

1.16

1.08

3.5

4.0

89.34

98.99

ng/l

0.49

122

1269

Respiratory tuberculosis, confirmed

464

1.29

1.07

4.6

4.0

98.70

91.46

ng/l

0.21

405

Benign neoplasm: Other and unspecified parts of mouth

114

963

1.20

1.07

4.4

3.7

97.19

87.05

ng/l

0.75

102

847

Endometroid carcinoma of ovary, including Hilmo

286

0.64

1.06

3.8

3.1

121.84

77.33

ng/l

0.77

246

Carcinoma in situ of other and unspecified genital organs

627

1.25

1.06

4.2

3.1

98.01

76.28

ng/l

1.49

550

Melanoma in situ of trunk

457

1.30

1.06

3.6

4.2

98.53

93.50

ng/l

0.14

407

Myelodysplastic syndrome

351

1.34

1.05

3.3

3.9

64.58

102.41

ng/l

5.11

295

Use of amantadine

457

1.30

1.05

3.1

3.4

76.02

81.24

ng/l

0.33

396

Transitory endocrine and metabolic disorders specific to fetus and newborn

422

1.31

1.04

8.1

10.6

53.42

50.36

ng/l

0.26

416

Serous carcinoma of ovary, including Hilmo

1167

0.83

1.04

2.8

3.2

72.21

82.65

ng/l

1.18

983

Malignant neoplasm of tonsil

352

1.33

1.03

2.8

4.4

103.82

99.32

ng/l

0.08

308

Benign neoplasm of other and unspecified female genital organs

166

1451

1.16

1.03

3.3

3.4

92.41

77.58

ng/l

1.05

138

1232

Laparoscopic right hemicolectomy

229

2044

1.13

1.03

3.6

3.8

100.60

94.44

ng/l

0.48

202

1732

Varicose veins of other sites

199

1758

1.14

1.03

3.3

4.2

75.41

92.35

ng/l

2.61

168

1536

Congenital malformations of eyelid, lacrimal apparatus and orbit

206

1.44

1.02

6.0

7.5

68.17

61.99

ng/l

0.16

194

Sequelae of injuries involving multiple and unspecified body regions

2.08

1.02

2.0

3.1

144.57

73.99

ng/l

—

Inflammation of lacrimal passages (acute and unspecified)

513

1.27

1.01

4.8

3.5

111.55

81.72

ng/l

1.49

446

Malignant neoplasm of ovary

146

1680

0.86

1.01

2.6

3.2

73.58

81.96

ng/l

0.74

128

1411

Intussusception

621

1.24

1.01

3.7

71.24

80.41

ng/l

0.66

539

Supernumerary ureter

1.92

1.01

2.3

5.6

77.89

51.99

ng/l

—

Adhesive middle ear disease

362

1.32

1.01

3.7

4.0

103.53

80.94

ng/l

0.48

325

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

230

2053

1.13

1.00

3.4

3.1

71.82

73.21

ng/l

0.11

207

1826

Benign neoplasm: Tonsil

337

1.34

1.00

4.3

3.2

70.75

81.58

ng/l

0.85

295

Carcinoma in situ of larynx

0.00

1.00

0.0

6.2

—

96.74

—

Small cell lung cancer

625

0.77

0.98

3.1

3.8

98.44

95.98

ng/l

0.05

527

Small cell lung cancer, including Hilmo

625

0.77

0.98

3.1

3.8

98.44

95.98

ng/l

0.05

527

Endometroid carcinoma of ovary

184

0.58

0.98

3.8

3.2

142.09

75.88

ng/l

0.71

161

Glaucoma, exfoliation

456

4220

1.09

0.97

3.1

3.4

90.86

94.97

ng/l

0.37

372

3470

Complications predominantly related to the puerperium

819

7728

1.06

0.97

2.8

3.4

72.52

75.80

ng/l

0.65

718

6856

Guillain-Barre syndrome

400

1.30

0.97

4.3

4.1

103.87

86.54

ng/l

0.56

354

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

1.99

0.97

5.3

5.4

89.70

116.56

ng/l

—

Sequelae of poliomyelitis, including avohilmo

252

1.39

0.97

4.1

3.2

106.87

85.97

ng/l

0.44

215

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

148

1289

1.16

0.97

3.9

3.8

91.50

86.61

ng/l

0.26

134

1127

Other/unspecified postprocedural disorders of ear and mastoid process

1.72

0.96

4.0

3.7

79.45

86.69

ng/l

0.17

Frontotemporal dementia, wide, incl. Pick's disease

184

1.46

0.96

3.2

3.8

81.94

86.79

ng/l

0.17

160

Retinoschisis and retinal cysts

699

1.22

0.96

4.2

3.8

96.07

92.91

ng/l

0.12

610

Chronic myeloproliferative disease

402

1.30

0.95

2.2

3.9

84.96

84.41

ng/l

0.02

352

Malignant neoplasm of eye, brain and central nervous system

1125

0.84

0.94

3.3

4.2

88.66

91.54

ng/l

0.09

984

Dementia due to Parkinsons disease, excluding more controls

599

1.24

0.94

2.6

3.5

78.04

100.41

ng/l

1.74

515

Bacterial agents resistant to antibiotics

2.27

0.94

5.8

5.0

225.17

88.11

ng/l

—

Exposure to excessive natural cold

244

1.38

0.94

5.7

4.3

120.62

89.46

ng/l

0.86

214

Use of riluzole

103

0.47

0.93

1.4

3.8

66.40

74.60

ng/l

—

Hypertrophy of bone

1.77

0.92

2.7

4.5

62.83

79.00

ng/l

0.66

Contact with other sharp object(s)

179

1583

1.14

0.92

4.7

73.07

83.56

ng/l

1.37

153

1433

Other protozoal intestinal diseases, including avohilmo

501

1.25

0.92

4.5

3.6

82.00

75.36

ng/l

0.27

451

Respiratory tuberculosis, bacteriologically and histologically confirmed

484

1.26

0.92

4.5

4.0

98.70

91.60

ng/l

0.21

421

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

112

960

1.18

0.91

4.3

4.5

77.60

79.25

ng/l

0.09

100

859

Normal-pressure hydrocephalus

150

1704

0.87

0.90

2.6

3.7

73.34

97.67

ng/l

5.02

125

1422

Malignant neoplasm of brain, including Hilmo

108

1258

0.85

0.89

2.9

4.1

87.87

89.43

ng/l

0.06

1103

Preterm labour and delivery

877

8317

1.06

0.89

3.6

3.5

81.66

78.95

ng/l

0.40

756

7318

Migraine with aura, drug-induced

273

1.35

0.89

2.0

3.4

66.08

73.58

ng/l

0.45

242

Other corneal oedema

265

1.36

0.89

3.8

3.6

103.82

84.72

ng/l

0.55

228

Malignant neoplasm of tongue, including Hilmo

677

1.21

0.89

2.8

3.6

68.73

92.19

ng/l

2.64

592

Malignant neoplasm, without specification of site

112

963

1.18

0.89

3.3

3.6

76.90

96.95

ng/l

2.34

802

Lens-induced iridocyclitis

1.89

0.88

5.1

3.2

97.75

68.81

ng/l

—

Lichen sclerosus et atrophicus

452

4207

1.08

0.86

3.0

3.2

78.99

80.92

ng/l

0.24

396

3532

Aggressive periodontitis

625

1.22

0.86

5.6

4.0

96.03

88.53

ng/l

0.29

554

Fall on and from ladder

235

2125

1.11

0.86

4.1

4.5

91.88

101.60

ng/l

0.89

215

1875

Cutis laxa senilis

232

1.38

0.86

2.2

2.7

69.50

76.13

ng/l

0.31

196

L02BX Other hormone antagonists and related agents

178

1586

1.13

0.85

2.8

4.9

117.15

111.06

ng/l

0.23

157

1374

Infectious mononucleosis, including avohilmo

187

1668

1.13

0.85

4.3

4.1

67.45

70.89

ng/l

0.37

171

1532

Infectious mononucleosis

187

1668

1.13

0.85

4.3

4.1

67.45

70.89

ng/l

0.37

171

1532

Inflammatory disease of cervix uteri

235

2129

1.11

0.85

3.3

78.50

80.92

ng/l

0.21

196

1795

Toxic effect of contact with venomous animals

133

1164

1.15

0.84

3.6

4.3

77.08

85.66

ng/l

0.82

120

1035

Use of glatiramer acetate

346

1.29

0.84

3.0

3.7

69.18

76.93

ng/l

0.23

321

Type 1 diabetes, wide definition, subgroup 2

341

0.72

0.83

14.0

4.4

196.08

83.38

ng/l

2.40

287

Diseases caused by chlamydiae

250

1.35

0.83

4.9

3.7

82.46

71.50

ng/l

0.25

226

Use of rivastigmine

700

6602

1.06

0.83

2.5

3.5

78.89

98.01

ng/l

11.10

581

5432

Benign neoplasm of male genital organs

482

1.24

0.82

4.8

5.2

103.37

116.11

ng/l

0.34

426

Benign neoplasm: Lip

592

1.22

0.82

3.3

4.0

79.33

88.08

ng/l

0.51

528

Complicated migraine, drug-induced

0.00

0.82

0.0

3.2

—

62.73

—

Colorectal neuroendocrine tumor and carcinoma

366

1.28

0.81

4.1

3.6

106.60

84.63

ng/l

0.56

319

HSIL lesion of the cervix uteri

499

4669

1.07

0.81

3.7

3.4

76.04

74.58

ng/l

0.14

452

4205

Syndactyly, including avohilmo

1.68

0.81

5.9

3.9

76.60

74.27

ng/l

0.03

Gestational diabetes (for exclusion)

916

6618

0.95

0.81

3.5

72.12

73.15

ng/l

0.16

825

6045

Simple and mucopurulent chronic bronchitis

134

1177

1.15

0.81

5.1

4.2

88.52

91.05

ng/l

0.11

114

1012

Disorders of optic chiasm

2.41

0.80

3.6

4.0

97.80

82.74

ng/l

—

Unspecified dementia

446

3732

1.08

0.80

3.2

3.6

94.18

103.47

ng/l

1.23

348

3097

Shigellosis, including avohilmo

148

1.45

0.80

6.7

3.6

109.41

77.39

ng/l

0.46

132

Erysipeloid, including avohilmo

107

1.56

0.80

4.8

3.4

142.00

70.11

ng/l

—

Other acquired deformities of musculoskeletal system and connective tissue

139

1226

1.14

0.80

3.5

4.0

88.25

87.53

ng/l

0.03

117

1075

Purulent endophthalmitis

192

1.40

0.79

8.9

3.7

142.34

88.61

ng/l

0.84

162

Other and unspecified bullous disorders

306

1.30

0.78

8.1

4.1

156.91

80.04

ng/l

1.46

269

Injury of blood vessels at wrist and hand level

149

1.45

0.78

8.0

3.7

150.05

82.37

ng/l

0.98

138

Acute alcohol intoxication ICD-9

807

1.18

0.78

3.9

4.6

94.92

100.92

ng/l

0.20

714

Benign neoplasm: Floor of mouth

1.63

0.78

4.0

4.9

122.24

84.98

ng/l

0.49

Malignant neoplasm of rectosigmoid junction, including Hilmo

808

1.18

0.78

3.7

90.81

95.15

ng/l

0.24

691

Otosclerosis

261

2389

1.10

0.77

3.7

4.0

95.48

91.05

ng/l

0.25

223

2052

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

157

1397

1.13

0.77

2.8

3.0

70.84

72.56

ng/l

0.12

147

1257

Malignant neoplasm of ovary, including Hilmo

203

2241

0.90

0.77

3.2

81.16

82.57

ng/l

0.08

181

1877

Complications following abortion and ectopic and molar pregnancy

129

1137

1.15

0.77

2.5

3.3

82.67

77.55

ng/l

0.17

104

977

Other diseases caused by chlamydiae

280

1.31

0.77

4.6

3.6

79.80

69.71

ng/l

0.25

250

Loose body in joint

532

1.22

0.76

3.3

4.2

73.61

91.30

ng/l

1.94

466

Other and unspecified degenerative diseases of nervous system

857

1.17

0.76

3.4

3.8

91.86

99.11

ng/l

0.34

729

Dissocial personality disorder

271

1.31

0.76

3.2

5.1

78.35

97.52

ng/l

0.64

249

Postprocedural disorders of ear and mastoid process, not elsewhere classified

246

1.34

0.76

3.3

3.6

88.92

86.94

ng/l

0.06

219

Bicuspidal aortic valve syndrome

105

912

1.16

0.76

4.8

5.0

92.58

86.04

ng/l

0.28

833

Anisometropia and aniseikonia

106

922

1.16

0.76

4.8

4.1

92.88

81.05

ng/l

0.26

824

Other and unspecified hydrocephalus

534

1.22

0.75

3.3

3.9

85.00

83.95

ng/l

0.03

473

Exposure to excessive natural heat

1.68

0.75

5.3

4.1

114.37

83.54

ng/l

—

Malignant neoplasm of gum

151

1.44

0.75

1.5

3.8

53.47

89.18

ng/l

2.88

128

Tooth agenesis EXCLUDE clefts and syndromes

855

1.17

0.75

9.7

5.7

80.29

64.86

ng/l

0.83

803

Foreign body on external eye

399

3721

1.08

0.74

4.5

4.9

90.42

98.60

ng/l

0.92

357

3344

Spontaneous abortion

1587

10996

0.96

0.73

3.5

3.4

75.06

77.85

ng/l

0.68

1399

9617

Accidental poisoning by and exposure to pesticides

1.61

0.72

9.0

4.3

120.11

79.14

ng/l

—

Other/unspecified mastoiditis and related conditions

118

1.48

0.72

4.8

3.8

97.91

84.80

ng/l

0.24

104

Other disorders of peripheral nervous system

161

1.40

0.71

2.5

3.8

72.54

82.44

ng/l

0.34

137

Poikiloderma of Civatte

1.74

0.71

1.3

4.0

103.29

89.95

ng/l

—

Haemorrhage in early pregnancy

908

8436

1.05

0.70

3.1

3.4

73.44

75.97

ng/l

0.41

806

7444

Subarachnoid haemorrhage

366

3415

1.08

0.70

4.9

3.7

101.59

91.17

ng/l

1.17

320

2899

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

1.92

0.69

2.0

1.8

29.40

64.52

ng/l

—

Gestational [pregnancy-induced] hypertension

750

7134

1.05

0.68

4.0

3.2

80.60

74.81

ng/l

1.09

680

6331

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

837

1.16

0.68

3.4

3.8

90.74

96.17

ng/l

0.26

714

Other infestations, including avohilmo

522

1.21

0.68

3.6

3.7

106.62

80.61

ng/l

0.79

462

Malignant neoplasm of corpus uteri, including Hilmo

391

3663

1.07

0.68

3.3

3.1

91.65

84.86

ng/l

0.78

317

3020

Poor fetal growth

270

2490

1.09

0.68

4.8

3.3

79.29

73.14

ng/l

0.46

248

2261

Adenocarcinoma and papillary adenocarcinoma of stomach

744

1.17

0.68

4.0

3.7

97.60

95.46

ng/l

0.07

632

Dermatitis due to ingested food

791

1.16

0.68

6.8

7.2

57.51

57.02

ng/l

0.03

753

Acute hepatitis A

103

1.50

0.68

2.7

3.9

72.01

85.88

ng/l

0.48

Other benign neoplasm of uterus: Corpus uteri

260

1.30

0.67

4.7

3.1

104.11

75.65

ng/l

0.52

228

Polyhydramnios

114

1006

1.14

0.67

4.4

3.8

76.10

76.43

ng/l

0.01

100

912

Infections of genitourinary tract in pregnancy

289

2677

1.09

0.67

3.4

3.3

87.88

75.42

ng/l

1.31

246

2327

Laparoscopic left hemicolectomy

505

1.21

0.67

2.3

4.0

94.33

91.46

ng/l

0.08

447

Blepharospasm

278

1.29

0.67

3.6

3.0

76.10

76.03

ng/l

0.00

246

Perichondritis of external ear

505

1.21

0.67

3.8

3.9

99.20

87.30

ng/l

0.47

438

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

198

1.34

0.67

3.2

4.0

82.40

85.13

ng/l

0.09

169

Other mosquito-borne viral fevers, including avohilmo

166

0.65

0.66

2.6

3.8

53.81

84.65

ng/l

1.53

146

Malignant neoplasm of uterus, part unspecified, including Hilmo

155

1.40

0.66

4.4

3.0

118.07

86.67

ng/l

0.70

130

Use of ropinirole

122

1085

1.14

0.66

2.5

4.0

88.11

94.87

ng/l

0.33

103

938

Use of interferon beta-1a

477

1.21

0.66

3.8

4.0

78.08

81.36

ng/l

0.10

443

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

190

1.36

0.66

3.1

4.1

75.00

91.58

ng/l

0.47

166

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

207

1.33

0.66

2.6

3.6

78.51

84.04

ng/l

0.19

186

Acute hepatitis A, including avohilmo

112

1.47

0.66

2.6

4.0

69.45

87.92

ng/l

0.70

100

Malignant neoplasm of heart, mediastinum and pleura

337

0.76

0.66

2.5

4.2

99.83

103.27

ng/l

0.05

293

Cicatricial alopecia [scarring hair loss]

243

1.30

0.65

3.7

3.0

72.32

80.01

ng/l

0.40

213

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

1.80

0.65

1.2

2.7

86.80

75.38

ng/l

—

Other protozoal intestinal diseases

342

1.25

0.64

4.2

3.6

76.35

75.36

ng/l

0.03

311

Spinal enthesopathy

765

1.16

0.64

3.9

3.3

116.01

101.33

ng/l

0.33

602

Cerebral atherosclerosis

378

1.23

0.64

4.9

3.8

90.47

89.47

ng/l

0.03

328

Biological medicines for asthma

507

1.20

0.64

3.0

4.0

76.76

80.03

ng/l

0.11

458

Ill-defined and unknown causes of mortality

313

3356

0.93

0.64

4.3

3.8

117.03

100.09

ng/l

1.42

228

2837

Superficial frostbite

147

1.39

0.64

5.2

4.0

148.49

86.19

ng/l

1.28

130

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

886

6987

1.05

0.63

3.5

4.0

84.87

98.10

ng/l

4.44

768

5894

Leprosy [Hansen's disease]

0.00

0.63

0.0

3.2

—

64.38

—

Sequelae of tuberculosis

508

1.20

0.63

3.0

3.7

89.55

97.02

ng/l

0.30

428

Cholesteatoma of middle ear

169

1536

1.11

0.63

3.8

3.9

93.10

93.17

ng/l

0.00

145

1320

Diseases caused by chlamydiae, including avohilmo

316

1.25

0.62

4.4

4.2

78.82

70.27

ng/l

0.22

288

Noise effects on inner ear

108

957

1.14

0.62

4.0

5.2

99.43

106.77

ng/l

0.27

847

Guttate psoriasis

326

1.24

0.61

5.1

3.7

114.54

81.42

ng/l

0.75

292

Other diseases caused by chlamydiae, including avohilmo

344

1.24

0.61

4.2

4.0

76.83

69.88

ng/l

0.19

309

Contact with other hot fluids

751

1.16

0.61

4.6

5.1

83.45

79.29

ng/l

0.18

678

Leprosy [Hansen's disease], including avohilmo

0.00

0.61

0.0

3.0

—

62.46

—

Acute myringitis

166

1.35

0.60

8.4

4.5

76.23

73.39

ng/l

0.08

151

Asymptomatic human immunodeficiency virus [HIV] infection status

106

1.45

0.59

2.5

4.6

79.33

86.86

ng/l

0.21

100

Tuberculosis

209

1925

1.09

0.59

3.8

3.6

93.66

97.22

ng/l

0.23

174

1604

Superficial injury of neck

419

1.21

0.59

3.4

4.8

74.42

83.06

ng/l

0.30

390

Other osteochondropathies

191

1752

1.10

0.59

4.2

4.3

91.85

86.71

ng/l

0.43

170

1568

Maxillary prognathism

115

1.42

0.58

5.3

6.6

73.87

67.03

ng/l

0.21

107

Malignant neoplasm of tongue

522

1.18

0.58

2.8

3.5

68.85

92.74

ng/l

1.95

457

Acute myeloid leukaemia and myelodysplastic syndromes

690

1.16

0.58

3.1

3.7

64.39

93.86

ng/l

5.63

584

Other obstetric trauma

103

1158

0.88

0.58

2.9

3.5

72.46

72.90

ng/l

0.02

1049

Abnormal reflex

124

1.41

0.58

4.7

3.7

114.98

82.69

ng/l

0.55

111

Mantle cell lymphoma

230

1.28

0.57

4.1

4.4

102.36

101.51

ng/l

0.01

198

malignant neoplasm of female genital organs

645

6032

1.05

0.57

3.4

3.1

87.79

83.68

ng/l

0.57

538

5005

Disorders of vagus nerve

1.67

0.57

8.8

3.8

66.00

70.08

ng/l

—

Other bursitis of knee

330

1.23

0.56

4.3

4.1

83.06

86.99

ng/l

0.15

295

Ectopic pregnancy

566

5397

1.05

0.56

3.0

3.5

73.08

77.84

ng/l

1.04

498

4751

Intestinal helminthiases, other/unspecified, including avohilmo

1.49

0.56

5.5

3.3

79.46

77.93

ng/l

0.04

Pedal cyclist injured in collision with motor vehicle

772

0.86

0.56

1.9

4.2

82.49

84.05

ng/l

0.06

692

Malignant neoplasm of cervix uteri, including Hilmo

694

1.15

0.54

5.5

3.1

101.96

76.72

ng/l

1.28

612

Rheumatic heart disease, other

1.59

0.54

3.8

2.6

84.42

59.24

ng/l

—

Sequelae of tuberculosis, including avohilmo

536

1.17

0.53

3.0

3.6

89.58

96.39

ng/l

0.28

452

Distal bite

110

980

1.12

0.53

11.0

6.0

65.76

61.37

ng/l

0.40

104

932

Outcome of delivery

385

2501

0.94

0.53

2.7

3.7

61.76

75.76

ng/l

6.15

363

2277

Benign neoplasm: Thymus

1.56

0.52

8.7

3.6

69.30

81.87

ng/l

—

Congenital aortic valve stenosis

118

1.39

0.52

4.4

7.7

45.36

63.74

ng/l

1.28

111

Chronic mastoiditis

716

1.14

0.52

3.9

87.85

92.27

ng/l

0.24

625

Malignant neoplasm of other and unspecified parts of tongue

390

1.20

0.51

3.2

3.5

68.80

89.99

ng/l

1.17

343

Chronic drug-induced interstitial lung disorders

1.60

0.51

2.7

3.2

60.66

66.57

ng/l

—

Injury of nerves and spinal cord at neck level

577

1.16

0.50

3.5

4.3

65.75

92.02

ng/l

2.52

509

Marfan's syndrome

119

1.37

0.50

4.0

4.4

98.63

83.99

ng/l

0.38

109

Antepartum haemorrhage, not elsewhere classified

206

1913

1.08

0.50

3.1

3.8

65.54

76.61

ng/l

1.61

191

1746

Alzheimer’s disease (Late onset)

1079

8604

1.03

0.50

2.8

3.6

88.55

99.89

ng/l

4.85

898

7081

Malignant neoplasm of lip

199

1.28

0.49

6.2

4.2

134.50

103.02

ng/l

1.01

170

Erythema annulare centrifugum

1.51

0.49

8.6

3.0

85.13

81.45

ng/l

—

Cerebral oedema

1.50

0.48

11.0

6.8

76.71

98.70

ng/l

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

570

1.15

0.48

3.2

3.4

68.06

90.78

ng/l

2.06

496

Endometriosis diagnosis and infertility diagnosis occurring together

252

2687

0.93

0.48

2.7

3.4

64.52

74.71

ng/l

2.32

229

2393

Pedestrian injured in collision with car, pick-up truck or van

664

1.14

0.48

5.4

4.0

114.16

86.22

ng/l

0.85

586

Mumps, including avohilmo

636

1.14

0.47

3.3

4.2

78.17

80.62

ng/l

0.11

566

Folliculitis decalvans

1.47

0.47

4.6

3.5

81.43

75.06

ng/l

—

Overjet

689

1.14

0.47

12.2

7.2

60.53

60.73

ng/l

0.02

658

Mumps

618

1.14

0.47

3.3

4.1

78.35

80.83

ng/l

0.11

550

Chylothorax

1.51

0.47

3.9

5.7

67.25

91.45

ng/l

—

Malignant neoplasm of other and ill-defined digestive organs

228

1.25

0.47

3.0

3.6

74.66

93.18

ng/l

0.97

197

Optic neuritis

110

998

1.11

0.46

3.8

75.49

79.25

ng/l

0.22

892

Other ill-defined and unspecified causes of mortality

291

3082

0.94

0.46

4.3

3.8

118.79

99.23

ng/l

1.68

216

2607

Congenital ichthyosis

1.49

0.46

10.0

3.9

207.30

78.19

ng/l

—

Dementia due to Parkinson's disease

820

0.88

0.46

2.6

3.8

78.04

100.28

ng/l

1.81

697

Fibrosarcoma, including Hilmo

229

1.24

0.45

3.3

4.2

74.61

83.09

ng/l

0.29

202

Use of rasagiline

772

1.13

0.45

2.3

4.0

74.45

93.96

ng/l

2.26

663

Non-small cell lung cancer, squamous

116

1272

0.91

0.45

2.6

3.9

66.13

99.14

ng/l

6.52

1061

Respiratory tuberculosis

172

1596

1.08

0.45

4.0

3.6

94.51

96.84

ng/l

0.12

147

1343

Maternal care for known or suspected fetal abnormality and damage

352

3140

0.95

0.45

2.8

3.8

66.35

77.18

ng/l

3.20

335

2884

Transient acantholytic dermatosis [Grover]

1.51

0.45

1.6

5.0

88.38

89.22

ng/l

—

Respiratory tuberculosis, confirmed and not-confirmed

172

1597

1.08

0.44

4.0

3.6

94.51

96.91

ng/l

0.13

147

1344

Disorders of hypoglossal nerve

1.67

0.44

6.4

1.5

188.86

65.91

ng/l

—

Acquired stenosis of external ear canal

239

1.23

0.44

4.2

4.6

108.51

92.33

ng/l

0.29

217

Other and unspecified syphilis

1.49

0.44

14.3

4.1

207.37

92.28

ng/l

—

Carcinoma in situ of uteri, other/unspecified

162

0.73

0.44

2.2

3.4

62.09

72.31

ng/l

0.51

143

Benign neoplasm: Testis

0.64

0.43

8.0

5.0

62.15

102.94

ng/l

—

Keratopathy (bullous aphakic) following cataract surgery

1.61

0.43

3.0

2.9

107.40

76.64

ng/l

—

Flexion deformity

1.59

0.43

2.8

2.5

101.20

73.57

ng/l

—

Carcinoma in situ, other/unspecified

1.59

0.43

7.4

2.8

99.60

76.56

ng/l

—

Inflammation of lacrimal passages (chronic)

482

1.16

0.43

3.0

3.3

97.95

85.39

ng/l

0.47

412

Malignant neoplasm of pancreas

208

2219

0.93

0.43

3.5

3.8

79.00

98.07

ng/l

2.96

174

1866

Lipodystrophy, not elsewhere classified

1.56

0.42

3.0

3.8

69.40

83.29

ng/l

—

Congenital varicose veins

105

1.36

0.42

8.0

4.8

120.12

69.07

ng/l

1.05

Myasthenia gravis, drug-induced

1.52

0.41

7.0

2.9

123.00

69.68

ng/l

—

Secondary malignant neoplasm of other and unspecified sites

518

0.86

0.41

2.3

3.6

112.29

95.21

ng/l

0.22

443

Other specified/unspecified disorders of tympanic membrane

106

1.36

0.41

10.0

4.2

100.57

80.63

ng/l

0.19

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

301

3168

0.95

0.41

3.3

4.0

93.68

98.79

ng/l

0.40

247

2685

Congenital musculoskeletal deformities of head, face, spine and chest

260

1.21

0.40

8.1

5.8

63.10

73.86

ng/l

0.62

248

Contact with blunt object, undetermined intent

142

1.29

0.40

8.2

4.0

84.83

80.19

ng/l

0.08

127

Endometriosis of rectovaginal septum and vagina

256

2423

1.06

0.39

3.0

3.3

76.06

82.51

ng/l

0.66

201

2080

Malignant neoplasm of corpus uteri

351

3353

1.05

0.39

3.2

3.1

91.89

85.15

ng/l

0.70

283

2770

Non-small cell lung cancer, adenocarcinoma

209

1968

1.07

0.39

2.7

3.9

86.79

96.61

ng/l

0.99

187

1648

Burn and corrosion of hip and lower limb, except ankle and foot

534

1.13

0.38

3.5

4.4

81.76

84.17

ng/l

0.06

480

Periodontal disease, other/unspecified

706

1.11

0.37

5.1

3.5

78.69

79.99

ng/l

0.06

619

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

230

2175

1.06

0.37

3.4

3.3

71.82

74.44

ng/l

0.23

207

1924

Alzheimer’s disease (Early onset), excluding more controls

101

1037

0.91

0.37

3.1

3.5

89.13

97.76

ng/l

0.38

880

Other fusion of spine

1.47

0.37

1.7

2.3

50.50

61.15

ng/l

—

Other maternal disorders predominantly related to pregnancy

2003

12759

0.98

0.36

3.6

3.4

79.25

76.46

ng/l

0.74

1755

11208

Malignant neoplasm of bronchus and lung

635

5482

0.97

0.36

3.1

4.1

84.28

99.20

ng/l

4.64

552

4608

Beningn neoplasm: Meninges, unspecified

499

1.13

0.36

2.9

3.4

86.76

81.54

ng/l

0.17

436

Colorectal adenocarcinoma

743

7119

1.03

0.36

3.6

4.0

98.65

97.24

ng/l

0.15

642

5975

Abscess of mediastinum

1.40

0.35

5.7

4.1

160.33

68.26

ng/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

246

1.19

0.35

6.0

7.1

68.17

61.58

ng/l

0.17

233

Bullous keratopathy

256

1.19

0.34

2.8

3.9

70.29

86.00

ng/l

0.89

220

Adenocarcinoma and papilloma adenocarcinoma of rectum

291

3045

0.95

0.34

3.4

4.0

94.81

98.64

ng/l

0.27

238

2573

Exposure to ignition of highly flammable material

0.65

0.33

2.2

3.9

123.50

88.50

ng/l

—

Congenital hypothyroidism without goiter

146

1.26

0.33

9.1

5.1

118.94

69.58

ng/l

0.96

133

Follicular lymphoma, hilmo

144

1350

1.07

0.33

3.3

3.9

78.54

91.20

ng/l

0.95

115

1167

Abscess of Bartholin gland

655

1.11

0.33

4.7

3.4

80.95

73.93

ng/l

0.41

581

Cyst of spleen

1.41

0.33

7.3

4.5

67.97

78.50

ng/l

—

Evidence of alcohol involvement determined by level of intoxication

192

1.21

0.33

7.0

4.6

90.04

81.92

ng/l

0.17

175

Mandibular retrognathia

170

1598

1.06

0.32

6.0

4.9

70.52

73.09

ng/l

0.23

152

1468

Enterobiasis, including avohilmo

456

1.12

0.31

3.4

5.6

60.71

66.63

ng/l

0.49

423

Acute poliomyelitis

381

1.14

0.31

4.4

3.2

106.89

81.55

ng/l

0.78

335

Prolapse and hernia of ovary and fallopian tube

151

1408

1.07

0.31

3.1

2.7

85.83

86.45

ng/l

0.04

119

1126

Leiomyosarcoma, including Hilmo

260

1.17

0.30

4.5

3.6

99.72

86.70

ng/l

0.30

225

Puerperal sepsis

440

4256

1.04

0.30

2.8

3.4

77.81

78.34

ng/l

0.04

370

3719

Malaria

121

1.26

0.29

3.2

4.2

98.53

84.19

ng/l

0.17

107

Benign neoplasm: Vagina

412

1.13

0.29

3.9

3.0

76.41

76.47

ng/l

0.00

359

Injury of heart

1.32

0.29

6.1

3.9

121.13

85.08

ng/l

—

Acute drug-induced interstitial lung disorder

214

1.18

0.29

6.1

3.8

119.40

86.21

ng/l

0.95

182

Use of selegiline

131

1392

0.94

0.29

2.5

4.0

73.02

97.25

ng/l

3.50

1195

Occupant of pick-up truck or van injured in other and unspecified transport accidents

120

0.74

0.28

4.6

87.02

88.94

ng/l

—

110

Acute poliomyelitis, including avohilmo

385

1.13

0.28

4.4

3.2

106.89

82.55

ng/l

0.74

339

Universal erythroderma, KELA reimbursement

309

1.14

0.27

4.3

4.0

83.43

87.16

ng/l

0.11

272

Benign neoplasm: Lymph nodes

1.23

0.27

2.9

3.0

107.38

77.89

ng/l

—

Non-small cell lung cancer

345

3290

1.04

0.27

2.8

4.0

80.90

101.47

ng/l

5.04

299

2743

Maternal care for other known or suspected fetal problems

559

3606

0.97

0.27

3.3

3.7

68.14

74.34

ng/l

1.00

503

3308

Anoxic brain damage

338

1.13

0.27

5.4

4.4

113.47

94.97

ng/l

0.35

299

Arteriovenous malformation of cerebral vessels

272

1.15

0.27

3.4

3.8

59.57

77.31

ng/l

1.53

242

Unspecified chronic bronchitis

103

964

1.07

0.26

5.4

3.7

106.49

94.85

ng/l

0.68

823

Operations 1 for CAVS

1.25

0.26

4.4

7.5

47.89

75.83

ng/l

—

Perforation of oesophagus

114

1.25

0.26

2.9

3.8

93.79

86.67

ng/l

0.11

Benign neoplasm: Connective and other soft tissue, unspecified

311

1.14

0.26

3.5

3.7

87.43

80.95

ng/l

0.26

275

Migraine without aura, drug-induced

245

0.85

0.25

4.8

3.6

116.78

74.81

ng/l

0.74

217

Contact with nonpowered hand tool

103

966

1.07

0.25

5.2

4.7

83.81

91.87

ng/l

0.37

868

Carcinoma in situ of cervix uteri

252

2422

1.04

0.25

3.5

3.2

82.24

74.33

ng/l

0.67

226

2139

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

450

1.11

0.25

12.4

10.4

59.16

50.64

ng/l

0.62

445

178

1693

1.05

0.25

4.0

3.3

90.73

93.97

ng/l

0.19

152

1390

Maxillary hypoplasia

0.73

0.25

1.7

5.4

65.50

63.89

ng/l

—

Dislocations, sprains and strains involving multiple body regions

1.39

0.24

14.2

3.6

152.20

92.50

ng/l

—

Fibrosarcoma

199

1.17

0.24

3.5

4.2

80.13

85.50

ng/l

0.14

176

Fall involving playground equipment

237

1.15

0.24

8.9

8.4

54.26

59.01

ng/l

0.16

229

Failed induction of labour

121

1143

1.06

0.24

2.9

3.6

59.82

75.54

ng/l

2.27

111

1036

Traumatic amputation of hip and thigh

1.35

0.24

35.8

2.7

166.20

71.00

ng/l

—

Communicating hydrocephalus

630

1.09

0.24

4.2

4.0

81.09

86.53

ng/l

0.26

549

Erosion and ectropion of cervix uteri

912

1.07

0.23

3.3

3.4

77.67

82.06

ng/l

0.28

773

Use of donepezil

911

8525

1.02

0.23

2.7

3.6

85.95

98.61

ng/l

6.34

720

7051

Benign neoplasm: Rectum/anal canal icd-9

247

1.14

0.23

4.8

3.4

129.50

90.14

ng/l

0.91

204

Deep endometriosis

295

3051

0.96

0.23

2.9

3.2

73.34

79.16

ng/l

0.68

235

2580

Other acantholytic disorders

1.30

0.23

1.7

4.5

89.70

94.78

ng/l

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

999

0.94

0.23

3.8

3.1

80.22

84.30

ng/l

0.24

842

Contact with and exposure to communicable diseases

826

8060

1.02

0.23

4.2

4.3

75.09

79.08

ng/l

0.71

696

7327

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

1.27

0.23

8.4

4.3

223.60

72.16

ng/l

—

Malignant neoplasm of rectum

297

3069

0.97

0.23

3.2

4.0

95.55

98.23

ng/l

0.18

243

2595

Hypertrophy of (infrapatellar) fat pad

219

1.15

0.23

2.8

3.9

79.26

76.12

ng/l

0.10

202

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

295

1.13

0.22

7.7

5.6

61.29

73.26

ng/l

0.77

281

Maternal care for cervical incompetence

107

1132

0.94

0.22

2.8

3.3

84.24

76.58

ng/l

0.27

981

Use of dimethyl fumarate

144

1.19

0.22

3.1

3.7

78.18

74.12

ng/l

0.10

135

Other spirochaetal diseases, including avohilmo

1287

12677

1.02

0.22

3.1

4.0

73.04

88.69

ng/l

14.53

1124

11007

Toxic effect of soaps and detergents

0.00

0.22

0.0

3.3

—

55.27

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

1.6

—

65.42

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

0.22

0.0

9.3

—

100.33

—

Malignant neoplasm of oesophagus

678

0.92

0.21

4.0

4.1

83.49

99.83

ng/l

1.12

590

Oral lichen planus, including avohilmo , including avohilmo

245

2366

1.04

0.21

3.0

3.7

84.31

85.89

ng/l

0.09

207

2029

Malignant neoplasm of bronchus and lung, including Hilmo

772

6313

1.02

0.21

3.3

4.0

84.53

98.60

ng/l

5.00

671

5309

Rubella [German measles], including avohilmo

624

1.08

0.21

5.4

4.8

101.59

94.68

ng/l

0.22

579

Non-small cell lung cancer, adenocarcinoma, helper endpoint

209

2169

0.96

0.21

2.7

3.9

86.79

96.42

ng/l

0.95

187

1844

Malignant neoplasm of oesophagus, including Hilmo

933

0.94

0.20

4.4

4.1

106.42

101.77

ng/l

0.17

805

Pectus excavatum, including avohilmo

114

0.78

0.20

5.6

7.0

72.52

64.10

ng/l

—

105

Malignant neoplasm of palate, including Hilmo

174

1.16

0.20

4.0

3.9

59.73

85.87

ng/l

2.66

151

Obstructed labour due to maternal pelvic abnormality

510

5216

0.98

0.20

3.5

74.42

79.71

ng/l

1.17

458

4545

Malignant neoplasm of rectosigmoid junction

442

1.09

0.20

4.0

3.6

83.22

94.75

ng/l

0.59

380

Acrodermatitis chronica atrophicans

1.20

0.20

5.7

3.4

81.67

73.29

ng/l

—

Pregnancy examination and test

387

2334

1.03

0.20

2.8

3.6

67.01

74.51

ng/l

1.37

356

2116

Contact urticaria

1.25

0.19

2.2

2.8

56.35

71.65

ng/l

—

Unspecified maternal hypertension

228

0.87

0.19

2.4

3.3

59.56

63.69

ng/l

0.23

212

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

232

1.13

0.19

3.0

4.0

62.52

88.21

ng/l

1.94

198

Dengue, including avohilmo

1.25

0.19

6.7

3.2

84.00

76.15

ng/l

—

Accidental poisoning by and exposure to alcohol

347

1.10

0.19

4.6

4.7

108.79

84.03

ng/l

0.53

312

Other parasitologically confirmed or unspecified malaria

1.20

0.18

4.4

5.4

122.86

85.73

ng/l

—

Burn and corrosion of head and neck

454

1.08

0.18

2.6

4.6

71.14

84.45

ng/l

0.68

410

Desensitization to allergens

120

1146

1.05

0.18

3.0

4.9

64.21

72.74

ng/l

1.15

113

1051

Other obstructed labour

208

2150

0.97

0.18

3.1

3.4

78.57

75.90

ng/l

0.17

181

1898

Plasmodium falciparum malaria, including avohilmo

1.14

0.18

2.1

3.8

71.86

82.73

ng/l

—

Systemic atrophies primarily affecting the central nervous system

131

1256

1.05

0.17

4.7

4.2

90.07

95.75

ng/l

0.30

118

1088

Other appendicitis

243

2359

1.03

0.17

5.4

4.0

102.51

88.23

ng/l

1.16

219

2086

Other spirochaetal diseases

1269

12535

1.01

0.17

3.0

4.0

72.63

88.75

ng/l

15.35

1108

10883

Rubella [German measles]

622

1.06

0.16

5.4

4.7

101.86

94.54

ng/l

0.23

577

Intrahepatic Cholestasis of Pregnancy (ICP)

157

1514

1.04

0.16

2.8

3.3

70.84

72.25

ng/l

0.10

147

1364

Obstructive hydrocephalus

411

0.92

0.16

3.2

4.7

71.77

81.25

ng/l

0.43

361

Malignant neoplasm of respiratory system and intrathoracic organs

737

6205

0.98

0.16

3.2

4.1

83.75

98.86

ng/l

5.16

636

5228

Schistosomiasis [bilharziasis], including avohilmo

0.79

0.15

1.6

5.0

78.00

ng/l

—

Brain astrocytoma, helper endpoint

0.82

0.15

3.9

3.6

67.29

79.31

ng/l

—

Other specified/unspecified disorders of ear

0.76

0.15

7.6

4.0

67.00

78.90

ng/l

—

Hydrocephalus

259

2527

1.03

0.14

3.4

3.8

74.93

93.35

ng/l

4.38

223

2122

Injury of blood vessels at hip and thigh level

0.79

0.14

3.9

4.0

106.58

86.84

ng/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1787

13032

1.01

0.13

3.5

3.4

76.66

77.43

ng/l

0.15

1626

11412

Use of galantamine

320

3135

1.02

0.13

2.7

3.4

82.98

97.12

ng/l

1.97

252

2568

Abnormalities of forces of labour

266

2720

0.98

0.13

3.4

3.6

70.17

78.67

ng/l

1.67

240

2463

Morphin

601

0.95

0.13

2.5

3.6

93.78

97.14

ng/l

0.07

515

Unattended death

241

0.91

0.12

1.7

4.0

59.17

91.12

ng/l

1.14

214

Arthropod-borne viral fevers and viral haemorrhagic fevers

275

2694

1.02

0.12

3.7

4.1

91.17

92.21

ng/l

0.05

248

2375

Postpartum haemorrhage due to anatomy

191

1862

1.03

0.12

3.1

58.89

69.68

ng/l

2.12

173

1707

Transient global amnesia

331

3251

1.02

0.11

3.3

3.8

85.19

94.85

ng/l

1.14

280

2750

Pterygium

853

0.96

0.11

2.8

4.0

91.80

97.22

ng/l

0.19

743

Colon adenocarcinoma, helper endpoint

459

4659

0.98

0.11

3.8

101.20

96.45

ng/l

0.51

409

3923

Labour and delivery complicated by umbilical cord complications

126

1223

1.03

0.11

2.5

3.4

66.10

73.04

ng/l

0.63

114

1093

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

199

1946

1.02

0.10

3.9

4.1

108.84

90.11

ng/l

1.30

173

1662

Use of levodopa decarbox-comt-inhibitor

982

0.96

0.10

2.5

4.0

81.16

99.66

ng/l

2.04

841

Traumatic amputation of wrist and hand

107

1037

1.03

0.10

3.7

5.1

89.83

102.22

ng/l

0.51

923

Abnormal findings on antenatal screening of mother

155

1511

1.03

0.10

2.5

3.5

65.21

70.80

ng/l

0.47

138

1392

Cyst of iris, ciliary body and anterior chamber

1.18

0.10

2.0

3.2

97.00

69.23

ng/l

—

Malignant neoplasm of rectum, including Hilmo

377

3823

0.98

0.09

3.4

4.1

92.28

98.85

ng/l

0.73

317

3233

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

488

1.05

0.09

3.5

3.6

78.93

95.10

ng/l

1.02

419

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

441

0.95

0.09

2.3

3.9

86.14

98.11

ng/l

0.36

375

Inhalation of gastric contents

1.06

0.08

4.8

5.5

74.00

99.18

ng/l

—

Medical treatment for female infertility

492

4818

1.01

0.08

3.0

3.5

72.50

72.86

ng/l

0.02

451

4404

Upper arm

0.79

0.08

7.4

4.3

71.20

85.79

ng/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

213

2168

0.98

0.08

3.6

4.2

89.12

91.63

ng/l

0.10

191

1920

Spirochaetal infections, other/unspecified, including avohilmo

1258

12500

1.01

0.08

3.0

4.0

72.63

88.66

ng/l

14.90

1099

10852

Rheumatic fever without mention of heart involvement

1.03

0.08

3.0

5.2

91.76

82.26

ng/l

—

Malignant neoplasm of other and ill-defined sites

1.09

0.07

4.0

3.2

75.63

92.28

ng/l

—

Polypectomy (DHB20)

182

1788

1.02

0.07

4.2

4.5

95.16

97.58

ng/l

0.16

169

1583

Congenital hydrocephalus

1.03

0.07

4.4

4.1

31.38

66.32

ng/l

—

Injury of blood vessels at forearm level

1.09

0.07

7.7

4.6

166.22

84.08

ng/l

—

Occupational exposure to risk-factors

847

1.03

0.07

4.0

4.7

79.57

99.71

ng/l

1.74

756

Major anomalies of jaw size

640

1.03

0.07

2.8

4.8

77.68

77.95

ng/l

0.01

582

Pectus excavatum

0.84

0.07

5.9

6.4

74.75

66.57

ng/l

—

Disorders of acoustic nerve

810

1.03

0.06

4.2

3.7

93.44

88.97

ng/l

0.14

712

Undefined dementia

452

4134

1.01

0.06

3.2

3.3

94.83

98.86

ng/l

0.39

351

3387

Alzheimer’s disease, strict definition

1133

9095

1.01

0.05

2.8

3.6

88.56

99.48

ng/l

4.63

942

7501

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.12

0.05

7.4

4.6

123.16

91.27

ng/l

—

Contact with machinery

283

2800

1.01

0.05

4.8

97.86

104.37

ng/l

0.50

252

2488

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2176

16943

1.00

0.05

3.7

80.72

84.40

ng/l

1.11

1919

14846

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

653

6567

0.99

0.04

3.3

4.0

91.23

94.95

ng/l

0.40

555

5565

Supervision of high-risk pregnancy

543

3283

0.99

0.04

3.1

3.7

65.44

76.30

ng/l

4.62

508

2990

Respiratory tuberculosis, not confirmed

119

1172

1.02

0.04

3.7

90.31

98.08

ng/l

0.47

103

990

Other congenital malformations of ear

229

1.05

0.04

4.6

5.9

61.75

64.16

ng/l

0.10

212

Benign neoplasm: Lower jaw bone

109

0.91

0.04

8.8

4.0

148.90

77.47

ng/l

—

Lyme disease

1247

12436

1.00

0.03

3.0

4.0

72.20

88.63

ng/l

15.76

1089

10797

Lyme disease, including avohilmo

1247

12436

1.00

0.03

3.0

4.0

72.20

88.63

ng/l

15.76

1089

10797

L02BB Anti-androgens

266

2676

0.99

0.02

3.2

4.6

108.12

110.71

ng/l

0.15

235

2301

Motorcycle rider injured in other and unspecified transport accidents

116

1148

1.01

0.02

4.8

5.2

87.93

85.99

ng/l

0.09

105

1048

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

182

1.05

0.02

3.8

4.0

69.96

80.08

ng/l

0.29

161

Maternal care for known or suspected disproportion

971

0.99

0.02

3.0

3.6

76.16

75.49

ng/l

0.02

881

Carcinoma in situ of breast, other/unspecified

491

1.02

0.02

2.5

3.1

63.54

77.49

ng/l

1.10

431

Respiratory tuberculosis, not confirmed, including avohilmo

120

1189

1.01

0.02

3.7

90.31

97.90

ng/l

0.46

103

1005

Vascular dementia (sudden onset)

1.08

0.02

2.5

3.4

77.30

97.81

ng/l

—

Mucinous and mucinous cystic tumor

133

1.06

0.01

1.7

2.9

64.86

69.67

ng/l

0.22

113

Pedal cyclist injured in collision with pedestrian or animal

153

1.05

0.01

6.3

3.6

108.72

73.14

ng/l

0.85

140

Other abnormal products of conception

875

5750

1.00

0.01

3.3

3.6

70.85

74.67

ng/l

0.83

799

5234

Complications of the puerperium, not elsewhere classified

862

1.01

0.01

3.3

3.4

75.33

70.20

ng/l

0.38

785

Osteochondrosis of ankle, juvenile

116

0.95

0.01

2.5

4.9

50.49

66.24

ng/l

0.91

105

Benign neoplasm: Cranial nerves

874

1.01

0.00

4.4

3.6

93.95

86.66

ng/l

0.26

764

Vascular dementia (multiple infarctions)

314

1.02

0.00

3.2

4.0

115.00

108.13

ng/l

0.09

274

Early lumbar disc prolapse operation

223

2228

1.00

0.00

3.9

4.2

81.35

83.11

ng/l

0.09

206

2029

Malignant neoplasm of pancreas, including Hilmo

278

2782

1.00

0.00

3.9

84.85

98.70

ng/l

2.02

234

2320

Lesion of sciatic nerve

136

1361

1.00

0.00

3.5

100.81

97.86

ng/l

0.09

117

1131

Diving or jumping into water causing injury other than drowning or submersion

103

0.97

0.00

2.7

5.1

74.20

85.45

ng/l

—

Left side

123

0.97

0.00

3.1

4.1

99.00

82.38

ng/l

—

106

Inhalation and ingestion of food causing obstruction of respiratory tract

257

1.01

0.00

4.3

83.33

77.89

ng/l

0.13

229

Prominent ears

156

1.03

0.00

5.4

5.8

63.81

63.92

ng/l

0.00

147

Arteriovenous malformation of peripheral vessels

135

1.04

0.00

5.6

4.6

66.32

77.42

ng/l

0.36

126

Smallpox

0.00

0.0

3.8

—

145.00

—

Smallpox, including avohilmo

0.00

0.0

3.8

—

145.00

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.93

0.00

2.2

3.9

68.11

69.82

ng/l

—

Brain astrocytoma, including Hilmo

0.94

-0.00

3.9

3.5

67.29

81.82

ng/l

—

Other transitory neonatal endocrine disorders

0.00

-0.00

0.0

8.3

—

39.13

—

Fetus and newborn affected by maternal use of alcohol

0.00

-0.00

0.0

8.1

—

32.41

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

-0.00

0.0

2.8

—

101.50

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.96

-0.00

6.3

4.1

134.38

84.28

ng/l

—

Anthrax, including avohilmo

0.00

-0.00

0.0

3.9

—

99.88

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

3.0

—

75.22

—

Plasmodium falciparum malaria

0.98

-0.00

2.0

3.9

64.83

82.73

ng/l

—

Anthrax

0.00

-0.00

0.0

4.3

—

101.86

—

Deficiency of vitamin E

0.00

-0.00

0.0

3.6

—

69.71

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

-0.00

0.0

3.3

—

60.00

—

Alcohol-induced pseudo-Cushing syndrome

0.00

-0.00

0.0

4.6

—

93.80

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.90

-0.00

2.0

5.9

65.20

87.02

ng/l

—

Immobility syndrome (paraplegic)

0.00

-0.00

0.0

1.5

—

121.83

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

3.0

—

65.43

—

Hereditary angioödema type 2

0.00

-0.00

0.0

1.4

—

98.38

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

-0.00

0.0

1.4

—

52.57

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

-0.00

0.0

5.0

—

38.80

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.92

-0.00

4.4

4.6

122.86

80.92

ng/l

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

5.3

—

78.22

—

Brain astrocytoma

0.94

-0.00

3.9

3.5

67.29

81.82

ng/l

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

3.7

—

63.33

—

Gangrene and necrosis of lung

0.00

-0.00

0.0

6.6

—

93.63

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parathyrin.intact [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS